Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AAAS ENSG00000094914 "Aladin WD repeat nucleoporin" Q9NRG9 12 53307456-53324864 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040086 Approved Approved "Nuclear membrane,Centrosome,Cytosol" NA NA "Nuclear membrane" "Centrosome, Cytosol" "HPA040086: AB_10805602" "unprognostic (1.53e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-3)" "unprognostic (1.70e-1)" "unprognostic (4.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.57e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (2.53e-1)" "unprognostic (7.44e-2)" 15.0 35.1 13.4 22.0 16.6 19.9 16.5 19.2 18.4 17.6 16.4 22.6 20.9 15.4 19.3 26.1 18.2 25.3 19.4 20.7 13.2 11.8 20.4 26.0 13.4 23.4 19.3 10.1 19.7 27.3 33.1 27.3 23.6 15.8 17.3 19.3 21.5 22.8 18.5 19.7 22.2 17.5 21.2 16.4 22.0 19.1 26.6 19.5 39.1 19.5 24.6 24.4 17.2 16.9 15.3 17.2 8.2 14.7 10.0 16.7 10.1 10.3 31.5 24.6 15.1 11.7 14.2 15.8 11.8 12.8 29.8 17.2 21.4 22.0 24.8 20.4 15.0 16.9 15.1 42.9 31.5 17.6 15.7 27.7 20.2 13.9 21.5 11.9 17.8 15.3 13.6 15.9 19.7 19.2 16.2 23.4 21.3 26.7 28.8 14.4 33.5 28.0 18.5 16.9 12.2 22.0 27.5 16.4 27.8 21.1 8.5 13.2 16.9 8.7 19.7 9.1 16.4 25.3 15.6 10.6 14.2 21.5 11.3 12.5 12.9 16.3 22.6 11.4 15.5 16.3 1.2 12.1 8.2 13.7 14.0 16.5 15.2 12.3 12.6 13.7 15.3 16.7 16.2 1.1 10.0 14.7 17.2 12.6 10.1 13.4 16.6 19.2 18.4 13.2 11.8 19.3 10.1 15.8 19.5 11.9 5.6 10.4 16.1 6.5 11.3 5.9 15.3 6.7 7.9 14.0 15.7 53.6 11.6 17.4 11.4 9.1 9.8 23.3 16.1 43.4 12.2 8.6 8.1 11.5 25.1 1.6 8.1 10.4 9.1 18.3 16.4 10.8 10.1 10.8 11.5 17.4 9.4 13.5 12.0 15.4 14.7 19.4 11.3 26.5 45.3 6.5 30.6 10.2 16.2 8.0 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.9 0.6 1.2 2.1 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.8 0.0 0.3 0.0 0.1 3.7 0.0 0.0 0.1 0.1 0.0 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.0 0.6 10.4 0.4 1.5 3.1 4.2 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.0 64.3 9.1 1.8 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.0 0.0 0.0 0.3 0.1 AC008397.2 ENSG00000285188 "CAMP-specific 3',5'-cyclic phosphodiesterase 4C " Q08493 19 18207961-18255419 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.4;intestine: 15.6;pancreas: 14.2" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;U-2197: 1.6;U-87 MG: 4.8" "HPA048975, HPA054218" Uncertain Approved "Midbody ring,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.2 1.9 15.6 0.0 0.0 1.3 1.1 3.6 4.0 1.0 22.4 0.6 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.8 0.0 0.0 1.7 0.0 2.1 1.1 3.7 0.0 8.0 0.6 0.0 0.4 7.1 0.2 0.0 0.0 0.4 0.8 4.1 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.4 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.9 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.0 0.2 1.6 0.0 0.3 0.2 0.1 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008695.1 ENSG00000273217 5 131425891-131796983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.1" "Lineage enriched" "Detected in many" 5 "T-cells: 11.1" "Cell line enhanced" "Detected in some" "A549: 7.0;HeLa: 1.3;HL-60: 1.4;HMC-1: 2.8;U-937: 1.7" "HPA037982, HPA037983" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" 4.0 2.5 3.6 2.4 4.3 3.8 2.9 3.4 4.1 2.7 2.7 3.8 2.1 2.4 3.5 2.4 2.5 2.5 2.4 2.6 2.5 2.5 2.5 2.5 2.6 3.5 5.8 2.6 4.0 2.5 2.4 6.1 4.5 3.5 2.5 2.4 1.4 2.5 2.4 4.2 2.5 2.5 3.0 3.3 2.5 2.5 4.2 5.2 2.4 2.5 1.1 2.4 3.0 4.0 2.0 0.3 2.3 0.9 2.4 11.1 2.8 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.6 0.9 2.3 3.3 0.4 5.7 1.4 3.6 3.8 0.3 2.0 11.1 5.0 0.6 2.4 0.9 0.0 2.8 2.8 3.6 4.3 3.4 4.1 2.5 2.5 5.8 2.6 3.5 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC134980.5 ENSG00000285472 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.3" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.3 ENSG00000279408 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.7" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC171558.1 ENSG00000274792 Unmapped 386278-387620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Group enriched" "Detected in some" 5 "Early spermatids: 4.8;Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "NTERA-2: 1.1;U-2 OS: 1.1" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Centrosome,Mitochondria NA NA 15000 Mitochondria "Nucleoplasm, Centrosome" "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.2 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 1.8 3.3 4.2 1.3 0.5 10.5 5.3 5.2 2.2 11.9 6.2 0.4 23.6 10.3 2.0 1.7 0.1 1.2 3.9 13.3 4.2 0.0 1.7 4.2 7.2 12.0 1.3 6.6 3.0 5.3 2.7 1.4 7.3 11.5 0.7 4.0 6.2 0.0 9.8 0.6 5.0 8.2 4.4 0.1 3.1 3.0 0.5 10.0 5.6 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 11.9 10.7 10.2 10.2 6.0 1.1 32.5 30.6 2.7 5.7 17.4 0.0 60.7 43.1 26.8 15.8 14.2 312.7 23.3 28.4 26.2 16.9 7.1 19.5 154.5 47.4 1.6 43.8 12.9 27.2 26.3 19.8 11.1 16.9 32.5 94.5 13.0 25.9 154.3 17.0 74.9 0.7 6.5 13.0 29.1 8.3 4.0 63.2 20.3 144.6 9.0 ACTR8 INO80N ENSG00000113812 "ARP8 actin related protein 8 homolog" Q9H981 3 53867066-53882202 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 28.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065236 Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA065236: AB_2685442" "unprognostic (9.05e-2)" "unprognostic (2.06e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.97e-1)" "unprognostic (5.67e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (2.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.82e-1)" "unprognostic (5.68e-2)" "prognostic favorable (7.88e-9)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.84e-1)" "unprognostic (1.15e-1)" 13.2 11.2 19.8 12.6 20.0 11.3 12.9 25.6 24.5 13.7 12.4 13.9 10.5 9.9 14.1 14.3 14.1 12.8 11.3 24.3 18.2 13.7 17.9 11.8 12.4 17.0 17.7 15.5 15.0 15.8 21.9 22.0 14.8 16.0 13.0 16.8 12.5 14.2 12.6 20.1 14.5 11.9 15.3 16.1 14.4 12.6 27.5 19.9 19.9 16.8 10.5 19.2 16.1 11.8 6.1 6.3 28.8 7.1 8.6 8.5 4.4 6.5 8.1 15.9 13.1 13.1 16.5 11.9 15.5 19.8 21.0 16.8 12.6 8.0 20.0 4.6 21.3 15.5 5.6 11.9 10.7 20.0 8.1 4.9 19.9 12.6 13.4 15.5 21.1 17.9 12.9 11.0 21.7 13.7 16.3 16.2 10.7 8.9 7.0 21.1 7.6 7.0 12.6 14.8 9.5 12.9 9.3 9.9 12.0 15.9 18.4 4.7 13.7 10.1 8.8 8.9 15.7 5.7 11.8 11.0 16.1 10.5 14.7 14.0 19.6 24.9 20.5 11.9 15.5 10.0 28.8 4.7 5.8 5.8 7.1 5.8 6.1 5.4 5.5 6.3 3.8 5.7 6.1 2.4 8.6 4.2 4.6 8.5 4.4 19.8 20.0 25.6 24.5 18.2 13.7 17.7 15.5 16.0 19.9 3.0 7.7 7.8 6.1 6.9 6.5 17.8 10.2 2.7 4.5 3.5 3.9 10.4 18.3 13.2 35.7 7.7 5.2 0.0 13.7 9.4 7.1 5.7 5.7 4.7 10.2 1.6 10.4 7.4 6.3 71.4 10.0 8.2 5.0 13.6 9.0 7.0 11.6 2.9 9.2 15.9 4.7 0.0 9.2 17.6 15.4 5.6 8.6 12.2 5.7 5.4 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140673153-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 12.3 10.6 15.3 11.3 16.6 8.8 13.4 15.4 27.0 12.3 15.1 26.3 13.2 8.8 10.3 11.4 18.0 20.0 10.3 10.2 16.6 18.2 12.3 12.5 12.8 15.6 19.5 13.1 14.5 22.8 21.4 12.7 19.9 18.2 14.4 13.2 10.7 16.8 14.0 12.5 25.8 13.0 10.9 24.0 13.6 13.0 7.6 13.3 20.6 25.1 9.9 16.2 13.4 18.9 8.2 12.0 3.2 5.0 5.1 7.3 2.2 16.0 11.6 2.7 12.7 10.0 11.4 16.5 8.3 10.2 8.7 5.8 10.5 11.4 21.6 12.6 5.8 20.4 13.3 13.9 9.5 2.6 15.9 14.2 4.5 4.5 5.1 13.9 3.0 11.3 9.5 29.1 5.0 6.9 9.0 7.5 15.4 7.9 10.6 3.1 20.0 22.5 7.5 4.0 12.8 12.6 17.8 0.1 10.4 4.7 16.1 10.8 7.6 11.4 16.7 11.4 5.5 14.8 6.1 7.9 10.9 3.8 18.1 16.0 7.4 11.2 15.8 16.1 12.1 12.9 0.0 3.7 3.2 5.4 5.0 4.9 8.2 4.8 5.3 5.7 4.2 7.3 4.7 0.1 5.1 3.0 12.0 6.0 2.2 15.3 16.6 15.4 27.0 16.6 18.2 19.5 13.1 18.2 13.3 8.9 5.1 8.2 18.5 11.0 11.4 5.8 5.1 2.7 1.2 8.7 0.0 25.4 5.0 5.3 16.9 9.0 8.5 0.0 6.4 18.4 7.1 15.5 11.5 8.6 27.9 11.1 16.1 6.7 7.9 12.5 3.1 11.8 3.3 7.2 13.8 11.6 5.9 14.4 12.7 4.8 4.8 0.0 6.9 5.9 3.1 12.2 28.3 7.7 11.3 16.1 ADPGK "ADP-GK, DKFZp434B195" ENSG00000159322 "ADP dependent glucokinase" Q9BRR6 15 72751369-72785846 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045194, HPA058525" Approved Approved Centrosome "Intracellular and membrane" NA NA 35000 Centrosome "HPA045194: AB_10964638, HPA058525: AB_2683742" "unprognostic (5.96e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (8.50e-2)" "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.22e-4)" "prognostic unfavorable (4.52e-7)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.07e-2)" 15.3 13.5 6.7 16.4 10.7 23.1 13.2 7.8 11.7 10.2 11.3 14.9 11.2 8.9 9.5 14.3 11.1 11.0 12.0 9.3 7.0 9.0 13.3 12.8 18.7 19.8 11.7 6.3 10.7 15.2 4.9 9.1 18.2 13.4 14.2 13.7 20.4 15.8 9.8 7.5 10.9 13.1 8.9 9.8 21.4 10.5 10.7 8.8 19.6 12.0 7.8 21.2 12.3 9.6 14.2 32.0 22.2 30.3 13.8 13.0 22.6 6.8 14.3 7.6 9.0 17.3 13.2 10.3 19.9 19.5 20.9 29.1 8.0 18.0 12.9 14.9 12.4 20.8 18.6 21.6 10.4 15.7 12.7 14.7 9.6 4.2 7.5 11.1 22.1 14.4 14.3 6.1 11.0 10.3 10.3 12.1 10.1 10.1 22.1 12.6 4.3 6.8 9.9 11.4 13.6 6.7 8.1 12.4 17.8 10.8 8.0 5.5 5.7 18.2 7.5 9.6 12.5 7.2 26.8 9.9 10.5 8.8 39.7 18.0 22.4 42.7 12.8 18.4 21.8 17.4 22.2 30.3 21.9 10.6 21.0 13.0 14.2 9.7 10.7 32.0 12.5 8.5 9.8 12.0 13.8 17.1 24.4 7.6 22.6 6.7 10.7 7.8 11.7 7.0 9.0 11.7 6.3 13.4 8.8 17.9 33.0 73.1 17.0 13.6 17.9 2.6 2.5 14.7 19.4 19.2 13.7 33.6 6.6 23.4 12.1 17.9 13.2 0.0 15.4 50.9 22.6 31.3 48.4 22.2 72.8 14.3 7.5 17.8 79.5 4.2 20.1 63.6 25.3 143.3 15.2 12.9 19.0 19.8 14.5 10.3 26.6 19.4 12.2 16.8 25.8 15.8 34.9 34.6 19.3 21.9 AGPAT2 "BSCL, LPAAT-beta" ENSG00000169692 "1-acylglycerol-3-phosphate O-acyltransferase 2" O15120 9 136673143-136687423 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 71.5;liver: 63.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 930.5;Paneth cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019544 Uncertain Approved Centrosome NA NA Centrosome "HPA019544: AB_1844646" "unprognostic (3.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.01e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (9.30e-3)" "unprognostic (5.06e-3)" "unprognostic (8.98e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (2.17e-1)" "unprognostic (5.61e-2)" "unprognostic (2.60e-1)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" "unprognostic (2.93e-1)" 71.5 5.3 2.3 8.1 2.2 8.4 35.2 2.0 3.0 7.4 20.2 2.2 5.9 31.3 4.7 7.1 11.7 4.1 15.8 12.4 2.8 2.4 10.9 63.1 12.1 11.1 2.5 2.8 5.3 47.7 2.5 6.2 4.9 2.6 5.5 3.3 8.9 12.9 6.2 9.5 7.0 33.6 4.0 1.9 6.8 11.0 5.2 1.9 5.1 13.4 7.0 8.8 6.6 4.9 7.0 20.3 33.2 28.4 2.1 2.5 9.8 14.7 20.8 2.4 11.5 17.9 5.6 10.5 9.8 7.8 6.7 5.1 23.6 29.2 4.9 22.1 5.6 10.9 40.1 3.5 6.1 0.7 50.5 15.9 7.2 8.6 5.1 12.3 7.5 17.6 5.3 8.5 5.7 3.0 5.8 3.5 6.6 8.7 0.8 2.8 26.6 0.5 23.5 6.3 27.2 37.8 11.1 8.9 26.9 7.9 9.3 5.5 8.9 12.7 13.4 16.1 2.0 8.5 29.8 6.8 8.9 9.2 2.9 6.2 1.2 0.1 3.1 0.1 16.3 8.9 6.0 28.4 33.2 2.2 25.3 2.1 4.1 1.9 2.5 14.9 7.0 1.6 1.8 19.1 2.1 22.2 20.3 2.3 9.8 2.3 2.2 2.0 3.0 2.8 2.4 2.5 2.8 2.6 1.9 14.9 59.7 17.6 50.1 40.2 2.1 34.7 68.8 10.7 18.2 69.8 0.0 6.7 46.4 135.1 138.9 26.4 930.5 0.0 193.7 28.9 36.3 80.5 13.8 203.0 114.8 38.1 34.3 22.1 50.6 271.0 24.7 62.8 129.9 36.9 126.5 13.3 140.9 350.7 19.1 33.5 3.6 45.3 29.6 1.1 36.6 71.0 5.7 20.3 115.8 138.0 AHI1 "FLJ20069, JBTS3, ORF1" ENSG00000135541 "Abelson helper integration site 1" Q8N157 6 135283532-135497776 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation" "Developmental protein" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 54.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 1056.4;Rod photoreceptor cells: 1624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031698, HPA046684" Approved Uncertain Centrosome NA NA Centrosome "HPA031698: AB_2673997, HPA046684: AB_2679752" "unprognostic (4.00e-2)" "unprognostic (2.86e-1)" "unprognostic (8.13e-2)" "unprognostic (1.02e-1)" "unprognostic (3.17e-2)" "unprognostic (2.18e-2)" "unprognostic (2.70e-3)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (4.58e-2)" "prognostic favorable (7.51e-5)" "unprognostic (2.81e-2)" "prognostic unfavorable (4.07e-9)" "unprognostic (2.49e-2)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" "unprognostic (6.19e-3)" 6.7 16.2 16.8 6.4 16.5 5.9 12.5 35.3 26.5 11.7 8.7 4.2 13.2 4.9 14.4 32.1 7.8 9.0 9.0 7.6 15.9 19.9 8.4 6.8 8.1 6.0 11.4 19.6 13.9 11.6 11.5 54.2 8.3 18.2 16.3 13.1 10.0 8.2 15.9 6.7 6.1 5.7 11.1 18.5 4.3 10.7 29.2 13.1 3.3 11.6 5.0 6.3 8.9 12.0 10.6 16.6 4.8 1.7 3.8 4.2 0.5 5.2 7.2 8.5 10.9 13.9 15.1 3.8 9.7 12.2 9.8 15.1 2.8 5.6 8.2 4.8 9.3 9.8 4.0 6.3 3.0 14.6 6.5 8.5 3.0 20.3 5.3 5.9 15.2 3.3 7.0 5.0 15.2 8.3 15.2 8.0 10.2 13.5 0.5 13.2 5.6 14.4 3.4 5.1 4.0 4.4 7.3 3.4 2.7 4.9 5.3 14.8 7.9 12.9 4.8 5.8 6.6 3.8 6.9 7.6 8.5 10.5 14.5 7.6 10.7 9.8 3.8 12.0 2.2 10.1 4.8 1.7 0.6 4.2 0.5 2.6 8.2 4.0 4.2 2.6 10.6 3.2 4.1 0.1 3.8 0.5 16.6 2.4 0.5 16.8 16.5 35.3 26.5 15.9 19.9 11.4 19.6 18.2 13.1 35.7 87.4 13.4 33.8 25.4 293.7 22.6 7.6 89.7 51.2 55.8 1056.4 21.3 11.6 24.5 265.7 46.0 7.7 0.0 38.6 16.0 36.7 32.6 56.6 15.8 12.0 311.4 97.8 16.5 4.7 272.8 62.7 18.8 30.4 11.8 34.2 96.6 20.6 37.4 61.2 9.7 1624.0 51.8 41.2 126.9 110.1 19.7 23.9 12.8 31.5 21.8 AK6 CINAP ENSG00000085231 "Adenylate kinase 6" Q9Y3D8 5 69350984-69370013 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 216.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005361, HPA070217" Supported Supported "Nuclear speckles,Centrosome,Cytosol" No No "Nuclear speckles" "Centrosome, Cytosol" "CAB005361: AB_2302969, HPA070217: " "unprognostic (5.47e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (8.58e-2)" "unprognostic (8.73e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-2)" "unprognostic (1.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" 27.6 27.7 25.1 16.9 25.4 14.8 23.3 21.5 23.6 17.6 22.7 11.3 16.4 18.3 18.3 30.4 26.7 15.4 15.1 17.9 23.2 22.2 30.2 42.3 17.0 18.7 20.9 16.2 18.8 17.2 15.8 26.3 21.5 23.3 18.2 20.6 12.3 14.5 14.6 41.4 11.9 24.0 16.7 19.6 21.8 17.0 46.1 17.5 25.2 24.3 24.2 18.8 19.7 13.7 22.2 22.0 14.3 15.9 16.6 21.2 10.0 17.1 9.6 12.6 16.8 20.6 13.7 23.6 25.9 9.7 12.8 15.9 26.7 14.9 36.9 24.6 11.7 30.5 5.8 19.7 12.4 19.5 15.1 9.4 18.1 20.4 20.4 16.9 21.5 7.9 8.0 16.4 12.7 18.2 12.2 8.2 21.2 16.9 12.2 16.4 20.0 19.8 14.6 10.4 8.6 6.4 23.3 15.6 20.4 20.0 14.0 6.5 6.4 13.4 10.8 18.6 10.7 11.5 24.3 10.8 9.6 15.4 17.8 21.4 14.7 30.5 32.7 12.4 31.7 12.4 13.7 13.0 14.3 15.5 15.9 16.1 22.2 18.4 19.3 18.0 18.1 20.1 21.2 2.1 16.6 14.2 22.0 18.1 10.0 25.1 25.4 21.5 23.6 23.2 22.2 20.9 16.2 23.3 17.5 20.8 35.4 37.1 87.7 0.0 18.7 49.5 17.8 33.5 30.7 22.7 9.8 72.3 157.5 66.4 145.7 28.1 24.8 0.0 67.7 77.3 45.1 82.1 19.8 41.0 62.2 19.1 9.4 27.6 25.3 216.1 31.1 35.2 0.0 50.5 24.5 36.8 52.7 29.1 30.1 110.2 20.0 51.8 65.6 42.4 42.4 0.0 55.4 25.9 41.3 76.3 AKAP9 "AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO" ENSG00000127914 "A-kinase anchoring protein 9" Q99996 7 91940867-92110673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 2100.9;Rod photoreceptor cells: 1161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008548, CAB012909, HPA026109" Supported Enhanced "Golgi apparatus,Vesicles,Centrosome" NA NA "Golgi apparatus" "Vesicles, Centrosome" "CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688" "unprognostic (9.57e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (5.97e-3)" "unprognostic (1.20e-1)" "unprognostic (1.47e-1)" "unprognostic (4.75e-2)" "unprognostic (1.31e-2)" "unprognostic (1.28e-1)" "unprognostic (6.59e-2)" "unprognostic (7.59e-2)" "unprognostic (6.32e-2)" "prognostic favorable (2.10e-6)" "unprognostic (8.89e-2)" "unprognostic (1.73e-1)" "unprognostic (7.77e-2)" "unprognostic (3.96e-2)" 13.7 15.9 18.0 22.6 17.1 14.9 15.6 35.8 17.5 14.4 24.5 4.7 17.2 25.5 13.0 17.1 15.3 12.4 15.0 14.8 13.3 7.0 19.5 25.1 19.9 13.2 12.4 12.3 22.3 21.3 22.1 40.5 12.9 14.0 11.9 25.3 11.1 20.1 25.9 29.6 16.1 29.1 12.0 11.1 10.4 15.0 6.9 14.4 10.3 14.9 15.7 8.6 14.0 14.2 34.4 39.5 31.9 16.6 10.6 20.3 3.4 11.4 7.1 10.6 6.7 15.2 11.2 7.5 8.5 5.9 4.4 5.6 12.1 10.0 10.4 12.5 7.5 9.3 10.6 10.2 5.6 8.2 9.4 8.7 11.4 12.5 7.9 6.2 18.9 12.2 7.0 8.9 9.1 10.4 9.3 9.5 12.0 16.9 17.1 7.5 16.6 12.8 7.5 8.1 9.4 8.9 7.8 17.7 8.4 6.1 12.6 17.3 12.1 18.2 20.4 8.8 13.1 5.3 9.2 17.4 8.9 11.5 15.5 11.6 12.2 13.5 14.0 7.9 9.6 10.0 31.9 16.6 21.4 18.4 9.3 15.4 31.4 18.7 16.7 7.2 34.4 20.3 19.3 23.2 10.6 16.3 39.5 14.9 3.4 18.0 17.1 35.8 17.5 13.3 7.0 12.4 12.3 14.0 14.4 488.4 309.8 122.9 114.8 91.9 252.0 215.2 267.5 697.3 270.7 167.5 2100.9 111.3 86.2 108.2 8.6 85.9 257.2 163.5 80.8 65.2 74.7 91.4 129.8 127.1 50.9 340.1 177.6 92.7 65.9 8.5 160.5 90.0 55.6 92.8 259.7 147.7 95.5 204.4 127.6 36.7 1161.3 135.8 61.8 76.2 133.4 97.7 279.2 105.4 127.3 84.0 AKNA KIAA1968 ENSG00000106948 "AT-hook transcription factor" Q7Z591 9 114334156-114394405 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 71.2" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 137.4;T-cells: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 32.0;MOLT-4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052367, HPA063993" Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA052367: AB_2681801, HPA063993: AB_2685169" "unprognostic (5.19e-3)" "prognostic favorable (1.22e-4)" "unprognostic (5.38e-3)" "prognostic favorable (2.14e-5)" "unprognostic (3.12e-1)" "prognostic favorable (1.25e-4)" "unprognostic (1.88e-1)" "unprognostic (3.28e-2)" "unprognostic (4.13e-2)" "unprognostic (6.62e-2)" "unprognostic (5.85e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.19e-2)" "unprognostic (6.61e-3)" "unprognostic (2.93e-1)" "prognostic favorable (2.29e-4)" 7.2 2.8 4.6 41.8 4.9 17.5 6.1 2.0 4.5 13.9 7.3 5.9 2.4 5.7 13.4 4.5 3.3 11.4 12.9 2.8 4.9 3.8 3.9 5.6 11.2 30.4 4.9 3.3 9.9 3.4 0.8 3.6 2.8 4.9 5.3 4.7 7.1 10.2 4.2 1.6 2.5 18.4 8.8 3.6 43.1 7.3 3.9 4.8 71.2 4.0 4.5 42.9 6.1 6.4 7.2 8.8 16.6 6.1 11.9 16.6 6.4 1.4 1.5 1.8 1.3 12.8 1.5 8.0 1.6 1.9 1.5 1.2 2.7 1.6 17.5 1.6 1.4 2.8 3.4 1.2 0.4 0.5 32.0 0.7 1.8 0.7 1.8 15.4 16.9 19.2 2.6 2.8 1.3 1.4 2.2 2.7 15.8 1.7 21.2 0.6 2.5 30.4 22.0 6.9 3.4 1.8 18.9 0.3 4.0 14.6 0.8 0.9 1.7 0.4 1.4 4.7 2.4 4.0 9.3 4.4 0.8 1.7 0.3 1.4 4.4 4.9 14.8 1.0 8.6 0.7 8.0 6.1 9.6 16.6 4.6 13.1 6.5 8.9 14.1 4.1 7.2 7.9 10.6 16.6 11.9 4.1 8.8 7.0 6.4 4.6 4.9 2.0 4.5 4.9 3.8 4.9 3.3 4.9 4.8 11.9 28.1 43.3 5.9 4.6 25.8 3.1 0.0 29.4 12.5 22.7 139.4 7.7 0.0 3.4 16.1 6.3 6.7 0.0 7.0 5.7 8.0 6.2 31.3 8.5 16.0 4.8 12.2 13.5 41.0 20.2 13.6 31.2 5.0 26.2 19.5 6.5 5.0 10.5 6.3 0.9 137.4 0.0 10.8 0.6 0.7 3.0 2.9 94.4 12.9 7.5 ALDH8A1 ALDH12 ENSG00000118514 "Aldehyde dehydrogenase 8 family member A1" Q9H2A2 6 134917390-134950122 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 26.2;liver: 90.1" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1" "Group enriched" "Detected in some" 7 "liver cancer: 26.3;renal cancer: 17.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026292, HPA055414" Enhanced Approved Nucleoplasm,Centrosome NA NA 24000 Centrosome Nucleoplasm "HPA026292: AB_1844741, HPA055414: AB_2682810" "unprognostic (1.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "unprognostic (1.75e-1)" "unprognostic (2.70e-2)" "unprognostic (6.32e-2)" "unprognostic (4.30e-3)" "unprognostic (1.12e-1)" "unprognostic (3.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (2.36e-2)" "unprognostic (5.86e-5)" 0.3 0.3 0.8 0.3 1.0 0.6 0.3 1.9 0.9 0.3 0.6 0.3 0.3 0.2 0.3 0.6 0.3 0.1 0.3 0.3 1.4 0.6 26.2 90.1 0.3 0.3 1.1 0.4 0.3 0.3 0.2 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.8 0.3 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.3 1.5 1.1 5.9 0.9 2.3 1.3 0.6 0.2 1.1 1.6 0.8 0.5 0.2 1.4 0.4 0.5 0.1 1.0 0.5 0.7 0.4 0.6 0.0 0.4 1.1 1.1 0.1 0.9 1.2 5.6 3.7 3.9 5.3 0.6 1.5 2.0 1.6 1.8 0.4 0.9 1.2 0.4 1.8 5.4 2.2 0.2 0.1 1.8 2.4 0.3 0.4 1.1 0.1 0.5 0.5 6.4 0.8 1.7 0.6 0.3 0.1 1.3 0.5 0.9 0.3 0.4 0.8 3.2 1.3 1.5 5.6 1.7 0.9 0.7 1.4 0.5 5.9 0.9 0.9 1.3 0.3 0.5 1.0 1.2 0.7 0.1 1.5 1.1 0.9 2.4 2.3 0.4 1.1 1.2 0.6 0.8 1.0 1.9 0.9 1.4 0.6 1.1 0.4 0.3 0.3 3.0 1.1 2.2 0.2 0.0 1.8 0.3 2.5 0.0 1.2 29.6 0.0 0.2 16.6 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.4 0.1 0.0 129.5 0.1 3.2 0.0 3.1 1.3 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.0 94.1 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 ALMS1 KIAA0328 ENSG00000116127 "ALMS1, centrosome and basal body associated protein" 2 73385758-73610793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.4;Late spermatids: 63.9;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RH-30: 24.2" "Low region specificity" "Detected in all" "HPA035276, HPA043200" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Centrosome, Cytosol" Nucleoplasm "HPA035276: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 3.4 1.7 3.0 6.5 5.5 6.3 3.9 5.5 4.5 6.0 4.0 5.4 4.3 2.0 7.4 3.9 2.2 7.9 4.3 1.6 3.4 3.5 2.1 2.7 2.5 2.0 5.0 11.0 4.0 6.1 6.6 3.2 3.6 3.6 3.3 4.7 2.3 5.8 2.3 1.8 2.4 4.2 3.2 2.1 2.8 23.2 3.4 6.7 5.1 1.9 3.2 2.9 4.1 0.8 1.3 1.3 0.4 0.5 1.2 0.0 8.5 3.4 6.3 4.6 2.5 4.1 3.9 2.9 3.2 4.8 3.6 3.7 1.2 8.1 1.8 4.9 6.4 3.8 10.6 3.3 7.3 4.8 2.9 5.3 3.7 3.0 2.1 7.4 2.6 3.1 2.0 6.7 3.3 2.3 4.3 7.5 6.0 4.3 4.0 2.5 7.0 3.4 8.1 2.4 3.1 7.8 24.2 3.4 1.2 3.1 5.1 6.1 6.7 1.1 2.7 5.1 1.4 1.8 2.7 6.8 7.1 5.4 7.0 5.0 2.5 8.6 2.6 4.2 3.0 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.6 0.1 0.1 0.8 0.4 0.6 0.0 0.5 0.4 1.3 0.1 0.0 6.0 9.3 0.0 2.6 2.2 23.1 5.8 2.5 21.4 12.5 10.4 23.6 2.6 0.0 3.9 55.4 8.6 3.8 0.0 3.0 2.2 4.8 3.9 4.7 2.1 2.8 20.6 7.0 0.6 3.0 63.9 7.5 3.1 3.3 2.8 5.6 5.7 2.9 0.0 8.5 1.1 38.5 6.5 3.9 25.2 24.4 2.9 1.6 2.5 4.6 1.8 ALPK1 "FLJ22670, KIAA1527, Lak" ENSG00000073331 "Alpha kinase 1" Q96QP1 4 112285509-112442620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027435, HPA027443" Approved Approved Centrosome NA NA Centrosome "HPA027435: AB_10599614, HPA027443: AB_10599421" "unprognostic (6.24e-2)" "unprognostic (1.92e-1)" "unprognostic (9.30e-2)" "unprognostic (1.69e-2)" "unprognostic (7.40e-2)" "unprognostic (5.45e-2)" "unprognostic (2.55e-2)" "unprognostic (7.47e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (7.14e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.82e-7)" "unprognostic (1.60e-1)" "unprognostic (4.17e-2)" "unprognostic (2.81e-1)" "prognostic favorable (1.17e-4)" 15.1 10.6 5.3 8.3 7.7 17.3 9.3 1.3 5.9 10.8 9.5 5.8 3.0 4.5 9.8 9.2 8.8 9.2 7.5 6.1 6.1 2.3 10.8 13.4 13.2 11.4 9.7 1.0 17.4 9.7 11.0 14.0 11.5 6.6 14.0 7.8 9.6 10.4 6.8 5.0 11.8 12.1 11.3 16.6 16.2 7.4 4.2 8.5 13.7 12.4 4.7 13.7 13.6 11.6 0.9 3.2 16.3 4.3 0.4 0.8 1.2 1.6 5.0 1.6 0.3 6.6 10.6 2.0 1.9 3.5 2.6 3.3 0.5 7.7 5.1 3.3 3.3 5.3 1.1 1.7 3.0 3.9 6.5 1.7 3.6 2.0 0.4 10.6 2.2 2.2 13.1 8.6 3.8 7.9 5.9 1.0 2.7 0.9 8.9 5.0 3.1 1.3 2.0 0.4 3.7 1.3 0.6 1.1 1.6 3.9 1.9 0.5 0.8 1.8 6.6 2.9 0.3 3.0 4.1 1.9 2.4 2.1 3.7 1.3 2.3 0.7 4.4 5.7 4.6 2.1 1.3 3.2 1.4 0.2 4.3 0.6 0.8 0.6 0.1 3.2 0.9 0.8 0.6 16.3 0.4 1.9 0.5 0.0 1.2 5.3 7.7 1.3 5.9 6.1 2.3 9.7 1.0 6.6 8.5 11.9 20.3 0.9 9.4 2.6 0.2 3.1 0.0 20.1 13.6 5.2 0.0 4.0 0.0 5.6 7.5 5.5 7.0 0.0 5.8 2.6 4.1 7.1 5.8 5.8 8.7 0.0 1.2 5.5 14.8 1.6 3.4 14.0 6.8 10.0 8.5 11.3 6.3 8.6 7.1 4.0 0.2 6.5 5.1 0.7 0.5 4.0 6.1 2.2 5.7 10.3 AMN1 ENSG00000151743 "Antagonist of mitotic exit network 1 homolog" Q8IY45 12 31671137-31729174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.5" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 268.2;Late spermatids: 111.1;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046157, HPA062290" Approved Approved Centrosome NA NA Centrosome "HPA046157: AB_10965846, HPA062290: AB_2684739" "unprognostic (2.11e-2)" "unprognostic (2.52e-1)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "unprognostic (2.80e-1)" "unprognostic (5.93e-2)" "unprognostic (8.60e-3)" "unprognostic (4.08e-2)" "unprognostic (6.48e-2)" "unprognostic (3.01e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-2)" "unprognostic (2.48e-1)" "unprognostic (4.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" 5.3 9.9 24.8 6.1 20.9 3.1 9.0 13.8 28.3 9.6 4.3 11.1 2.9 3.8 10.8 7.9 6.0 17.0 6.9 10.1 22.4 20.9 11.3 5.8 6.5 10.3 19.6 15.2 16.0 8.2 8.5 16.1 5.4 14.8 8.9 4.3 8.9 5.9 7.8 12.8 5.4 4.1 7.3 19.4 8.4 8.4 46.5 16.2 11.7 7.9 4.2 9.0 7.7 5.5 12.3 6.6 27.4 2.7 4.7 9.8 3.4 3.5 7.7 6.3 0.7 6.1 7.9 3.7 3.7 5.8 2.6 5.1 4.0 14.1 1.8 8.5 3.3 20.1 2.0 2.9 4.4 5.4 3.0 3.7 6.2 2.8 5.7 11.0 3.3 3.2 5.2 7.3 4.5 6.4 20.1 14.9 9.6 5.4 5.8 10.0 2.2 1.8 2.6 8.7 7.7 3.7 2.7 10.1 2.9 6.0 8.0 10.1 8.4 4.9 1.3 7.7 14.3 11.9 3.7 8.4 4.5 3.7 3.7 6.8 6.4 6.1 6.3 5.6 3.1 8.4 4.3 2.7 3.3 4.3 1.9 4.3 12.3 4.5 4.6 2.1 11.5 9.8 5.9 27.4 4.7 1.6 6.6 6.7 3.4 24.8 20.9 13.8 28.3 22.4 20.9 19.6 15.2 14.8 16.2 6.0 2.4 19.9 18.4 8.2 10.7 3.1 5.1 13.4 5.7 15.7 25.5 5.7 23.2 7.9 268.2 9.8 2.0 0.0 6.2 4.6 7.4 13.9 7.0 3.2 7.6 28.6 13.8 7.4 6.9 111.1 9.5 4.8 15.1 2.8 1.7 10.1 9.1 0.0 12.7 7.9 40.5 0.0 12.3 84.7 16.4 11.0 6.1 7.5 2.0 23.5 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173609561-173669862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.5 1.3 5.9 0.4 14.6 0.5 0.6 1.1 7.0 2.8 0.7 9.0 1.3 0.4 3.3 2.5 0.5 24.8 1.0 0.9 7.7 4.7 2.7 0.5 2.8 0.4 2.4 5.3 2.4 1.0 16.8 7.9 0.4 9.2 1.9 0.5 1.8 0.4 1.2 0.4 0.4 0.5 2.4 2.7 1.3 0.5 20.8 4.2 0.0 1.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 12.0 0.0 0.0 1.0 2.1 0.1 4.2 3.8 6.5 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 2.3 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.3 0.4 0.0 1.6 10.8 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.0 2.2 0.1 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 14.6 1.1 7.0 7.7 4.7 2.4 5.3 9.2 4.2 0.0 1.7 0.0 0.2 0.2 0.5 0.7 0.0 33.5 1.2 5.2 35.3 0.2 1.7 0.6 19.6 1.5 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 9.9 1.7 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.4 0.5 1.8 0.0 0.3 28.6 4.9 0.0 0.1 0.0 0.0 0.1 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 740000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 25.8 20.4 32.7 32.0 40.1 46.0 28.2 50.7 33.7 24.5 30.7 40.5 16.0 27.0 26.8 21.7 28.8 30.0 23.4 47.8 32.3 23.6 30.0 29.6 27.2 55.0 33.9 30.0 26.7 25.6 24.2 18.3 38.6 26.6 30.4 35.4 27.2 23.6 27.8 41.7 18.9 28.9 30.5 42.7 40.1 29.8 9.4 36.7 75.0 29.0 18.5 52.4 35.7 27.6 12.7 19.8 27.7 19.9 18.1 12.3 9.6 26.4 32.5 42.8 36.9 15.0 13.2 28.4 14.0 18.7 27.4 23.2 26.8 49.9 85.9 26.2 15.7 16.2 38.9 98.9 28.6 33.0 38.7 33.7 65.0 27.5 33.5 9.3 51.1 35.2 10.5 20.2 15.0 30.0 18.0 39.8 41.7 47.2 33.6 23.5 18.5 51.3 42.0 37.9 26.2 16.5 72.0 39.7 51.0 24.1 41.9 56.8 35.2 21.3 24.0 39.3 44.7 31.9 67.1 17.8 28.5 45.3 19.6 37.3 20.4 56.6 99.5 18.9 86.1 26.0 8.1 17.6 27.7 11.9 19.9 10.0 12.7 9.8 12.3 19.8 12.7 12.1 10.6 18.1 18.1 16.8 17.6 11.2 9.6 32.7 40.1 50.7 33.7 32.3 23.6 33.9 30.0 26.6 36.7 101.3 93.6 54.3 58.8 57.6 85.2 68.1 48.4 129.8 100.1 66.3 33.4 225.4 91.2 95.6 3.6 76.3 57.2 70.0 83.9 137.0 53.5 48.8 89.1 75.9 163.6 62.0 75.3 58.3 145.4 4.0 32.2 112.8 74.2 132.6 83.9 86.2 70.3 56.1 28.0 115.7 65.9 25.8 68.0 7.7 13.8 30.6 194.4 102.2 82.6 46.3 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983361-98015943 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 290000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 43.0 24.6 37.9 46.5 55.5 105.7 37.7 15.6 30.1 43.2 38.9 81.0 24.6 32.7 46.3 38.4 40.4 28.4 39.2 27.0 41.8 32.0 26.0 35.9 35.0 70.4 55.7 21.7 51.1 46.0 29.3 20.7 37.5 41.8 38.9 42.3 26.2 32.5 29.7 29.4 38.6 34.9 45.3 88.3 38.6 36.7 19.0 47.6 85.9 37.0 31.9 81.8 64.5 58.6 34.8 32.6 36.8 44.6 22.7 51.3 25.1 71.5 38.7 43.2 36.0 24.3 43.0 39.4 37.2 33.0 40.0 33.7 48.5 35.2 87.8 22.3 24.9 30.5 47.4 58.1 42.0 45.9 56.9 32.8 76.0 33.2 52.3 31.3 130.1 44.3 32.5 30.7 32.1 66.3 32.6 34.7 78.8 146.1 62.2 30.8 95.5 98.2 115.7 16.8 70.3 38.5 58.7 67.3 41.7 26.1 30.0 34.9 30.5 43.6 42.7 38.1 22.2 24.1 48.7 42.0 26.1 42.3 32.8 39.0 56.5 63.8 53.0 24.2 52.3 48.6 23.1 27.2 36.8 22.7 30.9 31.3 34.8 42.7 31.9 32.6 29.6 51.3 38.7 11.3 22.7 44.6 31.8 50.8 25.1 37.9 55.5 15.6 30.1 41.8 32.0 55.7 21.7 41.8 47.6 80.4 91.7 174.3 178.4 160.5 57.6 74.9 101.9 53.5 93.3 71.5 23.6 273.1 82.9 105.6 102.1 109.0 128.4 327.1 148.0 437.2 99.8 129.7 116.6 84.4 250.6 112.8 144.0 112.3 244.5 70.6 135.4 174.1 121.4 164.1 222.6 53.5 126.7 126.7 136.5 75.6 33.5 148.8 133.5 138.6 318.8 134.8 278.6 173.4 278.8 183.9 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 18000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavorable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 11.5 18.3 31.2 21.0 30.9 38.4 10.6 50.3 20.6 14.3 11.3 18.3 13.5 12.9 16.5 21.0 12.8 12.8 11.9 19.8 22.9 25.9 18.6 16.8 13.3 38.4 26.5 19.5 19.1 6.9 20.1 14.7 12.3 21.2 14.2 10.9 20.1 9.2 20.9 25.5 12.5 14.5 25.2 32.7 20.3 9.9 6.0 17.8 52.2 18.1 13.6 34.7 20.6 12.1 24.5 8.2 20.7 10.5 14.6 27.0 15.7 34.3 22.2 46.4 23.0 3.6 5.4 17.7 18.5 10.5 17.9 17.2 16.4 24.4 62.6 16.5 10.6 10.6 12.0 26.1 11.5 25.7 71.6 15.8 43.3 27.6 23.6 3.4 87.0 22.0 4.4 1.8 16.7 15.4 8.8 13.2 30.5 41.4 37.1 16.3 35.6 35.5 22.7 46.8 11.2 10.2 37.8 25.8 32.9 12.7 13.8 15.2 26.2 38.6 6.2 10.8 21.5 16.8 44.5 13.6 9.2 25.9 9.4 36.9 47.9 48.1 61.3 10.4 62.8 16.7 20.7 10.5 16.3 18.0 7.3 27.0 24.5 24.2 19.7 8.2 17.0 17.4 21.6 7.2 14.6 8.8 5.7 25.7 15.7 31.2 30.9 50.3 20.6 22.9 25.9 26.5 19.5 21.2 17.8 11.9 78.4 61.4 38.4 86.4 117.9 90.4 22.9 60.2 30.7 69.8 31.4 37.5 72.9 27.5 1.1 45.4 12.3 140.2 23.2 113.7 65.8 16.5 60.2 48.9 46.0 60.4 13.8 39.9 41.9 1.4 28.1 57.2 64.1 62.3 11.5 131.8 20.8 17.5 31.5 44.8 110.8 25.8 85.5 9.3 21.8 86.1 34.0 89.3 28.0 19.3 APPL1 APPL ENSG00000157500 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1" Q9UKG1 3 57227737-57273468 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 20.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011138, HPA073477" Approved Uncertain "Mitotic spindle,Centrosome" Yes No 28000 "Mitotic spindle, Centrosome" "HPA011138: AB_1844959, HPA073477: AB_2797272" "unprognostic (1.39e-1)" "unprognostic (3.45e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (3.68e-2)" "unprognostic (2.31e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (5.55e-2)" "prognostic favorable (7.26e-5)" "unprognostic (3.99e-2)" "unprognostic (8.76e-2)" "unprognostic (1.12e-2)" "unprognostic (1.55e-1)" 18.3 14.0 20.9 15.3 17.9 13.7 22.5 25.2 23.7 18.5 15.7 12.8 16.8 12.6 19.2 14.5 21.0 16.0 13.2 23.7 15.8 15.4 17.0 14.3 15.3 24.3 15.4 18.8 24.0 38.2 28.4 20.4 14.1 18.8 15.7 14.4 11.0 18.0 22.2 40.5 19.9 14.5 20.5 16.7 15.0 16.3 10.5 15.7 20.9 20.0 15.2 18.9 17.7 20.8 20.7 12.0 2.5 3.9 4.7 3.5 1.7 14.9 6.5 6.4 23.2 11.0 15.5 13.5 7.9 4.9 8.0 9.2 7.6 9.0 24.3 3.3 12.2 12.6 3.0 17.1 13.7 13.8 18.3 7.6 13.7 10.4 8.0 11.9 30.4 10.1 11.4 12.5 10.2 11.1 16.1 12.7 15.3 4.6 15.3 9.0 5.1 23.9 7.5 10.0 10.6 11.2 0.8 26.0 13.0 14.1 8.4 6.5 13.8 10.9 16.4 10.4 9.0 8.0 19.8 12.0 13.3 9.4 19.3 15.3 14.1 20.6 17.1 14.4 14.7 8.6 1.6 3.9 2.5 2.6 3.0 3.5 11.3 2.8 2.4 7.2 20.7 2.6 1.9 1.0 4.7 2.5 12.0 1.1 1.7 20.9 17.9 25.2 23.7 15.8 15.4 15.4 18.8 18.8 15.7 47.6 39.2 44.5 41.0 47.1 39.5 88.3 45.9 20.1 55.7 40.1 29.5 40.0 49.7 52.3 22.7 58.0 26.9 0.0 52.6 38.3 45.7 34.4 22.0 37.6 46.6 49.3 43.8 35.6 50.8 15.5 67.6 54.0 18.6 85.6 35.9 55.2 46.8 11.5 71.5 43.7 52.2 51.8 38.7 40.0 39.4 60.9 23.5 30.5 44.7 23.4 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 271.0;Glandular cells: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 38 "monocytes: 3.7" "Cell line enhanced" "Detected in many" "A-431: 48.5;hTERT-HME1: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 28.1 3.2 7.2 6.8 10.6 0.3 24.4 34.9 11.5 11.9 7.4 2.3 9.0 2.8 10.3 8.1 6.9 8.2 9.1 15.9 7.8 5.2 27.7 21.1 23.0 8.2 6.7 3.6 11.5 6.5 12.8 7.4 22.9 10.0 12.2 4.7 11.7 20.7 10.4 10.3 13.5 5.4 8.0 6.4 26.0 8.8 7.7 7.0 2.2 22.7 8.9 3.8 10.6 14.8 0.0 0.0 0.0 3.7 0.0 0.0 0.3 48.5 2.0 3.0 0.0 10.6 25.2 10.8 16.3 26.5 13.8 20.2 5.8 2.4 0.0 36.7 32.6 15.8 10.4 0.1 11.1 28.5 0.0 1.6 0.2 2.8 2.6 1.0 0.0 0.0 4.9 2.0 10.5 43.7 16.3 37.2 0.0 0.0 0.0 13.7 1.6 0.9 0.0 3.9 0.2 33.4 0.6 2.5 0.0 29.1 4.3 0.0 0.6 10.0 7.8 0.7 12.2 2.3 0.1 33.3 8.4 11.5 12.9 12.5 0.0 0.0 0.0 1.6 0.0 0.4 0.0 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 7.2 10.6 34.9 11.5 7.8 5.2 6.7 3.6 10.0 7.0 47.6 17.3 2.9 135.8 20.8 9.7 19.9 25.5 9.4 33.0 123.9 17.7 21.9 46.4 71.3 49.8 271.0 0.0 0.0 14.7 90.4 34.4 419.1 3.5 51.3 2.6 87.4 0.0 176.8 18.6 16.2 22.7 5.6 25.3 0.0 0.9 95.2 37.1 0.0 20.5 47.5 80.7 187.5 197.8 66.2 123.5 15.1 11.8 4.3 0.4 45.2 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 18.6;epididymis: 38.0;skin 1: 26.7" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 3.5;Early spermatids: 3.2;Late spermatids: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;HBEC3-KT: 12.2;RPTEC TERT1: 10.8;SK-BR-3: 11.6;T-47d: 14.0" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" No NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.3 0.3 0.3 0.0 18.6 0.3 0.5 1.6 0.3 0.4 5.2 0.8 0.6 38.0 15.8 0.0 0.9 0.3 0.3 0.1 4.1 0.3 1.8 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 3.0 0.0 0.3 1.9 5.1 0.3 26.7 0.3 0.7 0.3 0.3 2.6 1.2 0.6 0.3 0.3 5.2 6.6 3.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.1 0.8 0.0 3.4 0.0 0.0 0.0 0.0 12.2 0.2 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 11.6 0.0 1.5 14.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.3 0.3 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.2 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 35.5" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.2 0.2 0.2 3.2 0.2 0.0 10.8 0.2 0.2 3.5 7.6 0.0 1.6 2.3 1.4 15.7 0.4 1.1 11.7 0.2 0.2 0.2 13.8 0.4 16.1 0.0 0.2 0.0 1.3 12.9 0.0 35.5 0.4 0.0 14.6 5.6 0.2 13.9 0.5 0.2 1.0 9.6 0.0 0.2 0.2 4.1 0.6 0.0 0.0 8.0 0.7 2.0 0.5 0.4 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 16.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 6.0 33.6 0.0 0.9 0.0 0.0 1.4 2.5 45.5 18.2 12.2 0.0 0.1 8.3 4.2 1.2 0.0 4.1 0.0 5.0 0.1 0.0 13.9 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 7.7 0.0 3.3 5.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.4 ARL3 ARFL3 ENSG00000138175 "ADP ribosylation factor like GTPase 3" P36405 10 102673731-102714407 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036292, HPA063596" Approved Supported Nucleoplasm,Centrosome NA NA 17000 Centrosome Nucleoplasm "HPA036292: AB_10673618, HPA063596: AB_2685053" "unprognostic (1.36e-1)" "unprognostic (2.89e-3)" "unprognostic (4.19e-2)" "unprognostic (7.58e-2)" "unprognostic (2.98e-2)" "unprognostic (3.24e-2)" "unprognostic (2.45e-2)" "unprognostic (7.69e-2)" "unprognostic (4.00e-2)" "unprognostic (3.21e-1)" "unprognostic (3.99e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.71e-6)" "unprognostic (5.62e-2)" "unprognostic (3.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-1)" 8.8 13.8 24.8 6.6 29.4 2.9 11.4 24.1 32.9 14.1 8.9 9.6 8.2 6.8 17.1 16.7 10.2 23.0 8.3 29.9 19.9 21.4 22.7 8.1 9.6 5.5 20.2 16.0 25.2 9.9 18.9 21.0 7.7 17.6 12.1 7.7 21.5 8.8 14.5 7.9 7.9 6.4 13.4 14.2 5.3 9.0 13.6 9.3 4.1 17.3 5.5 7.2 16.0 13.8 5.0 7.8 14.9 8.1 4.5 11.1 5.8 8.4 14.6 20.1 14.7 9.4 14.0 3.5 6.7 10.3 8.2 9.0 5.0 4.4 3.5 6.5 10.8 9.9 6.3 7.6 9.0 10.3 9.2 7.9 5.7 10.4 4.7 10.1 2.6 5.8 7.1 7.6 11.3 6.7 21.9 9.3 7.1 2.5 3.6 13.6 8.7 5.4 4.2 7.7 5.4 5.8 4.5 14.9 3.1 10.9 4.5 7.1 15.5 5.1 1.1 7.9 11.6 26.8 2.6 5.3 5.6 7.9 11.3 9.2 2.5 5.0 6.5 14.8 7.9 4.8 2.3 8.1 2.7 4.5 6.5 11.1 5.0 7.8 6.5 7.8 3.5 4.8 5.7 14.9 4.5 5.5 5.7 5.2 5.8 24.8 29.4 24.1 25.6 19.9 21.4 20.2 16.0 17.6 9.3 50.6 35.3 24.6 62.4 28.5 163.4 124.2 25.5 234.2 69.4 59.3 110.0 37.6 198.9 63.3 31.0 37.3 8.7 0.0 38.5 31.6 63.5 46.4 32.3 23.7 54.8 92.2 71.9 38.1 15.3 15.4 56.1 32.0 72.6 102.8 28.8 161.1 29.6 11.5 97.9 174.9 241.8 25.8 102.0 184.2 20.1 27.7 27.0 20.1 26.6 42.6 ASAP1 "CENTB4, DDEF1, KIAA1249, PAP, ZG14P" ENSG00000153317 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 1" Q9ULH1 8 130052104-130443660 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 156.9;Late spermatids: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6" "Cell line enhanced" "Detected in all" "TIME: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011136, CAB037292, HPA048565" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA 25000 "Plasma membrane, Centrosome, Cytosol" "CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.77e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.63e-8)" "prognostic unfavorable (3.56e-5)" "unprognostic (3.34e-1)" "unprognostic (5.27e-2)" "unprognostic (8.56e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.50e-7)" "unprognostic (3.79e-2)" "unprognostic (1.19e-1)" "unprognostic (7.38e-2)" "unprognostic (1.22e-3)" 34.1 17.2 10.5 9.5 12.5 29.7 19.8 6.4 21.8 19.3 8.9 9.1 6.6 4.4 15.6 18.9 10.5 11.8 14.5 17.5 10.0 11.0 7.9 7.6 26.2 12.9 11.3 8.0 15.2 6.8 21.7 8.2 27.3 15.2 9.9 7.2 13.9 6.2 13.9 13.0 12.1 8.4 16.6 11.9 26.1 8.0 21.7 9.7 5.6 12.3 10.6 14.5 12.9 21.2 1.5 4.1 13.0 6.6 0.7 1.6 1.1 15.5 11.7 17.1 9.6 14.9 22.1 13.7 16.7 29.1 20.4 21.8 5.9 5.9 3.6 11.9 24.2 13.6 3.9 8.7 14.6 28.6 5.6 5.3 6.2 6.9 7.6 38.2 2.7 1.9 20.7 4.8 10.8 18.0 22.1 21.4 2.1 3.2 14.4 17.8 4.6 3.5 2.7 4.3 7.7 10.6 5.0 3.0 2.4 5.2 8.4 4.9 15.9 12.3 7.5 8.8 15.0 6.3 6.1 62.6 16.4 7.9 6.4 24.5 13.2 3.0 2.5 12.1 3.9 18.2 0.0 2.4 1.6 0.7 2.4 0.4 1.5 1.2 1.0 4.1 1.3 1.6 1.0 13.0 0.7 6.6 0.4 0.8 1.1 10.5 12.5 6.4 14.6 10.0 11.0 11.3 8.0 15.2 9.7 3.0 7.5 14.3 18.6 42.4 18.5 31.3 12.7 2.7 13.6 3.5 15.7 35.8 3.3 9.1 156.9 106.7 3.5 23.3 7.5 32.0 42.0 21.7 9.2 7.4 54.2 58.8 12.6 90.9 55.3 319.2 36.2 54.3 42.2 55.9 3.9 9.5 9.1 3.5 51.6 3.4 7.2 77.6 58.7 29.0 94.8 39.3 39.0 12.9 3.5 17.4 ATG5 "APG5, APG5L, ASP, hAPG5" ENSG00000057663 "Autophagy related 5" Q9H1Y0 6 106045423-106325791 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Host-virus interaction, Immunity" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034432, CAB037309, HPA042973" Approved Approved Centrosome "Intracellular and membrane" NA NA Centrosome "CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246" "unprognostic (1.21e-3)" "unprognostic (6.53e-3)" "unprognostic (2.68e-3)" "unprognostic (4.14e-1)" "unprognostic (1.13e-1)" "unprognostic (6.35e-3)" "prognostic unfavorable (8.84e-4)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.86e-1)" "unprognostic (2.37e-1)" "unprognostic (2.51e-1)" "unprognostic (6.42e-2)" 18.0 28.5 16.1 15.6 17.2 9.4 21.4 16.0 21.4 23.0 20.9 10.5 14.1 16.9 21.5 23.2 16.7 20.6 12.8 14.0 15.1 15.4 20.5 23.6 15.4 18.1 14.7 15.8 21.0 16.7 12.8 23.3 26.9 17.0 22.9 20.6 11.0 16.5 21.7 20.4 10.9 28.6 19.7 14.9 20.3 16.4 13.0 10.2 23.3 24.9 14.7 18.0 20.7 21.0 7.3 6.8 11.6 10.5 6.5 12.9 4.9 8.2 3.6 6.0 8.1 14.0 15.0 6.3 8.8 14.1 13.0 16.0 3.5 5.0 5.8 7.1 13.4 14.7 5.9 8.7 12.9 23.0 2.5 4.9 6.8 4.5 4.4 14.9 8.0 3.5 11.6 14.4 9.3 11.8 17.6 13.7 5.4 9.8 5.8 14.7 3.8 3.3 9.7 6.9 10.8 4.9 3.4 14.2 4.5 14.1 5.9 4.6 4.3 5.4 10.2 8.0 11.3 5.0 15.5 11.3 5.1 2.9 5.9 15.0 2.4 2.3 5.4 18.9 11.0 9.3 5.1 6.5 11.6 4.8 7.7 12.9 7.3 8.5 6.6 6.8 5.2 9.3 7.9 5.5 6.5 10.5 2.6 9.0 4.9 16.1 17.2 16.0 21.4 15.1 15.4 14.7 15.8 17.0 10.2 20.8 17.6 31.9 25.7 23.4 13.5 16.2 22.9 24.1 34.2 24.4 15.7 40.8 24.9 34.0 26.6 23.2 39.5 0.0 39.3 52.7 23.5 33.0 19.7 18.7 34.1 19.1 18.5 21.5 27.2 9.5 19.0 26.9 21.9 53.3 36.4 17.1 32.5 59.6 17.0 30.7 17.2 25.8 29.7 25.0 38.2 23.7 55.6 34.1 30.0 39.1 AUNIP "AIBp, C1orf135, MGC2603" ENSG00000127423 "Aurora kinase A and ninein interacting protein" Q9H7T9 1 25831913-25859458 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 35.3" "Group enriched" "Detected in some" 5 "Early spermatids: 45.3;Late spermatids: 96.4;Spermatocytes: 33.8;Spermatogonia: 40.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028730 Uncertain Supported Centrosome NA NA Centrosome "HPA028730: AB_10670830" "unprognostic (8.05e-2)" "unprognostic (1.98e-2)" "unprognostic (3.96e-3)" "prognostic unfavorable (3.94e-4)" "unprognostic (9.51e-2)" "unprognostic (8.86e-2)" "unprognostic (9.70e-6)" "unprognostic (5.00e-3)" "unprognostic (9.06e-3)" "unprognostic (4.59e-3)" "unprognostic (1.42e-3)" "unprognostic (1.12e-2)" "unprognostic (1.01e-6)" "unprognostic (3.61e-2)" "unprognostic (4.41e-2)" "unprognostic (4.70e-2)" "unprognostic (3.62e-1)" 0.4 1.6 2.5 3.4 1.4 7.2 0.6 2.1 4.0 0.5 1.1 0.2 0.1 1.3 0.5 0.8 2.1 0.5 0.4 0.8 2.8 0.9 0.6 0.8 0.6 1.6 0.9 1.4 0.5 0.5 0.2 0.7 7.0 2.6 0.6 1.3 0.0 0.6 1.7 0.9 0.8 1.1 0.5 0.5 1.2 0.8 35.3 0.0 5.3 0.5 3.2 2.3 0.9 0.9 1.4 2.0 4.4 3.5 1.5 2.3 1.1 11.7 3.4 5.4 6.8 0.3 0.4 5.3 6.8 3.1 13.6 11.1 2.8 9.1 11.7 5.2 2.3 4.7 9.6 14.5 6.6 10.9 6.5 11.7 25.6 5.5 4.3 0.1 12.4 11.2 0.3 3.3 8.3 5.8 1.0 3.0 9.0 15.7 5.8 3.7 6.4 9.0 10.6 9.5 7.7 4.3 7.4 10.5 7.2 4.2 3.9 7.9 3.7 9.4 10.7 7.4 6.2 3.9 6.4 1.3 4.0 6.2 8.3 6.0 2.2 4.6 8.7 2.7 20.9 6.4 4.4 2.5 1.7 0.6 3.5 0.4 0.9 1.0 0.8 2.0 1.4 0.9 1.3 2.2 1.5 2.1 1.6 2.3 1.1 2.5 1.4 2.1 4.0 2.8 0.9 0.9 1.4 2.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.1 0.0 0.0 0.0 0.0 2.0 8.3 0.0 0.5 45.3 0.0 0.0 0.0 0.4 10.2 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.8 96.4 2.0 1.0 0.0 1.8 0.0 0.2 0.5 0.0 0.7 0.0 0.2 0.0 0.0 33.8 40.1 0.4 6.2 0.0 0.3 0.2 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AVEN PDCD12 ENSG00000169857 "Apoptosis and caspase activation inhibitor" Q9NQS1 15 33866227-34039176 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 31.9;Extravillous trophoblasts: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020863 Approved Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane, Actin filaments" Centrosome "HPA020863: AB_1845219" "unprognostic (1.54e-3)" "unprognostic (1.99e-1)" "unprognostic (8.93e-2)" "unprognostic (5.77e-2)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (6.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (4.14e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.29e-10)" "unprognostic (7.66e-3)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-3)" 11.0 11.1 7.1 8.7 7.7 5.2 16.1 14.4 8.8 9.6 12.4 6.8 8.6 9.0 13.4 9.5 11.5 8.9 10.6 35.0 6.9 8.7 5.8 16.7 8.0 6.0 8.6 6.8 10.3 41.0 3.6 9.0 15.0 8.3 10.6 12.2 5.4 9.8 11.8 25.7 9.3 9.9 15.3 8.1 7.3 10.9 14.1 6.1 9.9 5.4 11.6 9.4 11.6 15.0 1.2 6.1 0.2 1.7 1.2 2.3 0.3 8.3 13.6 14.1 4.6 11.5 13.1 8.4 21.4 19.2 17.1 11.0 3.7 5.9 7.8 13.2 18.0 13.1 5.7 6.4 13.9 14.1 7.6 4.2 13.5 8.9 10.4 17.2 13.5 9.9 10.9 27.5 10.0 24.4 20.6 18.3 4.1 13.3 11.5 23.8 8.9 5.3 23.3 6.6 11.3 4.7 8.1 7.9 16.7 13.9 11.1 7.5 9.1 11.9 6.2 5.8 6.1 6.7 15.0 12.9 15.1 5.2 6.4 17.6 11.3 8.9 16.5 7.2 16.0 8.0 0.0 0.8 0.0 1.6 1.7 2.0 1.2 1.7 0.6 0.6 0.6 0.8 1.1 0.2 1.2 0.7 6.1 2.3 0.3 7.1 7.7 14.4 8.8 6.9 8.7 8.6 6.8 8.3 6.1 3.0 4.0 3.0 6.2 5.0 5.4 31.9 2.5 1.4 0.0 0.0 5.9 9.7 0.0 1.4 6.8 7.1 6.7 0.0 7.3 35.3 5.0 10.6 0.0 15.8 6.4 7.9 4.6 4.3 1.6 4.8 6.9 2.7 3.3 3.6 7.2 6.7 6.3 7.0 9.9 3.0 5.5 6.5 3.8 2.1 8.3 8.4 7.9 5.7 6.2 9.5 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3, NSP family adaptor protein" O75815 1 93561786-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 59.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4;memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavorable (8.41e-4)" "prognostic unfavorable (5.42e-4)" "prognostic unfavorable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 26.0 10.4 10.1 11.6 14.2 0.9 23.1 8.6 8.1 10.2 14.1 10.0 6.2 12.4 5.7 5.9 8.9 9.4 15.5 10.6 10.6 8.0 15.5 11.0 12.8 11.8 11.7 5.6 11.2 4.1 4.5 4.6 59.5 10.6 11.2 15.7 10.1 20.5 14.5 19.5 13.3 14.8 10.6 9.7 5.4 15.2 7.3 8.0 2.6 10.0 6.6 11.7 12.7 17.7 4.5 1.7 4.4 1.1 0.0 0.3 0.1 15.3 6.6 12.4 0.9 5.4 4.2 10.7 15.9 27.8 13.1 8.1 1.1 11.5 2.5 5.5 24.5 17.1 9.6 0.3 20.6 11.5 1.1 0.3 0.0 4.8 2.8 9.7 0.1 0.0 5.0 22.8 13.6 46.2 12.7 14.4 0.3 0.4 0.1 35.5 2.3 0.3 0.0 3.9 6.7 22.9 1.0 17.9 0.3 34.4 19.5 0.4 1.0 7.7 8.3 9.9 5.0 9.3 0.6 16.9 19.6 5.0 8.3 21.0 1.3 0.5 0.3 2.9 0.0 7.1 4.4 0.0 0.1 0.0 1.1 0.0 4.5 0.1 0.0 0.8 2.5 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.1 10.1 14.2 8.6 8.1 10.6 8.0 11.7 5.6 10.6 8.0 3.0 7.4 7.4 102.8 8.8 1.0 6.7 7.6 10.7 9.1 14.0 0.0 23.0 23.2 11.1 8.4 17.3 20.2 0.0 5.6 70.7 9.3 24.4 3.5 9.4 10.3 20.6 14.3 5.5 4.3 11.2 9.5 8.1 18.6 16.2 20.7 4.3 17.7 20.7 1.1 15.6 0.4 71.1 19.3 3.2 2.9 8.9 15.8 0.0 10.0 114.7 BCAS2 "DAM1, Snt309, SPF27" ENSG00000116752 "BCAS2, pre-mRNA processing factor" O75934 1 114567557-114581639 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067881 Supported Supported "Nuclear speckles,Centrosome" NA NA "Nuclear speckles, Centrosome" "HPA067881: AB_2685915" "unprognostic (6.93e-2)" "unprognostic (1.88e-2)" "unprognostic (8.58e-3)" "unprognostic (4.74e-2)" "unprognostic (2.49e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (8.23e-7)" "unprognostic (1.16e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.96e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (4.27e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.25e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.87e-1)" 23.2 28.0 36.7 17.6 34.1 43.0 25.0 30.4 40.6 21.3 19.7 16.5 17.3 16.7 22.9 33.2 26.0 16.6 20.7 24.5 31.6 41.8 28.7 32.9 17.5 22.4 37.0 28.8 26.8 18.2 22.9 32.5 17.4 39.0 24.1 21.0 13.9 19.5 26.7 38.4 19.0 19.0 20.1 26.9 20.8 18.3 21.2 24.6 20.0 27.8 24.5 22.1 31.1 19.5 30.4 24.8 30.9 22.6 35.4 40.1 32.9 19.3 7.1 14.7 13.9 7.8 9.1 22.0 14.6 11.3 19.4 20.0 9.9 8.0 17.2 20.2 9.4 13.1 9.4 17.0 14.4 27.0 15.6 15.3 9.0 14.1 14.3 14.2 22.7 9.8 8.3 15.9 20.0 24.8 9.1 12.6 18.8 17.2 12.9 15.9 118.8 20.2 16.9 25.5 11.9 16.2 14.5 26.0 12.0 13.6 17.0 19.2 12.8 18.2 14.1 22.4 12.7 12.4 18.0 11.1 11.9 15.9 23.8 27.4 14.1 14.5 27.9 23.2 19.0 44.8 21.6 18.5 30.9 29.3 21.9 40.1 30.4 36.7 35.7 19.4 26.7 38.2 37.2 17.6 35.4 22.6 24.8 35.8 32.9 36.7 34.1 30.4 40.6 31.6 41.8 37.0 28.8 39.0 24.6 26.8 38.4 63.6 94.6 69.1 63.3 63.3 28.1 42.8 36.4 47.1 35.3 67.4 81.2 56.2 17.0 43.9 22.2 23.3 58.4 73.6 49.8 51.7 99.1 27.7 58.7 36.5 47.9 27.0 31.0 13.7 36.8 54.3 64.1 50.5 30.7 70.3 45.0 31.1 41.1 72.5 55.6 38.8 78.0 57.0 37.7 55.5 84.7 66.0 31.3 106.5 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 1.0 1.0 9.7 0.3 0.1 4.9 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.6 0.3 0.6 0.2 0.1 0.1 0.3 0.0 0.7 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 1.4 0.0 0.2 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.1 0.6 0.1 0.2 0.5 8.6 0.6 0.1 0.2 0.2 0.2 1.4 0.7 0.2 0.1 0.3 0.4 2.7 0.1 0.4 0.5 0.1 0.1 5.6 0.2 1.4 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 8.4 0.3 0.0 0.0 0.0 8.9 0.6 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 8.0 0.3 0.0 3.3 0.0 0.0 0.0 1.0 0.0 2.1 0.0 0.9 0.0 0.5 2.9 0.3 0.1 2.4 0.0 0.0 0.3 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58513140-58831437 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 119.8;Collecting duct cells: 82.0;Distal tubular cells: 66.3;Ductal cells: 87.3;Leydig cells: 65.9;Proximal tubular cells: 113.1" "Cancer enhanced" "Detected in all" "renal cancer: 25.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "basophil: 8.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "A549: 19.9;BJ hTERT+: 21.1;CACO-2: 31.3;RPTEC TERT1: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070797 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA070797: " "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 11.8 5.7 1.1 5.7 1.5 0.2 9.4 0.5 2.5 9.8 5.1 1.1 4.8 1.0 7.8 12.3 8.1 7.1 11.6 12.1 1.1 1.4 43.0 2.5 5.8 5.2 0.9 2.2 19.0 24.2 0.8 4.6 3.2 2.1 7.8 3.9 18.7 4.8 4.1 22.4 6.5 2.8 6.0 3.9 2.7 3.2 4.9 0.8 0.8 5.1 7.5 3.2 8.6 10.4 0.1 1.1 8.7 0.3 1.0 0.2 0.1 0.0 19.9 0.3 0.0 6.4 8.3 0.0 13.1 21.1 11.9 14.3 31.3 4.2 0.0 13.8 13.3 3.1 0.2 2.1 2.3 16.7 0.0 2.0 0.0 2.6 0.0 4.1 0.0 0.0 12.9 0.7 9.3 10.1 14.9 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 1.3 0.0 5.0 0.0 49.5 2.4 0.0 2.5 0.0 0.1 1.1 0.8 0.0 0.2 0.0 2.9 2.7 0.5 1.6 0.0 0.0 0.0 8.4 0.0 2.7 8.7 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.2 1.0 0.3 0.9 0.1 0.1 1.1 1.5 0.5 2.5 1.1 1.4 0.9 2.2 2.1 0.8 0.0 0.3 0.5 1.1 6.4 0.1 2.2 119.8 17.4 2.3 82.0 0.0 0.4 66.3 87.3 4.0 0.4 0.0 0.0 3.1 0.2 29.2 2.0 0.0 0.5 2.7 0.0 3.5 5.5 0.6 2.2 65.9 0.5 20.3 1.8 1.0 7.5 22.7 0.0 47.0 113.1 0.2 6.5 13.7 0.0 2.1 4.1 3.4 0.0 0.8 0.1 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BRMS1 DKFZP564A063 ENSG00000174744 "Breast cancer metastasis suppressor 1" Q9HCU9 11 66337333-66345125 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010824, HPA019637" Approved Approved Centrosome NA NA Centrosome "CAB010824: , HPA019637: AB_1845448" "unprognostic (1.75e-1)" "unprognostic (2.64e-2)" "unprognostic (2.01e-1)" "unprognostic (4.31e-2)" "unprognostic (1.72e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (5.67e-3)" "unprognostic (2.54e-1)" "unprognostic (6.32e-2)" "unprognostic (1.61e-1)" 17.2 18.9 16.7 23.4 24.5 37.0 20.5 9.1 18.7 13.7 19.7 14.5 24.7 21.0 14.6 21.0 24.1 16.1 26.0 13.7 16.6 10.7 23.4 22.2 16.7 25.8 20.1 16.1 14.0 37.6 17.6 12.6 24.1 17.6 22.3 16.0 12.8 23.9 29.8 24.2 26.1 22.6 13.0 16.2 26.3 19.6 37.4 20.9 25.3 20.8 29.3 21.4 16.2 17.5 38.5 32.1 50.7 38.0 22.2 37.2 28.9 24.3 32.0 10.8 17.9 11.4 11.9 15.3 16.8 18.7 30.8 20.7 26.0 16.1 16.5 25.4 16.7 26.5 28.7 20.4 31.0 14.6 19.5 17.1 15.0 17.1 18.9 21.4 21.6 17.6 13.4 33.5 31.0 23.3 9.4 18.9 19.0 17.8 7.7 18.3 39.3 26.3 51.6 23.3 18.8 30.1 22.4 19.8 30.8 19.1 14.2 22.8 18.2 21.1 21.8 54.7 8.2 26.5 13.4 18.2 23.2 22.0 37.3 21.0 16.1 15.9 26.0 30.0 14.1 24.8 19.0 38.0 36.7 31.1 36.2 33.2 38.5 33.5 29.6 29.8 36.1 29.7 28.0 50.7 22.2 31.0 32.1 37.2 28.9 16.7 24.5 9.1 18.7 16.6 10.7 20.1 16.1 17.6 20.9 14.9 30.6 46.9 25.5 51.6 11.5 10.0 17.8 17.4 12.5 21.0 5.9 54.6 46.4 61.5 6.7 28.3 88.9 0.0 102.0 57.3 30.9 28.6 26.6 20.7 59.9 11.1 31.0 30.1 40.2 7.0 20.8 37.7 27.0 83.8 36.7 20.9 69.1 63.1 13.8 40.4 11.8 6.5 31.9 20.1 44.3 52.4 60.0 52.2 41.2 26.4 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 26.4 31.9 43.6 26.1 44.8 66.6 29.5 28.3 36.4 25.6 31.3 25.6 31.6 27.0 25.1 32.2 35.2 35.7 28.1 30.8 39.2 36.3 37.9 33.2 26.2 34.5 39.5 27.4 28.8 31.4 21.0 35.2 33.7 32.3 27.3 22.7 22.0 31.5 28.9 20.7 23.5 31.2 25.4 34.5 29.1 26.7 51.2 27.0 24.1 40.1 29.0 31.6 35.3 26.5 39.1 32.2 91.2 42.7 34.1 37.6 56.6 25.2 29.8 16.7 37.4 16.8 18.9 16.2 24.3 23.4 27.9 30.7 34.8 25.2 19.4 29.7 23.4 30.4 15.1 18.4 22.2 23.5 23.4 24.9 14.1 21.2 22.8 35.0 24.0 18.7 18.4 27.5 25.4 48.1 16.3 21.7 20.4 34.6 44.5 25.6 66.3 31.5 65.1 36.7 27.0 37.4 16.5 16.9 33.5 24.4 20.2 29.4 35.4 24.0 27.7 50.5 11.3 17.4 30.3 17.7 26.6 33.9 52.7 37.9 28.0 46.9 51.7 23.5 35.9 48.1 59.1 39.3 91.2 34.1 40.5 31.9 39.1 32.8 33.0 32.2 36.6 27.9 29.2 83.0 34.1 42.7 31.1 37.6 56.6 43.6 44.8 28.3 36.4 39.2 36.3 39.5 27.4 32.3 27.0 77.4 75.2 90.6 127.0 171.3 30.4 11.1 68.8 149.9 61.4 87.2 9.8 144.5 202.2 156.4 106.4 90.4 143.8 23.3 162.5 137.0 129.0 115.9 89.0 77.4 132.0 15.9 140.8 71.8 86.2 82.8 75.9 103.3 129.9 174.1 105.3 65.9 188.4 119.3 69.6 168.4 26.3 58.2 153.3 197.9 133.6 160.7 152.5 126.4 87.3 146.8 C11orf70 MGC13040 ENSG00000137691 "Chromosome 11 open reading frame 70" Q9BRQ4 11 102047443-102084560 "Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.5;testis: 54.7" "Group enriched" "Detected in many" 9 "Ciliated cells: 186.0;Early spermatids: 270.4;Spermatocytes: 221.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038585 Enhanced Approved Centrosome NA NA Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.5 3.7 2.9 1.1 4.2 0.1 3.1 0.7 1.4 5.9 1.6 5.4 11.6 0.8 5.3 11.9 2.3 25.5 4.9 1.7 3.9 4.5 3.0 0.3 7.2 1.2 1.7 1.3 7.5 0.8 3.7 13.7 4.0 16.0 5.6 0.8 4.2 1.1 7.0 0.5 1.6 0.8 5.5 1.9 0.2 1.6 54.7 2.2 0.0 3.3 1.1 0.8 3.8 2.5 0.6 0.3 2.3 0.6 0.3 0.4 0.2 0.0 6.7 6.8 0.0 6.1 14.8 0.2 2.6 6.8 3.7 5.2 0.5 8.7 0.0 1.6 5.2 1.8 1.7 1.6 0.8 2.7 0.0 1.0 0.0 1.1 0.0 4.3 0.0 0.0 6.3 8.5 9.5 6.4 7.2 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 10.0 1.9 7.5 0.0 8.6 0.1 0.0 0.0 7.6 0.0 1.0 0.9 2.9 8.9 2.1 0.1 0.0 0.0 3.0 0.0 0.4 1.6 0.6 0.4 0.3 0.2 0.2 0.5 0.3 0.3 0.1 0.6 0.4 0.3 2.3 0.3 0.2 0.3 0.2 0.2 2.9 4.2 0.7 1.4 3.9 4.5 1.7 1.3 16.0 2.2 0.0 3.4 0.0 5.8 10.2 0.3 0.0 2.5 186.0 13.6 0.0 2.0 6.6 0.0 0.0 270.4 0.1 0.0 0.0 0.0 0.2 8.0 1.2 1.1 0.0 0.4 0.0 9.1 1.3 0.0 24.5 10.6 1.1 5.0 0.0 0.4 7.8 0.0 0.0 5.3 0.0 0.8 12.9 2.8 221.4 17.7 4.0 1.6 0.0 0.0 1.8 C11orf80 "FLJ22531, TOPOVIBL" ENSG00000173715 "Chromosome 11 open reading frame 80" Q8N6T0 11 66744451-66843328 "Predicted intracellular proteins" Meiosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 50.6;Late spermatids: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038932, HPA038933" Approved Approved Centrosome NA NA Centrosome "HPA038932: AB_2676275, HPA038933: AB_10671867" "unprognostic (2.81e-1)" "unprognostic (4.39e-2)" "unprognostic (1.71e-2)" "unprognostic (6.69e-2)" "unprognostic (3.30e-1)" "unprognostic (2.09e-1)" "unprognostic (5.54e-3)" "unprognostic (4.16e-1)" "unprognostic (4.26e-2)" "unprognostic (6.59e-2)" "unprognostic (4.04e-2)" "unprognostic (2.53e-2)" "unprognostic (6.31e-2)" "unprognostic (1.23e-1)" "unprognostic (4.98e-1)" "unprognostic (3.72e-2)" "unprognostic (1.26e-1)" 2.8 7.6 15.0 12.9 15.0 4.8 10.3 26.2 11.9 7.1 10.1 1.7 4.7 7.7 5.9 13.3 16.4 5.4 4.6 4.2 8.3 7.2 13.4 2.2 4.4 5.8 5.0 11.9 3.3 4.7 10.9 12.4 3.9 8.0 10.0 9.0 5.5 10.7 9.5 1.3 35.6 17.3 4.2 2.7 6.8 5.1 15.2 2.5 15.1 3.6 7.6 15.3 4.8 8.8 10.6 9.7 3.1 1.0 1.7 4.2 0.7 8.7 4.7 9.6 6.5 0.5 3.1 1.8 3.7 4.4 4.4 5.5 16.1 10.7 14.3 2.1 3.0 2.9 16.0 4.4 5.6 4.4 3.6 2.6 2.3 5.7 4.0 1.0 1.6 2.7 0.8 19.5 3.4 6.5 6.7 13.9 5.4 4.1 5.5 2.6 9.6 5.7 5.2 15.2 25.1 6.5 3.3 4.5 11.0 19.0 3.0 7.1 7.2 6.0 16.8 13.0 8.8 11.6 1.1 6.1 3.1 5.7 3.3 5.3 3.9 8.5 10.3 3.5 2.8 3.9 1.9 0.9 3.1 2.1 0.5 3.7 10.6 3.8 3.0 0.5 8.9 4.2 3.5 2.3 1.7 1.0 9.7 4.0 0.7 15.0 15.0 26.2 11.9 8.3 7.2 5.0 11.9 8.0 2.5 17.9 5.1 14.7 2.8 10.3 3.0 0.4 0.0 4.0 5.7 33.2 17.7 1.5 8.3 15.1 50.6 1.6 14.7 23.3 10.4 1.9 3.5 3.2 4.6 0.9 2.8 0.0 13.2 1.8 1.2 92.7 2.3 1.8 3.3 7.2 9.1 1.5 12.6 10.8 0.4 3.5 7.1 6.5 2.2 11.6 24.7 17.6 1.3 6.1 8.1 2.7 C12orf73 "DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103950202-103965708 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Secreted - unknown location" NA NA "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favorable (1.61e-4)" 6.7 11.4 14.3 8.3 14.5 4.4 9.7 15.5 17.5 7.2 7.4 11.4 7.2 7.7 9.5 13.2 7.0 8.9 5.5 11.1 13.0 14.6 9.4 8.3 5.8 10.0 13.3 13.3 11.5 9.7 9.4 21.0 7.3 13.6 10.7 9.5 8.3 8.3 11.1 43.8 9.0 7.7 7.9 14.1 7.0 9.9 10.1 13.8 11.4 11.5 12.9 10.2 6.6 6.9 11.7 11.3 8.6 5.1 12.0 14.5 3.9 5.9 11.1 16.9 10.3 4.9 6.4 11.0 6.4 3.9 7.2 5.9 11.8 5.2 7.0 8.6 3.9 6.3 9.6 10.0 8.2 5.5 10.1 20.3 10.6 16.3 14.8 7.2 15.6 9.7 5.7 9.4 3.6 6.4 17.6 6.6 20.6 13.6 4.8 6.6 6.8 17.3 23.6 8.2 5.7 19.0 10.0 6.3 6.9 9.4 8.0 27.7 9.5 6.5 11.3 14.9 7.6 19.3 8.5 3.3 8.8 4.9 6.5 6.5 13.1 20.1 14.7 10.0 8.9 7.7 7.3 5.1 8.6 10.5 4.2 10.4 11.7 9.8 10.0 7.2 10.7 14.5 13.5 1.4 12.0 3.8 11.3 13.8 3.9 14.3 14.5 15.5 17.5 13.0 14.6 13.3 13.3 13.6 13.8 6.0 5.0 6.7 8.5 5.4 16.5 14.9 7.6 13.4 5.7 8.7 0.0 9.7 23.2 20.3 59.5 6.7 9.2 0.0 10.6 10.4 7.6 8.0 9.2 11.6 14.8 7.9 10.9 6.2 8.3 25.4 8.1 7.1 1.7 11.8 10.9 12.3 16.5 3.5 8.1 17.7 13.1 6.5 7.2 23.1 21.2 4.5 7.4 4.9 11.5 7.0 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 26.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5" "Low region specificity" "Detected in all" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA049367: AB_2680730" "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 2.7 0.7 6.3 5.6 3.9 9.3 6.8 0.6 3.3 4.7 3.0 1.4 10.8 1.5 2.1 3.7 6.8 1.5 2.4 1.8 9.2 1.7 2.0 0.8 2.0 11.7 2.0 2.1 0.9 2.1 3.9 1.0 44.6 1.6 7.1 1.3 18.8 4.5 9.5 1.5 6.3 4.2 3.9 1.5 12.9 3.0 1.4 1.5 0.4 4.7 6.2 10.3 18.9 10.0 26.3 8.8 10.3 8.2 3.3 8.3 5.4 12.2 4.1 0.1 1.7 1.9 2.1 5.1 1.5 2.0 4.8 1.3 3.1 11.5 0.1 17.4 1.2 2.0 17.7 0.7 34.3 2.7 0.0 2.7 0.0 1.8 0.3 5.2 0.3 0.0 4.5 29.3 4.6 20.1 3.6 15.6 2.1 0.0 0.0 0.1 10.3 0.0 18.7 1.1 13.2 11.8 0.5 0.0 1.0 0.0 14.0 3.9 1.0 6.2 3.2 3.1 1.4 30.5 5.2 15.9 3.1 8.0 1.3 4.4 4.3 3.1 13.5 0.0 4.4 0.6 0.0 8.2 10.3 0.6 2.7 2.2 20.4 4.5 3.6 8.8 26.3 7.6 4.7 3.2 3.3 0.8 0.1 8.3 5.4 6.3 3.9 0.6 3.3 9.2 1.7 2.0 2.1 1.6 1.5 3.0 0.6 38.4 47.6 8.2 17.9 1.2 0.0 1.4 3.4 1.8 55.0 38.4 3.3 2.8 1.3 2.1 0.0 0.0 1.0 13.5 4.8 4.1 0.0 0.0 4.3 14.3 0.0 1.3 0.8 0.0 3.1 1.6 18.6 0.0 0.0 8.8 2.2 0.0 3.2 1.7 69.6 0.0 3.4 0.9 6.4 6.0 62.1 0.9 0.0 43.2 C1QTNF2 CTRP2 ENSG00000145861 "C1q and TNF related 2" Q9BXJ5 5 160347751-160370641 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Fibroblasts: 32.3;Leydig cells: 21.6;Peritubular cells: 28.0;Smooth muscle cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 26.6;U-138 MG: 11.8;U-2 OS: 6.4;WM-115: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061290 Uncertain Approved "Golgi apparatus,Centrosome" "Secreted to blood" NA NA "Golgi apparatus, Centrosome" "HPA061290: AB_2684468" "unprognostic (2.28e-2)" "unprognostic (5.61e-2)" "unprognostic (4.09e-2)" "unprognostic (4.53e-2)" "unprognostic (8.92e-3)" "unprognostic (6.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.94e-1)" "unprognostic (5.91e-2)" "unprognostic (8.33e-2)" "unprognostic (3.23e-2)" "unprognostic (8.32e-2)" "unprognostic (2.11e-5)" "unprognostic (5.40e-5)" "unprognostic (1.14e-1)" "unprognostic (6.75e-2)" "unprognostic (1.10e-2)" 5.5 2.1 2.1 1.9 5.2 0.6 5.6 4.4 4.9 9.5 4.9 1.1 1.3 3.4 10.9 6.9 6.8 4.9 9.3 8.5 2.0 1.8 1.3 1.0 5.0 1.1 1.4 3.0 2.9 0.9 0.6 1.2 2.4 1.0 7.7 3.4 14.3 3.4 9.6 4.8 3.0 4.6 6.4 1.3 1.7 4.3 5.8 1.5 0.0 4.3 12.1 1.3 6.0 5.8 0.6 0.4 3.7 0.1 1.0 0.2 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.0 3.0 4.0 0.7 2.5 0.1 0.7 0.0 0.1 1.0 0.5 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 26.6 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.1 0.1 0.3 0.1 0.2 11.8 6.4 1.1 3.2 0.1 0.0 0.0 0.4 0.0 5.2 3.7 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.6 0.2 0.2 1.1 1.0 0.1 0.4 0.1 0.1 2.1 5.2 4.4 4.9 2.0 1.8 1.4 3.0 1.0 1.5 0.0 0.0 0.0 0.1 5.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 1.6 0.0 0.0 0.2 0.2 32.3 0.1 0.0 0.0 0.9 0.0 0.0 1.8 0.0 0.0 21.6 0.0 5.0 1.0 0.0 0.0 0.1 0.0 28.0 0.0 0.6 0.0 27.0 0.0 0.1 3.3 0.7 0.0 0.0 0.1 C21orf33 "D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI" ENSG00000160221 "Chromosome 21 open reading frame 33" P30042 21 44133605-44210114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 29.2;Melanocytes: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 43.8;U-266/70: 37.2;U-266/84: 31.0" HPA018517 Supported Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA 1800000 Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (9.61e-3)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-3)" "unprognostic (6.57e-2)" "unprognostic (8.19e-2)" "unprognostic (1.36e-2)" "unprognostic (8.61e-3)" "unprognostic (9.43e-2)" "unprognostic (4.60e-3)" "unprognostic (1.97e-3)" "unprognostic (1.40e-1)" "unprognostic (6.96e-2)" "unprognostic (1.30e-2)" 16.0 9.6 9.1 6.1 11.4 2.2 7.2 7.9 16.6 5.1 11.7 11.6 12.4 3.0 6.6 22.8 7.6 7.3 5.2 29.2 8.4 8.7 31.6 36.8 8.5 9.9 10.9 9.2 6.7 15.7 2.0 6.5 5.6 8.3 11.0 1.9 6.6 8.8 8.0 45.9 13.4 7.7 7.6 7.3 8.9 13.7 11.8 5.1 5.8 7.1 21.0 15.2 5.1 4.7 22.5 12.3 8.9 20.7 14.7 15.6 23.9 0.4 1.6 0.9 0.2 9.5 9.1 14.2 18.5 10.4 14.6 11.1 22.2 0.2 43.8 0.3 0.1 0.6 0.2 0.1 8.7 6.5 9.6 21.3 1.2 3.6 11.9 10.6 0.6 0.3 0.1 0.9 4.0 0.7 7.4 0.7 10.6 8.3 13.8 5.0 1.6 0.5 1.2 0.4 1.6 0.6 0.4 0.1 15.5 0.9 0.3 14.6 0.2 0.2 0.5 14.2 0.3 1.0 1.5 9.0 5.6 0.3 11.0 0.1 37.2 31.0 0.9 0.6 2.9 6.7 8.9 11.3 6.8 13.0 13.3 11.3 22.5 15.5 15.6 4.6 21.6 14.8 12.8 5.1 14.7 20.7 12.3 14.6 23.9 9.1 11.4 7.9 16.6 8.4 8.7 10.9 9.2 8.3 5.1 6.0 3.5 14.3 0.4 14.5 1.9 0.0 17.8 8.1 3.4 0.0 0.0 2.1 0.0 0.0 1.9 2.9 10.6 0.0 0.0 1.6 4.3 0.5 9.2 2.4 8.1 0.0 7.5 16.5 29.2 1.4 9.2 6.0 38.8 0.0 13.3 7.8 0.0 11.5 16.3 0.0 1.5 12.9 0.0 5.2 12.4 12.7 2.2 15.4 27.5 0.1 C2orf74 LOC339804 ENSG00000237651 "Chromosome 2 open reading frame 74" A8MZ97 2 61145068-61164829 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Distal tubular cells: 162.5;Early spermatids: 469.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA026826 Approved Approved Centrosome NA NA Centrosome "HPA026826: AB_10671091" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (4.54e-2)" "unprognostic (8.10e-2)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-3)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (6.65e-2)" "unprognostic (3.52e-1)" "unprognostic (6.22e-2)" 15.8 19.4 32.2 10.7 38.5 2.4 19.1 12.6 33.7 15.4 11.5 13.6 10.0 3.6 12.7 30.2 9.6 13.6 8.6 25.3 25.8 26.1 26.0 22.7 11.4 12.3 26.9 18.4 17.1 8.9 12.5 26.0 11.2 26.0 13.0 6.0 5.8 8.7 12.5 15.0 5.4 5.7 12.7 22.3 13.5 9.9 27.4 22.5 5.7 20.5 12.5 10.1 9.9 10.0 20.1 10.8 17.0 10.4 18.4 20.6 6.8 5.8 10.1 10.5 0.0 22.6 23.1 9.5 15.3 17.6 14.6 12.1 0.0 9.9 7.3 21.3 12.4 9.7 7.9 0.0 12.5 25.2 9.2 6.3 0.0 9.6 11.6 9.1 8.7 8.2 23.6 20.6 10.9 22.3 10.5 8.1 0.1 0.0 5.5 22.3 10.6 0.0 16.7 10.0 4.4 6.4 13.2 13.0 12.2 20.1 4.6 21.9 8.4 1.9 2.0 12.7 9.7 8.0 8.8 4.2 12.4 5.4 7.4 18.5 23.4 10.6 27.6 16.4 6.3 10.9 9.9 4.9 17.0 11.4 10.4 14.5 20.1 12.5 11.6 10.8 13.0 20.6 16.3 1.1 18.4 10.1 8.9 16.1 6.8 32.2 38.5 12.6 33.7 25.8 26.1 26.9 18.4 26.0 22.5 11.9 9.7 18.6 14.5 0.0 9.8 3.2 10.2 21.4 4.5 21.0 7.9 21.1 162.5 20.1 469.7 7.4 0.0 0.0 27.3 21.6 8.2 8.3 13.9 18.7 19.9 11.1 0.0 12.9 15.3 68.5 34.2 20.7 1.7 33.3 0.0 21.8 19.4 0.0 42.5 110.7 18.2 19.4 1.4 18.0 25.6 0.0 5.4 12.5 0.0 6.5 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819362-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Group enriched" "Detected in some" 12 "Early spermatids: 19.9;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.7" "Not detected" "Not detected" HPA053582 Uncertain Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "HPA053582: AB_2682199" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.4 0.1 0.5 0.4 1.0 0.9 0.4 1.8 4.0 0.4 0.4 0.4 0.4 1.3 0.5 0.4 1.7 0.4 0.4 0.8 0.5 0.5 0.4 0.6 0.6 0.4 0.4 0.4 1.2 1.3 0.0 0.4 0.4 0.4 0.4 0.0 0.4 0.5 0.4 2.6 2.0 0.4 0.4 0.4 0.4 0.3 3.6 0.4 0.4 0.7 0.4 0.4 0.5 0.4 1.1 0.5 1.7 0.9 2.2 1.1 0.1 0.7 2.0 1.0 1.3 0.0 0.3 1.2 1.7 0.0 0.1 0.0 1.2 1.0 2.6 0.4 0.0 0.7 1.1 0.0 0.1 0.3 1.5 1.8 2.2 4.7 0.5 0.0 0.8 0.8 0.2 0.1 0.0 0.1 0.5 0.0 0.9 1.3 1.2 0.0 4.4 1.2 1.2 1.3 1.2 0.4 1.7 1.1 2.5 0.1 1.1 1.2 0.8 0.3 2.6 0.3 0.3 0.7 1.0 1.5 0.8 1.0 1.7 2.0 0.8 2.4 0.5 2.7 3.7 1.0 1.7 0.6 0.2 1.1 0.4 0.4 0.6 0.6 0.8 0.4 1.1 1.1 1.0 1.2 2.2 0.9 0.5 0.8 0.1 0.5 1.0 1.8 1.3 0.5 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.3 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 C6orf106 "dJ391O22.4, FLJ22195" ENSG00000196821 "Chromosome 6 open reading frame 106" Q9H6K1 6 34587288-34696859 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 106.1;Late spermatids: 212.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034489, HPA034490" Approved Supported "Nuclear speckles,Centrosome,Cytosol" NA NA "Nuclear speckles" "Centrosome, Cytosol" "HPA034489: AB_10669991, HPA034490: AB_2674186" "unprognostic (3.76e-2)" "unprognostic (2.51e-1)" "unprognostic (7.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (8.40e-2)" "unprognostic (9.94e-2)" "unprognostic (7.57e-2)" "unprognostic (5.68e-2)" "unprognostic (3.55e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" 16.5 10.7 12.5 13.7 12.7 7.5 15.2 22.5 18.7 9.5 22.4 6.3 6.7 9.1 9.0 15.5 13.7 8.6 15.9 60.4 11.2 10.0 23.9 35.2 16.9 10.1 14.4 6.8 11.6 12.0 14.1 7.3 11.1 9.0 9.0 9.5 10.3 12.6 16.1 66.3 10.4 14.9 12.3 7.8 9.1 10.0 20.7 8.2 5.8 15.7 26.6 13.3 13.4 11.4 8.6 4.1 18.2 7.3 5.7 9.2 4.7 28.7 13.1 13.1 19.2 31.4 17.3 15.4 19.6 23.0 23.5 29.4 25.7 13.5 33.0 14.8 19.4 32.4 28.7 38.0 16.5 29.9 46.4 14.8 27.6 15.3 24.5 30.7 23.1 30.8 11.6 34.6 23.5 21.5 16.0 18.5 13.8 31.0 14.1 13.2 17.2 16.2 16.0 12.0 46.9 11.8 12.7 16.7 17.5 18.3 28.9 15.6 12.2 29.3 14.3 28.8 28.2 18.1 19.5 18.6 19.5 14.9 20.3 19.5 20.1 45.6 25.6 7.0 20.6 22.5 18.2 3.5 7.3 9.1 6.3 4.8 6.7 6.6 7.2 4.1 8.6 3.6 5.7 4.5 5.7 7.3 2.2 9.2 4.7 12.5 12.7 22.5 18.7 11.2 10.0 14.4 6.8 9.0 8.2 26.8 40.4 23.1 14.9 22.1 17.6 73.3 25.5 33.5 25.0 7.0 19.6 11.7 11.6 14.3 106.1 21.5 21.1 0.0 18.7 6.9 9.9 26.1 25.4 53.9 13.4 12.7 24.1 9.2 17.2 212.0 18.1 18.4 15.1 29.7 17.2 9.4 28.1 19.0 20.8 26.9 18.0 6.5 18.6 9.9 14.0 28.2 18.1 17.3 12.7 30.7 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 43.7;Spermatocytes: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.8 3.7 9.7 3.9 3.9 5.1 18.1 13.5 4.2 9.4 10.2 1.0 5.3 15.3 4.0 3.3 15.8 5.0 7.6 0.7 15.1 20.6 11.8 8.1 6.8 6.4 3.2 9.7 12.9 2.5 5.1 5.2 3.7 3.8 2.9 11.2 11.4 10.4 12.3 4.7 17.1 11.4 11.4 8.9 11.4 16.0 7.6 3.7 3.9 4.1 10.6 4.7 5.9 5.0 4.0 9.0 6.1 7.5 3.7 8.5 9.6 11.6 11.7 20.0 14.9 9.7 6.5 10.9 9.1 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 3.0 0.3 6.0 3.5 2.2 7.2 43.7 0.0 1.4 0.0 3.5 7.9 15.9 1.7 2.7 9.5 8.6 12.7 0.0 2.7 19.6 4.0 2.4 0.0 3.4 9.3 1.6 1.2 9.2 3.3 1.3 4.0 1.7 1.7 3.6 4.9 4.5 2.9 8.6 4.9 1.4 13.1 0.0 4.2 46.8 10.7 4.5 10.3 3.2 15.2 3.8 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.9 0.5 0.1 0.0 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 163.3 13.6 3.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261463 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5" "Cell type enriched" "Detected in some" 11 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA050835: AB_2681253, HPA075200: " "unprognostic (7.28e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 1.3 14.2 22.2 1.3 9.6 1.1 1.3 29.7 38.3 1.3 1.3 3.2 0.0 1.4 1.2 1.2 1.2 1.3 1.3 1.2 12.3 32.7 1.3 1.7 1.2 1.2 18.0 8.2 1.1 37.0 2.0 12.5 1.3 25.1 1.4 1.3 1.1 1.2 1.4 1.1 1.2 1.4 1.4 9.3 1.2 1.7 1.3 4.5 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 11.3 0.2 1.4 0.6 0.4 0.4 1.0 0.3 4.2 2.7 2.8 0.4 0.5 0.4 2.8 0.2 5.5 1.5 0.7 0.5 1.5 9.3 0.4 0.3 0.2 0.4 0.1 0.2 1.4 0.3 0.7 0.4 1.9 0.6 0.0 0.3 0.0 3.3 0.4 6.0 0.1 0.1 8.1 0.2 3.7 19.0 5.5 1.6 0.6 2.2 20.0 4.3 1.8 0.5 0.1 0.1 6.1 0.1 0.0 20.8 9.1 1.9 3.3 2.2 3.3 2.7 4.8 1.2 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.2 9.6 29.7 38.3 12.3 32.7 18.0 8.2 25.1 4.5 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 58.8 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 4.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595902-7618304 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 20.1;Hep G2: 11.4;SK-BR-3: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: AB_2684698" "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favorable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.8 2.8 8.0 1.9 9.2 0.9 4.1 12.0 15.5 4.5 11.4 0.8 13.5 20.9 1.5 8.0 14.7 4.8 7.6 0.9 5.2 4.8 9.7 14.2 4.5 1.1 2.6 6.5 1.0 15.7 4.2 6.2 3.6 7.0 6.7 4.1 8.8 22.1 16.0 1.1 33.9 17.7 1.0 1.0 1.1 14.5 9.1 1.1 0.9 9.6 2.5 5.7 4.1 6.9 0.0 0.1 0.0 0.0 0.0 0.6 0.0 8.4 1.4 0.2 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 20.1 4.5 2.3 3.6 0.0 0.9 7.5 3.3 2.2 0.0 1.5 7.7 0.0 0.3 11.4 0.0 0.0 3.5 0.0 4.3 0.0 0.3 0.3 0.0 3.4 0.7 0.0 0.0 9.6 0.1 0.1 5.2 6.2 3.7 0.5 0.0 2.8 1.5 4.5 6.5 6.9 1.0 9.8 0.0 1.3 8.2 1.3 0.0 0.0 1.6 0.0 0.3 4.0 0.7 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.0 9.2 12.0 15.5 5.2 4.8 2.6 6.5 7.0 1.1 8.9 19.2 0.0 2.4 8.8 22.3 0.8 17.8 0.0 4.5 8.7 0.0 0.4 3.3 5.2 4.4 0.6 31.9 0.0 10.2 0.6 0.3 9.0 5.7 20.3 0.2 9.5 12.6 0.6 1.3 2.7 1.4 0.4 0.0 0.0 18.0 1.3 11.5 21.0 0.0 11.3 12.8 0.0 0.7 0.5 1.7 16.6 0.5 0.9 14.0 4.3 CAPN7 PalBH ENSG00000131375 "Calpain 7" Q9Y6W3 3 15206152-15252918 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 99.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004745, HPA046617" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA004745: , HPA046617: AB_2679721" "unprognostic (2.70e-2)" "unprognostic (2.79e-1)" "prognostic favorable (4.85e-5)" "unprognostic (1.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.41e-2)" "unprognostic (2.22e-3)" "unprognostic (2.72e-1)" "unprognostic (1.42e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-2)" "unprognostic (1.12e-3)" "unprognostic (3.24e-2)" "unprognostic (7.84e-2)" "unprognostic (5.66e-2)" "unprognostic (1.05e-2)" 16.3 15.0 9.7 12.8 13.4 10.5 18.9 21.7 13.7 18.6 15.5 11.1 14.3 11.8 17.6 15.9 13.4 16.7 10.4 13.8 9.2 8.9 14.8 17.6 17.9 20.0 11.4 8.4 20.6 15.9 20.4 29.0 14.7 11.7 14.7 11.7 15.9 15.9 12.7 33.7 14.9 14.5 19.5 14.1 12.1 15.2 12.1 12.3 19.3 22.6 11.1 14.5 17.7 14.5 6.6 5.1 8.7 7.0 5.8 10.0 5.0 8.7 11.5 9.6 6.0 16.9 13.2 32.8 11.3 13.0 14.1 10.8 8.2 6.3 15.1 7.9 12.8 8.7 6.1 14.1 14.5 12.3 14.4 11.1 18.9 16.2 10.8 12.6 15.1 9.6 9.0 21.2 18.3 9.1 13.4 10.0 14.6 18.2 15.9 13.6 12.7 10.7 6.3 9.2 12.7 11.3 6.2 16.0 10.4 10.5 16.0 7.8 10.1 18.4 10.0 12.5 12.8 17.6 15.9 8.9 12.8 9.7 16.5 13.1 11.1 22.0 7.7 11.6 11.1 11.0 6.3 5.4 8.7 6.4 4.4 10.0 6.6 7.0 5.2 5.1 5.9 9.6 8.8 3.2 5.8 7.0 4.3 5.1 5.0 9.7 13.4 21.7 13.7 9.2 8.9 11.4 8.4 11.7 12.3 11.9 17.6 15.2 14.2 19.1 41.7 27.4 7.6 45.5 27.3 1.8 53.0 17.3 8.3 10.3 11.3 16.8 10.2 23.3 14.8 10.3 16.0 16.9 15.1 14.3 10.6 52.4 20.1 15.4 12.4 11.7 23.0 15.2 20.3 12.6 9.8 37.3 10.8 7.0 24.8 12.2 99.8 38.8 22.8 22.4 14.7 20.3 21.9 17.0 10.3 7.3 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favorable (8.36e-4)" 5.5 7.8 12.5 5.3 20.6 9.3 5.0 19.9 15.7 7.3 5.3 4.4 9.5 4.0 8.6 10.5 3.6 4.9 6.1 17.4 11.8 19.0 6.5 5.3 6.5 5.4 11.2 11.6 8.3 5.5 22.4 11.0 4.2 18.2 7.4 5.7 6.1 3.1 10.0 5.6 10.6 4.6 8.4 11.5 6.7 6.5 22.3 9.4 4.3 5.7 3.9 5.0 6.1 8.1 4.1 4.2 7.5 1.5 2.6 5.4 0.9 4.5 3.2 6.0 5.1 6.0 6.3 3.6 8.5 7.1 3.7 5.0 1.7 2.9 2.7 7.5 8.8 7.4 3.6 3.2 13.8 6.7 4.0 3.5 11.1 5.2 6.4 3.3 1.7 1.1 7.3 5.5 11.8 9.5 15.4 8.3 4.9 0.7 2.7 8.7 0.9 2.2 2.9 7.1 2.4 9.7 1.0 9.1 1.3 1.6 16.4 7.5 4.6 3.1 2.2 3.6 15.0 2.0 0.5 11.2 7.1 3.9 21.6 15.5 5.2 3.6 2.4 8.6 0.5 4.6 7.5 1.5 1.2 4.4 0.6 5.4 3.7 2.8 4.6 0.6 4.1 3.1 2.8 0.3 2.6 0.7 4.2 1.8 0.9 12.5 20.6 19.9 13.7 11.8 19.0 11.2 11.6 18.2 9.4 20.8 23.0 1.4 4.6 6.4 28.8 21.4 0.0 18.7 9.1 3.5 21.6 6.4 8.3 4.4 7.4 8.5 5.1 0.0 9.6 1.5 5.4 2.6 20.9 5.9 7.7 11.1 16.0 7.4 6.1 10.7 6.4 4.6 3.3 3.6 3.0 12.2 21.7 2.6 8.1 9.5 36.8 6.5 7.7 7.5 23.0 4.0 10.3 5.2 3.2 2.4 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.3 3.7 1.0 0.3 1.9 1.4 0.1 0.7 0.2 2.0 2.2 0.0 1.7 0.3 3.3 0.5 0.8 0.8 0.0 1.6 1.4 1.2 0.6 1.5 0.6 0.0 0.0 0.2 0.0 0.6 1.0 1.7 0.3 12.1 0.2 1.3 0.3 0.6 2.6 0.0 1.8 1.4 0.5 0.0 0.5 0.0 0.0 0.2 2.6 0.0 2.1 1.0 0.2 0.1 1.2 0.2 1.2 0.5 0.8 1.9 0.8 0.4 0.3 0.2 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 8.9 3.2 0.0 2.5 1.5 0.7 7.1 2.5 96.4 17.0 5.2 3.9 1.0 5.0 0.8 21.6 1.7 0.0 0.0 1.5 0.5 1.7 1.5 0.0 1.5 0.5 1.6 0.0 2.5 1.8 11.5 5.8 0.9 0.0 0.0 1.7 5.8 0.4 0.0 6.7 2.5 20.8 0.0 1.4 9.1 0.9 0.5 0.2 0.0 0.6 0.5 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42692663-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.2;fallopian tube: 13.6;testis: 15.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 24.5;Ciliated cells: 50.9;Distal tubular cells: 14.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;ASC diff: 2.4;Daudi: 1.3;HDLM-2: 3.0;NTERA-2: 1.5" "Low region specificity" "Detected in all" HPA047429 Approved Supported Centrosome NA NA Centrosome "HPA047429: AB_2680043" "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.7 1.0 3.0 0.7 12.2 0.6 0.7 0.8 4.0 1.3 0.9 6.3 2.3 1.1 2.1 7.0 0.7 13.6 1.5 1.7 3.7 2.7 1.1 1.7 2.5 0.7 1.9 4.6 1.5 2.0 1.0 3.7 0.7 8.1 0.7 1.4 1.5 1.6 1.1 2.0 0.6 1.1 0.9 3.4 0.8 0.8 15.0 2.5 0.0 1.9 0.3 0.6 0.7 0.5 0.0 0.0 0.1 0.2 0.5 1.2 0.2 0.0 0.0 0.0 1.1 2.4 0.9 0.8 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 3.0 0.9 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 3.0 12.2 0.8 4.0 3.7 2.7 1.9 4.6 8.1 2.5 0.0 1.1 0.0 0.2 0.9 24.5 1.1 2.5 50.9 7.9 3.5 3.9 0.1 14.9 0.8 11.5 0.5 0.2 0.0 0.2 0.4 1.0 0.9 1.1 0.0 2.4 0.0 0.0 0.6 0.8 12.4 1.4 1.8 1.7 2.8 0.1 1.5 0.2 0.6 0.7 2.5 5.4 0.0 0.7 8.8 5.1 1.0 0.0 0.0 0.0 0.6 CCDC14 "DKFZp434L1050, FLJ12892" ENSG00000175455 "Coiled-coil domain containing 14" Q49A88 3 123897305-123961408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035278, HPA035279" Uncertain Enhanced Centrosome NA NA Centrosome "HPA035278: AB_2674548, HPA035279: AB_10601253" "unprognostic (7.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.86e-1)" "unprognostic (1.41e-1)" "unprognostic (9.45e-2)" "prognostic favorable (5.27e-4)" "prognostic unfavorable (4.82e-4)" "unprognostic (6.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.76e-1)" "prognostic unfavorable (4.76e-4)" "prognostic unfavorable (3.50e-8)" "unprognostic (2.14e-2)" "unprognostic (2.86e-1)" "unprognostic (9.37e-2)" "prognostic favorable (2.72e-5)" 11.3 9.7 13.6 22.4 15.2 30.0 19.1 8.0 16.2 14.5 18.8 10.8 7.7 12.0 20.4 31.9 10.2 15.8 14.9 9.1 13.6 8.7 13.3 13.7 14.1 14.3 14.3 13.0 20.6 15.4 7.8 24.4 9.7 14.5 17.2 31.8 9.6 14.3 9.8 5.9 20.2 15.9 13.6 17.4 13.7 12.8 22.5 16.0 36.5 14.0 11.2 13.3 12.7 13.0 2.1 4.5 3.0 2.2 6.0 5.6 1.9 16.7 9.8 30.3 12.0 4.2 6.2 14.2 33.7 11.1 16.3 18.9 7.6 11.9 5.0 8.6 7.0 12.7 19.0 11.0 5.5 22.1 4.1 7.7 19.9 18.0 7.1 4.0 13.0 12.8 6.2 3.5 8.5 9.1 20.7 7.7 19.8 10.2 9.2 11.2 8.3 11.3 6.2 9.1 7.3 11.5 19.5 12.6 5.7 9.4 13.7 10.6 12.6 19.7 4.9 12.8 19.1 11.8 9.6 10.1 39.5 20.5 12.1 10.9 8.7 6.0 14.9 13.3 10.0 13.7 2.8 1.6 3.0 3.9 2.2 2.6 2.1 3.4 3.3 1.0 2.0 3.8 3.2 0.3 6.0 0.6 4.5 5.6 1.9 13.6 15.2 8.0 16.2 13.6 8.7 14.3 13.0 14.5 16.0 20.8 56.7 6.7 33.3 19.5 35.1 11.0 28.1 18.7 30.7 34.9 56.9 19.0 0.0 20.0 29.2 21.5 42.4 46.7 12.1 20.0 27.5 16.9 24.4 17.3 17.6 27.0 86.3 27.0 18.7 14.7 30.2 21.2 23.6 13.6 87.0 23.6 17.3 49.1 29.4 7.8 79.1 19.4 25.5 98.1 43.0 14.1 9.7 24.9 75.9 16.3 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.7 11.9 7.2 8.4 10.6 11.3 19.7 6.5 6.0 13.1 10.7 18.8 16.4 21.2 9.3 5.1 9.8 14.3 17.6 21.2 8.0 9.9 11.6 18.1 18.9 14.1 16.4 8.8 8.3 8.5 48.2 16.1 17.7 7.1 7.4 12.5 10.0 6.2 12.3 9.3 10.2 11.4 15.7 21.0 19.3 7.1 8.4 16.3 17.7 12.2 5.9 12.5 10.7 11.7 17.4 7.0 12.6 13.7 5.6 7.6 10.3 18.8 12.4 10.0 14.6 11.1 10.1 19.1 7.1 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 11.9 1.6 8.9 3.0 4.1 6.8 7.3 22.9 5.3 5.7 8.7 0.0 35.3 19.9 13.2 2.5 5.3 12.6 0.0 10.8 15.3 10.7 3.7 3.5 11.9 14.1 7.9 5.2 3.1 3.8 2.2 11.2 4.1 13.5 13.6 6.3 10.1 12.4 5.8 12.4 27.0 9.5 6.5 3.1 4.8 17.3 4.1 5.6 4.3 12.4 3.1 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HMC-1: 40.7;Karpas-707: 10.6;THP-1: 16.2;U-937: 11.7" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.6 9.3 1.4 0.5 0.2 0.8 0.0 0.2 0.0 10.1 0.0 7.0 1.8 0.5 0.4 4.3 40.7 0.0 0.0 0.1 0.0 0.6 0.2 3.0 0.2 10.6 0.3 0.4 5.8 3.6 0.3 1.7 0.2 5.5 0.1 8.6 0.1 0.1 2.3 0.0 0.0 0.2 0.5 0.0 1.2 16.2 0.0 0.0 0.3 0.0 0.1 2.3 0.7 7.5 0.5 11.7 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 0.0 12.5 29.6 3.8 2.4 39.7 11.9 0.0 8.1 3.4 8.7 0.0 2.6 0.0 11.0 9.4 4.3 33.2 0.0 24.8 4.1 2.6 3.4 25.5 7.2 12.7 0.0 17.3 8.0 22.4 10.9 1.4 23.3 5.0 22.6 20.8 11.7 25.7 31.7 0.7 2.3 4.4 0.0 2.3 12.5 1.5 1.4 1.1 31.6 17.9 14.8 CCDC92 FLJ22471 ENSG00000119242 "Coiled-coil domain containing 92" Q53HC0 12 123918660-123972831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 64.8;Sertoli cells: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038560, HPA057580" Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA038560: AB_10672717, HPA057580: AB_2683476" "unprognostic (4.77e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "prognostic favorable (7.15e-4)" "unprognostic (4.82e-2)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (5.01e-2)" "unprognostic (5.69e-2)" "unprognostic (7.14e-2)" "prognostic favorable (4.59e-5)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (3.08e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" 19.3 11.1 35.2 9.4 24.6 3.8 16.3 17.0 34.5 11.4 11.7 16.4 6.0 14.4 11.8 18.6 8.9 12.6 10.6 23.6 33.6 26.5 11.5 11.0 20.1 8.2 27.2 23.0 13.0 11.8 18.3 14.9 17.3 34.2 11.2 7.8 13.6 9.0 12.9 22.3 7.7 14.2 14.2 22.4 9.4 11.1 24.0 13.0 8.0 15.3 4.9 6.6 10.7 12.7 1.7 1.3 4.6 1.3 1.3 3.7 1.8 4.0 4.6 2.3 4.0 15.2 8.4 4.1 6.8 12.9 3.8 4.1 2.4 1.2 1.9 2.4 8.5 2.2 2.8 2.5 1.7 2.6 12.6 5.9 2.5 1.6 1.5 8.1 0.4 9.7 4.7 7.8 4.8 3.0 11.8 10.6 4.4 2.5 0.9 3.4 2.7 2.4 4.4 1.0 1.9 10.1 3.1 1.3 0.5 5.2 4.2 4.4 6.3 3.3 1.7 4.6 5.7 4.8 2.2 10.5 7.7 1.7 4.9 2.3 3.2 1.7 0.6 6.1 3.4 3.2 4.6 1.3 1.9 2.3 0.7 3.7 1.6 3.0 3.5 1.0 1.7 2.3 2.8 1.2 1.3 0.1 1.3 0.5 1.8 35.2 24.6 17.0 34.5 33.6 26.5 27.2 23.0 34.2 13.0 17.9 22.0 4.7 6.2 3.4 17.5 37.2 25.5 9.4 11.4 17.4 13.7 3.8 6.6 12.6 64.8 12.7 8.0 0.0 9.4 2.1 13.8 7.0 19.7 11.9 15.4 20.6 4.6 11.1 8.6 48.4 12.7 9.5 8.5 10.8 7.2 12.8 12.3 2.9 16.3 27.1 12.1 71.1 17.6 44.0 5.3 2.6 4.7 7.9 5.2 6.0 CCNF "FBX1, FBXO1" ENSG00000162063 "Cyclin F" P41002 16 2429394-2458854 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Cell type enriched" "Detected in many" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060596, HPA070495, HPA071600" Enhanced Supported Centrosome NA Yes Centrosome "HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424" "unprognostic (3.87e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-3)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.46e-7)" "unprognostic (2.45e-2)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-1)" 2.1 1.8 4.1 6.0 3.2 9.2 5.1 11.6 4.9 2.1 3.0 1.9 3.6 4.4 1.5 3.4 8.1 1.5 1.5 1.8 4.3 3.9 1.7 1.6 2.2 10.5 1.9 3.1 1.8 1.7 0.8 1.8 3.8 2.4 3.0 3.2 0.7 3.2 3.4 2.5 7.2 3.2 1.8 1.7 4.7 2.6 5.1 2.3 35.7 1.6 3.4 14.2 5.0 2.9 2.7 1.4 0.1 1.1 4.1 3.1 1.7 8.4 13.4 12.9 11.8 0.8 1.2 10.1 10.2 5.0 14.3 11.0 26.6 10.4 17.9 3.5 5.7 4.2 14.4 21.3 7.9 6.8 12.7 10.1 19.6 13.9 8.1 1.0 12.8 12.9 0.8 1.0 10.1 4.8 1.8 10.6 15.1 20.8 11.7 7.2 18.4 18.7 8.5 12.7 9.1 6.1 31.4 15.1 16.0 3.9 3.7 12.5 7.0 15.2 13.3 2.8 6.7 14.2 6.6 7.3 7.9 20.5 5.6 10.6 7.2 8.6 30.9 2.3 12.8 10.7 0.0 1.1 0.0 2.8 0.6 1.7 2.7 1.5 3.1 0.5 2.6 1.2 1.7 0.1 4.1 0.9 1.4 2.2 1.7 4.1 3.2 11.6 4.9 4.3 3.9 1.9 3.1 2.4 2.3 0.0 4.6 0.8 2.1 2.5 4.6 1.7 0.0 0.0 2.3 1.8 11.8 0.8 0.0 1.0 0.8 1.3 0.7 70.0 0.5 10.5 0.9 1.2 1.1 0.8 5.0 7.9 1.2 1.8 1.6 0.0 1.7 1.0 5.0 1.0 1.9 0.6 0.9 0.0 2.5 0.2 1.3 0.0 2.7 2.1 5.1 1.0 1.6 1.5 1.8 1.4 CCP110 "CP110, KIAA0419" ENSG00000103540 "Centriolar coiled-coil protein 110" O43303 16 19523811-19553408 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.0" "Cell type enhanced" "Detected in all" 8 "Ciliated cells: 147.2;Spermatocytes: 156.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039402 Approved Supported Centrosome NA NA Centrosome "HPA039402: AB_10671041" "unprognostic (2.83e-1)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-1)" "unprognostic (4.88e-2)" "unprognostic (9.68e-2)" "unprognostic (3.25e-2)" "unprognostic (2.68e-1)" "unprognostic (6.50e-2)" "unprognostic (1.92e-2)" "unprognostic (8.99e-3)" "unprognostic (2.74e-2)" "unprognostic (1.82e-1)" "unprognostic (3.01e-2)" "unprognostic (1.37e-1)" 5.2 5.9 19.0 6.0 39.1 12.6 9.0 19.1 28.4 7.6 4.5 13.2 4.6 3.7 8.9 7.3 6.4 13.0 5.7 4.4 23.6 15.0 4.5 3.4 8.1 7.1 40.0 13.3 10.6 3.7 9.6 17.2 4.6 20.6 7.3 5.5 2.1 4.8 7.1 4.3 5.5 4.5 7.6 16.0 5.8 6.1 31.6 36.6 10.9 6.9 1.9 7.1 5.7 6.6 4.5 4.0 13.0 5.3 2.3 5.6 2.5 11.3 5.2 13.1 12.6 6.5 5.9 6.7 12.2 7.0 10.9 12.3 4.2 6.1 16.7 7.7 5.9 8.2 8.0 13.4 3.8 18.3 7.6 6.1 8.3 7.3 7.3 3.3 21.4 10.8 2.8 5.3 12.2 7.5 6.7 8.3 17.2 8.7 8.4 12.6 8.8 21.8 8.3 10.0 5.4 4.0 27.9 24.4 5.8 5.0 4.8 25.8 13.1 13.1 6.3 3.9 9.1 11.5 13.1 4.9 12.7 8.4 8.5 9.9 9.4 8.7 12.2 8.1 9.2 7.4 13.0 3.8 6.7 5.5 3.6 3.5 3.3 4.9 5.2 4.0 4.5 5.6 3.2 7.7 2.3 5.3 2.6 3.9 2.5 19.0 39.1 19.1 28.4 23.6 15.0 40.0 13.3 20.6 36.6 29.8 28.8 15.2 7.6 11.9 15.8 10.9 12.7 147.2 39.8 22.7 31.4 9.2 5.0 8.1 3.0 7.7 5.6 23.3 4.1 5.8 15.8 11.8 27.9 5.5 6.2 28.6 1.2 9.8 14.6 6.4 19.5 9.8 10.1 5.4 8.7 16.7 6.6 6.6 15.6 3.8 64.9 19.4 13.7 156.0 36.8 12.8 20.5 11.7 6.0 5.9 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 9.2 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 0.6 8.9 0.0 0.1 4.7 5.2 0.0 0.0 6.6 0.2 0.0 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.6 4.3 6.8 0.0 0.3 0.0 5.5 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 0.0 0.0 0.0 0.0 1.1 2.9 0.7 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.2 0.7 0.0 0.0 1.2 0.3 0.5 0.1 0.0 0.4 6.9 0.0 0.0 0.0 4.1 1.1 0.0 3.3 13.5 0.0 0.0 1.0 2.0 1.1 0.0 0.0 1.7 19.4 8.0 3.4 0.7 1.1 0.2 0.0 0.0 0.1 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.2 11.1 13.9 10.9 0.6 1.3 5.9 16.4 7.7 18.9 18.8 8.5 7.4 14.8 5.8 4.9 7.5 12.8 14.8 10.8 17.0 18.0 25.0 19.8 12.6 9.3 0.7 28.7 10.9 0.4 0.5 14.5 6.5 1.8 9.5 15.3 87.8 18.7 11.0 17.7 23.3 13.6 4.2 25.7 8.4 19.4 23.1 6.5 4.4 12.7 18.0 9.5 8.9 9.8 2.8 6.5 6.4 12.8 3.6 14.8 23.7 11.2 14.9 6.4 11.8 17.2 7.8 14.4 19.7 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.8 0.4 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.9 88.0 0.3 0.4 46.7 0.0 16.8 1.0 0.2 0.0 0.0 6.2 0.0 0.0 3.7 0.6 6.1 0.6 0.9 0.0 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 6.5 0.9 23.9 49.8 1.6 4.1 1.3 2.5 0.4 CDIP1 "C16orf5, CDIP, LITAFL" ENSG00000089486 "Cell death inducing p53 target 1" Q9H305 16 4510675-4538828 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049352 Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA049352: AB_2680724" "unprognostic (6.38e-3)" "unprognostic (3.70e-3)" "unprognostic (2.95e-2)" "unprognostic (2.50e-3)" "unprognostic (2.74e-2)" "unprognostic (2.56e-2)" "unprognostic (3.48e-1)" "unprognostic (8.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.14e-5)" "unprognostic (9.05e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.43e-2)" "unprognostic (3.51e-2)" "unprognostic (9.88e-2)" "unprognostic (4.65e-2)" 17.7 14.2 36.8 6.9 41.6 5.1 8.2 36.4 54.6 13.6 9.5 16.3 2.7 30.0 13.4 4.4 8.0 10.9 9.5 25.0 33.8 37.1 23.7 13.2 9.6 8.2 34.2 38.9 18.7 22.9 10.4 19.3 8.5 26.3 13.2 4.1 7.8 10.8 14.7 34.0 9.1 24.2 8.7 20.7 12.0 9.2 10.1 15.7 13.0 10.6 6.7 6.9 7.8 6.3 8.7 9.2 19.3 19.2 14.3 15.9 7.2 3.8 1.6 5.5 1.6 0.4 0.0 0.1 6.0 0.9 5.9 5.1 9.5 1.6 0.2 6.1 4.9 1.8 0.1 5.0 21.2 1.0 13.4 9.5 18.0 6.4 24.6 4.0 8.6 11.3 5.9 11.0 5.3 0.9 1.1 4.7 8.7 0.3 4.9 6.7 0.4 6.7 11.3 12.2 4.3 4.7 25.5 4.9 49.0 1.2 0.1 16.6 7.2 12.0 0.5 7.5 2.5 2.2 4.8 0.2 3.1 9.0 2.1 0.2 13.1 12.1 18.1 0.1 8.8 2.0 3.2 7.9 19.3 15.9 12.5 8.6 8.7 5.7 8.9 7.6 8.3 11.4 9.7 6.2 14.3 19.2 9.2 9.1 7.2 36.8 41.6 36.4 50.3 33.8 37.1 34.2 38.9 26.3 15.7 14.9 6.5 15.6 20.1 26.3 67.6 23.4 2.5 0.0 6.8 15.7 11.8 1.2 44.7 11.0 75.7 16.0 12.0 0.0 7.9 1.3 12.5 12.9 23.0 15.6 16.4 66.7 9.2 24.5 12.4 17.9 16.7 12.3 13.5 2.8 2.3 40.4 9.9 14.4 15.6 47.3 13.1 6.5 13.7 6.4 19.0 13.0 5.6 23.0 3.3 10.6 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966769-55972784 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 107.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: AB_2685748" "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavorable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 10.7 7.6 4.5 20.8 6.5 18.7 11.5 4.2 4.3 12.6 11.6 3.5 6.0 6.1 10.7 6.4 13.6 10.8 12.6 10.1 5.4 2.2 8.3 16.7 19.5 12.2 6.0 2.0 14.2 8.3 5.2 4.2 49.0 7.3 10.8 9.1 51.2 9.3 9.9 10.8 14.6 9.3 11.8 5.0 12.5 10.1 7.8 5.1 39.3 9.5 10.7 14.7 16.7 10.1 9.3 10.8 5.2 3.9 4.5 7.6 4.3 16.8 9.1 20.1 11.1 4.1 5.3 37.0 21.0 11.0 26.2 24.5 19.2 16.3 16.1 15.8 7.8 10.5 10.8 15.3 9.2 26.6 18.9 15.0 18.5 15.1 7.3 1.3 14.6 13.4 2.8 2.3 17.7 6.1 7.6 13.2 16.7 17.5 14.7 18.1 13.0 30.3 12.4 8.0 11.5 13.6 29.6 19.3 12.1 7.6 16.6 8.3 10.7 24.0 8.8 107.8 12.0 19.0 10.7 7.3 18.1 17.5 13.9 15.3 8.3 9.6 20.0 10.3 10.7 15.6 5.2 3.6 3.1 7.0 3.9 7.0 9.3 3.2 5.0 2.7 6.1 3.0 5.3 1.7 4.5 1.6 10.8 7.6 4.3 4.5 6.5 4.2 4.3 5.4 2.2 6.0 2.0 7.3 5.1 14.9 3.7 5.2 20.1 24.8 0.0 2.6 12.7 5.3 9.1 1.8 0.0 78.7 1.7 10.5 0.4 15.0 2.1 0.0 5.0 67.5 17.6 10.9 10.4 8.9 11.6 1.6 5.2 8.6 4.8 0.2 13.8 6.3 82.7 47.7 6.3 3.8 9.0 0.0 4.2 3.8 3.4 0.0 14.4 2.9 7.7 27.5 142.8 5.7 6.8 18.0 CDK5RAP2 "C48, CEP215, FLJ10867, MCPH3" ENSG00000136861 "CDK5 regulatory subunit associated protein 2" Q96SN8 9 120388869-120580170 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035820, HPA035821, HPA046529, CAB079753" Approved Enhanced "Cell Junctions,Centrosome" NA NA Centrosome "Cell Junctions" "CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688" "unprognostic (7.72e-2)" "unprognostic (2.04e-2)" "unprognostic (2.84e-2)" "unprognostic (4.48e-2)" "unprognostic (6.63e-2)" "unprognostic (6.88e-2)" "unprognostic (6.70e-3)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (7.36e-2)" "unprognostic (2.26e-2)" "unprognostic (1.88e-1)" "unprognostic (4.94e-2)" "unprognostic (2.36e-1)" "unprognostic (3.33e-2)" "unprognostic (7.41e-2)" 10.3 12.0 12.3 13.0 23.2 21.3 15.2 20.0 19.9 15.7 13.0 22.0 9.1 5.8 11.9 8.4 12.8 11.2 10.2 18.3 14.9 7.9 7.8 20.1 10.9 14.0 21.6 9.8 18.6 9.3 17.0 20.3 8.8 15.1 14.5 9.2 10.6 21.3 11.6 41.7 16.0 10.2 15.6 14.2 11.2 12.3 19.8 25.7 23.4 11.9 8.5 14.9 12.8 16.5 7.4 2.7 13.7 5.2 4.7 4.5 1.9 9.5 16.9 23.5 14.1 10.1 15.0 12.6 12.4 9.5 14.1 13.2 13.2 12.7 17.9 5.7 12.1 9.6 21.2 18.5 14.2 13.6 14.3 7.4 15.3 30.9 23.5 9.5 18.9 10.2 27.0 9.5 12.4 16.5 10.6 12.2 21.7 14.1 15.6 18.4 21.6 20.2 12.1 21.7 20.5 12.8 19.8 28.1 8.4 10.0 7.7 15.4 17.7 21.5 11.8 14.3 10.6 27.8 13.0 8.1 12.2 13.4 14.3 14.0 11.4 15.8 20.1 12.7 12.1 25.7 13.7 2.2 3.5 4.5 2.1 4.4 5.7 4.2 4.1 1.3 7.4 3.5 3.5 2.9 4.7 5.2 2.7 3.3 1.9 12.3 23.2 20.0 19.9 14.9 7.9 21.6 9.8 15.1 25.7 26.8 36.1 14.1 10.3 6.3 24.3 48.4 15.3 41.5 20.5 1.8 15.7 9.3 6.6 10.8 27.1 10.3 5.9 23.3 12.4 10.0 11.9 11.1 16.2 18.8 9.3 17.5 8.1 6.7 10.0 25.6 20.4 12.9 11.8 13.6 10.2 23.9 9.9 5.9 21.9 3.6 28.0 32.3 13.2 57.4 36.8 5.9 6.1 13.8 6.7 7.3 CDKL2 "KKIAMRE, P56" ENSG00000138769 "Cyclin dependent kinase like 2" Q92772 4 75578005-75630716 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enhanced" "Detected in some" "A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040672 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA040672: AB_10794744" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (6.91e-2)" "unprognostic (3.80e-5)" "unprognostic (3.43e-2)" "unprognostic (2.71e-2)" "unprognostic (1.59e-1)" "unprognostic (8.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.88e-15)" "unprognostic (5.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-1)" "unprognostic (7.52e-2)" 0.7 2.4 7.1 1.2 11.1 0.7 1.2 7.7 13.2 1.7 2.0 6.2 0.0 1.0 1.7 2.3 2.3 4.1 1.4 1.3 5.1 6.7 11.8 0.7 9.2 1.3 7.1 7.0 3.8 1.6 5.7 8.9 0.7 12.5 2.0 2.4 3.4 1.2 2.0 0.7 0.9 0.9 1.5 7.4 0.9 1.5 27.7 6.1 0.0 6.9 0.0 2.0 1.1 0.9 0.4 0.0 0.2 0.0 0.0 1.6 0.1 5.7 0.7 0.3 0.0 0.3 0.3 0.0 0.3 1.8 2.4 2.0 0.5 1.2 0.1 0.9 0.1 2.3 0.8 0.0 0.5 2.3 0.2 3.8 0.0 0.2 0.0 4.4 0.0 0.1 1.5 2.1 0.4 0.8 1.9 0.1 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 8.2 0.3 3.1 2.5 0.0 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.4 1.6 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 1.2 0.1 7.1 11.1 7.7 13.2 5.1 6.7 7.1 7.0 12.5 6.1 23.8 55.4 0.0 0.4 0.1 16.6 0.8 0.0 28.1 7.9 8.7 3.9 0.0 6.6 2.0 24.5 0.0 0.0 0.0 0.2 0.5 0.2 0.3 1.1 0.0 0.1 9.5 1.7 0.6 0.0 16.4 1.7 0.5 1.7 0.0 0.2 10.4 0.1 0.0 1.1 20.7 19.5 0.0 0.0 46.8 1.7 0.3 0.2 1.0 2.6 0.1 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 139.0;Horizontal cells: 33.4;Muller glia cells: 111.9;Rod photoreceptor cells: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;BJ: 6.6;MOLT-4: 4.2;U-87 MG: 24.4" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: AB_2686574" "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 139.0 0.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.9 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 CENPJ "BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4" ENSG00000151849 "Centromere protein J" Q9HC77 13 24882284-24922889 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.8;Spermatocytes: 61.7;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060426 Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane, Centrosome" "HPA060426: AB_2684278" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (2.68e-1)" "unprognostic (1.01e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-2)" "unprognostic (2.15e-5)" "unprognostic (7.41e-2)" "unprognostic (1.50e-2)" "unprognostic (9.83e-2)" "unprognostic (2.44e-1)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.36e-2)" "unprognostic (5.51e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" 5.0 3.5 6.6 6.7 11.9 10.2 6.2 18.4 6.4 10.3 7.6 5.0 7.2 7.5 8.8 4.8 6.6 6.0 3.3 4.2 5.4 4.4 3.9 2.9 4.9 8.5 9.7 3.8 8.1 3.2 2.1 4.6 7.6 7.2 6.3 8.8 2.4 4.6 12.0 3.6 7.6 9.0 9.1 11.6 7.4 4.6 24.3 10.1 14.6 20.8 5.7 7.8 7.9 7.8 4.3 2.4 3.8 1.3 2.2 2.1 0.7 5.3 5.2 17.7 16.5 2.5 3.6 10.0 12.5 5.7 7.8 7.3 6.7 9.5 9.7 3.7 4.5 5.6 13.0 13.3 7.0 12.0 8.9 6.6 35.2 12.3 5.6 1.2 16.1 11.6 2.2 2.0 6.8 3.8 3.6 5.9 9.3 9.9 18.1 8.1 5.1 11.0 22.0 10.0 14.2 4.0 12.3 12.3 5.0 3.1 6.0 9.0 8.4 6.3 6.8 5.1 16.3 3.4 11.0 5.5 9.2 6.3 12.7 8.2 5.0 9.1 10.5 4.3 11.8 14.2 1.9 0.8 3.8 2.1 1.3 0.9 4.3 1.4 1.6 0.9 4.1 1.8 0.9 0.4 2.2 0.9 2.4 1.5 0.7 6.6 11.9 18.4 6.4 5.4 4.4 9.7 3.8 7.2 10.1 3.0 8.0 3.0 3.6 1.8 7.2 5.3 0.0 9.4 14.8 3.5 3.9 5.6 0.0 1.5 115.8 5.3 5.2 0.0 2.6 11.2 2.7 2.0 4.7 1.5 3.7 3.2 0.0 1.3 2.4 17.0 6.1 4.6 0.0 9.0 2.5 2.6 1.7 6.2 5.3 0.8 2.0 6.5 7.2 61.7 32.4 1.1 2.4 6.9 3.3 1.4 CEP152 "KIAA0912, MCPH9, SCKL5" ENSG00000103995 "Centrosomal protein 152" O94986 15 48712928-48811146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 151.2;Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039408 Approved Supported Centrosome NA NA Centrosome "HPA039408: AB_10795288" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.61e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.87e-4)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" "unprognostic (1.04e-2)" "unprognostic (5.82e-2)" "unprognostic (4.70e-3)" "unprognostic (3.47e-2)" "unprognostic (6.24e-3)" "unprognostic (5.29e-2)" "unprognostic (3.55e-1)" "unprognostic (4.60e-2)" "unprognostic (1.25e-1)" 4.0 3.0 3.5 10.1 5.5 21.4 4.8 9.9 10.3 3.7 6.9 0.9 5.4 4.7 3.3 3.4 5.5 3.3 3.0 4.4 4.5 1.5 7.1 2.4 4.4 6.3 3.3 1.6 5.5 6.0 2.4 5.8 9.0 4.7 3.5 5.1 1.8 5.1 6.9 1.7 4.7 7.9 3.3 9.0 6.1 4.1 15.8 4.8 18.4 6.2 2.4 7.1 3.7 7.6 5.3 4.4 6.0 4.1 3.6 3.3 1.4 4.7 3.6 7.6 9.2 1.3 2.5 4.9 8.4 3.5 6.2 7.7 7.9 4.1 11.0 3.7 2.4 8.8 11.4 8.5 3.0 9.3 9.7 5.2 17.9 18.8 4.2 0.9 15.0 8.4 0.9 2.5 6.9 4.1 2.5 4.5 11.7 10.8 13.5 5.3 2.7 10.9 14.0 4.8 5.7 3.7 13.5 10.2 13.7 2.2 4.6 9.1 6.1 6.6 5.5 2.5 8.6 4.1 7.3 3.7 15.4 8.2 11.9 9.4 5.7 6.3 13.0 4.9 21.8 10.7 4.5 3.2 5.3 2.7 4.1 2.3 2.9 3.0 2.8 2.4 5.3 3.3 3.3 6.0 3.6 4.1 4.4 3.1 1.4 3.5 5.5 9.9 10.3 4.5 1.5 3.3 1.6 4.7 4.8 6.0 3.2 12.8 3.7 3.4 1.2 3.3 5.1 10.7 1.2 3.5 2.0 26.2 0.0 4.1 151.2 4.5 5.9 46.7 5.8 7.2 5.4 2.8 8.1 2.6 6.6 0.0 3.5 5.5 3.3 32.8 22.2 7.9 1.7 3.6 5.1 2.7 5.5 3.5 25.5 0.7 3.9 6.5 3.7 17.9 9.8 3.0 39.2 7.5 6.3 2.7 CEP164 "KIAA1052, NPHP15" ENSG00000110274 "Centrosomal protein 164" Q9UPV0 11 117314557-117413268 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 428.0;Early spermatids: 226.1;Late spermatids: 212.9;Rod photoreceptor cells: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037605, HPA037606" Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA037605: AB_10672908, HPA037606: AB_10672498" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (7.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.47e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (1.90e-1)" "prognostic favorable (5.93e-4)" "unprognostic (6.54e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (7.93e-2)" 7.1 6.8 7.8 11.2 10.4 7.0 7.2 17.4 7.8 10.5 6.8 9.1 11.2 4.7 17.4 9.4 9.7 12.9 12.1 4.6 6.9 6.8 7.1 7.2 7.3 7.7 7.4 8.3 13.9 28.1 10.8 19.1 5.1 8.2 7.4 5.8 16.4 6.9 7.6 3.1 8.3 6.2 11.5 10.4 9.7 6.3 29.7 8.3 10.8 9.6 5.0 14.4 8.0 8.0 18.0 21.1 36.5 16.6 11.8 21.4 4.3 9.0 12.6 9.3 18.4 9.4 16.0 3.0 17.9 10.1 12.9 12.7 15.5 14.7 17.9 13.0 11.0 12.7 12.0 10.3 10.5 11.1 17.7 8.5 5.4 12.4 4.9 13.8 7.7 12.1 11.1 9.0 19.5 19.1 11.6 16.7 8.9 14.6 11.7 10.1 7.8 7.1 7.0 6.6 5.9 13.7 9.6 11.1 7.0 5.7 7.8 10.8 15.7 14.3 8.7 10.3 10.9 12.0 9.1 18.0 15.4 9.6 14.8 16.4 4.2 5.0 10.6 7.5 8.8 10.2 30.7 15.7 9.4 15.9 12.9 10.1 15.2 20.0 17.9 5.8 18.0 18.9 15.1 36.5 11.8 16.6 21.1 21.4 4.3 7.8 10.4 17.4 7.8 6.9 6.8 7.4 8.3 8.2 8.3 6.0 16.2 12.3 9.5 6.8 78.2 4.2 7.6 37.5 11.4 10.4 428.0 3.8 1.7 9.8 226.1 15.7 5.1 0.0 12.7 5.7 11.2 7.3 18.5 8.1 11.2 69.9 14.9 8.6 6.9 212.9 22.2 10.3 5.0 18.0 8.8 21.5 9.9 5.8 15.9 4.5 288.7 0.0 13.7 36.7 17.4 7.0 1.8 15.9 9.3 4.7 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Group enriched" "Detected in many" 37 "Early spermatids: 1512.0;Late spermatids: 3749.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Yes No Centrosome "Mitotic spindle, Cytosol" "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.2 11.1 8.2 15.9 2.9 16.1 9.6 12.1 11.5 3.2 5.9 4.5 9.9 13.7 4.1 3.0 11.3 6.9 17.3 10.0 6.5 4.7 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.6 16.9 27.7 28.2 2.7 11.3 4.7 15.3 1.3 5.0 4.4 16.6 1.2 14.5 9.0 9.4 1.5 2.5 1.0 19.1 25.7 8.2 0.7 7.7 10.8 2.8 11.2 31.1 22.6 6.7 12.1 18.5 4.6 5.9 9.0 12.0 7.5 51.9 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 17.9 16.6 13.7 4.2 13.5 41.1 19.0 7.6 25.4 11.4 12.2 5.9 3.1 0.0 18.9 1512.0 31.0 0.7 0.0 6.1 6.7 26.8 3.3 22.0 6.8 31.5 42.9 10.4 18.4 34.9 3749.4 40.9 70.8 21.9 31.5 1.9 11.4 19.1 0.0 33.2 2.1 18.3 25.8 15.7 71.0 23.8 10.0 1.6 7.0 1.6 3.1 CEP170B "Cep170R, FAM68C, KIAA0284" ENSG00000099814 "Centrosomal protein 170B" Q9Y4F5 14 104865280-104896770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 216.0;Rod photoreceptor cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000871, HPA059017" Enhanced Approved Microtubules,Centrosome,Cytosol NA NA Cytosol "Microtubules, Centrosome" "HPA000871: AB_2666124, HPA059017: AB_2683883" "unprognostic (1.09e-1)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.38e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (4.96e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.41e-4)" "prognostic favorable (3.26e-4)" "unprognostic (1.62e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (1.17e-2)" 10.3 8.8 19.9 7.3 26.3 1.3 10.9 25.9 39.7 6.6 18.0 5.3 9.1 24.7 7.4 5.0 14.7 8.5 15.1 4.9 18.5 12.4 9.9 9.4 8.0 2.1 8.9 19.7 4.6 25.4 9.0 10.5 4.8 13.5 10.3 8.9 5.3 17.5 12.5 4.6 35.0 24.6 6.7 6.5 3.8 23.2 10.9 6.0 0.2 10.1 6.2 5.6 8.8 11.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 10.8 9.1 0.7 8.6 3.7 2.7 20.2 8.6 3.4 4.3 2.9 9.6 6.7 0.0 10.5 6.5 3.0 24.2 2.0 10.1 1.1 4.0 4.2 0.0 9.6 6.2 7.4 0.0 8.9 2.6 12.9 4.5 6.7 3.4 4.3 0.0 2.7 0.1 3.7 23.1 0.0 0.1 2.9 15.6 7.9 3.6 0.0 2.6 4.3 18.6 2.3 2.4 12.8 7.6 11.5 1.5 13.1 1.6 9.5 6.9 7.6 19.0 5.7 0.4 0.0 0.0 5.5 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 19.9 26.3 25.9 39.7 18.5 12.4 8.9 19.7 13.5 6.0 8.9 15.4 0.0 10.8 21.2 17.6 3.3 28.1 5.3 4.5 17.4 216.0 2.8 1.7 10.8 0.6 3.6 52.0 0.0 20.6 6.3 3.5 18.4 5.7 10.6 1.2 38.1 21.2 6.7 0.3 1.0 3.4 2.9 8.5 1.8 37.4 11.8 23.7 32.3 8.1 4.3 113.9 6.5 6.7 1.4 3.8 21.5 5.6 0.0 25.2 19.3 CEP19 "C3orf34, MGC14126" ENSG00000174007 "Centrosomal protein 19" Q96LK0 3 196706277-196712293 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 26.8;Early spermatids: 19.5;Spermatocytes: 38.6;Spermatogonia: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 45.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047614, HPA071138" Enhanced Supported Centrosome NA NA Centrosome "HPA047614: AB_2680103, HPA071138: AB_2686348" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (5.11e-2)" "unprognostic (9.31e-2)" "unprognostic (5.51e-3)" "unprognostic (4.66e-2)" "unprognostic (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (2.36e-2)" "unprognostic (1.91e-1)" "unprognostic (3.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.33e-2)" 3.2 5.2 10.2 5.7 11.7 2.4 2.4 7.3 10.8 3.6 2.3 3.0 2.6 2.0 3.3 6.2 3.2 8.0 3.8 2.4 8.4 9.0 5.2 2.3 3.2 5.0 6.5 6.0 3.8 1.4 6.1 9.2 3.9 8.3 3.5 2.2 2.5 2.3 4.4 1.3 3.3 2.0 3.0 4.4 6.1 1.7 17.5 4.4 8.3 5.1 0.4 6.3 4.0 2.6 1.4 3.4 45.3 1.3 2.3 3.5 1.2 5.2 3.7 5.1 3.1 11.7 9.0 1.5 4.3 8.1 4.6 6.0 1.8 3.5 3.9 12.2 2.1 10.1 2.3 3.4 1.1 5.5 5.4 3.4 5.9 1.9 0.5 4.7 2.7 7.6 4.1 5.1 6.0 1.6 8.5 1.9 4.8 3.2 4.8 4.7 2.7 6.7 4.8 2.6 2.3 6.1 7.9 3.1 2.7 4.9 0.5 5.1 3.6 5.8 0.8 6.5 4.6 4.6 5.2 1.5 5.4 1.2 8.3 2.8 14.8 14.1 8.0 7.7 6.9 5.2 12.9 1.3 17.5 1.8 0.9 2.0 1.1 2.6 2.3 0.8 1.4 3.5 2.2 45.3 2.3 1.0 3.4 1.4 1.2 10.2 11.7 7.3 10.8 8.4 9.0 6.5 6.0 8.3 4.4 0.0 1.3 2.7 1.0 1.8 4.5 2.0 0.0 26.8 2.3 1.8 0.0 1.4 5.0 1.6 19.5 4.5 0.0 0.0 0.7 1.2 3.7 1.0 1.1 0.2 2.7 4.8 0.0 5.5 3.8 3.1 6.1 2.5 0.0 14.4 0.2 7.6 1.0 0.0 4.9 3.5 7.4 0.0 1.9 38.6 38.7 0.6 0.3 3.2 0.4 0.1 CEP192 "FLJ10352, KIAA1569, PPP1R62" ENSG00000101639 "Centrosomal protein 192" Q8TEP8 18 12991362-13125052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039392, HPA040503" Uncertain Supported Centrosome,Cytosol Yes No "Centrosome, Cytosol" "HPA039392: AB_10697549, HPA040503: AB_10670919" "unprognostic (6.94e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-3)" "unprognostic (6.87e-3)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (9.00e-2)" "unprognostic (6.61e-2)" "unprognostic (1.28e-1)" "unprognostic (7.89e-2)" "unprognostic (2.39e-1)" "unprognostic (4.54e-2)" "unprognostic (1.66e-3)" 7.6 6.5 7.9 14.9 11.8 16.3 8.3 14.5 11.8 8.8 7.7 11.1 7.1 6.7 13.6 9.3 7.6 8.8 9.9 7.1 8.1 4.7 6.9 6.1 8.7 11.0 8.7 11.8 17.4 9.5 10.4 11.1 7.8 11.8 8.0 9.4 7.9 10.4 6.6 6.2 8.2 9.6 9.5 7.6 8.4 8.2 16.4 9.8 18.3 11.1 6.0 12.2 12.1 8.6 3.9 1.8 2.1 4.9 0.9 3.5 1.0 9.9 5.4 14.7 7.6 6.4 10.0 4.7 7.0 9.2 11.1 11.8 7.4 4.4 11.2 4.7 7.0 8.0 4.9 12.7 6.6 13.1 4.4 4.5 10.2 8.2 3.8 3.3 16.1 7.9 6.9 2.5 9.2 8.5 6.3 9.0 8.1 14.0 7.5 8.6 5.0 13.9 7.0 4.6 18.5 3.3 12.0 11.5 5.8 3.8 10.1 10.7 6.0 11.1 5.5 3.4 7.2 4.4 8.4 9.0 8.7 20.6 9.9 9.5 5.1 7.3 12.8 5.6 7.3 8.4 1.5 2.1 1.5 3.2 1.5 2.4 1.8 2.1 2.0 0.9 3.9 2.3 3.5 2.1 0.9 4.9 1.8 1.8 1.0 7.9 11.8 14.5 11.8 8.1 4.7 8.7 11.8 11.8 9.8 8.9 10.9 5.9 3.9 1.6 11.7 21.4 7.6 4.0 10.3 7.0 21.6 3.5 0.0 3.9 21.9 3.5 4.9 0.0 3.1 2.7 3.0 5.3 2.3 4.7 3.8 11.1 0.0 7.4 9.4 9.5 9.5 5.4 1.7 11.8 9.1 6.6 4.0 5.8 13.1 1.1 16.3 25.8 3.5 19.1 21.3 2.8 1.6 10.1 6.4 7.1 CEP250 "C-NAP1, CEP2" ENSG00000126001 "Centrosomal protein 250" Q9BV73 20 35455164-35519280 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064875 Supported Centrosome NA NA Centrosome "HPA064875: AB_2685379" "unprognostic (6.35e-2)" "unprognostic (2.94e-1)" "unprognostic (2.31e-1)" "unprognostic (1.21e-3)" "unprognostic (1.99e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.60e-1)" "unprognostic (7.81e-2)" "unprognostic (3.47e-2)" "prognostic favorable (9.27e-6)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.97e-6)" "unprognostic (1.30e-1)" "unprognostic (6.40e-2)" "unprognostic (2.90e-3)" "unprognostic (4.57e-2)" 7.2 8.3 15.2 12.9 23.6 20.0 6.3 35.1 19.7 9.9 8.3 12.0 13.1 7.2 11.4 9.8 9.8 12.8 7.7 6.5 10.8 12.7 6.0 5.3 7.3 21.7 10.6 11.3 15.6 7.7 19.0 17.8 6.7 11.5 11.9 8.9 11.2 10.3 9.8 8.8 13.4 9.6 10.3 11.8 17.4 7.9 18.5 14.7 12.2 8.3 6.2 14.1 10.2 9.4 6.0 12.7 14.8 2.2 6.4 10.0 4.0 13.0 15.2 7.4 13.8 11.2 10.2 11.3 6.5 7.2 10.3 8.2 20.2 10.7 14.0 8.7 9.2 33.2 14.5 8.0 19.7 11.6 2.6 3.1 26.3 11.3 18.6 6.8 12.8 14.6 7.3 12.0 17.5 24.9 11.8 10.6 15.1 9.0 13.4 17.5 6.7 15.6 13.0 5.1 6.9 17.2 9.1 21.5 3.8 9.8 14.8 10.2 11.1 17.8 12.3 8.5 6.2 8.5 11.2 17.0 46.8 12.2 17.3 9.4 4.7 5.1 13.0 25.4 8.7 7.9 14.8 1.7 4.5 10.0 2.2 6.3 5.4 4.3 8.0 3.7 6.0 5.2 5.7 0.7 6.4 1.4 12.7 4.5 4.0 15.2 23.6 35.1 19.7 10.8 12.7 10.6 11.3 11.5 14.7 6.0 7.4 9.3 5.3 1.4 20.0 9.1 5.1 21.4 19.4 8.7 11.8 9.9 5.0 5.6 9.2 3.0 4.9 0.0 1.7 5.6 3.6 4.5 4.7 3.9 7.5 15.9 2.9 5.5 7.9 15.4 4.0 5.9 1.7 1.0 5.4 7.5 4.9 4.0 3.5 1.5 29.7 0.0 4.1 20.1 9.8 2.4 2.5 12.1 6.1 3.3 CEP290 "3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6" ENSG00000198707 "Centrosomal protein 290" O15078 12 88049014-88142216 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" Activator "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB029995, HPA043918, HPA064397" Approved Supported Centrosome NA NA Centrosome "CAB029995: , HPA043918: AB_2678730, HPA064397: AB_2685255" "unprognostic (7.42e-2)" "unprognostic (4.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "unprognostic (3.26e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-4)" "unprognostic (2.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.94e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.21e-6)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (2.44e-2)" "unprognostic (3.84e-3)" 7.0 7.7 14.4 15.5 17.2 9.3 9.8 15.2 19.5 10.0 8.1 5.4 7.6 5.2 13.3 11.8 4.9 10.6 7.3 6.4 11.3 10.9 7.9 4.7 7.0 8.2 13.2 13.4 17.7 6.7 21.7 22.4 8.3 12.7 10.4 7.5 4.9 4.8 7.7 4.0 7.0 6.1 8.7 14.0 7.5 7.6 15.7 15.5 8.9 12.1 4.1 6.4 8.5 7.5 9.3 5.7 1.9 1.9 3.2 6.5 0.7 8.6 8.0 10.2 4.7 8.7 18.1 5.1 10.7 6.6 5.5 5.1 11.5 5.2 8.7 4.2 5.4 7.9 9.3 3.9 4.8 9.2 5.8 6.8 7.5 5.5 5.8 8.0 9.7 4.2 8.4 5.8 11.5 10.9 16.5 10.4 9.0 14.6 3.2 10.8 4.1 6.8 12.6 4.0 2.2 9.5 4.9 12.0 6.7 7.5 8.8 7.8 9.5 6.3 4.7 8.1 9.0 11.1 5.0 11.1 13.8 6.4 8.9 10.2 9.0 10.6 9.1 4.4 4.9 5.7 0.0 1.6 1.9 5.4 1.1 5.6 6.5 5.5 5.2 0.7 9.3 5.6 6.5 0.3 3.2 1.9 5.7 4.2 0.7 14.4 17.2 15.2 19.5 11.3 10.9 13.2 13.4 12.7 15.5 80.4 28.0 13.4 16.3 5.7 62.7 49.5 28.1 115.1 51.2 27.9 96.2 10.3 6.6 22.2 50.4 23.2 6.3 23.3 11.3 8.1 15.0 9.7 18.5 5.0 11.9 62.0 4.7 12.9 6.4 20.6 26.4 9.4 13.5 7.2 15.1 37.2 15.7 3.5 35.3 8.7 153.7 32.3 12.5 108.8 38.7 4.8 4.7 16.6 14.0 6.7 CEP350 "CAP350, KIAA0480" ENSG00000135837 "Centrosomal protein 350" Q5VT06 1 179954738-180114880 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 741.2;Late spermatids: 585.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028355, HPA028357, HPA030845, CAB079754" Enhanced Enhanced Centrosome NA NA Centrosome "CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633" "unprognostic (9.52e-2)" "unprognostic (1.18e-1)" "unprognostic (2.78e-1)" "unprognostic (4.20e-2)" "unprognostic (3.68e-2)" "unprognostic (7.12e-3)" "unprognostic (5.17e-3)" "unprognostic (2.85e-1)" "unprognostic (3.65e-3)" "unprognostic (3.84e-2)" "unprognostic (4.86e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.22e-1)" "unprognostic (8.38e-2)" "unprognostic (1.46e-2)" "unprognostic (1.13e-1)" 17.2 11.3 13.8 18.9 18.0 26.5 14.0 23.1 14.8 15.3 16.9 13.1 10.5 11.1 13.9 11.9 13.4 11.9 10.8 12.8 13.1 9.4 11.4 12.6 12.4 16.9 17.7 12.3 18.0 13.7 27.2 25.5 14.4 16.2 11.6 13.9 9.0 13.5 12.1 44.2 15.1 22.1 11.5 14.6 17.8 13.4 28.8 18.5 29.8 13.9 11.6 16.5 17.0 20.1 7.2 5.9 8.1 3.7 3.2 6.1 1.3 12.9 9.4 12.2 4.3 10.3 9.6 11.4 8.8 11.9 7.6 8.4 10.4 7.8 14.4 9.6 8.0 6.6 16.1 9.1 5.1 10.0 13.9 6.3 10.2 11.9 6.5 11.3 20.1 9.6 9.6 8.0 9.9 13.1 5.6 9.3 13.7 19.8 10.9 8.2 9.5 11.8 5.6 11.3 12.7 2.4 10.3 13.4 11.1 5.4 27.1 8.6 9.1 14.7 9.9 16.8 9.0 10.7 18.2 9.5 10.9 7.6 9.6 9.3 19.1 24.1 28.1 5.1 8.7 16.1 2.3 3.7 8.1 5.4 3.4 6.1 4.1 3.9 3.4 3.0 7.2 4.2 3.5 7.3 3.2 3.0 5.9 5.7 1.3 13.8 18.0 23.1 14.8 13.1 9.4 17.7 12.3 16.2 18.5 110.2 57.9 32.6 27.9 33.8 54.3 69.8 28.1 71.0 53.4 12.2 80.5 16.2 5.0 20.5 741.2 46.8 32.1 23.3 33.4 20.9 31.5 29.9 27.8 25.1 25.1 58.8 44.4 71.2 59.9 585.2 49.8 51.5 18.6 83.8 25.2 34.6 32.4 21.0 39.6 8.4 50.5 25.8 38.7 171.0 27.4 40.8 22.0 43.7 25.5 37.7 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.6 4.5 10.7 13.0 6.7 7.5 10.0 4.3 8.1 6.0 8.9 6.3 11.8 5.1 10.3 8.0 22.8 9.6 9.7 8.6 13.5 9.0 6.4 14.6 10.5 8.2 10.5 0.7 5.4 40.3 5.0 4.5 11.2 16.0 8.6 16.8 10.6 17.1 9.8 8.2 15.3 0.8 6.3 5.7 10.2 16.9 13.9 13.1 11.4 9.7 13.0 8.5 22.5 5.4 25.5 12.8 27.1 7.1 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.4 9.8 1.4 15.0 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 29.8 54.7 0.8 31.2 8.7 15.6 23.2 17.8 48.2 38.7 19.2 33.4 5.9 61.3 18.3 163.4 7.1 4.6 0.0 15.5 3.6 6.2 27.5 19.7 12.4 2.2 20.6 15.0 4.9 0.8 214.6 9.2 3.3 10.1 1.0 9.5 19.7 13.7 7.0 12.0 17.0 29.1 6.5 11.8 140.5 9.1 7.0 8.0 4.9 22.3 24.8 CEP72 "FLJ10565, KIAA1519" ENSG00000112877 "Centrosomal protein 72" Q9P209 5 612272-667168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Melanocytes: 128.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.2;NK-cells: 7.7;T-cells: 3.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.0;HeLa: 21.8" "Region enriched" "Detected in single" 8 "cerebellum: 15.8" "Not detected" "Not detected" "HPA058235, HPA074879" Approved Supported Centrosome NA NA Centrosome "HPA058235: AB_2683649, HPA074879: AB_2686720" "unprognostic (2.06e-1)" "unprognostic (3.15e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (8.50e-2)" "unprognostic (9.74e-2)" "unprognostic (2.94e-3)" "unprognostic (3.20e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.38e-2)" "unprognostic (4.38e-3)" "unprognostic (1.81e-3)" "unprognostic (3.60e-2)" "unprognostic (2.93e-1)" "unprognostic (4.68e-2)" "unprognostic (1.24e-2)" 2.5 2.3 4.7 6.5 6.5 7.1 4.0 7.3 5.9 5.4 3.0 6.6 2.0 3.8 4.8 3.1 4.6 4.5 9.1 2.2 4.5 2.7 2.8 4.2 4.8 6.4 3.8 3.5 7.6 6.2 3.7 4.5 4.0 3.3 3.5 2.5 4.8 4.6 3.2 2.6 6.0 3.4 4.9 3.3 4.0 4.9 18.8 4.3 9.4 4.9 2.6 7.9 2.9 3.6 3.2 0.7 0.6 1.0 7.7 3.2 1.4 4.3 7.2 6.5 9.1 0.6 0.6 11.7 1.9 0.8 4.4 3.8 6.4 6.7 5.2 5.0 0.8 8.1 4.3 4.5 3.3 1.7 27.0 7.1 5.7 21.8 2.5 0.8 6.6 3.9 0.7 1.4 3.8 2.5 0.8 1.7 10.3 5.8 6.2 2.1 3.4 9.8 5.8 4.2 3.8 6.8 7.5 3.7 7.2 1.4 3.5 5.0 3.8 14.0 4.6 1.2 2.1 4.6 5.1 0.5 4.2 6.2 3.9 2.7 3.9 3.7 5.2 2.6 9.3 4.4 0.0 0.6 0.6 2.4 0.2 3.2 2.6 2.1 2.2 0.2 3.2 3.0 3.0 0.0 7.7 1.0 0.7 2.6 1.4 4.7 6.5 7.3 5.9 4.5 2.7 3.8 3.5 3.3 4.3 3.0 1.0 1.3 0.9 5.0 2.0 2.0 2.5 4.0 0.0 0.0 0.0 0.9 0.0 2.5 2.1 1.1 0.5 0.0 0.7 4.6 0.8 0.4 0.0 0.8 1.2 3.2 0.0 0.6 1.2 1.5 1.1 0.8 128.2 1.8 0.7 0.8 1.6 0.0 2.5 0.3 2.0 0.0 1.0 25.7 8.5 3.1 1.4 0.0 1.1 2.4 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234153-26279038 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.1 2.7 4.8 3.8 11.0 12.4 3.1 7.7 8.8 2.4 3.7 15.5 4.6 3.5 2.6 3.3 5.6 2.7 2.6 19.4 5.5 4.0 3.8 3.7 3.2 5.3 20.4 4.9 2.4 3.3 4.4 4.7 3.6 7.8 3.0 4.5 4.0 3.5 2.5 87.8 8.4 3.3 2.9 10.4 4.3 3.7 26.8 13.5 12.1 5.4 5.5 6.6 3.0 3.8 2.4 3.8 15.6 5.0 2.1 3.4 2.8 13.5 6.7 10.8 11.5 3.0 2.8 21.3 6.9 3.2 9.5 10.2 8.6 12.7 12.9 9.4 2.8 5.2 12.0 12.1 5.7 9.6 9.4 10.5 18.2 13.2 9.1 3.1 16.6 20.2 1.4 5.7 8.0 5.8 4.5 4.2 17.5 24.5 18.0 7.0 4.9 15.9 20.2 10.5 6.7 11.2 16.3 12.6 12.0 4.8 2.1 18.4 8.5 9.7 8.1 8.0 6.2 7.4 11.9 4.9 7.8 13.0 9.1 10.6 14.2 20.7 16.1 4.8 29.3 14.7 3.4 4.6 15.6 3.0 4.4 2.5 2.4 2.0 2.3 3.8 1.3 1.8 3.4 0.5 2.1 5.0 1.3 3.2 2.8 4.8 11.0 7.7 8.8 5.5 4.0 20.4 4.9 7.8 13.5 0.0 2.1 0.0 4.2 6.2 9.6 26.8 2.5 1.4 4.5 5.2 11.8 2.0 6.6 1.7 0.8 1.8 3.9 0.0 1.1 3.6 2.1 2.2 2.3 2.5 4.3 0.0 1.7 1.8 5.2 2.3 1.4 4.0 1.7 4.6 3.1 1.3 2.1 3.4 0.4 0.8 10.1 0.0 1.0 43.5 37.7 5.4 34.9 3.5 4.7 3.2 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 9.9 6.3 12.9 11.1 3.4 8.9 13.0 5.1 5.2 6.3 9.6 7.6 5.7 15.9 3.3 7.1 6.3 12.6 11.1 9.7 13.1 4.2 8.5 14.1 12.2 14.6 11.5 15.3 7.6 10.1 10.2 7.0 15.7 8.4 5.3 16.6 16.2 11.6 6.9 11.6 19.4 9.8 8.0 10.2 7.9 14.0 23.5 11.8 7.4 15.9 8.2 14.8 6.9 10.2 13.1 20.2 11.2 10.3 7.9 14.5 11.3 6.6 6.9 11.9 9.5 16.9 6.2 11.8 8.8 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 38.7 22.9 11.5 23.2 14.3 26.0 16.7 12.7 65.6 39.8 3.5 43.2 7.8 6.6 16.8 45.2 9.8 15.1 0.0 10.2 9.0 11.5 13.9 27.8 6.6 7.4 17.5 7.5 12.3 9.5 14.2 19.2 10.4 11.8 15.4 12.4 22.7 11.6 11.5 20.1 5.0 86.8 12.9 15.0 30.7 28.8 17.8 5.5 19.7 17.0 19.0 CETN3 CEN3 ENSG00000153140 "Centrin 3" O15182 5 90392261-90409786 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.1" "Cell type enriched" "Detected in all" 5 "Spermatocytes: 417.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035608, HPA063704" Enhanced Supported Centrosome NA NA Centrosome "HPA035608: AB_10601098, HPA063704: AB_2685097" "unprognostic (2.08e-1)" "unprognostic (7.31e-2)" "unprognostic (2.41e-1)" "unprognostic (1.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "prognostic unfavorable (2.22e-4)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (8.77e-2)" "unprognostic (5.03e-1)" "unprognostic (5.64e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.53e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" 8.6 11.6 13.7 8.0 16.3 3.6 12.4 11.5 17.9 11.5 8.9 8.7 8.9 5.2 11.0 11.5 11.4 12.0 5.6 14.4 15.6 11.4 10.6 6.9 12.1 9.3 18.2 13.2 17.1 5.8 11.8 34.3 10.0 20.6 10.3 10.7 5.9 7.8 9.7 11.7 8.2 5.6 7.7 37.2 7.6 6.7 63.1 16.5 7.3 7.9 6.1 10.5 7.5 9.6 17.2 19.9 9.4 10.5 11.4 14.9 4.7 16.1 7.1 29.0 5.9 16.3 22.2 17.4 17.7 10.9 17.0 21.2 10.8 19.9 30.6 17.7 8.3 32.8 11.6 24.7 23.9 28.1 24.5 11.4 15.6 10.7 13.5 11.7 11.4 9.7 13.9 15.7 12.4 20.6 17.6 10.6 23.9 19.6 13.7 19.0 10.7 18.9 18.1 10.2 5.7 18.5 17.2 20.2 15.6 15.0 6.0 15.9 16.2 17.2 8.8 12.5 26.9 16.7 15.5 11.9 10.2 14.6 14.2 23.6 12.8 22.7 27.2 12.0 25.9 10.3 7.8 6.7 9.4 9.3 8.1 9.7 17.2 10.3 9.9 7.4 14.6 14.9 11.9 0.8 11.4 10.5 19.9 8.0 4.7 13.7 16.3 11.5 17.9 15.6 11.4 18.2 13.2 20.6 16.5 17.9 31.4 22.9 31.3 12.7 17.9 44.5 22.9 77.6 27.3 34.9 17.7 56.1 81.2 17.8 15.5 19.2 7.9 46.7 8.9 55.5 21.6 16.4 5.8 38.4 22.1 20.6 23.1 49.1 23.8 25.0 40.9 8.8 18.6 19.8 18.7 79.2 11.7 18.4 30.4 29.3 24.5 58.2 23.1 417.2 55.6 13.8 34.9 20.8 22.4 16.2 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538947-219543787 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 137.8;Extravillous trophoblasts: 162.1;Syncytiotrophoblasts: 259.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" NA NA Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.96e-4)" 8.6 14.1 9.7 8.4 11.8 1.4 6.8 8.5 19.4 22.1 8.6 11.3 23.0 18.4 17.0 24.6 7.9 9.2 17.1 36.3 12.2 10.7 11.3 52.1 11.6 5.4 9.0 10.5 38.1 60.7 16.3 36.9 62.7 10.4 19.3 3.8 27.4 31.6 19.9 4.3 9.0 13.3 9.1 8.3 4.5 15.6 34.2 7.0 3.8 17.9 7.4 10.6 11.9 8.5 1.3 11.1 6.9 0.1 2.1 3.0 0.8 18.8 3.7 2.8 23.5 10.7 16.9 32.2 19.1 16.2 5.4 5.0 10.4 16.6 5.9 41.2 18.5 18.6 24.1 1.8 11.5 0.8 9.1 6.5 2.1 5.3 45.1 15.0 1.8 12.4 22.6 20.4 5.5 5.3 19.7 0.0 2.0 13.0 14.4 5.1 29.5 0.2 4.9 11.6 6.4 14.5 0.0 8.9 11.5 6.5 8.5 6.9 10.6 9.2 9.0 26.2 5.5 3.0 6.4 0.4 20.1 11.0 24.0 9.9 17.4 5.3 2.7 18.4 1.9 20.3 2.1 0.0 6.9 2.4 0.1 3.0 1.3 1.9 1.6 0.0 0.1 2.2 0.8 0.0 2.1 0.0 11.1 1.2 0.8 9.7 11.8 8.5 19.4 12.2 10.7 9.0 10.5 10.4 7.0 0.0 14.6 4.5 19.1 12.9 13.8 27.7 25.5 2.7 6.8 71.5 9.8 137.8 8.3 48.8 3.2 3.5 16.9 0.0 70.1 162.1 52.1 34.2 10.3 49.9 16.5 41.3 41.2 6.7 1.3 5.7 23.0 2.8 64.1 2.8 36.9 62.9 60.3 26.6 59.4 16.4 11.4 25.8 16.5 11.6 5.5 9.7 259.5 7.5 11.3 28.6 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007666-124093607 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 49.7;Kupffer cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.4" "Group enriched" "Detected in many" 10 "granulocytes: 29.4;monocytes: 15.4" "Cell line enhanced" "Detected in many" "Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol NA NA 560000 Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavorable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 16.4 10.0 8.7 17.0 20.6 5.7 10.7 3.4 17.9 9.8 15.4 6.6 4.0 8.8 8.6 10.8 11.3 13.1 11.7 6.4 11.3 5.3 9.0 11.9 13.9 35.4 6.5 9.6 35.0 12.6 2.9 7.7 5.9 9.2 8.5 8.3 14.4 8.2 13.4 11.0 8.3 12.5 9.5 9.0 31.5 11.4 4.8 8.7 2.8 19.3 6.1 12.6 12.5 12.0 2.1 2.0 29.4 15.4 0.0 0.1 3.2 12.8 8.7 3.2 0.7 3.2 1.7 0.0 2.6 3.5 1.4 2.0 0.2 7.0 0.0 8.5 10.7 0.9 14.7 0.6 8.5 1.2 0.0 2.4 0.0 3.9 6.4 1.0 0.0 16.6 1.0 9.8 4.0 3.4 3.5 2.8 0.0 0.0 27.6 7.0 7.1 0.0 0.0 2.8 1.9 0.0 36.3 4.4 8.5 7.1 1.2 0.3 0.7 7.0 3.9 0.0 8.4 2.9 0.0 3.3 0.3 0.1 10.1 0.4 25.1 6.0 6.9 0.1 0.0 0.0 0.0 8.8 6.2 0.0 14.0 0.0 2.0 0.0 0.0 1.8 2.1 0.1 0.0 29.4 0.0 15.4 2.0 0.1 3.2 8.7 20.6 3.4 17.9 11.3 5.3 6.5 9.6 9.2 8.7 20.8 11.1 9.7 14.5 14.9 4.4 2.2 7.6 9.4 9.1 19.2 0.0 1.5 0.0 8.2 24.2 10.8 0.0 0.0 0.6 1.9 2.7 14.0 5.7 6.4 9.4 0.0 1.7 49.7 47.8 27.7 9.5 23.2 1.7 1.8 0.0 0.1 5.9 0.0 1.8 0.3 0.3 19.4 11.3 8.4 9.2 10.2 0.8 2.2 0.0 15.2 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 89.5;Spermatocytes: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 460000 "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 13.7 25.5 20.6 11.5 25.7 18.6 12.5 34.6 32.9 11.3 14.6 16.5 7.3 10.2 13.7 10.4 11.7 9.5 10.1 16.6 19.2 19.3 9.7 37.7 8.5 14.1 18.8 21.1 23.8 7.9 20.0 20.8 13.8 33.0 13.5 15.0 9.1 8.7 12.0 26.3 10.7 9.9 16.1 22.5 8.8 12.9 25.4 22.2 28.6 8.0 10.8 14.7 12.6 9.7 8.6 8.4 6.0 8.7 11.7 10.0 3.6 26.4 25.6 55.0 23.5 13.0 20.5 12.8 30.4 18.5 28.9 30.8 20.8 9.0 28.9 10.7 20.4 31.0 30.1 39.4 17.2 36.4 26.0 30.1 48.2 20.5 20.0 9.7 36.7 20.2 10.4 9.2 16.2 35.2 15.1 21.8 25.4 34.0 27.1 23.9 18.2 31.2 9.5 29.5 19.7 20.6 33.1 58.5 25.3 9.3 16.3 25.6 21.8 41.3 14.8 15.1 25.4 27.3 10.0 18.7 28.1 24.9 47.7 44.8 15.4 33.2 41.6 17.6 17.4 27.5 5.4 5.7 6.0 9.0 8.7 8.8 8.6 6.7 10.0 8.4 8.0 8.2 8.5 0.9 11.7 7.8 5.4 7.5 3.6 20.6 25.7 34.6 31.2 19.2 19.3 18.8 21.1 33.0 22.2 23.8 20.5 16.4 7.9 7.6 18.2 57.6 10.2 33.5 21.6 8.7 35.3 13.2 8.3 10.6 89.5 13.5 8.1 0.0 6.6 12.2 13.2 11.2 35.9 6.2 16.0 12.7 11.6 14.1 12.9 37.9 18.1 13.5 6.8 16.2 14.1 14.9 12.6 12.4 27.3 8.7 24.2 19.4 6.6 81.4 60.7 10.2 9.6 9.6 14.9 7.8 CLEC11A "CLECSF3, LSLCL, P47, SCGF" ENSG00000105472 "C-type lectin domain containing 11A" Q9Y240 19 50723329-50725718 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.1" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 101.2;Fibroblasts: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 17.2" "Group enriched" "Detected in many" 4 "dendritic cells: 12.0;monocytes: 17.2" "Group enriched" "Detected in many" 4 "HEL: 45.4;HMC-1: 84.1;NB-4: 111.7;THP-1: 90.3;U-937: 46.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042690 Approved Approved Centrosome "Secreted in other tissues" NA NA 45000 Centrosome "HPA042690: AB_10795511" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.40e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.33e-1)" "unprognostic (8.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.29e-2)" "unprognostic (5.26e-2)" "unprognostic (4.99e-2)" "unprognostic (2.79e-2)" "unprognostic (8.30e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (6.09e-2)" "unprognostic (8.66e-3)" "unprognostic (4.00e-2)" "unprognostic (1.57e-2)" 5.5 5.4 3.0 5.6 3.1 77.1 4.5 4.5 3.6 33.6 6.5 1.2 6.7 3.9 26.6 27.8 6.7 13.5 10.7 5.6 2.6 3.4 7.4 5.4 7.5 3.5 2.9 1.3 16.1 2.6 2.0 7.5 6.9 4.0 18.9 2.1 8.9 2.9 10.2 3.4 5.0 5.2 8.5 3.4 4.9 3.1 4.9 0.8 4.0 3.8 4.5 2.6 8.4 10.1 0.3 12.0 1.2 17.2 3.4 3.2 6.7 0.3 0.4 0.0 0.3 4.4 6.0 10.3 17.7 4.8 2.0 2.0 0.0 0.0 0.0 0.2 8.8 0.1 0.2 0.0 0.0 1.4 0.0 2.9 45.4 0.0 0.0 2.8 0.0 84.1 4.4 0.0 0.2 0.2 0.0 2.2 2.0 0.5 0.3 3.7 0.3 0.3 111.7 0.2 0.0 0.5 3.8 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 6.8 0.0 0.1 90.3 12.7 0.1 5.5 0.0 0.1 0.2 0.2 0.0 6.4 46.9 5.8 1.0 17.2 0.2 0.6 7.2 0.0 0.3 0.2 0.1 12.0 0.3 1.5 3.2 1.2 3.4 3.3 3.2 0.1 6.7 3.0 3.1 4.5 3.6 2.6 3.4 2.9 1.3 4.0 0.8 3.0 4.8 1.4 26.8 28.4 18.8 2.8 10.2 5.3 3.4 27.9 9.8 8.6 101.2 10.9 4.6 14.5 0.7 0.0 2.6 36.0 98.6 20.9 5.7 4.4 44.2 20.6 25.4 62.6 21.5 13.3 65.6 36.7 74.2 4.6 3.4 42.6 5.0 1.4 63.3 6.3 17.5 64.7 31.1 20.5 10.0 40.1 15.3 4.3 3.4 13.1 CLHC1 "C2orf63, FLJ31438" ENSG00000162994 "Clathrin heavy chain linker domain containing 1" Q8NHS4 2 55174791-55232563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 44.2;Early spermatids: 38.5;Late spermatids: 28.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045418, HPA053557" Uncertain Approved "Nucleoli fibrillar center,Centrosome" NA NA "Nucleoli fibrillar center, Centrosome" "HPA045418: AB_10962144, HPA053557: AB_2682188" "unprognostic (1.60e-1)" "unprognostic (2.86e-1)" "unprognostic (3.43e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.91e-2)" "unprognostic (6.41e-3)" "unprognostic (1.03e-3)" "unprognostic (1.39e-1)" "unprognostic (3.54e-4)" "unprognostic (6.36e-2)" "unprognostic (1.05e-4)" "unprognostic (1.84e-1)" "unprognostic (1.47e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.15e-4)" 4.8 5.7 10.4 3.6 8.7 3.5 6.7 15.7 11.9 6.0 5.3 12.9 9.3 3.9 8.5 9.8 5.5 9.5 6.2 4.6 8.2 5.1 5.2 3.5 5.3 6.6 6.0 8.3 7.4 5.5 8.4 23.6 6.9 8.9 9.1 6.6 8.9 5.8 8.9 3.0 9.6 5.6 7.1 12.0 7.2 4.9 23.2 8.8 10.1 8.3 1.6 5.2 6.6 6.1 1.3 2.9 4.0 2.0 3.2 2.1 1.0 4.3 3.2 8.2 4.9 3.4 4.6 7.2 5.7 5.4 2.9 2.7 6.3 4.0 6.4 3.4 2.6 3.5 6.6 3.5 4.9 6.0 5.7 4.1 9.2 9.6 5.7 3.7 5.6 4.6 6.6 4.0 3.6 8.3 8.1 2.8 5.8 4.7 3.8 3.3 3.5 4.1 6.2 3.0 1.7 1.3 5.0 4.7 4.0 4.6 5.0 9.5 5.8 3.3 5.4 5.4 6.7 4.0 3.1 8.4 7.3 4.9 3.4 4.0 7.5 1.9 3.7 5.4 5.7 1.8 1.2 0.6 4.0 0.9 2.0 0.1 1.2 1.7 0.9 1.0 1.3 2.1 1.0 0.4 3.2 1.6 2.9 1.1 1.0 10.4 8.7 15.7 11.9 8.2 5.1 6.0 8.3 8.9 8.8 0.0 2.6 2.4 4.8 1.6 11.3 3.7 0.0 44.2 10.3 3.5 15.7 2.8 5.0 3.7 38.5 2.2 1.1 0.0 1.2 1.5 2.5 4.0 0.0 0.2 2.0 9.5 7.0 6.2 4.7 28.8 3.7 2.9 1.7 1.0 2.0 8.0 1.0 0.0 5.3 2.4 20.6 0.0 1.8 20.2 2.1 1.9 2.9 1.0 3.2 3.6 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 66.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: AB_2677487" "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 12.3 12.6 11.3 15.2 12.4 16.6 14.0 14.2 13.4 13.4 14.0 12.5 12.8 10.8 19.8 13.5 14.8 16.1 9.8 13.0 10.5 9.4 13.1 13.5 11.4 14.7 9.7 11.9 14.7 14.0 16.0 23.0 11.3 13.3 13.1 15.7 12.2 12.0 10.9 13.5 14.9 14.7 12.8 10.5 15.1 12.2 40.5 10.9 30.2 13.8 11.9 17.4 13.0 12.6 15.0 14.1 16.0 21.0 9.0 18.5 11.2 8.4 9.5 9.9 9.3 4.8 5.5 66.1 7.1 7.2 10.2 11.5 7.2 7.3 13.9 4.8 5.1 6.6 7.4 11.7 9.4 10.2 12.0 12.0 17.8 8.6 6.9 14.0 14.6 6.9 4.0 8.5 11.2 14.9 6.8 8.3 13.0 18.5 10.8 5.9 6.9 13.0 7.1 14.9 9.8 9.1 13.2 6.7 13.8 6.5 9.9 5.6 10.9 10.5 14.8 8.6 7.3 14.4 16.6 5.1 6.3 9.0 8.3 11.8 11.2 22.9 13.9 6.5 11.1 7.6 12.8 11.2 16.0 11.4 15.7 12.3 14.8 18.5 13.6 14.1 15.0 18.5 16.2 8.8 9.0 21.0 7.8 14.4 11.2 11.3 12.4 14.2 13.4 10.5 9.4 9.7 11.9 13.3 10.9 14.9 21.4 14.3 5.8 9.3 15.9 10.8 7.6 32.1 15.9 14.0 31.4 11.6 5.0 11.2 42.3 11.4 11.8 0.0 11.7 14.6 9.8 6.0 10.4 8.5 10.3 14.3 15.0 11.1 14.8 29.1 8.9 12.9 11.8 47.7 8.3 8.0 9.9 14.4 9.9 5.6 18.7 6.5 10.6 35.7 32.4 12.7 6.9 18.3 13.6 6.7 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 58.9;Spermatogonia: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.9" "Lineage enriched" "Detected in many" 4 "monocytes: 6.9" "Cell line enhanced" "Detected in many" "HEL: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 13.2 5.6 4.3 5.2 5.1 12.5 7.4 15.5 4.5 16.6 8.6 4.2 6.7 2.2 22.6 6.0 6.0 8.0 7.4 4.9 4.2 3.8 5.0 20.0 5.4 4.8 4.9 2.6 15.2 3.6 10.0 13.2 6.1 6.3 9.8 4.0 7.0 3.8 6.3 5.9 3.5 4.4 11.9 8.1 8.6 4.4 8.2 6.8 4.4 5.5 5.8 2.8 11.7 13.5 0.3 1.5 0.8 6.9 1.2 0.2 0.5 5.9 4.1 9.0 5.1 4.5 10.5 0.3 7.0 4.7 5.2 7.2 0.3 2.0 4.3 1.1 4.8 5.7 0.3 10.4 2.9 8.2 0.2 3.7 25.5 8.7 1.5 4.9 3.5 5.6 6.6 1.5 4.4 4.3 4.9 7.4 1.6 0.9 1.0 8.3 0.5 2.8 5.6 7.0 1.0 7.7 4.2 8.3 2.1 3.0 1.5 5.7 5.9 8.5 0.2 2.2 3.7 1.7 8.9 5.4 7.2 2.8 7.8 6.0 3.6 4.3 0.1 3.4 4.4 3.2 0.6 2.7 0.1 0.1 3.3 0.0 0.3 0.2 0.1 1.5 0.3 0.1 0.1 0.8 1.2 6.9 1.5 0.2 0.5 4.3 5.1 15.5 4.5 4.2 3.8 4.9 2.6 6.3 6.8 6.0 14.5 0.8 12.1 7.8 9.1 10.6 5.1 2.7 2.3 8.7 0.0 1.5 5.0 7.5 13.2 20.3 1.3 23.3 10.4 4.0 13.6 3.2 7.0 35.9 15.7 19.1 2.4 19.6 34.5 6.5 42.3 18.3 8.5 26.2 2.6 25.0 4.2 0.0 29.0 6.3 8.4 12.9 15.0 58.9 51.1 4.8 0.8 3.2 3.0 3.5 CNTRL "CEP1, CEP110" ENSG00000119397 Centriolin Q7Z7A1 9 121074863-121177610 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 156.6;Spermatocytes: 334.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 35.4" "Low region specificity" "Detected in all" "HPA020468, HPA020480, HPA051583" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542" "unprognostic (4.33e-3)" "unprognostic (2.89e-3)" "unprognostic (2.09e-2)" "unprognostic (7.97e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.21e-5)" "unprognostic (1.05e-2)" "unprognostic (3.22e-3)" "unprognostic (3.74e-3)" "unprognostic (2.02e-1)" "unprognostic (1.78e-2)" "unprognostic (5.47e-2)" "unprognostic (3.60e-3)" "unprognostic (9.83e-3)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" "unprognostic (1.13e-2)" 7.7 4.7 5.5 22.2 11.7 24.0 6.8 10.9 8.7 8.4 5.5 4.9 5.9 3.8 7.3 6.4 5.6 8.4 5.1 4.4 6.6 4.3 4.0 3.8 9.3 20.3 8.1 4.1 10.6 5.2 4.0 17.3 5.8 7.0 7.2 5.5 4.4 6.3 8.6 2.8 5.2 8.8 5.7 9.7 14.8 7.1 30.2 9.8 26.7 6.2 4.2 19.2 8.6 7.1 12.7 10.5 15.0 6.9 4.8 10.4 2.5 5.4 3.6 10.2 7.3 1.5 2.3 1.8 3.8 2.8 3.0 2.6 2.1 6.0 25.1 1.5 2.7 5.4 11.5 3.4 2.3 4.9 15.1 2.6 13.1 6.7 2.5 2.1 35.4 15.9 1.4 1.7 3.1 7.6 1.3 6.5 10.4 8.4 14.3 2.9 3.5 13.9 12.1 3.5 7.0 3.0 13.1 15.4 7.2 1.4 2.5 3.8 5.8 12.9 2.3 2.9 1.8 4.9 17.0 4.8 3.2 5.5 4.9 7.0 10.0 10.9 17.0 2.6 14.6 7.2 12.2 6.9 15.0 7.5 4.5 5.7 10.8 7.7 5.5 3.4 12.7 9.3 6.6 2.7 4.8 5.8 10.5 10.4 2.5 5.5 11.7 10.9 8.7 6.6 4.3 8.1 4.1 7.0 9.8 26.8 26.2 35.1 12.7 3.0 28.2 7.0 5.1 156.6 48.9 3.5 35.3 1.5 3.3 3.8 56.2 14.4 2.1 0.0 5.2 2.1 5.9 3.8 49.9 2.0 22.5 28.6 8.1 12.3 34.6 27.0 12.7 37.9 8.5 22.6 7.3 7.0 5.3 3.5 11.3 1.1 64.1 38.8 5.1 334.4 72.6 5.0 0.7 29.8 5.2 4.7 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949918 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 9.0 7.4 7.5 9.2 10.1 18.4 9.3 11.2 12.7 13.0 10.9 9.8 9.9 6.8 21.3 12.6 11.0 10.4 9.0 7.1 9.5 8.0 9.2 8.7 15.0 8.4 9.3 9.9 11.4 11.0 16.5 9.6 9.9 9.9 9.9 12.5 10.3 9.6 8.6 6.8 16.9 9.1 16.3 7.0 9.9 8.4 51.2 6.4 16.0 10.4 6.2 11.2 9.3 10.0 2.1 7.6 9.4 3.4 3.4 3.5 2.6 22.3 14.7 21.9 12.1 9.3 12.8 7.1 19.5 18.3 27.3 20.9 12.4 8.3 23.0 10.3 17.0 12.2 18.0 17.0 13.6 30.6 22.6 13.3 15.2 24.0 9.8 13.7 14.1 23.6 11.7 10.1 19.2 19.4 13.2 16.8 23.1 11.0 11.3 18.9 7.2 21.4 13.6 4.9 8.1 11.5 22.8 15.1 8.6 12.6 6.9 7.2 12.9 15.8 8.1 6.2 12.2 11.0 9.0 13.7 15.3 13.0 20.6 26.8 17.3 11.6 15.9 13.1 18.1 21.7 9.4 2.5 1.0 2.9 3.4 2.6 2.1 2.2 3.5 1.7 1.5 1.4 2.4 0.4 3.4 1.4 7.6 2.9 2.6 7.5 10.1 11.2 12.7 9.5 8.0 9.3 9.9 9.9 6.4 6.0 15.8 4.5 6.8 7.0 5.8 3.0 5.1 4.0 7.9 12.2 7.9 3.3 1.7 4.4 2.1 5.8 3.6 0.0 6.0 3.6 5.0 5.0 18.4 3.4 5.7 3.2 2.9 5.5 5.9 3.4 4.9 7.2 3.3 0.0 5.6 5.3 5.0 3.5 7.4 2.6 6.5 0.0 3.5 40.6 8.3 7.5 2.1 4.9 7.3 4.1 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" NA NA 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: AB_2667054" "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 8.9 1.7 7.1 0.7 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.3 0.2 3.4 0.7 0.7 0.0 13.0 0.0 3.6 49.0 0.5 0.0 0.0 17.3 3.6 0.0 0.0 17.2 0.0 0.0 0.0 0.3 1.8 2.4 0.0 0.4 5.6 0.0 2.0 0.0 0.0 0.1 0.1 0.5 69.0 22.8 101.3 12.7 0.0 59.1 7.6 0.3 0.0 2.7 7.0 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 0.0 9.3 0.0 67.8 23.2 533.2 32.3 40.8 0.0 3.4 21.0 585.1 0.4 0.0 15.1 5.5 57.1 1.6 0.0 1.5 0.1 129.4 402.2 0.0 7.9 0.8 66.7 564.2 115.4 9.2 11.5 463.7 12.5 82.7 1.8 12.7 511.1 19.3 2.9 583.8 9.6 443.0 840.8 614.9 17.7 9.6 18.2 0.7 1.9 3.7 11.3 CPT1C "CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 39.6;Horizontal cells: 30.2;Late spermatids: 17.8;Rod photoreceptor cells: 18.1" "Cancer enhanced" "Detected in many" "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.8;AN3-CA: 15.8;SCLC-21H: 13.1;SH-SY5Y: 33.9;U-87 MG: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome NA NA Centrosome "HPA014529: AB_1847206, HPA063621: AB_2732706" "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 9.3 11.2 3.1 18.9 0.8 1.1 16.3 34.0 4.1 1.9 8.9 0.2 2.7 6.4 5.3 1.8 4.1 7.6 2.8 11.9 12.8 1.6 1.6 2.5 2.6 8.0 13.4 3.8 1.2 0.7 15.6 1.9 11.4 2.8 1.7 7.4 1.5 4.8 1.7 1.5 2.4 7.8 6.6 4.2 1.4 4.1 6.3 0.0 1.7 0.2 1.7 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 18.8 15.8 6.8 5.4 0.0 6.0 11.9 7.7 10.8 0.3 0.0 0.3 0.0 5.9 0.9 1.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 11.1 0.0 0.0 6.2 0.0 6.2 0.0 2.0 10.6 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.8 1.2 3.9 0.0 0.0 0.0 0.4 0.0 13.1 33.9 0.0 0.0 0.0 0.3 0.0 0.0 8.6 0.4 0.1 3.6 3.0 0.1 1.4 0.1 14.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.2 18.9 16.3 23.4 11.9 12.8 8.0 13.4 11.4 6.3 0.0 0.0 0.0 3.3 1.9 39.6 1.2 2.5 0.0 0.0 0.0 15.7 0.8 0.0 0.0 7.9 4.5 0.0 0.0 0.0 3.6 3.1 1.5 0.0 0.0 0.3 30.2 0.0 3.1 1.2 17.8 3.1 0.0 0.0 0.0 0.0 14.9 0.5 0.0 12.4 0.0 18.1 0.0 5.3 2.7 6.9 1.6 0.9 0.0 0.0 0.9 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 911.2;Ciliated cells: 2667.4;Club cells: 874.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 110.7;CAPAN-2: 61.7;HaCaT: 66.8;HDLM-2: 47.3;HeLa: 54.3;OE19: 188.5;T-47d: 86.8" "Low region specificity" "Detected in all" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 44.3 3.3 3.8 37.5 4.9 5.5 97.2 3.2 4.0 37.7 44.0 4.5 65.3 25.7 20.0 83.0 28.4 23.7 33.8 45.5 4.5 4.7 20.4 2.6 56.7 53.0 4.7 4.5 11.2 4.2 1.1 7.3 38.5 4.8 11.7 13.2 9.9 21.8 71.0 12.9 48.8 106.3 25.9 5.1 16.6 20.3 7.5 1.9 24.2 32.0 83.4 58.3 18.4 18.9 111.4 79.3 56.3 49.4 56.9 121.1 75.8 0.0 110.7 0.7 0.1 1.9 1.4 10.3 0.2 0.0 1.5 0.0 3.4 61.7 33.4 0.6 29.5 0.4 66.8 0.0 0.0 0.1 47.3 0.0 2.6 54.3 18.6 0.4 0.0 0.0 0.6 0.0 3.6 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.9 1.7 0.3 1.0 188.5 5.7 26.2 0.0 6.9 0.0 0.0 2.9 0.2 0.4 0.1 0.0 0.1 86.8 15.9 0.2 0.0 0.1 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.1 19.4 43.3 56.3 47.7 38.5 32.7 111.4 92.1 51.4 79.3 43.6 21.9 25.7 2.9 56.9 49.4 62.1 121.1 75.8 3.8 4.9 3.2 4.0 4.5 4.7 4.7 4.5 4.8 1.9 911.2 276.7 125.9 1.0 165.7 0.0 0.8 2.5 2667.4 874.7 48.8 0.0 0.5 1.7 9.2 2.8 10.9 494.0 0.0 2.8 3.1 16.3 0.4 486.4 0.8 53.8 0.0 73.6 27.0 188.7 20.7 23.3 296.9 350.9 697.9 172.6 0.2 20.6 407.1 8.9 2.2 0.0 219.9 30.1 0.1 10.4 219.9 1.3 239.7 156.7 2.6 CRMP1 "DPYSL1, DRP-1" ENSG00000072832 "Collapsin response mediator protein 1" Q14194 4 5748084-5893058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.1;pituitary gland: 23.0" "Group enriched" "Detected in some" 6 "Bipolar cells: 117.0;Horizontal cells: 198.6;Muller glia cells: 68.8" "Cancer enhanced" "Detected in all" "glioma: 37.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 25 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "AF22: 20.8;HAP1: 29.8;NTERA-2: 21.6;REH: 56.6;RH-30: 33.4;SCLC-21H: 43.3;SH-SY5Y: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035640, CAB037313" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "CAB037313: AB_1078571, HPA035640: AB_10670838" "unprognostic (1.56e-1)" "unprognostic (7.22e-2)" "unprognostic (5.14e-2)" "unprognostic (8.08e-3)" "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (1.84e-2)" "unprognostic (1.20e-1)" "unprognostic (2.79e-1)" "unprognostic (9.71e-2)" "prognostic favorable (4.54e-4)" "unprognostic (2.26e-1)" "unprognostic (8.52e-3)" "unprognostic (1.21e-2)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.60e-3)" 1.8 8.2 24.2 2.5 21.7 0.7 1.0 32.0 63.1 3.3 2.0 5.9 0.1 1.5 11.7 0.7 2.7 4.3 4.3 2.6 22.2 23.9 2.4 0.9 4.2 1.8 9.9 18.1 6.9 4.8 0.9 23.0 4.6 12.3 3.0 1.9 4.6 2.6 3.1 1.0 3.3 2.5 11.6 4.7 1.4 3.5 2.8 4.5 0.0 2.4 0.9 1.3 2.9 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 20.8 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 7.0 0.5 29.8 0.0 0.0 0.5 0.2 0.0 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 21.6 0.0 0.6 56.6 33.4 5.0 0.0 0.0 43.3 27.4 0.0 0.1 0.3 14.6 0.2 0.0 1.7 1.0 7.2 0.6 0.6 3.8 0.5 0.0 2.5 0.2 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 21.7 32.0 34.2 22.2 23.9 9.9 18.1 12.3 4.5 0.0 1.4 0.0 0.0 0.3 117.0 0.8 0.0 0.0 0.0 0.0 17.7 0.1 0.0 0.0 1.0 2.7 0.0 0.0 0.0 0.1 3.1 0.4 0.0 0.0 0.4 198.6 2.4 0.0 0.0 3.8 0.6 0.0 1.7 0.0 0.0 68.8 0.7 0.0 0.4 0.0 20.1 6.5 2.5 0.6 9.8 0.1 0.2 0.0 0.0 0.0 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972979 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 135.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" NA NA "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favorable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favorable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 5.0 3.8 3.2 3.2 7.0 2.1 2.5 12.9 3.0 3.9 2.8 5.4 2.2 2.4 5.1 2.4 3.2 9.9 2.3 2.1 4.6 3.5 2.4 1.8 3.9 3.2 2.1 2.5 5.0 4.2 3.0 3.6 2.2 11.3 3.3 0.6 30.6 135.2 2.9 8.2 14.4 3.1 1.8 2.3 6.4 3.5 1.9 4.3 2.1 2.5 2.3 1.8 2.9 3.8 1.1 0.6 1.7 0.8 1.3 2.8 0.6 4.1 1.7 3.2 3.2 2.3 2.1 1.3 3.0 1.0 1.0 1.1 0.2 1.9 10.9 2.8 1.2 0.3 5.0 0.8 2.2 0.1 0.9 5.8 5.0 5.3 0.8 3.9 0.3 5.1 1.8 5.2 0.9 0.9 1.7 1.6 7.9 0.7 2.8 0.3 3.5 3.3 1.2 11.6 0.9 2.7 3.1 4.2 3.7 0.7 1.2 9.9 10.6 3.2 2.1 9.7 1.0 4.2 1.4 4.4 2.8 3.7 7.0 2.3 5.0 3.6 2.2 2.8 0.7 3.3 0.0 0.4 1.7 1.6 0.8 2.8 0.7 1.3 1.3 0.2 1.1 1.1 0.9 0.1 1.3 0.3 0.6 1.3 0.6 3.2 7.0 12.9 3.0 4.6 3.5 2.1 2.5 11.3 4.3 0.0 5.8 0.5 4.2 5.6 20.9 3.2 2.5 14.7 3.4 5.2 25.5 1.1 0.0 4.8 3.5 6.8 0.7 0.0 2.0 5.8 4.5 2.1 1.1 2.4 2.0 3.2 3.5 6.7 2.2 1.9 17.8 2.2 5.0 2.8 3.7 11.9 3.2 2.3 12.0 1.3 111.2 0.0 9.2 1.4 13.2 4.4 0.9 3.8 2.5 1.4 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 296.8;granulocytes: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.6 14.4 13.8 10.8 10.0 8.3 21.9 10.0 10.5 24.1 21.3 53.9 12.7 17.4 14.7 10.1 23.3 16.8 18.6 23.7 26.0 8.4 9.2 57.1 7.9 26.3 10.4 18.0 76.0 8.7 14.1 13.6 13.6 8.4 14.3 25.0 15.4 7.2 12.8 12.9 29.2 24.0 12.5 17.6 21.0 20.6 26.8 13.1 10.5 13.1 11.1 13.3 17.4 24.9 17.6 13.4 12.3 14.5 10.6 24.1 14.4 15.8 16.2 8.4 10.6 20.3 17.0 11.3 12.7 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 26.8 26.6 37.0 27.7 20.3 25.3 35.5 20.4 21.4 31.8 17.4 17.7 122.6 31.5 25.9 296.8 26.1 24.4 0.0 30.3 56.0 26.8 18.9 250.2 39.2 44.0 17.5 20.1 31.3 29.7 86.0 31.7 43.3 25.3 129.0 23.0 28.3 25.6 19.8 31.5 32.3 21.0 19.4 40.1 76.5 43.0 19.6 44.3 32.4 19.5 18.6 CUEDC1 ENSG00000180891 "CUE domain containing 1" Q9NWM3 17 57861243-57955323 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 17.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.6" "Cell line enhanced" "Detected in many" "T-47d: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023050, HPA024836" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023050: AB_1847332, HPA024836: AB_1847333" "unprognostic (4.46e-1)" "unprognostic (3.76e-3)" "unprognostic (4.77e-2)" "unprognostic (4.87e-3)" "unprognostic (4.04e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (6.69e-2)" "unprognostic (1.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (2.52e-2)" "unprognostic (2.65e-2)" 9.8 10.6 11.7 8.6 19.3 5.2 9.3 8.5 16.6 22.3 18.5 39.1 11.8 5.0 13.4 13.9 21.2 21.6 12.9 24.2 12.6 12.1 12.0 3.7 13.7 4.4 30.0 8.0 6.4 11.6 7.1 11.5 7.8 18.5 13.0 7.2 19.3 19.1 18.4 48.9 5.5 7.3 19.2 18.7 6.6 12.2 2.9 28.3 2.5 11.2 15.8 4.7 15.4 10.4 0.0 17.6 1.8 1.3 0.1 0.0 0.1 8.3 25.9 27.1 4.8 4.4 8.1 0.9 5.9 12.0 12.5 9.0 4.7 32.2 0.1 24.2 11.4 10.6 6.7 2.9 12.7 4.4 16.3 5.0 0.3 16.8 3.9 10.7 0.1 2.0 8.3 7.7 7.2 6.1 11.0 6.0 0.1 0.3 0.1 11.4 4.7 0.4 0.2 0.9 9.6 7.1 0.8 7.0 1.2 8.5 5.5 11.2 6.1 2.5 2.7 10.2 4.8 37.5 0.9 7.6 33.4 21.1 9.1 13.1 0.0 0.1 0.1 14.5 1.1 26.6 0.6 0.4 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 1.3 17.6 0.0 0.1 11.7 19.3 8.5 15.4 12.6 12.1 30.0 8.0 18.5 28.3 17.9 5.1 1.3 13.8 3.7 32.2 15.6 10.2 12.0 10.3 21.0 60.9 0.6 6.6 20.2 0.3 8.4 4.5 0.0 22.5 0.2 10.6 18.5 0.0 2.9 14.5 9.5 3.4 2.5 9.7 2.3 6.4 6.8 5.0 3.6 4.6 25.1 20.7 0.0 4.9 7.1 59.5 6.5 10.4 0.0 0.4 2.0 0.6 0.0 5.5 15.4 CXorf56 FLJ22965 ENSG00000018610 "Chromosome X open reading frame 56" Q9H5V9 X 119538149-119565408 "Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038245, HPA038617, HPA064831" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364" "prognostic unfavorable (3.45e-4)" "unprognostic (3.88e-3)" "unprognostic (7.82e-2)" "unprognostic (1.03e-3)" "unprognostic (8.92e-2)" "unprognostic (7.74e-3)" "unprognostic (6.38e-3)" "unprognostic (3.89e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-2)" "unprognostic (9.63e-3)" "unprognostic (1.68e-3)" "unprognostic (9.26e-3)" "unprognostic (4.68e-3)" "unprognostic (1.45e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-1)" 15.9 14.5 18.7 12.7 29.1 19.1 21.1 21.0 24.2 15.0 15.6 18.3 15.1 12.3 17.6 14.5 13.6 17.6 12.4 16.3 16.0 20.5 18.2 14.3 14.6 15.7 18.0 21.3 24.0 16.3 20.5 12.6 29.0 20.2 15.3 15.0 18.6 14.6 16.1 16.4 17.4 12.5 16.2 17.8 15.0 13.0 12.7 17.6 12.8 20.2 13.2 19.0 14.4 13.1 19.4 12.0 16.8 15.4 7.7 12.9 10.9 16.5 19.4 11.7 13.3 13.4 9.8 15.0 11.4 11.8 17.9 16.2 16.8 16.8 26.1 28.7 13.3 37.4 11.0 29.5 15.1 25.2 15.7 22.3 9.3 17.7 11.2 10.7 25.8 15.0 10.8 13.1 21.9 18.8 10.4 12.5 16.5 20.9 16.7 8.7 29.0 16.2 13.6 17.5 21.9 20.1 15.8 12.1 19.7 10.7 13.0 8.1 14.1 22.1 12.3 15.3 13.4 10.2 11.3 12.0 10.8 7.5 20.0 24.1 14.5 25.6 26.6 9.8 25.3 13.8 5.7 12.8 16.8 12.4 15.4 11.4 13.5 10.8 12.9 12.0 19.4 11.1 10.5 6.5 7.7 14.1 11.3 12.4 10.9 18.7 29.1 21.0 24.2 16.0 20.5 18.0 21.3 20.2 17.6 3.0 11.5 11.1 7.2 5.6 15.6 10.6 5.1 8.1 4.5 3.5 5.9 16.9 18.3 7.7 1.2 6.8 8.1 0.0 5.8 16.9 6.7 4.9 17.3 3.9 8.9 7.9 8.2 4.9 10.5 1.0 8.9 7.4 11.8 19.8 5.6 17.0 5.8 8.5 10.6 10.5 10.2 12.9 9.1 3.4 7.8 5.1 29.7 5.7 8.4 7.3 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708633 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 94.7" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 55 "dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9" "Cell line enhanced" "Detected in many" "HMC-1: 38.8;HUVEC TERT2: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome NA NA Centrosome "CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390" "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 14.6 4.9 10.4 8.8 25.5 3.8 4.1 2.9 17.6 8.1 16.6 6.5 8.1 7.8 8.7 16.1 4.5 12.2 21.6 4.1 12.4 8.1 14.7 21.3 28.6 8.5 4.6 10.4 32.7 21.2 4.8 16.6 94.7 6.6 5.1 7.5 5.9 9.3 7.3 1.5 3.7 11.0 8.1 4.8 16.4 15.0 6.3 7.3 34.5 7.2 1.5 5.2 13.2 10.5 0.1 5.3 6.9 11.9 0.1 0.1 2.1 0.0 18.3 8.8 6.2 0.2 0.1 14.0 1.2 1.7 7.2 8.2 2.6 0.1 0.1 1.8 0.3 0.1 17.1 5.4 0.4 3.1 0.1 4.4 8.8 2.5 8.9 7.9 0.0 38.8 0.5 2.9 1.3 0.5 11.3 22.0 2.5 6.6 3.7 6.0 0.5 2.6 0.0 10.0 16.9 0.0 0.7 7.8 0.0 20.1 18.3 4.0 4.5 0.0 1.8 7.7 13.5 0.0 5.8 0.1 0.0 0.1 0.0 0.0 14.6 3.0 0.0 0.1 2.4 1.2 1.3 5.3 6.9 0.0 11.9 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 1.6 0.1 11.7 5.3 0.0 2.1 10.4 25.5 2.9 17.6 12.4 8.1 4.6 10.4 6.6 7.3 47.6 65.3 5.9 0.6 3.2 19.8 1.9 40.8 16.0 40.9 21.0 2.0 5.6 1.7 27.2 1.2 13.0 2.1 0.0 20.1 14.4 11.4 3.9 23.1 16.3 21.3 17.5 0.0 79.2 64.1 2.2 13.8 42.1 11.8 30.7 7.7 14.5 31.5 1.7 12.7 5.9 2.9 0.0 2.3 3.9 4.1 2.8 11.9 0.7 2.8 9.3 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: AB_2678963" "prognostic unfavorable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavorable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 18.4 20.5 13.8 18.1 15.7 10.6 20.2 11.3 14.3 16.0 16.7 13.0 12.9 13.1 18.1 16.7 24.0 15.3 10.7 15.9 12.4 11.8 35.2 26.5 12.4 18.4 16.5 12.1 20.9 28.9 15.7 34.6 21.2 16.2 16.4 18.5 7.4 15.9 11.3 21.1 13.7 16.8 15.3 13.9 20.4 14.7 25.3 15.0 26.4 17.1 22.6 24.3 16.9 15.5 28.6 26.4 10.3 22.1 24.0 27.2 20.2 25.3 22.8 21.3 21.7 15.5 18.0 16.0 18.9 14.5 18.0 18.5 22.4 24.8 35.3 32.4 19.8 17.8 19.1 28.8 24.2 34.9 33.6 20.5 48.7 13.7 25.4 17.7 19.9 21.0 14.6 16.7 26.5 44.1 11.3 24.9 24.3 32.7 15.5 27.3 20.6 37.8 21.0 32.6 71.8 35.6 24.6 25.9 36.3 26.2 21.2 27.2 25.8 11.8 18.5 21.4 19.6 28.6 13.7 16.4 18.3 29.5 23.6 25.3 17.1 29.8 49.9 24.7 43.6 23.4 8.6 18.6 10.3 18.4 22.1 25.2 28.6 19.8 19.7 26.4 22.1 19.8 20.2 2.0 24.0 16.0 13.7 27.2 20.2 13.8 15.7 11.3 14.3 12.4 11.8 16.5 12.1 16.2 15.0 14.9 14.2 31.8 57.7 70.6 19.2 17.3 7.6 14.7 31.8 31.4 23.6 50.1 33.2 41.0 33.6 28.9 16.1 0.0 42.0 61.5 36.1 25.3 40.3 14.7 39.5 15.9 13.9 17.2 15.4 10.8 22.5 25.0 25.3 30.7 16.0 25.8 34.4 10.5 16.6 66.3 19.8 12.9 36.3 85.0 87.9 67.2 28.4 26.3 25.4 52.2 DCTN2 "DCTN-50, RBP50" ENSG00000175203 "Dynactin subunit 2" Q13561 12 57530102-57547331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039715, HPA040040" Enhanced Supported Centrosome NA NA 3200000 Centrosome "HPA039715: AB_10795154, HPA040040: AB_10794870" "unprognostic (1.70e-2)" "unprognostic (1.82e-1)" "unprognostic (1.54e-1)" "unprognostic (6.88e-2)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.38e-7)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" "unprognostic (1.71e-1)" "unprognostic (4.26e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-2)" "unprognostic (9.50e-3)" "unprognostic (2.09e-1)" "unprognostic (1.52e-3)" "unprognostic (3.41e-3)" 24.3 32.6 40.9 18.5 44.3 19.6 25.8 93.4 72.9 28.7 31.5 26.8 23.1 21.4 29.7 34.0 38.5 28.7 21.9 37.4 38.3 48.6 24.8 19.6 21.1 20.7 49.7 44.8 31.0 34.7 31.4 24.6 23.1 41.8 24.7 33.9 15.2 32.7 31.5 40.0 29.7 22.9 42.2 40.2 17.3 28.7 28.7 25.9 18.1 24.8 28.7 29.4 22.5 27.1 24.3 34.7 31.0 36.2 24.9 32.9 38.2 23.9 28.7 31.9 23.5 50.9 53.5 18.5 27.3 47.3 51.4 39.2 20.7 21.0 25.1 32.0 42.9 20.8 18.3 26.3 32.6 40.7 28.7 29.7 22.4 18.0 23.3 35.5 15.3 16.6 47.5 54.8 32.0 55.3 62.6 51.8 24.9 34.0 36.2 48.4 27.9 25.6 19.4 15.5 13.5 32.0 18.8 26.4 22.1 39.7 28.0 48.8 33.0 26.3 21.7 23.7 28.1 36.4 13.9 41.7 31.2 24.4 19.0 17.6 23.9 23.5 25.0 29.1 18.5 30.6 25.1 31.7 31.0 28.2 36.2 29.9 24.3 28.9 30.5 34.7 22.1 21.6 26.5 18.9 24.9 35.8 26.2 32.9 38.2 40.9 44.3 93.4 72.9 38.3 48.6 49.7 44.8 41.8 25.9 44.7 30.4 47.7 74.9 57.7 78.9 59.3 58.6 34.8 29.6 33.2 29.5 95.8 68.0 141.2 83.9 67.9 85.5 46.7 197.8 99.2 72.6 71.3 35.7 28.2 90.2 68.3 47.1 60.8 44.2 191.8 72.2 52.1 72.6 220.0 65.6 123.5 174.8 74.8 68.6 81.6 46.0 90.5 111.5 116.9 29.6 59.8 136.6 58.6 77.2 73.2 DCTN4 ENSG00000132912 "Dynactin subunit 4" Q9UJW0 5 150708440-150759109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017532, HPA038026" Uncertain Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "CAB017532: AB_1122152, HPA038026: AB_2675792" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.87e-3)" "unprognostic (7.82e-3)" "unprognostic (1.37e-2)" "unprognostic (2.08e-1)" "unprognostic (8.41e-2)" "unprognostic (1.38e-1)" "unprognostic (5.86e-2)" "unprognostic (9.68e-3)" "unprognostic (1.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.83e-1)" 26.1 27.9 27.9 13.3 27.3 41.0 25.7 30.3 36.5 19.8 15.9 32.4 17.7 15.9 20.6 27.6 20.0 18.4 16.5 20.6 27.3 29.0 20.0 22.0 17.8 13.3 30.8 24.0 26.3 32.5 23.9 27.7 25.9 33.2 24.1 18.6 21.3 15.7 22.4 42.0 19.0 15.4 21.3 34.7 13.9 18.0 22.9 25.4 18.8 24.8 15.3 14.5 23.3 16.2 5.0 10.9 16.4 10.7 3.0 6.9 5.2 9.5 11.5 20.9 34.8 25.5 24.7 17.1 17.0 17.1 20.5 20.8 21.5 12.1 9.4 23.8 20.1 18.0 11.7 25.6 19.9 25.2 18.8 20.1 12.1 13.3 13.4 23.3 14.6 17.3 24.9 17.8 18.3 32.3 21.0 14.5 11.7 18.4 12.1 26.6 10.0 8.9 7.8 10.5 11.3 18.1 7.9 12.6 10.4 15.2 16.5 47.4 19.9 18.0 24.6 25.2 15.1 23.8 19.5 16.1 23.0 12.9 15.0 17.9 10.7 13.8 5.6 26.4 19.6 18.7 3.2 10.7 10.5 5.5 7.8 5.6 5.0 6.2 5.4 10.9 4.4 5.9 6.9 16.4 3.0 6.4 5.1 4.3 5.2 27.9 27.3 30.3 33.3 27.3 29.0 30.8 24.0 33.2 25.4 44.7 29.8 14.5 12.5 15.8 19.1 31.7 33.1 13.4 11.4 15.7 19.6 18.8 10.0 10.6 1.9 15.7 15.7 0.0 14.1 14.7 17.4 17.4 11.6 33.6 26.2 28.6 36.1 22.1 41.2 3.3 20.4 19.3 11.8 10.0 26.4 26.6 16.5 17.3 18.0 17.3 31.0 12.9 14.3 18.6 16.7 17.9 24.8 12.9 16.2 14.4 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073845-31104791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065197 Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No Yes Nucleoplasm "Nucleoli fibrillar center, Centrosome" "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 6.3 5.3 6.4 8.0 8.7 21.0 5.9 18.1 10.5 7.6 6.1 6.0 8.8 7.1 11.0 3.7 7.6 7.5 5.1 4.0 7.0 2.7 6.5 7.0 4.9 14.9 8.4 4.6 9.6 19.0 7.7 9.3 5.6 7.1 8.0 8.6 5.0 11.3 7.1 8.8 14.2 12.1 8.0 6.7 10.9 8.0 8.2 9.4 33.2 7.2 6.4 11.1 5.8 7.8 5.8 4.9 1.3 7.3 4.3 5.5 1.9 12.5 12.2 14.2 12.7 2.2 4.8 20.9 7.8 3.9 9.1 9.8 14.5 21.4 16.4 10.9 4.1 8.5 12.4 11.2 10.7 7.3 15.0 23.0 19.5 20.3 8.9 0.8 13.7 12.7 4.5 4.8 11.6 9.1 5.9 4.4 19.7 9.5 36.8 6.5 10.4 23.5 20.5 29.9 15.3 6.6 18.9 22.2 22.8 4.8 14.3 10.2 7.5 8.0 12.3 3.9 24.8 10.4 8.7 3.6 8.0 15.7 15.4 14.1 14.9 11.5 39.2 9.4 11.0 7.2 0.0 2.3 1.3 4.2 2.5 3.3 5.2 4.0 3.1 3.1 5.8 4.1 5.5 1.1 4.3 7.3 4.9 3.4 1.9 6.4 8.7 18.1 10.5 7.0 2.7 8.4 4.6 7.1 9.4 3.0 7.4 12.7 4.5 5.4 7.7 2.2 5.1 6.7 5.7 0.0 13.7 5.2 0.0 2.2 1.3 3.0 4.0 0.0 2.9 5.8 4.3 5.0 5.7 6.6 4.3 7.9 0.0 6.2 4.6 0.9 6.6 4.6 6.8 5.4 5.0 2.3 2.5 2.9 4.2 1.1 25.5 0.0 3.5 3.2 17.6 5.6 2.2 6.9 7.4 4.1 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell type enhanced" "Detected in many" 10 "B-cells: 28.3;Erythroid cells: 23.3;granulocytes: 16.1;T-cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HEL: 8.8;HMC-1: 27.4;MOLT-4: 8.4;THP-1: 8.1;U-937: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 13.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.8 0.0 0.9 0.0 4.3 27.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 5.7 0.1 0.0 8.4 6.7 0.0 0.3 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.1 0.0 18.3 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 3.0 4.8 28.3 0.0 0.3 0.0 0.9 2.5 2.7 0.0 1.8 0.0 0.1 1.7 0.4 0.6 0.0 1.1 23.3 0.0 0.2 0.2 0.0 16.1 0.0 12.9 0.0 0.0 1.8 9.9 0.4 0.0 9.2 3.3 3.6 0.6 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.3 0.2 0.7 0.1 0.2 32.3 0.8 0.1 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.1 2.7 2.9 1.1 6.8 7.2 0.7 4.0 8.8 9.5 10.3 1.0 10.9 5.2 1.7 6.2 1.5 9.1 2.2 18.5 4.6 3.5 2.3 1.6 6.5 17.6 3.2 3.1 1.2 6.5 10.9 2.3 1.7 7.7 7.1 4.3 3.2 5.0 7.7 4.5 1.2 1.1 0.5 8.9 4.0 4.0 2.0 7.2 7.3 4.2 2.5 1.9 5.7 7.7 1.9 2.1 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.4 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 20.8 17.9 18.2 23.9 29.2 10.8 13.9 45.9 16.0 18.2 33.2 17.7 40.2 33.2 24.7 15.1 15.7 74.2 0.0 26.8 7.7 17.9 21.4 5.8 70.1 24.0 14.3 18.5 14.1 11.6 27.0 18.7 16.2 43.9 11.8 37.9 14.1 42.2 46.0 19.4 44.2 44.1 25.8 21.7 26.2 9.3 40.0 21.9 26.1 38.6 36.3 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" No No "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: AB_2682491, HPA062700: AB_2684838" "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 10.4 7.3 9.7 6.9 14.6 13.9 9.8 9.7 14.3 12.2 23.2 14.8 10.7 9.9 19.7 13.9 13.9 12.5 9.2 16.9 9.0 5.8 10.4 7.5 8.7 12.6 8.2 6.7 13.9 6.5 12.1 13.5 8.4 10.9 13.3 14.3 12.4 10.4 12.6 12.5 11.1 12.4 14.7 9.9 8.4 13.4 12.5 9.4 12.1 8.5 7.6 11.2 15.9 11.8 4.6 6.7 2.0 4.9 5.8 8.2 4.4 7.3 4.5 12.0 4.9 4.6 6.0 8.5 4.4 7.9 10.2 7.8 21.2 7.2 8.5 7.9 8.4 7.9 11.7 8.3 13.0 10.1 2.1 4.1 11.3 10.1 12.0 5.5 13.1 5.9 7.0 8.4 9.0 8.4 6.3 4.5 14.5 11.4 4.9 5.4 6.0 21.4 10.1 6.9 13.4 9.9 10.5 17.5 6.8 3.7 8.5 10.6 8.3 12.1 7.3 11.2 7.8 10.0 10.8 4.4 14.7 8.1 5.8 9.2 4.9 6.4 8.8 8.6 6.0 7.6 0.0 4.9 2.0 5.3 4.5 5.2 4.6 4.5 5.6 6.7 4.3 8.2 4.3 1.0 5.8 3.8 2.4 2.8 4.4 9.7 14.6 9.7 14.3 9.0 5.8 8.2 6.7 10.9 9.4 0.0 3.0 0.8 1.2 0.5 5.8 4.8 5.1 4.0 4.5 1.8 3.9 3.1 1.7 2.5 2.9 2.4 3.3 0.0 1.0 2.0 2.4 2.1 8.1 5.5 4.3 4.8 5.2 5.5 3.7 0.4 5.8 3.1 3.3 2.8 6.2 2.6 1.7 2.9 6.0 1.7 4.6 0.0 2.3 1.7 10.0 1.8 2.5 1.7 4.4 1.0 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 13.7 15.4 18.7 14.7 16.6 11.8 14.5 15.7 16.4 13.7 11.8 20.7 19.1 9.0 14.7 15.5 10.6 15.5 10.0 20.1 17.3 17.0 14.2 15.2 10.8 14.0 19.4 10.8 16.2 24.4 24.9 18.9 9.0 17.7 14.7 10.3 15.4 14.4 16.3 29.4 9.4 9.0 15.2 19.6 11.1 10.5 15.4 14.0 19.3 18.0 9.4 12.8 12.5 9.7 9.1 10.5 7.8 13.1 14.1 13.2 8.0 8.6 19.6 5.9 7.8 7.4 10.1 8.3 6.4 7.0 9.5 8.0 9.6 5.8 30.6 7.0 7.7 8.4 14.6 14.6 5.1 7.0 8.0 13.4 18.0 12.7 10.9 5.6 17.4 6.3 4.1 5.8 2.6 8.5 5.5 7.3 9.9 10.4 7.4 8.5 6.3 7.8 10.2 9.3 6.9 10.8 11.7 25.5 17.9 3.1 9.8 10.1 9.8 13.0 4.3 7.2 5.9 6.4 11.6 9.5 11.0 10.4 4.5 11.0 6.5 20.3 14.7 3.7 23.0 4.4 7.8 5.9 5.1 9.9 7.1 12.8 8.5 9.5 13.2 10.5 9.1 11.6 9.6 0.7 14.1 13.1 7.5 8.8 8.0 18.7 16.6 15.7 16.4 17.3 17.0 19.4 10.8 17.7 14.0 6.0 14.4 12.9 4.8 3.8 15.3 28.6 17.8 10.7 9.1 3.5 3.9 14.6 5.0 4.9 5.0 7.1 4.3 0.0 3.1 3.8 8.8 4.7 16.1 15.7 8.3 9.5 2.9 3.7 8.2 7.9 18.4 10.3 1.7 10.0 8.9 16.6 3.3 5.8 19.1 8.4 19.5 19.4 8.5 27.9 15.2 4.6 3.1 10.4 13.5 2.7 DNAH14 "C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277" ENSG00000185842 "Dynein axonemal heavy chain 14" Q0VDD8 1 224896262-225399292 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 32.4;testis: 29.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 102.3;Spermatocytes: 58.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 3.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 25.5" "HPA027718, HPA028545, HPA031379" Uncertain Supported Centrosome NA NA Centrosome "HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851" "unprognostic (1.16e-1)" "unprognostic (1.77e-2)" "unprognostic (2.95e-1)" "unprognostic (1.86e-2)" "unprognostic (5.92e-2)" "unprognostic (1.09e-3)" "unprognostic (9.94e-4)" "unprognostic (4.23e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.51e-1)" "unprognostic (2.33e-9)" "unprognostic (6.76e-2)" "unprognostic (7.39e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" 1.6 5.2 6.3 2.7 2.5 2.5 5.2 0.9 3.4 3.1 2.9 0.2 3.8 1.7 3.3 6.5 2.0 2.6 5.3 3.7 7.0 5.5 4.2 6.8 5.4 0.6 2.9 4.6 5.5 11.2 3.4 32.4 2.6 7.2 4.3 3.7 3.6 3.4 7.8 0.6 1.0 1.1 4.6 8.5 1.0 3.8 29.9 0.8 3.2 7.1 0.9 0.4 2.5 1.9 0.6 0.2 0.4 0.2 3.5 0.9 0.0 10.4 5.4 4.9 5.4 2.0 4.1 11.8 2.2 2.0 4.0 3.5 8.4 11.5 0.0 5.4 2.2 0.0 0.1 7.6 2.1 6.8 0.0 12.6 5.0 3.6 1.8 2.4 10.3 1.7 3.9 4.6 5.5 3.9 4.3 1.3 7.3 25.5 0.0 6.8 2.8 1.8 10.8 13.9 11.8 6.6 0.0 18.8 9.5 3.7 4.8 8.3 9.4 8.4 6.3 16.9 8.6 11.6 9.0 0.2 0.0 8.0 0.2 0.1 11.6 7.2 0.1 0.0 0.0 7.5 0.0 0.1 0.3 0.1 0.2 0.0 0.6 0.3 0.7 0.2 0.3 0.4 0.5 0.4 3.5 0.1 0.0 0.9 0.0 6.3 2.5 0.9 3.4 7.0 5.5 2.9 4.6 7.2 0.8 11.9 11.5 0.0 10.9 1.8 29.3 4.4 10.2 5.3 4.5 19.2 31.4 8.6 6.6 11.0 102.3 2.9 1.1 0.0 8.7 10.5 3.0 8.7 13.9 7.6 3.0 27.0 7.9 2.5 0.0 31.3 2.6 1.6 3.3 1.0 4.3 11.2 8.0 0.0 3.2 6.4 3.4 6.5 0.9 58.5 19.2 0.6 9.6 0.0 4.1 6.8 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.8;Late spermatids: 143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 8.2 11.4 24.1 9.6 21.9 3.9 13.7 8.6 19.8 17.8 10.1 8.5 19.7 7.3 9.8 15.0 12.3 33.5 12.7 9.9 17.7 15.2 16.0 7.1 12.8 7.5 9.5 15.7 15.8 14.9 19.2 19.3 11.9 7.9 13.2 9.2 13.1 16.4 16.3 4.4 11.4 8.0 7.7 6.4 7.5 11.1 36.5 9.7 13.2 26.1 6.6 8.6 8.4 9.1 12.6 14.8 17.5 11.2 15.7 16.6 8.1 8.9 4.5 9.1 8.2 11.7 11.8 0.0 3.8 7.4 5.9 6.5 2.8 10.5 2.2 8.3 5.5 6.8 4.3 5.7 10.1 4.2 5.5 7.5 1.3 1.3 3.1 18.6 7.1 1.9 9.5 33.2 7.8 14.2 15.5 8.4 10.9 2.6 4.5 7.3 11.1 6.6 7.1 3.6 13.3 3.7 6.5 3.9 2.9 12.4 5.3 12.9 6.9 7.9 6.1 15.4 6.9 11.0 6.9 5.1 5.4 5.5 8.1 3.8 2.8 0.8 1.0 16.1 2.4 5.2 15.6 9.6 12.8 13.5 9.5 16.6 8.7 11.2 12.1 9.8 12.6 13.3 11.0 17.5 15.7 11.2 14.8 10.2 8.1 24.1 21.9 8.6 19.8 17.7 15.2 9.5 15.7 7.9 9.7 6.0 8.0 3.7 11.7 4.9 13.6 3.6 15.3 28.1 12.5 3.5 2.0 23.5 26.6 24.0 73.8 4.5 8.0 0.0 13.8 16.6 7.6 8.9 15.0 2.9 12.2 11.1 12.1 9.8 3.8 143.7 10.9 4.9 8.5 6.4 13.8 10.1 16.3 8.6 7.1 15.7 13.1 6.5 4.4 52.4 14.3 9.3 16.6 6.5 13.4 10.8 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.5;lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 6 "B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003218, HPA073349" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol NA NA Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695, HPA073349: " "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favorable (6.89e-6)" 6.7 12.9 5.6 27.4 8.4 20.8 6.1 1.2 4.1 3.1 3.9 9.2 0.9 3.9 3.0 4.3 6.0 4.1 8.2 2.9 6.3 3.3 7.5 3.9 16.8 35.3 10.2 2.3 2.5 6.4 7.6 3.5 10.4 8.1 4.9 4.1 4.4 10.5 2.4 1.7 3.3 15.0 3.4 13.6 43.5 4.9 7.2 8.9 61.0 5.1 3.0 27.1 10.5 4.0 7.3 15.4 40.5 21.5 6.6 5.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.4 17.3 1.2 0.0 0.0 0.7 0.2 0.1 0.0 5.9 0.6 0.0 0.0 0.0 0.0 17.2 2.3 0.1 3.2 0.0 0.0 0.0 0.0 0.0 3.7 8.7 0.0 1.0 16.1 27.2 0.1 0.0 0.2 20.2 0.0 6.7 0.0 17.9 0.0 0.0 0.0 0.2 1.2 0.3 0.4 51.7 3.4 0.0 0.1 0.2 0.0 3.5 0.0 0.0 0.0 10.9 0.3 14.2 14.7 16.7 4.6 15.1 3.8 7.3 5.5 4.8 15.4 6.8 4.4 4.2 40.5 6.6 21.5 4.4 5.3 6.4 5.6 8.4 1.2 4.1 6.3 3.3 10.2 2.3 8.1 8.9 8.9 31.0 83.1 1.5 5.7 0.2 2.0 22.9 1.4 3.4 7.0 72.6 44.4 1.7 0.8 24.2 4.8 0.5 0.0 5.9 3.1 2.9 1.1 23.2 2.5 50.8 0.0 8.1 3.1 113.9 11.5 2.8 79.1 8.5 79.4 8.9 1.0 1.4 17.5 0.4 8.7 3.8 12.9 14.4 15.4 4.1 3.3 35.7 76.2 1.0 3.0 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155388-184173610 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" Yes No "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: AB_2683658" "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.77e-5)" "prognostic unfavorable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 22.8 18.5 18.0 16.8 19.4 15.3 25.1 18.3 23.2 22.6 27.6 24.7 23.9 16.2 32.1 16.4 20.0 22.2 22.2 27.9 19.9 12.3 16.8 13.1 20.6 12.1 21.4 16.0 30.0 22.7 17.2 17.8 56.0 17.4 19.7 15.8 31.1 18.7 26.2 26.3 27.6 19.1 30.3 16.4 17.8 19.4 15.6 20.1 7.3 20.9 13.3 14.6 24.5 26.3 2.5 2.7 4.1 4.0 1.5 3.1 1.2 20.1 6.6 16.0 18.1 16.6 16.7 41.3 11.9 12.3 14.5 12.1 19.3 8.1 14.1 32.1 15.6 15.7 17.2 13.1 9.5 10.1 22.2 13.7 15.8 9.9 11.7 24.9 8.8 12.3 16.8 17.1 10.5 12.1 24.4 10.6 9.5 15.7 19.6 15.2 19.2 12.9 10.4 14.1 14.8 9.5 20.6 18.6 12.3 13.5 16.6 17.4 22.0 15.0 17.3 29.2 16.3 43.1 11.2 10.4 13.2 12.8 13.8 18.6 21.0 15.5 15.8 13.1 9.4 10.1 0.2 2.4 4.1 2.3 4.0 3.1 2.5 1.5 2.4 2.3 2.0 2.0 1.3 3.6 1.5 2.8 2.7 1.1 1.2 18.0 19.4 18.3 23.2 19.9 12.3 21.4 16.0 17.4 20.1 23.8 16.0 9.3 11.7 16.7 18.7 25.7 5.1 8.1 17.0 21.0 25.5 27.9 19.9 11.6 10.5 12.8 27.8 0.0 14.3 16.8 18.6 17.6 16.2 17.8 17.3 58.8 33.0 22.1 17.5 35.6 31.1 13.3 11.8 4.6 20.2 18.5 17.1 17.3 35.0 14.9 17.2 19.4 22.1 8.8 10.2 19.1 43.6 9.6 19.0 22.2 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964510-102056443 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol NA NA 120000 "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 23.3 17.2 24.3 13.9 42.9 21.1 12.7 43.9 53.4 16.9 18.4 35.0 10.2 13.9 18.6 12.5 18.3 15.5 16.1 26.6 26.1 26.6 11.2 9.4 14.6 14.0 29.1 23.4 24.7 15.4 28.1 16.4 14.8 51.5 16.7 11.9 15.5 18.0 18.6 44.5 42.0 13.8 17.7 30.3 15.4 15.5 17.2 12.6 15.1 18.1 11.1 12.9 19.1 12.8 2.7 6.3 4.5 6.0 7.8 4.7 3.3 24.2 36.4 20.0 15.4 44.9 29.3 12.2 21.1 19.6 24.9 21.9 15.4 12.3 13.9 17.3 28.7 18.2 22.2 19.6 23.6 9.0 12.0 11.8 9.9 23.7 25.1 20.4 14.6 10.4 19.0 12.5 58.6 43.8 18.4 27.2 17.4 8.6 16.0 28.2 23.8 9.5 3.6 12.1 10.4 45.0 9.1 21.0 8.0 20.1 38.7 22.8 18.5 27.8 14.1 18.3 10.3 11.7 6.3 59.6 29.5 12.6 40.7 28.7 11.0 11.1 9.4 40.6 8.7 18.1 3.6 3.4 2.5 4.6 6.0 4.7 2.2 3.0 4.0 6.3 2.7 3.6 4.2 4.5 7.8 3.9 3.3 3.0 3.3 24.3 42.9 43.9 53.4 26.1 26.6 29.1 23.4 51.5 12.6 116.1 83.2 18.6 34.8 46.5 118.7 165.8 38.2 78.9 83.0 73.3 131.6 39.7 11.6 96.5 11.8 85.7 77.8 0.0 70.2 36.3 58.5 39.8 31.3 31.8 36.0 173.2 68.5 46.6 49.4 11.3 65.3 61.6 67.4 110.0 56.8 57.8 107.3 66.6 67.1 39.6 100.6 84.1 73.1 83.0 71.1 56.0 31.2 49.0 49.4 39.7 DYNC1LI1 DNCLI1 ENSG00000144635 "Dynein cytoplasmic 1 light intermediate chain 1" Q9Y6G9 3 32525971-32570874 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 165.8;Spermatogonia: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035013 Approved Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA035013: AB_10600807" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.78e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (5.38e-2)" "prognostic unfavorable (9.19e-9)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (7.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (2.21e-2)" "unprognostic (2.14e-2)" "unprognostic (5.51e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-2)" 16.1 11.6 15.8 14.8 18.6 27.5 18.9 24.5 28.0 13.4 13.8 12.7 9.2 11.6 17.0 11.6 13.9 14.7 14.1 40.1 16.3 23.4 18.4 15.9 16.3 15.8 18.3 16.4 15.2 18.6 16.8 18.9 14.9 26.5 18.6 14.2 14.1 12.0 12.9 41.1 32.1 13.0 19.7 16.6 18.1 13.8 34.0 11.7 19.3 12.8 16.6 17.2 15.5 13.5 6.2 15.3 29.8 25.1 7.5 6.1 10.7 13.3 14.5 22.5 14.1 13.0 15.3 62.3 20.7 28.6 37.5 30.8 15.3 11.6 16.8 14.1 21.0 17.8 6.9 22.6 16.2 35.8 15.8 15.6 22.2 10.6 13.6 16.0 25.1 13.0 12.3 13.0 26.4 20.7 13.7 24.1 19.2 25.7 15.5 20.0 10.7 19.2 11.1 23.3 12.9 19.5 17.0 12.0 17.5 15.3 12.3 9.7 14.3 14.6 18.0 15.6 18.9 15.0 14.7 17.9 20.7 17.4 17.9 20.8 11.2 28.2 27.2 11.5 21.8 16.0 11.3 13.3 11.7 5.2 16.8 5.4 6.1 5.6 5.7 15.3 6.2 3.9 5.0 29.8 7.5 25.1 8.4 6.1 10.7 15.8 18.6 24.5 28.0 16.3 23.4 18.3 16.4 26.5 11.7 23.8 24.1 30.7 27.6 38.1 44.2 87.1 12.7 57.6 42.1 14.0 17.7 31.9 39.7 46.8 67.1 34.6 15.3 46.7 40.4 30.5 29.2 19.6 16.2 24.9 36.1 62.0 29.6 23.4 32.9 26.8 24.2 50.1 27.0 83.0 18.0 30.8 44.9 17.3 26.9 37.2 71.7 45.3 37.1 165.8 163.3 43.8 9.3 28.0 13.6 14.0 DYNC1LI2 DNCLI2 ENSG00000135720 "Dynein cytoplasmic 1 light intermediate chain 2" O43237 16 66720893-66751798 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057201 Approved Centrosome,Cytosol NA NA Centrosome Cytosol "HPA057201: AB_2683366" "unprognostic (6.03e-2)" "unprognostic (2.40e-2)" "unprognostic (8.28e-2)" "unprognostic (1.57e-2)" "unprognostic (5.35e-2)" "unprognostic (2.80e-1)" "unprognostic (7.58e-2)" "unprognostic (3.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (4.77e-2)" "unprognostic (1.92e-1)" "unprognostic (7.70e-3)" "unprognostic (1.34e-1)" 26.5 21.4 63.8 16.8 63.5 16.7 19.0 28.8 43.3 23.0 24.4 61.2 17.6 19.5 23.9 19.5 23.7 17.9 22.5 26.6 68.3 48.3 20.3 13.0 20.8 11.0 75.0 28.9 22.1 20.2 44.7 19.3 21.1 51.1 25.3 28.7 13.6 20.8 24.5 17.2 23.1 19.8 30.1 89.5 15.5 22.6 14.9 55.0 6.7 28.8 7.9 12.6 20.4 20.0 9.0 12.1 16.3 17.1 8.2 14.9 7.9 15.1 16.0 23.8 21.3 30.8 30.5 21.6 24.9 20.0 20.4 26.6 21.6 15.0 6.3 19.9 24.4 14.8 22.1 18.2 17.8 30.0 4.3 13.1 7.8 18.5 20.4 17.1 8.2 11.6 19.9 24.5 23.5 16.3 28.7 28.6 6.6 12.7 8.4 26.4 10.8 5.1 10.8 14.3 16.9 27.8 11.3 50.3 7.6 20.3 21.4 23.9 16.7 45.0 9.8 28.9 17.9 11.8 8.3 36.3 26.5 13.2 12.9 16.9 10.7 7.8 12.6 22.8 8.0 16.6 10.1 17.1 16.1 13.4 9.8 14.9 5.2 11.3 10.7 12.1 9.0 9.6 9.1 16.3 8.2 13.1 7.6 10.9 7.9 63.8 63.5 28.8 43.3 68.3 48.3 75.0 28.9 51.1 55.0 95.3 106.1 25.9 55.1 58.7 77.3 44.2 50.9 123.1 95.5 26.2 31.4 49.4 6.6 70.7 85.1 86.2 65.1 0.0 50.4 50.0 55.7 71.0 34.8 29.3 26.9 101.7 101.8 51.5 44.8 54.2 58.7 48.5 65.8 19.0 68.1 106.0 84.7 57.5 75.7 38.3 61.1 116.4 75.0 66.6 52.2 61.1 70.9 23.5 54.7 68.6 E2F1 "RBBP3, RBP3" ENSG00000101412 "E2F transcription factor 1" Q01094 20 33675683-33686404 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;lymphoid tissue: 21.9" "Cell type enriched" "Detected in many" 5 "Spermatogonia: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000329, HPA008003, CAB019308, HPA029735" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176" "unprognostic (7.46e-2)" "prognostic favorable (9.22e-6)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.33e-5)" "unprognostic (1.51e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (1.05e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.62e-4)" "unprognostic (1.91e-1)" 2.4 5.3 6.8 12.7 9.7 32.5 2.1 1.1 6.4 1.2 4.4 5.1 0.7 3.9 1.4 0.8 5.1 1.5 4.1 2.0 7.1 3.6 0.9 1.7 8.1 9.3 6.2 2.9 3.4 1.2 2.3 0.3 3.3 5.9 1.7 4.8 0.3 1.6 1.4 1.4 5.4 4.9 3.3 6.2 4.8 3.4 12.1 6.0 21.9 1.0 4.9 7.7 1.9 3.1 2.2 0.6 0.7 3.7 1.4 1.2 0.6 16.0 15.6 18.1 14.1 1.8 1.3 13.8 15.4 7.5 19.7 16.6 27.6 16.6 29.6 15.6 6.9 23.9 12.1 8.8 8.2 8.8 8.9 12.6 24.2 23.2 16.0 0.1 11.3 15.3 1.0 0.5 10.8 1.9 2.0 5.0 18.6 6.4 20.9 12.1 14.2 24.0 24.0 5.4 16.2 22.5 23.9 49.4 12.2 3.3 9.8 27.1 19.1 18.8 13.1 7.6 5.4 16.4 14.3 2.7 23.0 13.5 15.9 21.8 20.5 13.8 24.4 19.2 6.7 13.6 0.0 0.0 0.7 0.1 0.9 0.0 2.2 0.6 0.4 0.2 0.2 0.2 1.2 0.3 1.4 3.7 0.6 0.8 0.6 6.8 9.7 1.1 6.4 7.1 3.6 6.2 2.9 5.9 6.0 0.0 0.6 2.9 0.7 2.6 2.2 0.4 0.0 0.0 2.3 0.0 0.0 2.6 0.0 0.9 0.7 0.1 0.5 0.0 0.2 7.9 1.1 0.6 0.0 0.8 3.8 0.0 0.0 0.6 0.0 2.3 2.0 0.9 1.7 0.0 2.9 1.2 0.5 0.0 1.1 0.0 2.0 0.0 0.9 3.8 37.5 1.5 1.5 0.7 4.6 0.9 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavorable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 9.2 6.7 6.3 16.6 9.7 27.9 9.0 20.3 10.0 10.5 8.1 7.7 6.8 7.1 12.2 8.3 7.5 9.8 6.4 7.5 7.4 5.4 5.9 5.0 7.2 12.5 8.8 7.3 13.4 14.0 6.3 18.1 8.2 8.0 10.0 7.3 5.2 19.7 12.7 12.7 8.3 9.0 9.5 7.8 9.3 8.4 21.2 9.0 20.2 7.7 4.5 10.7 10.1 8.7 9.6 9.9 9.1 7.0 6.9 9.7 3.5 9.0 8.8 11.1 12.1 5.2 8.6 5.8 11.4 11.1 13.2 15.0 11.2 7.7 12.2 5.7 7.2 7.3 11.5 17.5 2.7 15.0 8.0 13.9 8.5 7.5 6.5 8.8 12.8 8.8 5.3 4.4 12.6 5.7 11.5 6.2 6.2 8.0 9.4 7.4 3.6 12.7 8.8 16.4 5.6 8.0 10.1 10.6 7.9 4.6 4.2 6.0 11.8 8.5 4.3 7.7 10.7 7.8 4.8 3.9 7.0 7.2 9.2 12.9 12.2 8.1 19.2 7.5 6.3 3.9 9.1 7.0 6.5 7.8 5.8 9.7 9.6 6.9 7.1 6.8 8.1 7.3 7.5 8.4 6.9 4.2 9.9 7.4 3.5 6.3 9.7 20.3 10.0 7.4 5.4 8.8 7.3 8.0 9.0 11.9 8.9 5.6 5.1 5.3 21.0 11.4 10.2 6.7 10.3 10.4 31.4 5.9 0.0 3.9 140.9 7.1 4.7 0.0 6.2 4.9 6.6 5.1 19.7 7.4 3.6 19.1 4.1 6.7 5.3 46.0 19.5 5.8 6.8 4.6 5.7 12.8 7.6 6.5 18.7 2.6 23.7 6.5 6.1 26.7 19.4 7.2 3.8 12.5 6.5 4.2 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 39.7" "Cell type enhanced" "Detected in some" 10 "Exocrine glandular cells: 10.8;Hofbauer cells: 6.6;monocytes: 15.4;Proximal tubular cells: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 7 "RH-30: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" NA NA Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 9.3 6.1 3.1 3.8 3.0 1.6 10.1 3.7 3.8 8.9 5.4 2.5 8.7 2.8 10.1 8.1 6.4 7.2 8.3 3.9 2.5 1.6 10.8 6.1 7.2 5.5 2.1 2.7 10.7 34.4 6.0 3.6 4.5 3.5 7.7 3.7 6.1 39.7 14.6 2.8 6.2 3.3 7.0 2.9 3.8 6.0 4.3 1.4 1.5 8.4 5.1 6.2 7.7 6.9 0.7 3.9 1.2 5.4 1.8 10.6 2.6 1.9 3.5 1.8 2.2 5.3 5.0 1.5 2.2 4.4 3.7 3.7 2.1 3.3 1.1 2.5 3.0 2.6 1.9 1.4 1.3 3.7 1.2 2.1 5.6 1.9 3.5 4.7 1.4 2.4 5.3 3.5 3.8 4.0 6.0 3.9 5.2 3.3 8.9 2.2 1.5 1.6 3.9 1.3 1.4 3.2 3.3 59.3 3.8 2.5 2.2 1.7 2.4 3.9 2.8 2.4 1.7 4.7 3.7 3.7 5.5 3.1 2.2 2.3 1.9 0.8 1.5 4.2 6.0 3.7 0.5 3.9 0.1 2.5 1.5 10.6 0.7 4.9 2.9 3.9 0.7 2.5 1.9 1.2 1.8 5.4 2.0 3.0 2.6 3.1 3.0 3.7 3.8 2.5 1.6 2.1 2.7 3.5 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 2.7 5.0 4.7 0.0 0.0 0.0 0.0 10.8 4.0 0.0 0.0 2.3 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.4 0.0 0.0 6.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.9 16.0 21.5 21.7 17.3 16.0 12.2 20.5 14.2 26.2 23.8 15.6 18.0 32.0 12.8 17.7 24.8 10.5 20.8 29.9 16.1 17.8 16.1 28.9 24.8 17.4 19.0 21.8 18.0 17.2 16.2 29.9 19.1 15.3 22.6 27.6 30.2 10.0 26.1 18.7 26.0 24.8 25.7 16.4 27.5 13.1 10.4 19.5 18.4 15.0 19.2 18.7 17.5 14.1 10.6 18.2 19.2 17.6 14.7 26.9 19.2 13.9 25.6 21.1 27.7 29.3 13.9 26.7 27.4 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 6.0 10.5 27.4 16.0 7.4 23.6 21.6 25.5 14.7 13.6 31.4 13.7 38.8 51.4 24.8 6.1 18.9 16.3 0.0 20.7 32.8 14.8 8.1 21.9 25.2 24.9 36.5 16.7 25.8 14.9 10.7 21.3 12.1 15.1 23.4 12.0 39.0 16.7 14.7 28.7 36.1 25.6 6.5 19.3 55.3 23.8 7.3 22.4 26.2 20.4 7.3 EMC6 "MGC2963, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668815-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA062681: AB_2684831" "unprognostic (2.21e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 14.6 18.5 15.5 12.2 15.5 21.4 12.5 9.9 21.2 8.9 15.9 14.9 10.0 16.9 9.8 10.8 15.6 9.5 12.1 26.2 14.5 12.3 19.8 42.1 10.2 10.7 14.2 11.0 8.7 24.5 7.6 9.3 16.6 12.2 12.9 9.7 14.6 17.8 10.5 100.1 10.6 16.8 10.1 13.6 12.5 18.8 27.4 11.1 14.3 14.9 31.5 14.3 9.7 9.1 34.5 56.1 40.7 42.0 25.2 43.4 38.5 31.2 30.8 13.5 14.1 9.7 7.8 26.0 22.5 11.0 18.5 17.1 18.6 11.8 19.7 32.8 10.5 16.3 30.2 15.6 15.8 13.4 19.0 58.3 14.3 21.6 25.8 14.1 9.9 14.7 9.8 18.0 17.0 11.9 14.6 14.0 23.7 17.9 14.3 13.5 19.0 20.2 29.2 19.4 19.1 34.8 18.9 12.6 18.6 25.9 8.9 11.1 20.2 18.4 14.5 23.9 14.1 16.9 10.7 15.3 15.5 19.2 23.3 32.8 14.0 15.4 12.9 24.3 13.0 18.6 34.5 42.0 40.7 34.9 39.7 32.0 34.5 39.0 38.3 35.8 32.3 40.6 36.7 31.6 25.2 27.9 56.1 43.4 38.5 15.5 15.5 9.9 21.2 14.5 12.3 14.2 11.0 12.2 11.1 14.9 23.4 62.6 99.3 79.0 40.5 0.3 94.3 53.5 23.9 55.8 33.4 102.2 140.9 117.4 202.1 52.2 55.0 23.3 123.7 126.4 43.1 113.2 54.3 108.8 90.3 31.8 49.3 39.3 53.3 121.5 35.6 54.6 64.1 101.0 61.0 85.4 129.4 63.1 32.2 149.9 38.8 38.8 51.5 146.4 87.0 89.1 107.9 52.2 68.0 156.9 ENGASE FLJ21865 ENSG00000167280 Endo-beta-N-acetylglucosaminidase Q8NFI3 17 79074939-79088599 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 51.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021551 Enhanced Approved Centrosome,Cytosol No No Cytosol Centrosome "HPA021551: AB_1848156" "unprognostic (7.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (6.16e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-3)" "unprognostic (9.62e-2)" "unprognostic (4.09e-2)" "unprognostic (9.07e-2)" "unprognostic (7.00e-3)" "prognostic favorable (2.60e-4)" "unprognostic (4.79e-2)" "prognostic unfavorable (8.97e-6)" "unprognostic (8.38e-3)" "unprognostic (6.03e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.73e-5)" 10.0 10.1 9.5 20.7 18.4 8.9 11.4 7.0 13.9 10.9 15.1 12.4 8.8 20.3 11.4 6.8 6.5 10.6 8.6 10.3 9.3 5.8 9.2 10.2 10.1 10.7 16.8 8.5 16.3 9.3 11.3 9.8 8.1 13.6 12.3 12.5 10.7 12.1 9.6 35.4 11.9 17.3 7.3 11.9 24.9 11.4 3.9 14.0 8.1 13.6 7.0 9.1 17.5 51.4 0.2 0.7 0.0 1.1 0.0 2.1 0.6 4.5 9.8 3.4 6.3 3.6 1.5 6.6 3.5 1.8 2.9 2.0 5.2 5.0 0.0 4.2 3.5 4.8 6.8 5.4 3.8 1.6 2.7 7.3 4.1 10.0 3.1 2.7 4.7 7.8 4.1 5.3 2.5 2.8 5.6 3.0 8.9 5.9 2.9 1.8 3.9 0.4 4.5 1.5 9.5 8.8 8.6 11.7 3.0 1.5 12.9 2.9 5.7 5.6 25.9 2.6 5.3 9.1 4.4 3.9 5.6 4.2 4.8 3.4 6.9 1.2 2.0 2.3 8.7 4.0 0.0 0.7 0.0 0.0 1.1 0.9 0.0 0.1 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.5 0.6 2.1 0.6 9.5 18.4 7.0 13.9 9.3 5.8 16.8 8.5 13.6 14.0 0.0 13.6 6.4 3.8 3.9 10.7 4.8 7.6 0.0 6.8 10.4 33.4 4.2 0.0 3.5 1.5 6.5 16.4 0.0 3.6 3.8 4.8 7.4 4.7 10.6 7.5 7.9 25.1 9.8 10.8 1.0 3.1 8.2 0.0 5.4 15.9 5.6 2.5 11.5 1.8 1.7 24.7 12.9 6.0 2.2 1.4 5.1 5.6 5.7 18.8 4.1 ENKD1 "C16orf48, DKFZP434A1319" ENSG00000124074 "Enkurin domain containing 1" Q9H0I2 16 67662945-67667265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041163, HPA041478" Approved Supported "Plasma membrane,Centrosome,Cytosol" Yes No "Plasma membrane" "Centrosome, Cytosol" "HPA041163: AB_10794986, HPA041478: AB_10794668" "unprognostic (6.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-3)" "prognostic favorable (1.68e-4)" "unprognostic (4.41e-1)" "unprognostic (1.06e-1)" "unprognostic (3.78e-3)" "unprognostic (1.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (5.69e-2)" "unprognostic (6.58e-2)" "unprognostic (1.67e-1)" "unprognostic (2.44e-1)" "unprognostic (3.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" 8.5 7.7 4.9 5.9 7.0 3.8 6.6 5.0 6.9 10.4 11.7 6.1 18.6 4.7 11.2 14.2 8.2 14.5 11.0 6.1 5.4 5.2 10.9 4.7 8.9 2.9 4.5 4.4 10.9 38.8 23.7 12.0 4.8 8.3 12.7 3.6 7.9 11.7 12.6 6.0 7.2 5.1 12.9 4.3 6.1 7.3 19.6 6.4 7.1 20.4 5.2 4.9 12.9 6.4 0.6 4.2 3.0 1.3 0.7 1.5 0.5 6.9 4.8 11.4 5.3 3.8 3.9 5.6 5.5 3.4 4.4 5.4 3.5 10.7 2.6 9.4 3.4 0.0 8.2 2.9 6.6 5.5 4.0 6.6 2.6 14.5 8.2 6.1 4.6 3.6 3.4 4.7 6.0 5.5 10.3 3.5 8.7 4.3 1.7 2.2 3.5 5.0 19.3 5.4 7.3 1.9 17.9 1.2 19.3 4.6 0.7 11.5 12.5 11.7 1.1 6.0 2.7 10.3 6.6 9.3 5.4 7.6 10.1 0.1 12.6 5.6 2.8 8.1 6.9 1.6 0.0 1.3 0.0 0.3 0.5 1.5 0.6 1.2 0.7 0.5 0.0 0.8 1.1 3.0 0.7 0.7 4.2 0.0 0.5 4.9 7.0 5.0 6.9 5.4 5.2 4.5 4.4 8.3 6.4 20.8 15.6 0.8 6.2 6.2 3.6 5.0 17.8 36.1 2.3 8.7 3.9 2.8 1.7 11.9 28.8 9.0 2.0 0.0 9.2 2.1 7.0 5.2 1.1 14.7 4.2 3.2 12.7 11.1 3.8 14.5 12.0 2.9 5.0 2.8 5.9 9.5 8.2 0.0 13.4 5.9 10.8 6.5 6.6 20.2 7.3 4.5 2.9 1.9 4.4 2.4 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No No Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 11.0 9.7 8.9 5.6 0.6 1.1 4.9 11.9 5.5 10.4 11.0 7.9 6.9 17.9 4.5 4.2 14.1 9.2 16.8 8.8 18.6 10.2 12.2 6.2 3.4 4.6 0.0 12.0 8.7 0.1 0.5 14.5 2.7 1.7 5.8 9.1 8.1 4.4 10.6 8.7 11.4 7.0 16.2 10.8 15.0 9.6 16.0 3.2 2.6 6.9 7.4 5.3 8.8 5.9 2.2 7.6 4.5 2.7 3.5 7.1 11.4 13.3 7.7 3.5 5.3 15.5 5.0 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 0.0 0.0 0.8 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.1 0.3 0.0 0.1 0.1 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 19.7" "Cell type enriched" "Detected in some" 31 "Syncytiotrophoblasts: 218.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 11.7;SuSa: 9.8" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 19.1;SuSa: 12.9;T-47d: 5.4" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 58.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA010726, HPA037749" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 68000 Centrosome Vesicles "HPA010726: , HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.6 2.1 15.3 0.6 9.5 0.5 2.0 1.1 21.1 1.3 0.6 1.4 0.0 0.7 2.5 0.7 1.5 1.7 1.2 6.0 12.7 3.7 0.7 0.5 0.7 0.8 3.7 7.9 2.3 1.0 0.5 0.5 1.0 2.9 1.2 0.6 2.7 0.8 0.9 20.5 1.6 0.7 2.9 2.7 2.2 0.6 1.0 0.8 0.0 0.9 3.2 0.6 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 15.3 9.5 1.1 21.1 12.7 3.7 3.7 7.9 2.9 0.8 0.0 0.0 0.0 0.0 0.1 6.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.4 1.4 0.0 6.8 0.0 0.0 0.6 0.0 0.0 2.5 0.0 1.4 0.0 0.3 0.2 0.2 0.0 0.8 0.0 0.0 0.0 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202635188-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Yes No Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: AB_2672760" "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 5.8 12.5 10.1 11.1 10.3 4.3 10.0 20.8 18.1 5.5 7.9 3.2 7.1 7.0 5.0 7.5 9.6 6.6 6.2 4.3 8.6 10.8 8.3 3.6 6.2 13.0 5.9 9.1 8.8 11.6 24.7 7.5 11.0 4.7 8.6 7.9 3.7 8.6 9.3 5.8 9.0 6.0 7.3 5.7 8.2 6.6 12.6 5.8 22.4 5.5 4.8 11.7 7.2 12.7 9.0 4.8 2.3 8.9 4.5 9.9 3.3 1.6 2.0 8.9 6.1 3.0 1.7 8.6 0.5 0.8 0.5 1.0 2.5 3.5 6.7 5.5 1.0 1.3 1.6 7.5 3.8 1.5 0.1 6.1 5.6 3.8 9.4 2.4 4.7 2.5 2.3 5.3 1.1 1.7 4.0 2.4 8.9 8.0 1.4 0.5 3.2 12.7 9.9 9.0 4.7 3.8 10.1 1.8 7.8 4.7 4.3 15.1 13.1 6.6 4.4 3.2 7.8 1.9 6.6 1.4 1.1 2.1 1.5 0.9 4.9 2.8 8.9 2.0 3.7 1.1 0.3 4.5 1.6 1.6 8.9 4.0 9.0 3.6 3.1 4.8 8.5 9.9 6.8 2.3 4.5 8.8 1.7 1.3 3.3 10.1 10.3 20.8 18.1 8.6 10.8 5.9 9.1 4.7 5.8 3.0 6.9 14.1 1.9 15.2 4.7 3.9 10.2 2.7 2.3 17.4 3.9 6.1 0.0 6.7 1.7 3.3 5.2 0.0 5.5 4.9 8.4 7.0 5.7 1.7 2.5 6.4 24.8 5.5 22.9 0.9 12.0 9.9 3.3 1.0 12.9 1.9 5.7 7.0 22.3 4.9 2.7 6.5 3.1 4.4 16.3 17.3 2.3 6.4 11.9 5.4 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome NA NA "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: AB_2683813" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 2.5 0.1 5.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 4.4 0.0 0.0 0.2 0.0 11.7 1.9 7.2 16.3 0.0 0.0 0.0 0.2 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.4 0.0 3.5 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 3.0 18.2 0.0 0.4 0.1 15.9 0.7 0.0 0.0 3.4 3.5 0.0 0.0 0.0 1.4 42.2 2.9 0.0 0.0 0.0 0.1 1.8 0.8 0.0 0.0 0.2 35.0 0.0 1.8 0.0 14.6 1.7 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.1 0.0 1.5 6.5 0.2 1.1 0.9 0.0 0.0 0.0 0.0 0.1 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Cell line enhanced" "Detected in many" "PC-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.5 1.8 14.9 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.0 0.0 20.4 0.3 8.6 5.5 7.8 4.5 3.4 13.2 10.7 0.0 3.2 4.0 3.9 0.0 4.8 0.0 4.4 0.1 2.3 1.8 0.0 20.1 4.9 0.0 0.2 17.9 0.1 0.0 9.0 5.4 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 3.9 9.6 2.3 0.6 0.3 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.7 15.7 0.0 5.6 10.0 23.4 0.0 0.0 0.0 0.0 15.9 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 15.7 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 FAM45A ENSG00000119979 "Family with sequence similarity 45 member A" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 12.2 13.2 16.2 8.5 20.0 17.0 9.5 10.2 17.6 11.6 12.5 10.2 6.5 7.6 9.4 10.7 16.0 9.0 8.5 10.8 13.5 10.4 16.6 18.9 8.6 6.8 10.6 17.6 17.3 8.8 11.6 5.4 10.8 18.4 8.9 11.0 7.7 10.7 8.3 14.0 12.0 9.7 9.8 13.5 8.4 9.7 7.1 11.5 10.1 14.8 10.8 9.9 13.1 14.7 2.3 9.9 30.2 19.2 3.8 10.0 6.0 8.3 9.8 12.5 14.5 21.4 21.4 5.5 11.9 29.8 10.7 10.3 9.5 11.2 5.9 4.5 14.6 11.2 12.7 10.6 10.5 9.3 10.0 6.0 1.3 3.4 8.3 24.4 3.5 2.8 22.3 9.0 7.8 11.0 22.2 14.4 5.1 2.8 6.7 13.4 6.7 4.4 6.0 7.5 6.3 4.0 4.8 15.7 4.3 10.3 8.9 2.1 8.3 8.5 9.0 17.4 12.2 8.6 12.3 14.6 7.6 3.9 7.9 6.0 7.3 2.7 6.5 12.3 15.3 3.4 23.0 15.1 30.2 4.2 18.3 3.4 2.3 6.3 5.5 9.9 1.9 3.1 4.1 20.1 3.8 19.2 2.5 10.0 6.0 16.2 20.0 10.2 17.6 13.5 10.4 10.6 17.6 18.4 11.5 8.9 21.6 15.2 23.3 15.8 17.0 32.3 28.1 20.1 17.0 24.4 0.0 45.9 94.5 28.0 2.0 15.3 46.3 0.0 43.7 21.6 29.9 20.6 19.7 52.9 46.9 7.9 24.2 51.0 96.9 4.7 23.9 34.6 28.7 36.1 27.9 29.4 40.7 45.6 25.8 78.7 16.9 19.4 11.8 18.5 23.2 22.2 37.9 28.7 34.5 24.3 FBF1 "ALB, FBF-1, FLJ00103, KIAA1863" ENSG00000188878 "Fas binding factor 1" Q8TES7 17 75909574-75941140 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 33.1;Spermatocytes: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023677 Supported Centrosome NA NA Centrosome "HPA023677: AB_1848440" "unprognostic (7.40e-3)" "unprognostic (9.90e-3)" "unprognostic (6.62e-2)" "unprognostic (1.38e-3)" "unprognostic (3.14e-3)" "unprognostic (7.88e-4)" "unprognostic (5.76e-4)" "unprognostic (6.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.24e-3)" "unprognostic (6.31e-5)" "unprognostic (6.76e-2)" "unprognostic (1.08e-9)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "unprognostic (3.59e-1)" "unprognostic (1.77e-1)" 4.5 5.5 9.0 4.8 14.9 6.5 3.8 6.1 11.8 3.6 3.1 9.1 8.4 4.0 5.8 11.8 6.4 8.3 5.9 2.7 11.1 6.0 3.9 1.9 4.5 5.5 10.0 8.6 4.9 5.3 5.3 9.8 3.2 10.3 6.4 3.2 5.6 6.0 7.0 2.5 18.0 5.1 3.0 9.4 6.6 3.6 40.4 11.1 5.2 14.0 2.1 5.5 3.6 6.1 0.8 1.9 0.5 1.4 1.1 2.2 0.7 9.2 12.3 3.7 6.8 3.4 2.4 10.2 5.3 1.0 3.7 2.7 3.1 5.4 4.5 3.5 2.5 5.2 5.8 2.2 3.8 2.8 2.6 4.1 4.1 7.4 2.3 1.7 1.3 6.4 2.4 4.6 6.2 4.1 1.9 2.8 16.4 7.4 5.2 2.5 10.3 11.4 4.5 3.1 2.8 5.3 9.2 6.0 3.9 1.9 1.5 4.2 3.9 7.6 5.8 3.0 2.9 16.1 3.2 1.7 8.2 6.5 4.2 4.8 9.1 2.3 1.8 5.2 3.0 7.9 0.5 0.4 0.4 1.9 1.4 0.5 0.8 1.3 2.0 0.1 0.0 1.5 1.8 0.2 1.1 0.8 1.9 2.2 0.7 9.0 14.9 6.1 11.8 11.1 6.0 10.0 8.6 10.3 11.1 0.0 1.6 0.0 4.8 2.7 5.1 1.2 0.0 6.7 10.3 3.5 9.8 5.6 3.3 0.9 12.2 1.1 3.5 0.0 0.6 1.7 2.1 2.1 2.3 0.0 1.9 4.8 1.2 0.0 0.0 33.1 6.1 0.6 3.3 1.0 1.4 3.4 0.7 1.1 5.6 1.1 7.9 0.0 1.9 23.4 8.9 2.3 3.0 0.0 1.9 2.2 FBXO9 "FBX9, NY-REN-57" ENSG00000112146 "F-box protein 9" Q9UK97 6 53051991-53100873 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064246 Approved Centrosome NA NA Centrosome "HPA064246: AB_2685225" "unprognostic (6.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.71e-1)" "unprognostic (9.38e-2)" "unprognostic (3.38e-2)" "unprognostic (3.06e-3)" "unprognostic (6.73e-2)" "unprognostic (1.40e-3)" "unprognostic (2.89e-3)" "prognostic favorable (1.51e-4)" "prognostic favorable (1.82e-4)" "unprognostic (2.50e-1)" "unprognostic (3.41e-1)" "unprognostic (2.29e-1)" "unprognostic (8.73e-2)" "unprognostic (1.56e-2)" "unprognostic (6.64e-3)" 22.6 77.8 19.0 25.2 22.3 47.2 22.8 33.5 42.6 19.4 22.3 15.2 37.2 17.4 21.3 26.6 25.1 20.6 22.6 28.7 20.0 23.8 27.3 38.0 40.5 28.9 22.7 30.5 20.6 32.9 32.7 22.5 28.9 30.4 21.3 18.0 21.8 35.3 43.7 32.0 20.9 19.9 26.9 13.8 22.2 27.0 18.2 17.1 13.8 24.8 29.9 18.3 20.7 18.6 16.0 15.6 14.6 24.2 14.8 14.6 8.4 28.0 11.5 10.8 32.0 22.2 18.0 24.9 27.2 27.7 25.1 25.1 22.3 12.2 14.4 18.6 26.8 15.8 17.2 23.3 21.7 32.3 17.8 23.3 34.4 21.2 31.6 18.6 32.6 21.8 23.3 24.0 17.3 17.9 25.4 21.2 14.9 34.0 22.5 26.3 18.5 14.1 21.4 9.5 27.1 16.7 16.4 29.0 17.4 27.5 21.1 38.8 14.8 27.3 20.0 35.8 22.7 30.8 31.9 17.2 36.1 24.8 39.3 30.8 23.8 29.9 22.2 17.4 22.6 19.8 14.6 24.2 13.4 12.8 12.6 14.4 14.4 13.1 12.6 15.6 16.0 14.6 11.1 14.4 14.8 12.2 12.3 13.5 8.4 19.0 22.3 33.5 42.6 20.0 23.8 22.7 30.5 30.4 17.1 71.5 78.7 19.3 17.6 12.6 77.5 35.4 38.2 46.8 60.3 19.2 62.8 34.4 33.2 58.3 113.4 26.9 23.7 116.8 66.7 35.9 19.3 26.9 30.2 57.2 22.4 73.1 28.7 25.2 35.1 96.7 35.6 31.6 18.6 22.6 22.4 61.2 54.3 17.8 30.4 47.7 75.8 19.4 25.5 24.7 22.2 14.2 63.0 28.0 21.1 14.8 FCHO2 ENSG00000157107 "FCH domain only 2" Q0JRZ9 5 72955981-73090522 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Group enriched" "Detected in many" 8 "granulocytes: 15.9;monocytes: 4.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037685, HPA037686, HPA077850" Enhanced Approved Vesicles,Centrosome,Cytosol NA NA Centrosome "Vesicles, Cytosol" "HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: AB_2686860" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "unprognostic (1.01e-2)" "unprognostic (1.10e-1)" "unprognostic (6.59e-2)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (6.25e-2)" "unprognostic (1.31e-1)" "unprognostic (5.67e-2)" "unprognostic (6.56e-3)" "unprognostic (1.21e-1)" "prognostic favorable (7.00e-5)" "unprognostic (1.43e-1)" "unprognostic (3.27e-3)" "unprognostic (9.59e-2)" "unprognostic (1.76e-1)" 32.2 9.6 10.7 10.0 12.2 8.3 18.0 23.1 18.3 16.2 18.3 8.9 15.3 15.5 23.7 13.0 30.2 14.6 15.7 12.5 11.2 7.0 18.6 16.0 22.8 18.5 10.8 9.5 16.1 11.1 17.5 11.4 19.2 10.9 12.6 16.1 9.9 17.1 12.6 17.7 15.2 20.8 16.6 11.9 18.9 12.2 10.5 12.4 3.2 22.4 11.7 11.8 14.6 22.5 0.7 1.1 15.9 4.5 0.7 1.3 0.5 9.0 7.4 7.1 6.2 10.0 13.3 20.9 8.0 11.9 6.1 9.6 3.7 15.9 2.2 11.2 11.1 11.4 6.9 6.0 14.1 8.3 2.3 7.0 4.4 6.1 4.6 5.0 0.9 4.6 8.9 7.3 8.1 13.1 13.9 13.8 2.2 5.0 3.9 12.5 4.2 0.0 4.4 2.2 1.8 3.7 2.0 6.9 2.6 14.8 12.9 2.8 4.5 11.0 7.8 5.0 10.5 9.5 6.3 14.3 8.0 3.8 8.8 5.6 1.4 2.5 0.4 5.2 0.6 9.7 11.5 2.6 6.4 1.3 3.5 0.8 0.3 0.4 0.5 1.1 0.7 0.2 0.4 15.9 0.7 4.5 0.4 0.3 0.5 10.7 12.2 23.1 18.3 11.2 7.0 10.8 9.5 10.9 12.4 53.6 34.0 1.5 11.1 9.3 10.4 13.3 17.8 24.1 25.0 33.2 3.9 12.1 11.6 13.9 1.6 27.0 19.3 0.0 15.2 6.9 12.1 18.9 17.4 9.6 18.4 11.1 14.3 62.0 68.1 1.4 12.4 21.1 15.1 10.0 13.0 16.7 22.5 21.6 13.1 17.0 8.9 25.8 11.4 11.6 13.8 13.4 11.4 4.3 12.4 29.3 FGF11 "FHF3, FLJ16061, MGC102953, MGC45269" ENSG00000161958 "Fibroblast growth factor 11" Q92914 17 7438273-7444937 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 17.5;Muller glia cells: 12.7;Suprabasal keratinocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 9.4;HaCaT: 17.3;LHCN-M2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066605, HPA075188" Enhanced Approved Centrosome NA NA Centrosome "HPA066605: AB_2685693, HPA075188: AB_2732283" "unprognostic (7.35e-2)" "unprognostic (1.14e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-4)" "unprognostic (9.15e-2)" "unprognostic (3.28e-2)" "unprognostic (7.31e-2)" "unprognostic (3.11e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.69e-2)" "unprognostic (2.89e-3)" "unprognostic (2.00e-6)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.90e-3)" "unprognostic (4.97e-3)" 3.3 23.5 10.5 3.0 13.8 2.1 2.9 4.5 11.6 6.4 1.6 4.6 0.1 1.8 3.1 1.9 13.0 1.7 3.2 11.6 11.7 4.6 3.4 1.1 1.3 6.2 8.1 5.2 1.6 1.3 1.5 1.0 2.0 10.6 1.4 1.4 6.8 3.7 1.7 8.8 19.7 1.3 2.9 4.1 2.4 1.6 2.8 9.9 2.5 7.2 7.1 9.0 2.9 8.7 0.0 0.0 1.6 0.6 0.0 0.3 0.0 9.4 0.6 5.3 0.0 3.1 0.1 2.7 0.2 3.3 0.3 0.6 0.2 1.0 2.8 0.7 0.1 0.1 17.3 2.0 5.4 1.2 5.9 4.2 5.2 0.5 1.3 0.5 0.2 5.8 0.6 1.5 0.4 0.2 0.5 0.2 2.2 2.0 0.2 11.4 2.1 1.7 2.3 1.9 0.4 0.2 4.5 4.8 1.2 0.7 0.8 1.1 5.4 0.6 0.6 0.4 3.1 0.3 0.4 0.2 0.3 5.7 0.0 0.2 0.4 1.3 0.9 1.3 3.2 0.6 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 10.5 13.8 4.5 11.6 11.7 4.6 8.1 5.2 10.6 9.9 0.0 0.0 0.0 0.3 4.8 2.8 0.4 2.5 0.0 0.0 1.8 5.9 0.3 3.3 0.5 1.3 0.8 0.4 0.0 0.2 0.4 0.4 0.5 0.0 0.0 0.3 17.5 0.0 0.6 0.3 3.4 1.7 0.3 1.7 0.0 0.3 12.7 1.0 0.0 2.1 0.1 2.5 0.0 0.9 1.2 1.3 8.4 0.6 0.0 0.6 0.9 FGFR1OP FOP ENSG00000213066 "FGFR1 oncogene partner" O95684 6 166999182-167094789 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.3" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 225.5;Late spermatids: 194.1;Spermatocytes: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071876 Approved Supported Centrosome NA NA Centrosome "HPA071876: AB_2686467" "unprognostic (9.14e-2)" "unprognostic (2.24e-1)" "unprognostic (3.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (9.59e-2)" "unprognostic (1.00e-1)" "unprognostic (6.95e-2)" "unprognostic (8.83e-2)" "unprognostic (1.08e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 6.2 12.2 11.2 12.9 12.5 9.8 10.2 11.9 13.0 10.1 9.5 6.9 11.8 10.8 13.6 14.1 8.8 19.1 7.9 6.4 10.8 9.1 12.2 24.9 6.7 9.4 6.4 11.5 11.8 10.2 8.2 17.2 6.6 9.4 7.4 12.1 8.9 8.1 11.6 5.8 7.9 13.0 7.4 7.4 9.4 7.8 50.3 8.0 14.5 12.5 6.2 11.8 7.0 8.2 6.8 10.0 24.1 4.1 3.5 6.8 3.0 11.6 6.5 16.5 11.2 9.7 7.3 20.0 15.1 10.1 12.4 12.0 24.0 9.9 13.9 8.6 9.2 33.0 11.0 14.4 10.7 23.3 8.7 12.4 9.6 11.7 26.0 5.2 17.0 10.1 4.0 7.9 25.3 11.9 7.7 8.5 15.8 31.2 11.9 15.8 10.7 13.7 25.0 14.0 22.5 5.0 15.8 11.2 11.5 12.9 6.3 12.3 12.3 12.3 13.2 5.2 12.1 10.9 21.1 5.5 12.3 20.6 14.7 18.8 10.2 14.0 14.1 13.9 16.0 15.0 0.2 4.1 13.5 3.3 3.6 4.9 6.8 3.9 3.1 6.5 5.0 2.3 3.7 24.1 3.5 3.6 10.0 6.8 3.0 11.2 12.5 11.9 13.0 10.8 9.1 6.4 11.5 9.4 8.0 11.9 15.6 12.7 7.4 5.4 20.9 11.2 15.3 30.8 12.5 5.2 21.6 12.3 10.0 11.1 225.5 5.5 15.2 46.7 6.4 13.6 6.8 4.7 4.7 18.8 9.2 9.5 10.3 6.2 7.6 194.1 12.0 7.7 5.0 15.4 12.7 9.3 8.4 12.9 12.0 14.3 55.1 6.5 6.6 97.9 28.4 5.6 5.3 13.1 13.2 4.3 FKBP11 FKBP19 ENSG00000134285 "FK506 binding protein 11" Q9NYL4 12 48921518-48926474 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 175.6;salivary gland: 62.0" "Cell type enhanced" "Detected in all" 7 "Exocrine glandular cells: 145.3;Melanocytes: 258.1;T-cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 37.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 44.0;Karpas-707: 40.1;OE19: 56.1;RPMI-8226: 40.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome NA NA Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 5.6 4.6 1.1 8.2 1.4 3.7 3.7 0.9 2.2 7.5 6.9 0.9 21.6 9.2 4.4 12.9 4.4 4.8 8.1 3.4 1.3 2.4 4.8 38.4 5.8 16.6 1.0 1.3 3.7 175.6 0.2 12.3 3.3 1.6 4.8 6.3 1.9 62.0 20.9 1.4 1.7 7.6 2.9 1.0 18.7 10.0 1.9 0.9 2.2 4.7 4.9 14.5 8.2 4.3 11.1 8.3 1.1 0.3 5.1 37.6 7.3 2.0 2.7 0.5 0.7 12.0 18.2 1.0 15.9 22.8 17.6 20.8 10.2 11.4 30.9 0.5 25.9 0.2 8.5 5.5 7.0 9.1 6.5 1.1 1.1 2.9 0.1 44.0 0.6 0.8 20.3 13.5 13.5 25.1 7.5 9.9 10.5 0.4 40.1 6.4 5.8 4.6 1.1 1.4 56.1 5.1 12.7 0.7 40.1 2.2 0.4 6.5 1.9 5.3 7.9 3.5 0.6 0.4 0.9 7.9 3.4 0.6 0.3 0.3 23.5 19.4 15.7 2.1 0.7 5.6 0.9 0.2 0.6 22.5 0.3 37.6 11.1 15.6 17.7 0.3 4.8 9.4 14.4 1.1 5.1 0.1 8.3 6.4 7.3 1.1 1.4 0.9 2.2 1.3 2.4 1.0 1.3 1.6 0.9 14.9 18.4 30.6 44.0 25.1 4.9 1.7 35.7 28.1 19.4 8.7 37.3 19.0 6.6 17.0 15.1 19.7 11.7 46.7 145.3 59.9 74.1 89.1 12.7 90.3 9.7 1.6 24.1 49.1 14.2 13.2 25.6 9.7 258.1 5.4 84.9 1.5 80.1 7.0 13.1 12.2 15.0 6.5 22.1 8.0 6.8 18.6 35.4 152.0 40.1 37.6 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 13.9 27.2 16.9 14.8 24.9 10.0 17.4 19.4 15.0 25.3 22.3 14.6 32.0 17.8 22.4 32.2 10.6 18.2 17.9 14.0 15.0 23.1 20.4 43.0 18.1 12.0 14.6 14.8 25.0 37.4 14.1 59.0 79.8 15.7 15.6 16.2 15.1 22.5 31.6 9.1 9.2 24.7 17.5 14.8 16.2 18.5 18.8 16.6 13.2 34.2 11.6 12.7 17.8 15.4 6.6 7.6 8.7 6.9 3.9 7.9 3.2 4.5 5.2 19.2 5.0 24.3 30.8 3.7 21.3 28.5 20.6 15.0 7.1 11.1 3.4 4.0 16.0 8.9 4.9 11.4 7.2 30.0 8.6 8.8 5.6 15.0 13.0 14.8 5.2 0.9 15.7 10.1 18.2 21.2 19.3 21.2 4.8 6.9 8.5 22.3 1.8 5.1 10.4 9.4 9.8 4.4 4.9 7.6 6.3 17.3 8.4 7.3 12.0 8.0 7.2 15.2 12.7 3.8 10.2 16.6 10.7 7.4 9.9 15.0 10.4 5.4 3.2 8.1 6.7 11.0 3.4 5.7 3.6 5.2 4.0 7.5 6.6 6.1 4.4 3.6 4.9 7.9 6.7 8.7 3.9 6.9 7.6 4.7 3.2 16.9 24.9 19.4 14.5 15.0 23.1 14.6 14.8 15.7 16.6 50.6 43.5 17.9 23.8 16.4 46.2 21.6 25.5 32.1 30.7 34.9 35.3 10.1 11.6 24.5 39.5 33.8 23.2 0.0 31.5 29.4 31.7 42.8 30.1 63.7 22.7 33.4 41.8 27.6 26.5 7.9 31.4 34.7 35.4 25.2 35.7 64.1 29.0 25.4 37.1 38.9 46.7 6.5 26.9 73.8 28.1 10.5 27.0 19.3 22.5 24.4 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986720-65062652 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome NA NA Centrosome "HPA062743: AB_2684861" "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 7.4 9.0 6.3 4.9 21.9 2.3 7.8 11.4 13.7 8.0 6.3 24.3 6.2 5.6 6.4 6.6 13.5 9.0 5.1 12.0 8.1 7.9 8.0 5.6 7.0 5.1 34.0 7.2 7.4 5.9 13.6 7.9 8.2 25.4 8.9 7.9 4.4 8.0 9.6 14.3 10.3 5.1 11.6 75.0 4.6 5.7 9.0 22.2 4.7 5.6 5.8 7.3 7.4 7.8 2.4 6.4 12.3 10.3 2.8 8.8 5.3 18.7 13.6 10.6 6.0 6.8 6.0 7.8 10.8 8.0 12.3 12.7 7.2 7.7 3.2 6.2 11.4 6.8 12.5 25.5 8.4 10.1 4.5 7.2 12.7 3.7 10.5 4.4 4.3 17.6 5.1 7.3 5.3 2.9 11.5 10.2 5.9 6.8 4.6 7.1 12.4 6.5 7.2 4.6 11.6 13.9 6.4 9.9 4.0 8.4 6.9 6.8 6.7 6.7 13.3 14.7 8.8 12.2 7.5 8.0 8.9 18.4 4.0 6.9 2.4 2.7 3.2 10.3 5.6 20.5 12.3 10.3 9.2 3.6 8.6 8.8 2.4 5.5 4.3 6.4 1.9 4.5 3.3 2.7 2.8 4.3 4.9 5.1 5.3 6.3 21.9 11.4 13.7 8.1 7.9 34.0 7.2 25.4 22.2 11.9 2.1 0.0 2.9 2.2 4.4 6.1 2.5 1.4 6.8 3.5 2.0 13.7 0.0 5.9 5.2 2.9 3.3 0.0 4.2 12.8 5.8 5.0 0.0 7.3 7.0 4.8 7.5 5.5 9.5 4.5 5.2 3.4 5.0 7.2 5.5 7.0 4.0 0.0 8.1 4.6 4.0 19.4 2.7 2.1 3.2 3.1 6.9 2.5 5.0 2.6 FOPNL "C16orf63, DKFZp686N1651, FLJ31153, FOR20, PHSECRG2" ENSG00000133393 "FGFR1OP N-terminal like" Q96NB1 16 15865720-15888625 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 271.9;Late spermatids: 399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040599 Supported Supported Centrosome NA NA Centrosome "HPA040599: AB_10794036" "unprognostic (1.10e-1)" "unprognostic (6.29e-2)" "unprognostic (1.16e-3)" "unprognostic (7.16e-2)" "unprognostic (2.45e-1)" "unprognostic (3.77e-2)" "unprognostic (2.23e-2)" "unprognostic (6.01e-2)" "unprognostic (1.72e-1)" "unprognostic (4.92e-1)" "unprognostic (4.35e-2)" "unprognostic (4.78e-1)" "unprognostic (6.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (5.45e-3)" 12.0 21.6 15.6 13.4 17.3 13.2 21.4 13.1 19.5 14.2 16.0 14.5 9.5 13.7 11.7 9.3 21.3 12.8 15.4 15.4 14.0 14.7 19.4 18.3 11.3 23.8 16.5 11.3 16.8 14.3 15.5 16.4 14.7 17.9 14.3 15.3 14.5 11.4 13.2 32.7 18.3 12.5 13.1 12.9 13.9 11.4 21.7 13.0 25.7 36.0 22.1 16.4 20.5 13.0 13.9 14.9 23.7 12.9 16.0 15.3 13.6 15.2 16.4 5.9 0.9 13.5 16.8 0.7 8.5 9.9 8.8 10.4 8.8 1.5 11.1 11.0 2.1 16.4 12.3 14.6 1.1 18.5 11.7 10.8 1.6 3.9 3.3 11.3 3.1 12.3 1.5 20.0 1.9 13.5 2.6 14.8 25.7 29.7 1.4 2.3 11.6 9.6 11.8 14.6 10.7 0.9 2.1 13.9 1.1 1.1 4.7 5.3 0.4 0.8 11.1 18.3 12.9 1.3 1.3 5.0 1.2 1.1 17.3 29.8 4.0 12.8 18.4 16.0 25.8 12.9 23.7 12.9 6.0 11.7 12.7 15.2 13.9 14.4 13.8 13.4 13.7 15.3 14.1 3.7 16.0 10.5 14.9 13.6 13.6 15.6 17.3 13.1 19.5 14.0 14.7 16.5 11.3 17.9 13.0 29.8 12.8 34.0 26.8 36.2 8.2 21.7 10.2 22.7 17.0 10.4 3.9 34.2 43.1 17.3 271.9 14.3 9.1 70.0 19.9 22.6 21.2 22.0 32.4 20.2 18.7 11.1 18.6 12.9 25.3 399.8 29.7 17.4 23.6 17.2 20.2 22.0 17.5 22.6 30.8 31.9 8.9 6.5 22.5 31.6 23.2 36.3 24.3 29.8 22.1 22.7 FP565260.6 ENSG00000280071 21 5079294-5128425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA018517 Uncertain Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (4.87e-2)" "unprognostic (2.69e-3)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (2.96e-1)" "unprognostic (6.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.39e-2)" "unprognostic (7.65e-2)" "unprognostic (1.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.33e-2)" "unprognostic (6.67e-4)" "unprognostic (1.88e-2)" "unprognostic (6.80e-2)" "unprognostic (4.25e-1)" "unprognostic (2.84e-2)" 3.9 6.7 2.8 2.0 6.6 1.3 3.4 8.2 7.0 3.0 5.7 5.2 2.5 5.7 2.2 5.0 3.9 3.3 2.8 15.5 3.2 12.9 14.4 4.8 10.5 6.7 4.7 5.6 2.7 4.0 0.9 6.4 4.2 3.0 4.7 4.4 4.9 2.3 17.1 1.3 3.6 2.4 3.0 2.6 2.2 1.4 3.9 1.1 4.2 11.1 2.4 3.9 2.0 47.1 43.8 19.9 46.4 37.1 41.4 46.1 13.2 12.5 13.9 24.4 13.3 12.7 6.8 0.0 2.6 0.8 1.2 2.0 13.6 1.2 15.4 16.3 13.8 9.5 20.0 10.4 1.2 9.1 8.9 51.5 13.3 12.7 12.1 22.1 9.8 20.3 17.6 8.0 14.7 11.9 16.1 17.5 20.2 15.3 9.6 27.8 22.0 24.2 27.2 37.2 20.4 45.2 10.5 48.2 18.2 12.3 14.1 23.7 18.4 34.7 12.9 7.5 35.7 31.1 5.7 8.0 9.9 0.8 8.0 20.7 21.1 8.7 16.4 45.8 6.7 19.9 33.6 16.9 31.6 36.0 31.6 43.9 41.4 32.9 43.8 47.1 39.7 30.2 6.8 37.1 46.4 28.9 40.0 46.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 3.5 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;HEL: 7.9;U-2 OS: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA050483: AB_2681140, HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavorable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 14.0 7.4 33.6 7.0 47.2 8.2 4.2 29.1 53.8 6.9 5.6 17.3 3.0 2.3 18.1 1.9 2.9 7.9 4.1 4.6 24.8 21.4 2.9 2.0 6.9 6.6 15.6 33.7 7.8 5.1 1.8 5.8 5.0 22.3 12.8 3.2 4.4 13.0 13.3 8.5 18.3 6.1 5.5 14.9 24.2 6.1 4.3 15.4 0.0 3.9 0.1 5.2 4.0 5.9 1.8 1.7 0.0 0.5 0.0 0.4 0.3 3.0 0.0 1.9 8.1 0.9 2.1 2.1 2.0 0.9 1.8 0.5 2.4 0.1 1.4 2.0 0.0 0.5 2.5 0.9 0.0 0.0 7.3 3.4 7.9 3.5 0.0 1.2 0.3 4.0 0.0 0.0 1.6 0.0 2.3 1.0 4.3 6.7 0.0 0.3 2.0 0.8 0.1 0.6 0.0 1.1 3.5 0.7 0.1 0.3 0.0 0.5 1.3 0.5 0.0 3.3 0.6 1.5 1.2 4.6 3.3 8.4 0.3 3.8 7.1 0.8 0.0 1.8 3.6 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 33.6 47.2 29.1 53.8 24.8 21.4 15.6 33.7 22.3 15.4 11.9 19.8 5.2 6.1 10.5 22.1 8.9 2.5 1.4 18.2 3.5 0.0 0.4 0.0 1.2 2.4 11.9 0.0 0.0 0.7 0.2 9.6 5.4 7.0 0.0 1.1 22.3 6.9 28.8 7.2 1.7 14.1 10.5 0.0 5.4 3.8 9.7 2.2 1.5 24.1 0.7 13.8 12.9 15.5 1.1 1.5 9.7 0.5 1.0 1.2 1.8 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533412-35545316 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 154.6" "Cell type enriched" "Detected in some" 4 "Late spermatids: 6946.0" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA042666: AB_2678104" "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 0.3 0.5 0.3 0.8 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.6 0.5 1.6 0.6 0.2 0.8 0.8 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 0.7 1.3 0.0 0.3 0.3 0.3 0.3 0.0 4.2 1.3 0.3 0.3 4.4 0.6 0.3 0.3 1.2 0.4 154.6 0.3 0.3 3.6 0.3 0.3 0.6 0.3 2.1 1.0 1.2 0.8 1.4 2.0 0.8 4.5 16.5 4.6 6.9 0.0 0.0 3.9 1.3 0.0 0.0 0.0 10.0 7.6 7.5 2.2 0.0 1.9 5.5 0.0 0.0 0.0 7.3 8.0 5.0 10.5 5.1 0.1 4.5 6.0 0.0 0.0 0.0 0.0 2.9 0.0 7.3 12.0 4.4 0.0 14.1 1.7 2.1 6.2 2.9 2.2 5.3 3.2 5.8 0.0 4.5 8.3 3.7 1.7 4.2 4.9 3.3 3.4 1.9 1.5 5.3 6.0 1.3 1.9 12.3 3.3 4.4 2.9 8.1 1.9 0.0 0.8 1.2 1.1 0.6 2.0 1.1 0.4 1.9 1.0 2.1 1.1 1.2 0.0 1.4 0.3 0.8 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1712.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 6946.0 23.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 25.8 0.2 30.4 13.5 0.1 0.0 0.0 0.0 0.0 GINS4 "MGC14799, SLD5" ENSG00000147536 "GINS complex subunit 4" Q9BRT9 8 41529206-41545046 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "B-cells: 13.0;monocytes: 15.4;Spermatogonia: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024663, HPA026580" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA024663: AB_1857224, HPA026580: AB_1857225" "unprognostic (7.74e-2)" "unprognostic (3.72e-2)" "unprognostic (2.25e-3)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.70e-1)" "unprognostic (4.01e-2)" "unprognostic (1.71e-3)" "unprognostic (8.01e-3)" "unprognostic (4.03e-3)" "unprognostic (1.50e-2)" "unprognostic (4.34e-4)" "unprognostic (1.79e-1)" "unprognostic (3.67e-5)" "unprognostic (2.40e-3)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (3.22e-1)" 2.0 3.0 2.3 6.2 4.7 9.0 2.7 1.6 3.7 2.7 3.4 6.8 0.0 2.5 2.4 3.0 6.0 1.6 2.4 5.7 3.7 1.8 2.2 2.2 2.5 7.9 5.9 3.3 2.6 1.3 1.6 1.2 4.8 2.8 1.8 5.1 1.9 2.6 0.8 3.7 3.4 3.7 2.4 4.7 5.0 2.1 8.6 5.6 14.0 2.1 5.7 9.6 2.1 3.0 5.8 5.2 3.9 1.4 2.7 6.7 1.7 9.7 14.0 19.8 8.9 1.2 1.6 8.2 13.9 8.4 14.4 17.0 12.9 8.5 13.5 5.7 7.0 11.0 7.4 15.9 11.4 21.3 5.0 8.9 19.6 10.3 8.7 0.3 4.2 10.2 0.8 0.5 23.8 5.3 3.3 7.1 16.4 9.6 4.5 10.1 6.6 17.6 4.8 11.0 10.4 7.7 16.6 18.5 5.7 5.1 9.3 6.1 4.8 9.8 4.4 4.0 10.5 11.3 4.7 4.9 9.8 14.9 18.0 13.9 5.3 7.8 16.1 7.0 10.1 23.7 2.4 1.4 0.5 3.0 1.3 1.7 2.4 4.8 2.0 0.7 5.8 3.1 2.0 3.9 2.7 0.7 5.2 6.7 1.7 2.3 4.7 1.6 3.7 3.7 1.8 5.9 3.3 2.8 5.6 0.0 1.4 13.0 2.6 2.5 5.0 0.8 0.0 0.0 1.2 8.7 2.0 6.2 0.0 1.3 0.5 0.7 0.4 0.0 1.6 10.0 2.6 1.1 1.1 0.5 4.0 0.0 3.4 1.3 1.9 0.0 1.1 4.0 0.0 15.4 2.3 1.9 1.5 0.0 2.1 0.8 1.8 0.0 1.4 7.7 11.5 1.0 4.9 4.9 3.3 0.8 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome NA NA 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: AB_2677870" "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.8 19.0 0.1 23.7 15.2 8.7 12.6 15.2 11.2 13.9 0.0 3.2 0.1 4.1 13.5 9.6 3.0 10.6 12.9 14.9 0.1 9.7 17.8 18.3 1.3 24.0 2.3 3.8 16.3 32.8 6.0 17.3 9.1 7.5 0.0 1.4 0.0 21.0 0.5 0.1 0.1 5.5 0.1 7.5 8.3 7.3 8.9 33.5 10.0 13.9 9.6 13.5 0.2 10.8 16.3 2.6 0.4 13.3 25.1 17.7 5.8 4.7 0.1 0.0 0.1 6.6 1.3 11.1 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 17.9 14.4 0.8 17.7 195.4 3.7 6.1 15.3 36.1 13.6 27.9 0.0 72.1 74.6 6.5 0.9 24.0 2.9 0.0 3.3 66.5 57.4 6.1 27.9 16.8 8.7 25.4 19.1 18.4 1.0 3.5 31.1 5.8 97.8 4.6 7.3 46.1 6.8 7.0 70.0 9.8 5.0 109.9 38.2 6.2 40.1 187.2 153.4 0.0 8.5 14.5 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 329.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 14.1 5.0 9.6 5.6 9.2 11.1 7.9 10.7 8.6 10.9 10.9 7.6 4.9 7.6 7.1 11.4 6.7 7.5 9.0 10.9 15.3 8.5 5.5 6.6 8.6 6.5 7.9 10.3 6.1 8.2 9.3 12.6 8.7 7.6 13.1 5.8 8.6 7.5 10.8 9.6 7.9 8.4 9.6 6.8 5.8 5.7 22.6 4.9 12.1 10.8 6.2 10.8 7.5 8.5 11.7 7.8 6.5 9.1 11.8 9.2 12.7 13.8 12.1 8.0 9.0 8.8 15.3 10.2 14.3 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 41.7 29.8 72.9 89.8 134.3 27.1 11.7 28.1 46.8 34.2 55.8 329.9 74.3 54.7 94.8 7.0 65.3 47.7 23.3 88.0 115.2 72.4 62.2 45.1 49.5 96.4 23.8 80.9 47.9 103.4 6.0 45.1 89.9 70.9 77.5 58.1 44.4 82.3 52.6 44.6 40.9 23.4 51.8 82.4 64.2 49.4 164.6 89.4 82.8 47.9 147.8 GNB5 GB5 ENSG00000069966 "G protein subunit beta 5" O14775 15 52115105-52191369 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 264.1;Cone photoreceptor cells: 263.1;Horizontal cells: 104.9;Muller glia cells: 196.6;Peritubular cells: 110.0;Rod photoreceptor cells: 285.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032353, HPA041942, HPA044198" Uncertain Approved "Nuclear speckles,Centrosome,Rods & Rings" NA NA 11000 "Nuclear speckles" "Centrosome, Rods & Rings" "CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: AB_2678853" "unprognostic (2.38e-2)" "unprognostic (3.58e-1)" "unprognostic (1.97e-3)" "prognostic favorable (1.47e-6)" "unprognostic (6.15e-2)" "unprognostic (1.37e-2)" "unprognostic (2.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-3)" "unprognostic (2.10e-1)" "prognostic favorable (3.32e-11)" "unprognostic (1.40e-3)" "unprognostic (8.12e-3)" "unprognostic (3.55e-3)" "unprognostic (1.52e-1)" 6.2 11.2 17.7 8.2 25.6 3.7 8.9 42.5 30.7 15.2 9.2 4.0 9.6 4.6 21.2 13.4 9.0 20.4 15.4 17.3 13.0 18.6 26.9 10.3 5.8 14.7 13.6 21.9 38.1 13.7 35.5 14.7 4.4 21.3 12.9 4.5 20.4 6.5 20.3 1.7 4.8 7.0 13.3 5.9 8.3 7.5 11.7 9.2 7.0 16.2 1.9 14.1 14.6 14.0 21.6 9.9 3.6 1.9 10.8 19.7 9.3 8.0 20.8 5.8 10.2 9.9 12.4 5.6 15.8 15.4 14.1 15.4 5.8 6.1 14.0 4.9 12.9 23.8 11.9 10.2 15.0 10.7 10.9 7.7 9.4 28.1 6.6 11.8 4.7 34.1 11.4 12.7 11.3 4.2 15.0 8.8 12.4 0.7 13.3 15.4 14.4 7.4 13.4 5.3 2.7 9.2 10.0 20.1 17.1 10.0 24.7 9.3 8.1 15.1 1.4 12.3 7.4 4.9 14.7 21.6 12.7 13.9 14.3 15.8 8.5 16.3 15.4 26.6 11.5 20.4 3.6 1.9 0.2 10.7 1.7 8.9 21.0 14.0 12.8 4.8 21.6 13.2 11.3 1.0 10.8 1.4 9.9 19.7 9.3 17.7 25.6 42.5 30.7 13.0 18.6 13.6 21.9 21.3 9.2 20.8 25.0 36.0 19.7 17.1 264.1 20.9 35.7 28.1 28.4 17.4 263.1 4.3 16.6 22.9 1.3 15.5 1.0 0.0 16.4 22.2 20.2 9.6 28.9 6.6 3.5 104.9 18.9 12.9 4.5 1.6 36.8 9.4 18.6 1.8 1.6 196.6 16.5 3.5 110.0 28.3 285.1 45.3 23.7 2.1 5.1 14.3 2.4 23.0 1.9 15.5 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "liver: 6.2;testis: 15.7" "Cell type enriched" "Detected in some" 16 "Early spermatids: 37.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SuSa: 2.3;U-266/70: 5.2" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.1 0.1 0.0 0.0 0.2 0.3 0.0 5.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6B ENSG00000215186 "Golgin A6 family member B" A6NDN3 15 72654738-72666394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 34 "liver: 8.4;testis: 10.5" "Cell type enriched" "Detected in single" 60 "Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SuSa: 1.3;U-266/70: 2.5;U-266/84: 1.1" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (5.47e-3)" "unprognostic (1.88e-2)" "unprognostic (2.07e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.6 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in single" 72 "Early spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.3;SuSa: 1.6" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 1.3 0.0 0.1 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.0 0.7 0.0 0.1 0.1 0.0 0.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.2" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.6;Karpas-707: 1.1;NTERA-2: 1.5;SuSa: 3.2;U-266/70: 2.9;U-266/84: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (7.95e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved Approved "Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Centrosome, Mitochondria" "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.4 29.1 6.8 21.3 15.8 13.5 23.7 16.9 16.8 14.2 14.8 12.0 27.3 9.0 24.7 18.3 6.7 20.5 4.5 16.8 2.1 15.1 15.3 14.1 13.6 8.8 15.3 6.9 21.3 14.8 15.7 14.5 10.1 11.5 11.7 15.3 10.2 31.9 13.6 57.9 13.3 6.4 6.8 19.4 70.8 9.3 8.6 42.8 12.3 11.6 11.8 16.2 22.1 28.5 12.4 3.9 18.3 19.5 7.7 13.2 23.0 7.5 18.9 17.8 13.7 5.9 23.4 8.5 17.9 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 35.7 40.2 43.2 39.6 25.5 57.0 39.1 40.8 26.8 11.4 41.8 60.9 106.7 21.6 110.5 4.7 29.4 99.5 0.0 78.8 116.9 52.6 52.7 65.6 67.2 78.9 52.4 54.6 43.0 45.7 6.6 37.4 40.2 69.2 59.5 47.2 94.2 69.6 80.7 35.3 71.5 53.5 58.2 37.1 132.9 51.7 19.4 91.4 48.0 73.6 37.1 GRAP ENSG00000154016 "GRB2-related adaptor protein" Q13588 17 19020673-19047637 "Plasma proteins, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.3;lymphoid tissue: 20.9" "Cell type enhanced" "Detected in some" 20 "B-cells: 11.5;Endothelial cells: 11.3;Ito cells: 41.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 28.2;T-cells: 37.3" "Cell line enhanced" "Detected in some" "Daudi: 32.2;HUVEC TERT2: 13.3;JURKAT: 10.2;REH: 16.9;TIME: 26.1;U-698: 22.6" "HPA046595, HPA066654" Uncertain Approved Centrosome NA NA Centrosome "HPA046595: AB_10966385, HPA066654: AB_2685699" "unprognostic (3.02e-1)" "unprognostic (6.85e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (3.43e-2)" "unprognostic (3.86e-6)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (4.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (5.11e-2)" "unprognostic (2.67e-5)" "unprognostic (2.25e-1)" "unprognostic (1.57e-2)" "unprognostic (2.16e-1)" "unprognostic (5.77e-3)" 2.8 1.4 0.7 5.7 0.9 2.4 2.8 0.1 0.4 1.4 0.6 0.3 1.4 0.0 0.5 1.9 2.1 0.6 0.8 0.6 2.2 2.7 3.5 15.8 1.0 0.6 0.1 0.0 0.7 2.5 1.0 0.4 0.4 1.6 0.3 0.8 7.7 1.1 1.0 20.9 0.5 2.5 2.7 14.2 1.7 0.8 28.2 2.7 5.6 2.5 4.9 37.3 13.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.2 0.1 0.0 0.0 0.0 6.6 0.5 0.3 0.0 0.0 16.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.2 26.1 0.0 0.0 3.2 0.0 0.0 0.0 22.6 0.0 0.0 0.1 5.6 2.5 0.3 5.9 1.3 5.9 28.2 18.5 7.7 2.7 22.8 37.3 17.9 0.7 4.9 0.1 2.0 15.4 13.0 6.0 2.6 11.5 0.0 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 1.9 11.3 0.0 0.0 0.0 0.6 0.1 0.0 2.3 0.8 6.4 0.0 0.0 41.7 6.5 0.0 0.0 0.8 0.0 2.8 0.1 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.4 0.9 0.2 6.9 0.0 0.0 GRAPL ENSG00000189152 "GRB2 related adaptor protein like" Q8TC17 17 19127469-19159176 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ito cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 10.8" "Lineage enriched" "Detected in many" 5 "B-cells: 10.8" "Group enriched" "Detected in some" 6 "Daudi: 22.2;HUVEC TERT2: 9.2;TIME: 24.6;U-698: 20.6" "HPA051796, HPA066654" Uncertain Approved Centrosome NA NA Centrosome "HPA051796: AB_2681613, HPA066654: AB_2685699" "unprognostic (2.85e-1)" "unprognostic (3.37e-1)" "unprognostic (5.09e-4)" "unprognostic (4.49e-2)" "unprognostic (6.45e-2)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.76e-1)" "unprognostic (5.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.28e-2)" "unprognostic (8.29e-2)" "unprognostic (2.14e-1)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" 4.6 1.6 0.7 9.5 1.7 1.0 1.7 0.4 2.0 1.5 1.3 0.1 2.9 0.7 3.6 1.9 2.5 1.6 2.2 3.4 1.7 0.8 2.8 1.8 4.6 15.6 1.1 1.2 1.1 0.4 0.0 1.0 1.7 1.0 1.4 1.3 1.0 1.4 1.3 2.3 0.7 9.7 1.9 0.9 20.6 0.8 1.1 0.5 7.7 2.7 1.7 17.0 1.7 2.3 10.8 0.1 0.0 0.0 0.0 2.2 0.7 0.0 1.2 1.5 0.0 0.2 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.3 22.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 3.1 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.7 0.0 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.1 24.6 0.0 0.2 1.1 0.0 0.0 0.0 20.6 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 10.8 1.4 0.3 0.1 4.1 2.2 0.7 0.0 0.0 0.0 0.0 0.9 0.7 0.7 1.7 0.4 2.0 1.7 0.8 1.1 1.2 1.0 0.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.8 10.4 20.5 16.2 0.4 1.2 9.8 19.0 9.0 27.7 22.9 10.8 8.3 20.7 5.0 7.3 12.7 11.5 18.3 4.8 17.8 12.4 19.7 13.8 14.6 8.4 0.0 24.7 16.9 0.2 0.3 11.9 6.1 2.9 11.9 15.0 10.5 26.0 16.5 12.2 22.1 12.1 14.3 9.0 11.7 22.0 23.0 13.5 4.5 4.0 10.6 14.5 18.1 11.8 8.4 9.6 10.0 9.6 9.4 15.8 30.0 12.9 19.9 14.9 7.1 21.0 10.0 11.9 23.0 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 0.0 0.0 0.8 0.6 2.5 0.6 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 3.9 0.4 0.5 93.5 0.2 27.0 1.1 0.6 0.0 0.5 16.0 0.0 1.2 5.5 6.2 3.8 0.3 3.5 0.0 0.0 2.0 0.2 0.4 0.0 0.7 0.4 0.1 6.5 0.9 47.7 20.4 2.3 1.3 2.9 3.7 1.4 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381313-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 3.8;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 8.3;granulocytes: 3.5;Proximal tubular cells: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" NA NA "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: AB_2683429" "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 3.3 5.8 7.0 4.7 11.8 3.5 5.8 13.9 14.3 5.0 3.2 5.0 2.2 4.5 6.7 4.0 1.8 7.1 2.5 3.2 6.2 5.2 5.1 2.5 2.9 6.0 4.0 7.2 8.4 16.0 3.2 15.9 3.0 8.7 3.5 4.9 7.6 9.1 3.3 2.9 4.5 3.6 3.5 4.2 5.0 4.2 9.6 4.6 5.5 5.5 0.4 5.7 2.8 4.0 3.1 1.7 5.1 1.2 3.8 4.1 1.2 1.7 2.2 9.4 5.0 2.3 4.7 2.5 1.2 1.0 2.2 2.1 6.5 3.9 7.4 3.3 1.2 3.6 5.3 5.1 1.3 3.0 5.1 3.0 3.8 8.4 2.1 1.2 3.4 2.0 1.1 1.5 3.4 1.3 2.1 1.4 9.6 2.4 4.4 0.7 2.1 4.7 5.6 1.5 2.3 3.3 6.9 5.5 4.6 0.7 1.8 12.2 4.3 2.9 1.3 0.8 3.7 3.8 1.0 0.8 3.9 3.8 6.1 1.4 4.8 2.3 6.8 1.2 3.0 2.2 3.5 1.2 1.2 3.7 0.7 2.5 3.1 3.8 1.7 1.7 3.1 4.1 4.1 5.1 3.8 0.8 1.2 3.3 1.2 7.0 11.8 13.9 14.3 6.2 5.2 4.0 7.2 8.7 4.6 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 1.8 0.0 0.9 8.3 1.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 HAUS1 "CCDC5, FLJ40084, HEI-C, HsT1461" ENSG00000152240 "HAUS augmin like complex subunit 1" Q96CS2 18 46104332-46128333 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040601, HPA040652" Supported Supported Centrosome,Cytosol NA NA Cytosol Centrosome "HPA040601: AB_10794743, HPA040652: AB_10793966" "unprognostic (1.74e-2)" "unprognostic (1.89e-2)" "unprognostic (8.13e-3)" "unprognostic (1.92e-1)" "unprognostic (2.29e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.39e-1)" "unprognostic (4.76e-3)" "prognostic favorable (1.55e-4)" "unprognostic (3.75e-1)" "prognostic unfavorable (6.76e-4)" "unprognostic (5.97e-3)" "unprognostic (5.40e-2)" "unprognostic (9.79e-3)" "unprognostic (3.66e-2)" "unprognostic (7.96e-2)" 15.2 11.8 10.3 14.6 13.1 23.1 14.5 15.8 12.2 14.3 13.4 6.2 13.1 9.9 15.5 28.4 15.9 13.8 11.6 9.3 10.3 8.0 14.4 12.1 10.9 22.9 13.6 6.8 20.4 12.0 6.5 18.1 13.0 12.0 14.8 16.3 7.3 11.4 14.4 7.1 8.6 13.4 12.2 14.4 17.9 12.2 11.8 15.4 38.4 14.3 14.4 26.1 13.9 12.3 28.1 23.4 13.0 18.2 19.3 34.9 19.3 18.7 11.3 43.1 23.2 11.1 17.2 11.6 18.3 18.3 29.4 29.2 11.1 10.6 35.8 11.1 13.1 13.6 20.0 25.8 15.6 32.4 20.1 17.3 26.3 12.2 20.9 9.3 47.9 16.2 8.3 6.2 18.1 9.3 13.0 32.0 25.8 18.7 10.2 26.1 10.9 37.9 23.0 27.5 9.0 6.7 38.1 30.9 25.6 23.2 13.2 20.3 21.1 17.0 5.9 13.8 17.8 8.6 23.3 18.0 17.2 11.7 7.4 19.1 12.0 18.2 33.2 11.0 40.7 19.6 4.4 18.2 13.0 16.0 16.4 17.7 28.1 21.6 18.9 21.6 23.7 15.4 18.1 2.0 19.3 12.7 23.4 34.9 19.3 10.3 13.1 15.8 12.2 10.3 8.0 13.6 6.8 12.0 15.4 11.9 12.6 27.6 18.2 15.5 4.5 8.7 15.3 30.8 33.0 14.0 3.9 42.3 14.9 32.5 5.8 26.6 9.0 0.0 37.0 91.5 29.6 7.0 28.9 7.7 44.3 11.1 11.6 17.8 38.3 8.6 21.0 31.9 20.3 43.3 22.2 18.1 25.9 10.5 24.4 18.9 8.0 19.4 16.5 51.9 57.7 13.6 19.8 25.9 26.4 6.7 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548810-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 18.7 11.3 13.1 12.1 11.5 49.9 18.6 13.3 15.4 9.9 11.9 11.1 5.6 8.9 14.0 10.4 12.8 9.7 9.3 10.8 14.1 13.6 10.3 11.0 16.8 16.6 14.6 13.9 12.1 12.1 8.4 9.9 11.6 13.1 8.8 10.8 8.5 10.5 8.5 13.5 11.8 9.5 12.3 18.7 11.2 9.7 13.7 11.7 18.4 10.1 11.8 13.0 10.8 14.0 10.3 7.2 7.5 13.5 4.4 8.7 4.3 11.4 6.1 11.2 7.2 5.6 6.4 10.9 11.7 7.0 11.0 9.3 12.4 7.3 7.4 5.7 6.4 10.7 19.3 11.9 7.5 11.1 9.6 6.9 10.1 10.7 9.6 8.1 17.7 9.3 5.5 5.7 8.8 9.1 5.7 11.1 9.9 17.6 9.1 10.7 7.2 13.0 14.3 9.8 16.1 8.0 14.7 13.7 9.6 7.0 8.3 9.1 7.6 11.7 11.3 6.9 8.5 11.3 13.2 8.7 17.0 12.4 26.2 21.7 13.9 39.0 22.2 10.6 19.5 12.9 7.3 7.7 7.5 8.4 9.0 8.3 10.3 8.3 6.0 6.5 8.9 6.1 8.3 3.8 4.4 13.5 7.2 8.7 4.3 13.1 11.5 13.3 15.4 14.1 13.6 14.6 13.9 13.1 11.7 11.9 15.6 14.6 18.4 12.0 7.6 4.0 7.6 21.4 11.4 3.5 15.7 11.4 3.3 13.3 21.6 11.3 6.5 0.0 14.3 22.8 9.4 20.3 23.2 7.3 19.4 15.9 16.6 10.4 15.8 5.3 10.3 19.4 1.7 21.6 9.7 6.1 15.3 8.6 10.6 11.0 15.2 19.4 11.2 23.2 8.5 13.4 11.2 15.3 9.0 16.0 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Nucleoli,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" Nucleoli "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favorable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 13.1 9.4 16.1 10.3 16.4 9.4 7.9 9.1 19.3 12.7 9.3 8.9 20.3 7.9 10.8 17.1 7.0 9.9 15.1 11.9 20.3 9.1 13.3 11.9 9.4 12.1 12.0 16.5 9.3 4.3 3.1 6.4 12.6 11.1 11.8 6.2 7.8 8.5 17.4 7.2 46.9 7.4 12.1 8.9 16.4 8.8 6.1 18.4 14.2 10.8 8.8 9.8 7.5 11.8 20.2 22.3 10.1 31.1 16.7 18.5 15.8 13.9 22.4 10.0 19.3 3.5 4.8 13.8 9.7 5.5 11.2 19.9 16.3 7.8 13.3 31.1 6.5 15.5 11.9 14.2 9.7 8.7 16.0 23.5 9.7 20.9 12.2 3.2 16.0 14.0 7.4 2.5 9.9 6.3 4.9 7.9 12.2 12.2 6.8 6.6 26.9 15.0 19.3 6.2 22.3 22.4 14.1 16.4 20.1 3.5 8.8 11.1 8.4 5.2 11.5 3.9 5.0 4.5 7.7 5.1 9.7 19.2 22.5 17.7 10.1 26.5 52.2 5.1 28.8 13.2 4.7 26.2 10.1 17.0 31.1 17.8 20.2 18.5 17.1 22.3 16.6 18.4 16.7 3.4 16.7 27.1 12.6 15.5 15.8 16.1 16.4 9.1 19.3 20.3 9.1 12.0 16.5 11.1 18.4 6.0 7.2 4.5 1.3 6.4 1.9 2.0 2.5 5.3 2.3 0.0 3.9 10.4 5.0 7.9 0.0 5.0 5.8 0.0 7.1 20.6 6.2 1.0 19.6 3.9 10.6 3.2 2.4 11.1 11.1 0.0 5.5 8.1 3.3 14.4 11.6 1.9 6.1 10.5 7.1 11.8 1.3 6.5 6.6 1.6 6.3 4.1 7.8 7.4 13.3 1.1 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.2 6.7 9.3 7.1 10.9 5.7 6.3 5.7 6.9 8.1 7.8 7.7 3.2 11.1 7.8 9.0 3.0 5.6 12.0 6.6 11.8 8.0 6.0 16.1 8.4 8.1 9.1 12.8 20.0 6.2 9.7 10.4 10.6 7.7 12.0 19.7 11.0 12.0 11.6 62.4 16.8 7.3 9.5 6.2 6.0 10.2 27.3 3.9 7.3 7.1 4.1 5.5 10.4 11.2 7.3 10.8 6.5 18.5 11.6 8.0 10.8 13.0 8.6 7.5 5.8 9.6 9.0 10.4 18.2 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 50.6 37.0 12.9 14.8 54.6 47.6 27.1 22.9 64.3 20.5 26.2 66.8 9.7 5.0 12.5 82.7 29.3 18.8 70.0 18.3 7.9 25.0 26.7 45.1 33.6 19.9 69.9 35.7 23.9 54.6 73.8 20.4 35.5 20.3 15.4 24.2 28.9 17.0 17.3 35.0 13.4 60.3 25.8 37.0 35.4 26.0 70.4 11.9 47.3 22.4 23.0 HK2 ENSG00000159399 "Hexokinase 2" P52789 2 74833981-74893359 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 26.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 54.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028587, HPA061711" Enhanced Supported Vesicles,Centrosome,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "Vesicles, Centrosome" "HPA028587: AB_10602605, HPA061711: " "unprognostic (1.28e-1)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (2.85e-2)" "unprognostic (2.57e-1)" "unprognostic (2.17e-1)" "unprognostic (4.43e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.20e-1)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (7.67e-2)" 27.0 2.2 4.4 9.5 5.0 20.4 10.8 0.7 4.5 5.3 23.2 7.3 5.7 1.3 2.6 40.1 13.6 4.8 9.1 8.3 2.8 2.3 2.1 1.4 16.5 5.0 8.5 1.1 14.9 3.5 1.1 1.7 13.2 5.4 4.0 19.2 9.6 10.3 0.5 29.3 9.7 8.9 1.7 10.9 7.4 8.7 24.8 7.4 4.3 7.1 22.3 9.2 29.0 8.3 0.8 6.2 26.2 7.1 0.0 0.8 2.0 16.5 0.1 3.8 14.0 32.9 3.4 14.3 6.4 9.4 7.3 10.5 13.2 3.0 12.0 6.2 3.0 9.4 5.7 17.5 13.6 21.2 3.4 3.7 16.3 3.8 18.2 10.4 23.8 26.9 5.8 14.8 13.8 24.3 8.2 3.4 6.9 14.2 0.0 2.1 11.8 5.7 24.4 13.9 15.7 11.5 9.3 8.1 9.3 4.4 23.4 2.8 13.7 4.1 20.9 8.2 5.8 1.1 3.8 2.8 23.3 4.1 9.6 11.7 8.3 2.3 6.0 54.3 17.5 6.0 6.6 7.1 26.2 0.1 5.7 0.3 0.6 0.4 0.1 6.2 0.8 0.7 0.7 5.9 0.0 3.7 0.1 0.8 2.0 4.4 5.0 0.7 4.5 2.8 2.3 8.5 1.1 5.4 7.4 14.9 37.6 2.9 5.5 45.8 6.2 6.0 7.6 0.0 6.8 5.2 78.5 0.7 0.0 4.4 87.9 3.6 116.3 0.0 3.8 12.3 8.5 17.2 21.9 0.0 15.7 20.6 37.5 1.3 14.6 32.5 13.6 18.9 21.9 1.0 32.2 4.3 18.4 86.0 7.4 0.0 43.3 12.9 2.3 3.1 4.5 49.8 6.9 2.2 19.9 69.9 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.2 14.5 1.4 2.7 20.3 20.1 9.8 25.2 22.9 27.0 40.9 35.2 19.2 6.2 34.4 24.5 31.4 19.1 43.1 31.9 9.7 21.0 9.5 13.2 0.4 18.6 19.4 0.7 1.1 23.7 18.6 4.2 14.3 24.2 19.9 28.8 26.2 7.7 19.6 10.6 23.4 14.2 14.6 21.4 36.4 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 13.5 27.7 15.0 9.3 18.1 15.4 14.5 26.9 15.5 25.9 28.4 12.0 28.9 17.4 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 0.0 0.6 15.5 0.8 2.3 0.6 1.7 7.6 4.0 4.5 0.0 0.0 5.1 0.0 0.6 60.3 0.1 1.3 256.9 0.2 50.4 2.4 0.8 0.0 1.7 17.7 0.0 1.2 3.1 3.5 44.1 2.0 4.3 0.0 3.6 1.6 0.0 0.1 0.0 0.7 2.4 0.7 6.5 0.0 80.6 18.5 1.3 3.8 1.0 4.2 0.9 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 259.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6" "Group enriched" "Detected in many" 22 "dendritic cells: 20.9;monocytes: 34.6" "Cell line enhanced" "Detected in many" "Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA 64000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favorable (4.68e-4)" 41.4 5.8 12.2 12.3 11.1 3.3 28.8 10.7 11.3 27.6 16.3 8.6 13.9 8.7 22.2 21.4 11.6 14.6 21.6 14.7 12.7 7.8 33.4 74.2 21.9 17.0 13.7 9.2 33.1 14.1 24.5 5.5 14.3 11.2 22.3 17.7 8.7 14.1 20.1 4.9 8.1 11.1 13.2 14.8 18.5 11.5 11.7 14.6 1.0 7.3 8.5 6.5 21.3 12.0 0.5 20.9 1.2 34.6 0.1 0.2 9.2 0.2 0.3 1.5 4.1 17.5 18.8 0.1 1.1 1.7 0.1 0.7 7.8 4.4 0.2 13.8 4.5 0.3 0.4 3.2 0.0 0.0 0.2 1.6 0.1 13.0 60.9 7.9 0.0 0.2 24.9 0.0 6.2 0.0 1.4 4.4 0.1 0.2 0.3 13.1 0.9 0.0 0.2 7.8 10.4 1.6 0.1 0.5 0.0 18.8 31.6 0.1 0.4 5.9 7.7 0.0 31.3 0.2 14.3 1.2 1.3 3.4 1.8 4.4 0.1 0.0 0.2 5.9 7.5 0.9 0.8 34.6 0.2 0.2 26.7 0.1 0.5 0.1 0.1 20.9 0.3 0.1 0.2 1.2 0.1 14.6 0.6 0.2 9.2 12.2 11.1 10.7 11.3 12.7 7.8 13.7 9.2 11.2 14.6 26.8 39.0 13.7 77.1 31.6 0.5 1.6 140.1 52.2 86.4 57.6 0.0 45.4 104.5 84.7 1.2 4.9 45.2 0.0 42.0 69.7 45.8 47.7 0.0 146.0 259.0 0.0 15.7 23.4 235.2 1.6 121.7 155.2 54.0 68.5 65.8 22.3 57.9 100.1 99.0 189.5 0.5 77.6 52.5 0.5 0.6 22.6 31.5 5.0 76.2 102.7 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 115.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-2197: 3.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 115.1 2.7 0.0 0.0 0.0 0.0 0.0 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575513-48580111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 13.3" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4" "Region enriched" "Detected in single" 36 "pons and medulla: 3.7" "Region enriched" "Detected in single" 23 "pons and medulla: 7.5" HPA057432 Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA057432: AB_2683437" "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 4.4 2.4 0.0 1.5 0.0 0.0 2.9 0.0 0.0 4.2 8.1 1.2 2.3 13.3 2.7 8.5 1.5 0.4 0.0 0.0 5.7 0.7 3.6 0.6 0.0 0.0 0.7 1.8 0.0 1.0 0.6 1.1 0.0 4.8 0.8 0.9 4.3 2.0 2.4 3.0 3.9 0.5 0.6 0.2 1.3 1.7 0.3 2.4 0.0 0.1 0.6 0.7 0.1 0.1 0.3 0.0 0.1 4.9 3.9 1.9 0.0 0.0 0.2 0.1 2.2 2.0 3.1 23.4 1.5 0.4 0.1 4.1 0.0 0.0 8.0 11.3 7.6 0.7 0.0 5.0 0.0 14.4 3.8 0.0 5.7 0.0 0.8 6.6 5.2 11.4 0.2 5.6 0.0 1.8 0.0 0.0 2.1 0.0 0.0 4.4 1.6 4.6 1.9 0.0 0.0 0.6 0.0 2.9 1.6 0.4 1.5 2.5 0.3 0.2 0.8 0.2 1.9 4.0 0.7 1.6 0.0 2.2 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.2 0.5 0.0 0.1 0.2 0.1 0.0 0.6 0.0 2.4 0.0 0.1 0.0 0.0 1.7 0.9 3.4 0.0 0.8 0.0 1.4 0.0 61.1 0.0 18.4 10.0 0.1 0.0 7.1 0.8 0.0 0.0 11.0 9.7 0.4 3.5 0.0 3.2 0.0 0.0 15.4 1.8 0.0 0.3 1.9 5.0 0.0 2.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 5.2 0.2 21.8 1.6 5.0 10.5 1.5 2.6 HPS4 "BLOC3S2, KIAA1667, LE" ENSG00000100099 "HPS4, biogenesis of lysosomal organelles complex 3 subunit 2" Q9NQG7 22 26443423-26483837 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 40.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033106, HPA050189" Approved Approved Centrosome NA NA Centrosome "CAB033106: AB_2264349, HPA050189: AB_2681046" "unprognostic (1.55e-2)" "unprognostic (1.02e-1)" "unprognostic (9.82e-2)" "unprognostic (5.30e-3)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (1.83e-3)" "unprognostic (1.59e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (6.46e-2)" 7.9 9.6 10.7 7.4 16.3 11.3 8.4 43.1 16.4 11.9 8.0 14.1 9.5 6.6 11.2 10.1 10.5 11.8 7.4 5.0 9.4 11.8 10.7 7.9 8.0 10.8 10.7 11.9 15.8 15.5 14.5 18.7 6.7 12.0 8.9 6.9 15.7 10.8 10.2 5.0 17.1 7.4 8.9 10.5 9.0 8.8 18.2 8.3 18.0 12.3 4.0 12.7 8.0 8.8 7.8 7.3 12.6 4.0 9.2 6.9 5.7 7.5 3.5 7.5 7.7 5.7 6.8 4.0 4.6 9.0 10.4 9.4 3.7 3.7 7.2 3.7 5.6 5.9 6.3 7.2 10.0 9.5 5.3 7.4 7.3 3.2 6.2 10.2 8.5 8.3 6.6 8.3 9.5 17.0 8.9 6.8 12.2 8.0 9.2 7.5 3.2 14.3 3.0 4.5 7.0 3.9 40.2 8.9 9.4 4.8 4.8 8.6 6.4 4.4 5.2 22.5 5.9 5.5 6.5 4.2 12.3 22.9 6.0 5.7 13.7 10.6 23.8 8.0 5.5 7.8 12.6 4.0 4.0 6.6 3.0 6.2 7.8 5.4 5.6 5.6 6.7 6.4 6.9 1.4 9.2 2.6 7.3 3.6 5.7 10.7 16.3 43.1 16.4 9.4 11.8 10.7 11.9 12.0 8.3 11.9 29.6 43.3 22.6 11.1 48.8 5.5 7.6 25.4 20.5 40.1 108.0 17.7 14.9 16.1 17.5 18.5 12.7 46.7 23.5 16.2 12.7 21.7 40.5 11.3 21.3 41.3 25.5 26.4 15.5 19.4 30.2 16.9 45.5 4.6 18.9 25.2 32.6 14.0 18.7 10.2 120.3 0.0 8.8 33.5 39.0 13.0 16.7 17.9 20.6 22.8 HSPA4L "APG-1, HSPH3, Osp94" ENSG00000164070 "Heat shock protein family A (Hsp70) member 4 like" O95757 4 127781821-127840733 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.0;vagina: 32.0" "Group enriched" "Detected in many" 4 "Early spermatids: 393.1;Late spermatids: 711.4;Spermatocytes: 194.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "HAP1: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034450, HPA039149, HPA061446" Enhanced Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (5.33e-2)" "unprognostic (9.40e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (1.23e-3)" "unprognostic (2.41e-1)" "unprognostic (3.90e-1)" "unprognostic (2.38e-4)" "unprognostic (1.40e-2)" "unprognostic (3.28e-1)" "prognostic favorable (3.80e-9)" "unprognostic (8.53e-2)" "unprognostic (1.56e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (6.78e-4)" 1.6 9.3 7.4 1.4 9.0 2.8 5.5 16.6 11.4 2.9 2.5 1.7 1.6 2.5 1.5 1.7 10.9 5.9 3.5 5.3 6.1 10.1 10.6 5.9 1.9 1.0 6.6 6.6 3.5 3.6 12.2 23.2 2.8 20.1 3.9 3.5 3.5 4.6 4.7 1.5 6.5 1.6 3.8 5.0 1.4 2.1 73.0 5.2 1.0 3.7 4.1 4.0 2.8 32.0 0.7 0.5 3.9 0.4 0.5 0.4 0.1 9.1 12.0 6.5 10.3 4.5 4.6 7.6 4.2 1.7 4.0 4.5 8.8 4.2 0.0 7.7 1.2 3.3 2.1 38.0 15.0 5.6 17.0 11.3 4.9 16.5 10.7 1.7 18.8 8.4 4.2 14.0 2.6 9.6 4.2 5.2 4.3 8.7 5.6 5.0 6.6 6.0 1.6 1.5 9.7 10.0 0.0 0.7 0.9 13.8 4.2 12.0 4.4 7.5 13.1 0.7 4.1 10.0 3.2 1.4 1.4 0.0 1.7 10.0 11.0 12.6 2.9 5.5 12.9 4.3 1.6 0.4 3.9 0.4 0.2 0.2 0.4 0.3 0.3 0.5 0.7 0.4 0.4 1.3 0.5 0.3 0.4 0.3 0.1 7.4 9.0 16.6 11.4 6.1 10.1 6.6 6.6 20.1 5.2 3.0 9.4 0.8 68.9 25.2 54.9 12.6 12.7 56.2 31.8 8.7 98.2 9.5 16.6 6.7 393.1 5.4 0.4 0.0 2.5 1.7 7.0 17.8 15.1 8.3 1.0 38.1 17.6 2.5 1.6 711.4 9.5 7.3 8.5 4.6 2.0 15.2 3.2 0.0 9.2 19.6 62.8 0.0 15.5 194.6 9.3 37.1 14.0 2.9 2.9 72.9 HSPBP1 "FES1, HspBP1" ENSG00000133265 "HSPA (Hsp70) binding protein 1" Q9NZL4 19 55262231-55280381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005865, HPA070398, HPA071444" Supported Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396" "unprognostic (3.07e-2)" "unprognostic (6.36e-2)" "unprognostic (5.41e-2)" "unprognostic (8.05e-2)" "unprognostic (9.24e-2)" "unprognostic (1.43e-1)" "unprognostic (3.71e-3)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (1.52e-1)" "unprognostic (6.20e-3)" "unprognostic (7.23e-2)" "unprognostic (4.28e-3)" "unprognostic (2.44e-2)" "unprognostic (2.62e-1)" "unprognostic (9.45e-2)" "unprognostic (2.14e-2)" 14.1 13.9 24.5 15.8 42.9 16.4 13.8 13.3 32.5 11.3 17.3 9.1 13.0 18.8 14.8 12.4 14.5 30.3 13.3 19.1 25.3 20.1 15.4 18.0 18.2 17.6 16.2 20.0 17.4 21.1 13.0 10.2 9.8 15.2 12.0 8.3 7.6 19.3 13.6 35.4 15.4 17.2 16.8 15.0 11.6 15.3 21.1 9.3 11.7 12.0 24.4 8.9 10.5 10.5 24.0 23.0 3.0 19.0 18.4 20.5 11.5 22.3 40.2 7.1 10.4 4.2 3.5 21.9 11.8 4.7 11.8 10.1 22.7 15.6 14.8 11.5 6.3 7.2 15.6 8.4 11.4 3.1 12.6 69.2 19.7 12.8 20.8 9.2 18.4 10.4 4.9 10.3 11.7 5.6 5.2 5.9 12.1 15.7 8.4 4.1 21.2 16.6 17.1 25.6 19.1 33.8 16.2 11.3 31.9 8.0 14.7 19.6 29.4 14.5 15.0 11.3 4.0 11.4 14.4 8.1 14.2 15.4 8.0 21.4 13.4 31.0 15.3 15.8 16.0 15.0 0.8 11.5 3.0 18.0 19.0 18.7 21.0 19.8 20.5 23.0 24.0 19.9 19.3 0.8 18.4 16.0 13.1 17.8 11.5 24.5 42.9 13.3 32.5 25.3 20.1 16.2 20.0 15.2 9.3 8.9 8.6 26.9 31.3 23.8 14.1 11.0 25.5 60.2 20.5 33.2 5.9 45.1 61.3 55.5 7.9 15.1 23.6 0.0 40.0 45.3 20.7 24.9 10.4 20.8 34.3 12.7 21.7 7.4 12.3 12.8 18.1 14.0 16.9 35.1 29.8 13.7 36.5 41.9 16.6 45.8 11.0 25.8 20.6 34.2 23.9 25.7 31.4 16.0 46.5 36.6 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684453 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 274.1" "Cell type enhanced" "Detected in all" 12 "monocytes: 3286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 110.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 108.1;HEK 293: 69.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" NA NA "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 34.2 37.4 24.9 19.1 20.6 69.8 31.5 11.3 57.3 21.9 34.0 22.9 13.2 20.7 18.6 11.6 12.1 28.1 33.5 46.1 20.0 14.6 31.2 117.5 25.4 22.4 19.0 35.3 59.7 15.0 274.1 17.2 14.8 20.0 27.2 26.4 13.3 24.5 72.7 8.8 16.6 20.4 19.2 15.8 21.3 16.2 7.1 14.2 19.0 46.8 15.1 10.2 31.8 38.0 0.3 25.0 110.4 26.0 90.9 42.4 18.0 0.2 20.0 8.2 10.1 13.3 2.1 31.5 22.8 2.7 10.2 4.3 40.0 1.0 0.5 27.1 39.0 2.6 17.2 5.3 0.1 3.0 108.1 69.9 14.4 12.3 48.9 3.9 10.7 40.5 3.6 0.4 4.7 0.2 2.8 0.2 1.0 0.8 17.1 15.8 6.7 1.1 1.2 15.0 47.9 15.7 1.4 5.7 10.7 10.2 9.0 15.6 22.1 1.2 17.3 1.7 21.7 2.9 6.4 4.1 12.6 2.2 18.7 1.3 1.3 1.0 12.4 16.0 33.0 6.8 9.0 8.2 110.4 42.4 24.2 25.3 0.3 13.1 29.5 25.0 0.2 16.4 31.4 11.2 90.9 26.0 1.1 1.0 18.0 24.9 20.6 11.3 57.3 20.0 14.6 19.0 35.3 20.0 14.2 131.0 257.3 44.9 93.2 116.7 9.4 147.7 272.6 71.0 147.9 96.0 15.7 219.0 470.9 258.1 11.1 189.7 226.3 46.7 138.3 130.1 269.8 153.6 916.1 393.6 669.0 6.4 409.1 414.4 336.8 15.3 115.1 499.1 268.2 3286.8 521.6 478.8 95.2 300.6 30.8 190.8 24.4 19.4 173.1 1.6 4.7 91.5 557.0 879.8 224.4 39.6 IFT81 "CDV-1R, CDV1, MGC4027" ENSG00000122970 "Intraflagellar transport 81" Q8WYA0 12 110124335-110218797 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 199.4;Spermatocytes: 160.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019087, HPA020051" Enhanced Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA019087: AB_1851462, HPA020051: AB_1851465" "unprognostic (2.54e-1)" "unprognostic (1.47e-1)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "unprognostic (9.79e-2)" "unprognostic (1.10e-1)" "unprognostic (7.95e-2)" "unprognostic (3.91e-1)" "unprognostic (3.21e-1)" "unprognostic (1.40e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (1.88e-1)" "unprognostic (2.45e-1)" 5.3 9.6 8.9 4.6 13.2 1.7 9.2 14.4 11.9 12.6 11.5 6.6 18.8 3.0 14.9 19.6 6.4 18.8 8.9 7.3 8.9 8.5 10.0 4.4 8.5 3.0 5.9 8.4 14.7 5.1 21.8 30.4 5.2 10.7 13.7 6.2 11.8 8.9 15.5 6.4 5.9 4.6 17.7 8.5 4.0 7.4 29.8 8.4 6.2 14.3 5.4 3.1 13.5 10.4 1.8 3.5 3.0 1.3 2.1 1.9 1.3 7.1 13.6 28.1 11.9 5.2 10.7 2.1 4.6 7.1 9.9 8.5 2.6 4.0 2.3 2.5 8.8 7.1 6.4 10.3 5.4 12.9 3.0 5.6 4.9 8.0 4.2 4.4 3.0 2.4 7.6 6.1 9.4 2.4 24.2 6.2 4.7 6.0 1.3 9.1 1.5 6.1 5.1 13.9 4.1 4.5 7.3 7.4 3.1 12.3 4.8 17.5 19.4 12.5 2.6 18.6 8.2 14.1 4.6 4.1 5.6 2.9 4.6 4.2 4.1 4.0 3.2 13.6 3.9 6.3 0.3 1.3 0.6 0.7 0.8 1.9 1.6 1.7 0.8 3.5 1.8 1.5 0.7 3.0 2.1 1.0 3.5 0.7 1.3 8.9 13.2 14.4 11.9 8.9 8.5 5.9 8.4 10.7 8.4 11.9 16.1 2.0 11.5 5.5 16.8 16.5 10.2 199.4 37.5 14.0 39.3 2.2 13.3 8.9 31.3 4.5 0.7 0.0 3.5 1.2 10.0 4.0 3.5 4.0 2.1 23.8 20.7 3.7 1.9 13.2 13.0 1.8 33.7 1.8 4.8 18.2 5.1 1.7 26.2 8.4 36.1 6.5 12.2 160.5 28.1 5.6 0.8 0.0 3.5 3.8 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 INPP4B ENSG00000109452 "Inositol polyphosphate-4-phosphatase type II B" O15327 4 142023160-142847432 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 19.2" "Group enriched" "Detected in many" 6 "NK-cells: 9.1;T-cells: 19.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.6;SK-MEL-30: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037681, HPA037682" Approved Approved Centrosome NA NA Centrosome "HPA037681: AB_10670389, HPA037682: AB_10671377" "unprognostic (9.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.25e-2)" "unprognostic (1.77e-1)" "unprognostic (8.24e-2)" "unprognostic (3.03e-3)" "unprognostic (5.76e-3)" "unprognostic (1.95e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.58e-2)" "unprognostic (1.26e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (1.39e-2)" 15.4 4.7 8.4 8.5 12.5 2.2 21.2 5.1 10.3 28.1 7.1 1.8 5.6 5.0 19.7 18.4 9.1 9.2 8.7 18.4 5.9 6.1 6.1 2.0 9.9 10.8 5.5 8.9 15.4 4.0 2.3 3.8 6.2 4.6 8.3 5.8 1.7 4.9 6.8 10.8 4.7 7.3 10.2 3.1 7.0 7.0 19.6 2.4 8.2 6.5 4.9 7.4 15.8 14.6 0.0 0.0 2.2 0.1 9.1 19.2 3.7 9.3 3.9 2.6 1.2 2.0 1.2 0.5 11.3 13.3 2.9 5.5 1.0 52.6 0.2 3.2 10.1 4.5 14.3 0.0 13.2 6.9 0.0 0.4 2.2 1.5 0.0 0.6 0.4 1.8 2.1 1.8 2.0 7.0 8.8 1.6 0.0 0.0 0.5 6.3 16.7 0.3 0.0 0.1 5.7 2.8 0.1 8.7 0.4 4.0 17.4 0.2 0.2 1.3 4.0 23.4 1.6 12.0 1.6 1.0 6.7 8.2 9.9 0.1 0.1 0.0 0.0 1.5 10.3 17.4 2.2 0.1 0.0 3.3 0.0 6.5 0.0 19.2 8.5 0.0 0.0 13.2 5.7 0.2 9.1 0.0 0.0 9.8 3.7 8.4 12.5 5.1 10.3 5.9 6.1 5.5 8.9 4.6 2.4 0.0 1.1 0.0 9.8 6.0 7.3 36.2 7.6 17.4 9.1 8.7 0.0 1.4 5.0 12.2 163.6 10.8 8.4 0.0 26.9 3.9 4.1 13.4 5.8 0.0 6.2 6.4 8.5 3.7 4.4 196.7 12.7 1.9 69.2 0.0 3.4 0.8 47.4 0.0 6.0 0.8 0.6 84.1 43.7 3.1 2.0 2.3 1.6 16.6 3.4 41.0 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520643-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.2;Ciliated cells: 12.0;Club cells: 6.8;granulocytes: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 16.5;U-937: 15.3" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" NA NA Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589" "unprognostic (2.03e-1)" "prognostic favorable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favorable (2.94e-4)" 4.2 9.8 5.5 10.6 6.7 15.4 5.4 22.6 6.1 8.4 7.8 7.4 3.8 3.6 7.8 4.6 6.4 8.6 6.6 5.9 4.8 3.2 4.4 1.7 5.6 15.6 6.8 6.2 11.5 2.9 3.7 11.5 4.5 6.5 6.5 10.0 5.3 18.2 7.9 1.5 8.3 9.3 5.4 4.9 13.3 4.5 9.7 10.4 17.8 4.6 2.8 15.0 8.6 7.5 5.5 3.6 2.2 2.7 2.7 9.0 4.0 0.1 0.0 6.2 7.2 1.8 2.1 0.0 1.5 3.2 1.8 5.6 0.6 2.6 6.2 5.3 1.3 4.5 4.6 7.0 2.0 1.4 4.6 2.5 5.2 0.5 0.0 1.6 5.3 0.4 2.8 2.0 2.1 2.1 3.2 2.3 4.1 3.3 9.8 1.3 4.5 5.2 16.5 2.9 6.4 2.6 4.3 2.2 5.0 1.5 2.5 1.0 2.3 2.1 2.1 0.2 2.8 2.2 10.0 1.3 4.8 2.7 0.0 1.7 11.3 8.9 9.2 1.6 15.3 0.9 0.0 2.5 2.2 5.1 2.2 6.1 5.5 5.8 5.9 3.6 4.9 9.0 5.8 1.6 2.7 2.7 3.5 3.1 4.0 5.5 6.7 22.6 6.1 4.8 3.2 6.8 6.2 6.5 10.4 11.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 12.0 6.8 3.5 0.0 1.5 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 23.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 ITPRIPL2 "FLJ22994, LOC162073, MGC126798, MGC126800" ENSG00000205730 "ITPRIP like 2" Q3MIP1 16 19113932-19121629 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042011 Approved Centrosome NA NA Centrosome "HPA042011: AB_2677795" "unprognostic (1.07e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (9.64e-2)" "unprognostic (1.97e-1)" "unprognostic (2.20e-1)" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (5.60e-2)" "unprognostic (1.90e-2)" "unprognostic (5.26e-3)" "unprognostic (4.24e-2)" "unprognostic (1.53e-1)" "unprognostic (7.23e-2)" "unprognostic (6.37e-2)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" 32.6 10.7 6.2 8.3 6.0 0.9 25.8 1.2 4.1 16.0 11.4 4.3 8.2 6.1 12.7 10.6 16.4 10.2 12.7 9.9 3.8 2.8 6.4 9.5 16.7 5.1 5.6 2.1 11.6 15.0 8.5 4.7 26.5 5.7 19.1 5.9 9.5 8.5 8.9 7.3 19.7 9.1 11.3 4.0 7.8 9.9 4.9 5.7 2.0 12.0 12.8 8.0 14.2 25.7 0.5 1.9 1.3 6.6 0.2 0.6 0.6 9.1 5.4 2.1 7.1 18.5 28.3 14.2 14.7 10.4 4.3 4.0 2.2 16.6 0.0 15.1 11.5 5.1 10.5 3.0 4.5 5.7 0.0 3.0 0.7 10.9 3.8 12.0 0.0 0.0 18.7 12.5 8.3 9.5 7.8 5.6 0.0 1.3 0.0 10.2 6.2 0.0 0.2 2.2 1.9 7.2 0.0 0.3 0.0 6.5 15.5 0.2 2.7 12.0 1.2 7.1 3.6 7.2 1.4 11.1 15.1 6.5 7.7 5.5 0.1 0.0 0.0 8.8 0.3 7.5 1.3 2.8 0.3 0.6 3.4 0.3 0.5 0.3 0.5 1.9 0.3 0.2 0.5 1.0 0.2 6.6 1.2 0.1 0.6 6.2 6.0 1.2 4.1 3.8 2.8 5.6 2.1 5.7 5.7 47.6 33.6 2.4 22.3 11.3 0.5 5.6 7.6 22.7 33.0 24.4 2.0 13.4 1.7 13.6 0.3 28.7 14.4 0.0 27.1 8.2 28.3 27.3 5.7 22.2 21.0 4.8 13.8 41.1 49.9 0.4 24.7 27.1 13.5 27.9 19.6 1.7 33.4 8.6 28.3 0.1 0.3 38.8 24.5 0.2 1.9 15.2 12.0 1.3 16.3 29.4 IVL ENSG00000163207 Involucrin P07476 1 152908545-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 97.1;tongue: 152.1" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 62.0" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" NA NA 8000000 Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: AB_2682739" "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 39.0 0.1 0.0 0.4 0.1 4.2 11.5 97.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 1.8 0.1 0.0 18.7 0.1 0.2 34.2 0.1 1.0 0.0 0.1 0.1 0.1 0.0 1.9 0.1 152.1 49.1 4.9 43.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 78.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 23.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 7.4 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Cell type enriched" "Detected in some" 15 "Bipolar cells: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.1;RT4: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 0.0 0.0 0.0 0.1 0.0 64.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 KIAA0753 "MNR, OFIP" ENSG00000198920 KIAA0753 Q2KHM9 17 6578148-6640927 "Disease related genes, Predicted intracellular proteins" Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 41.5;Early spermatids: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023057, HPA023494" Enhanced Enhanced Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA023057: AB_1852338, HPA023494: AB_1852339" "unprognostic (3.72e-2)" "unprognostic (5.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.93e-2)" "unprognostic (5.17e-2)" "unprognostic (1.47e-1)" "unprognostic (4.19e-3)" "unprognostic (1.47e-1)" "unprognostic (3.01e-3)" "unprognostic (1.82e-1)" "unprognostic (6.10e-3)" "unprognostic (1.47e-2)" "unprognostic (9.57e-2)" "unprognostic (1.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" 6.5 7.0 7.5 11.7 12.8 4.5 9.9 7.4 9.4 10.1 7.7 7.3 20.1 4.4 17.8 15.6 8.5 13.4 10.7 5.0 8.3 7.7 8.7 4.3 8.3 6.6 4.9 7.9 15.4 10.5 26.4 26.0 7.4 8.0 9.6 9.2 9.6 7.0 13.6 5.4 7.4 6.4 11.5 7.2 9.0 7.9 20.1 5.1 13.7 12.1 4.1 6.8 8.4 7.7 2.3 1.8 5.5 2.2 1.1 2.0 0.7 15.9 12.3 16.1 11.2 6.1 10.5 6.1 8.6 8.1 12.3 10.8 9.1 3.7 5.7 5.8 7.9 8.3 14.9 15.1 7.8 19.7 5.7 12.1 3.3 10.7 6.4 9.1 5.6 7.3 6.9 11.0 12.3 10.1 12.6 9.0 7.7 8.0 0.8 9.5 5.6 6.1 4.9 9.8 7.7 6.5 8.9 5.4 1.9 10.9 10.3 6.0 10.8 11.4 3.0 6.6 11.0 5.1 3.6 8.3 11.6 5.3 6.1 12.7 1.4 1.9 2.4 8.1 3.2 7.8 0.0 2.0 1.7 1.8 2.2 2.0 2.3 1.5 1.6 1.3 1.4 1.2 1.1 5.5 1.1 1.1 1.8 1.1 0.7 7.5 12.8 7.4 9.4 8.3 7.7 4.9 7.9 8.0 5.1 6.0 10.5 1.4 2.6 2.9 3.8 3.0 5.1 41.5 11.4 0.0 15.7 1.8 0.0 3.8 63.1 3.6 2.1 0.0 3.4 0.9 2.8 3.6 1.1 1.8 2.2 9.5 6.9 4.3 3.7 9.9 4.0 2.2 0.0 1.0 4.8 2.4 3.4 4.0 3.2 2.9 10.8 0.0 3.3 14.1 7.5 2.0 1.0 0.0 4.0 2.6 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152333-122362758 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 18.4 17.1 25.6 18.0 34.1 42.9 26.1 33.4 34.2 22.9 18.7 24.1 17.9 15.6 20.9 25.4 12.3 16.8 16.4 15.3 25.5 22.0 24.0 17.4 19.5 14.8 26.4 26.2 34.3 16.6 68.2 33.1 14.3 33.6 19.1 18.8 22.6 16.6 21.5 40.1 23.1 20.8 18.6 29.3 20.0 15.2 20.4 24.2 15.3 25.4 12.6 13.6 18.0 18.5 3.1 2.3 7.7 3.6 1.7 3.5 0.7 16.4 5.4 12.5 8.3 21.0 27.3 6.5 7.5 14.1 7.7 8.5 4.0 8.7 8.7 4.4 17.6 10.4 6.2 7.7 9.2 12.6 6.5 4.9 9.5 9.8 7.4 10.9 8.9 5.3 15.7 11.1 9.2 12.8 21.1 16.4 9.4 6.2 10.5 15.8 5.5 7.7 7.0 4.2 7.9 5.9 4.4 17.5 2.2 13.6 12.4 7.4 6.6 4.7 5.4 10.5 21.2 5.9 7.3 21.9 9.6 9.6 7.9 7.6 10.2 6.5 6.3 10.2 7.9 7.0 3.3 1.4 7.7 3.3 3.6 3.5 2.5 2.3 2.3 1.4 3.1 2.0 2.3 6.6 1.7 1.7 2.3 2.9 0.7 25.6 34.1 33.4 34.2 25.5 22.0 26.4 26.2 33.6 24.2 80.4 33.9 13.7 17.7 18.5 114.9 62.7 7.6 37.5 44.3 40.1 117.8 8.9 1.7 11.4 26.6 33.8 40.9 23.3 15.1 5.7 21.1 21.2 20.8 21.5 11.1 87.4 20.7 36.2 31.0 20.3 47.5 20.1 15.1 17.2 25.2 59.6 17.8 25.9 47.7 10.5 143.8 32.3 29.9 49.5 31.9 21.3 10.9 32.4 23.9 23.0 KIAA1211L "C2orf55, MGC42367" ENSG00000196872 "KIAA1211 like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;epididymis: 27.7" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 95.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 22.3;HDLM-2: 32.0;Karpas-707: 9.4;MCF7: 8.5;SiHa: 9.1;SK-BR-3: 12.2" "Group enriched" "Detected in many" 15 "amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" Yes No "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: AB_2681337, HPA061678: AB_2684584" "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favorable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favorable (1.33e-5)" "unprognostic (2.22e-2)" 2.7 0.8 19.0 1.3 23.7 0.5 3.5 2.4 27.4 4.6 5.0 0.8 3.5 6.7 1.5 27.7 9.1 19.3 2.5 1.4 12.9 1.9 2.5 0.4 3.9 0.6 2.7 18.3 1.4 3.7 9.6 4.3 4.0 0.1 1.6 4.0 0.0 9.0 4.3 1.3 4.3 6.1 2.1 1.2 1.0 6.8 3.6 3.6 0.0 4.3 3.3 2.5 2.4 3.2 0.0 0.7 1.4 0.3 0.2 0.9 0.0 4.3 0.2 0.1 1.7 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.2 2.6 0.0 5.7 0.0 0.1 3.9 0.1 0.2 0.0 32.0 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.6 0.0 1.3 0.0 0.0 9.4 0.0 8.5 0.1 0.6 0.0 4.3 0.4 0.0 0.0 0.4 1.7 3.4 3.2 0.5 9.1 12.2 0.0 0.0 4.7 0.7 5.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.7 0.0 0.0 19.0 23.7 2.4 27.4 12.9 1.9 2.7 18.3 0.1 3.6 14.9 2.9 0.0 3.1 0.6 0.0 4.2 5.1 95.0 23.9 3.5 0.0 0.3 3.3 3.7 11.8 9.0 10.0 0.0 6.5 1.1 0.2 1.7 0.0 0.0 2.6 0.0 15.1 6.7 1.5 17.2 0.3 0.9 0.0 0.0 11.4 0.0 4.8 8.6 0.4 2.2 0.0 0.0 0.4 15.9 12.6 5.3 0.3 0.0 8.8 5.1 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;fallopian tube: 25.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 34.8;Intestinal endocrine cells: 22.8;Ito cells: 19.6;Mucus-secreting cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.5" "Lineage enriched" "Detected in single" 55 "T-cells: 5.5" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: AB_2686593" "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.6 0.9 9.3 1.6 29.5 1.1 1.1 25.8 14.1 2.1 3.1 17.4 0.0 6.6 1.1 1.1 1.1 25.2 1.6 1.1 11.9 6.6 0.9 1.6 3.1 1.0 25.0 4.2 1.1 3.0 0.9 0.3 0.8 6.5 0.9 2.1 0.8 2.5 1.3 1.0 0.8 5.2 1.6 6.2 11.6 2.2 1.2 29.9 0.0 2.3 0.0 1.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.9 1.6 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 9.3 29.5 25.8 14.1 11.9 6.6 25.0 4.2 6.5 29.9 0.0 0.0 0.0 0.3 0.0 0.9 1.1 0.0 34.8 7.9 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 2.5 0.2 0.2 0.0 0.0 0.1 0.0 22.8 19.6 1.2 0.0 0.0 0.0 3.3 0.0 10.6 7.5 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.2 1.4 0.1 0.0 0.0 1.3 0.1 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF6 "C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317" ENSG00000164627 "Kinesin family member 6" Q6ZMV9 6 39329990-39725405 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 58.9;Muller glia cells: 13.8;Rod photoreceptor cells: 14.4;Spermatocytes: 18.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 20.8;RPMI-8226: 8.1;SCLC-21H: 11.4;SK-MEL-30: 4.6" "Low region specificity" "Detected in many" "HPA038811, HPA058624" Enhanced Approved Centrosome NA NA Centrosome "HPA038811: AB_10795140, HPA058624: AB_2683781" "unprognostic (4.94e-2)" "unprognostic (3.38e-2)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (1.55e-1)" "unprognostic (8.25e-4)" "unprognostic (3.12e-3)" "unprognostic (1.00e-1)" "unprognostic (3.06e-1)" "unprognostic (3.48e-2)" "unprognostic (9.12e-4)" "unprognostic (1.08e-1)" "unprognostic (3.07e-2)" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" 1.3 1.4 5.1 0.7 9.1 0.9 1.9 2.2 11.4 1.4 1.0 18.8 0.1 1.7 1.0 2.6 1.3 9.9 1.6 1.3 7.3 7.1 1.4 1.3 2.4 1.2 11.8 3.2 1.8 1.6 1.2 5.6 1.2 8.6 1.1 0.9 1.7 1.0 0.9 1.6 1.2 1.1 0.8 10.6 0.9 0.9 12.6 7.8 0.0 2.0 0.0 0.9 0.7 0.4 1.2 2.7 2.5 0.6 1.3 0.7 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.9 0.2 0.5 0.1 0.0 0.1 0.1 0.9 20.8 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.4 8.1 0.2 0.0 11.4 0.1 0.0 0.1 4.6 0.3 0.1 0.0 0.1 0.0 0.1 2.7 0.6 0.2 0.0 0.0 0.6 0.0 1.4 1.9 0.6 0.4 0.5 0.3 0.5 0.7 0.5 0.4 0.2 1.2 0.6 0.7 2.5 1.3 0.4 2.7 0.3 0.1 5.1 9.1 2.2 5.4 7.3 7.1 11.8 3.2 8.6 7.8 0.0 1.1 0.0 0.6 0.1 3.1 1.2 0.0 58.9 2.3 0.0 9.8 0.3 1.7 1.1 7.8 0.7 0.0 0.0 0.7 0.2 1.1 0.2 0.0 0.0 0.2 3.2 2.4 0.0 0.0 8.0 0.3 0.0 0.0 0.0 0.0 13.8 0.1 0.0 0.0 2.4 14.4 0.0 0.6 18.2 2.5 0.4 0.2 0.0 0.0 0.3 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391536-33409924 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 60.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 21.5;Erythroid cells: 70.0;Extravillous trophoblasts: 32.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055997, HPA062674" Enhanced Approved Centrosome NA Yes Centrosome "HPA055997: AB_2683001, HPA062674: AB_2684829" "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 0.9 0.8 0.0 18.0 0.3 9.6 1.5 0.0 0.5 1.7 5.7 0.1 0.3 3.0 0.9 1.6 10.1 0.5 2.2 0.8 0.0 0.0 0.7 0.7 2.2 6.3 0.1 0.2 1.5 0.3 0.2 0.2 3.6 0.4 0.6 2.5 0.6 1.7 0.1 0.4 3.3 4.2 0.7 0.4 4.7 2.5 9.7 0.2 60.9 0.4 7.4 14.6 0.6 2.8 0.8 0.3 0.0 0.1 0.2 1.4 0.7 10.7 1.8 10.3 10.9 0.2 0.4 6.3 7.8 2.0 6.2 5.2 3.8 4.8 7.1 3.0 1.6 8.2 5.8 2.6 3.6 6.8 4.2 5.9 5.7 8.7 5.5 0.0 4.7 6.4 0.0 0.9 5.1 1.5 0.7 0.6 5.2 1.7 17.6 4.6 2.7 2.8 9.4 4.7 3.0 2.2 7.1 5.8 2.4 0.9 2.4 9.4 4.2 2.8 6.0 1.5 4.1 6.3 4.9 1.4 3.3 10.1 5.4 11.6 5.8 11.0 6.9 0.0 7.0 5.8 0.0 0.1 0.0 0.4 0.0 0.6 0.8 0.3 1.4 0.3 0.8 0.3 0.3 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.2 0.0 4.5 5.2 0.7 4.9 0.4 0.4 0.0 0.0 2.3 0.0 0.0 6.7 0.0 0.6 21.5 1.4 2.9 70.0 0.0 32.5 2.9 0.8 1.1 0.0 11.9 0.0 0.0 2.5 2.5 9.8 0.3 4.9 3.3 5.4 3.4 0.2 0.2 2.8 0.7 0.0 0.5 0.0 1.0 11.2 6.9 3.1 5.6 4.3 4.6 2.4 KLHL21 KIAA0469 ENSG00000162413 "Kelch like family member 21" Q9UJP4 1 6590724-6614607 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 63.3;Cardiomyocytes: 54.0;Suprabasal keratinocytes: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 9.7;neutrophil: 31.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 31.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051364, HPA059307" Uncertain Supported Centrosome NA NA Centrosome "HPA051364: AB_2681455, HPA059307: " "unprognostic (6.13e-3)" "unprognostic (5.26e-2)" "unprognostic (2.30e-2)" "unprognostic (9.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.39e-2)" "unprognostic (5.77e-3)" "unprognostic (2.28e-1)" "unprognostic (8.52e-2)" "unprognostic (4.85e-2)" "unprognostic (4.02e-1)" "unprognostic (6.33e-3)" "prognostic favorable (1.71e-4)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (9.74e-2)" "unprognostic (4.19e-2)" 18.1 11.3 8.7 7.8 16.1 13.6 20.0 7.3 12.7 11.9 14.6 19.1 12.0 4.6 13.7 6.0 17.3 8.5 14.8 20.5 8.6 7.3 11.7 9.1 8.7 7.5 31.2 5.4 18.0 21.0 8.7 11.2 4.4 14.0 15.7 3.5 17.1 20.4 19.4 58.7 15.1 5.4 22.9 9.9 6.5 10.1 6.6 22.4 4.5 10.1 13.8 7.4 19.4 19.5 2.2 1.8 31.2 3.0 1.4 3.8 2.5 9.9 6.0 3.1 9.8 17.2 10.8 7.9 14.1 11.3 9.4 5.6 17.4 6.4 0.4 12.5 8.6 8.4 16.6 6.6 15.5 5.2 21.2 10.7 11.5 10.7 15.6 14.3 6.8 7.1 12.0 5.3 21.2 7.2 8.8 3.9 5.9 12.7 9.3 7.6 3.4 7.0 6.0 5.6 5.1 22.3 10.9 12.7 12.5 5.5 3.1 12.3 3.1 11.0 8.9 24.8 2.8 5.8 8.2 13.2 30.5 3.7 27.9 33.6 10.7 13.2 7.0 29.6 13.0 11.4 3.6 3.0 9.7 3.6 1.2 3.3 2.2 3.4 3.6 1.8 1.4 2.9 2.7 31.2 1.4 1.1 1.7 3.8 2.5 8.7 16.1 7.3 12.7 8.6 7.3 31.2 5.4 14.0 22.4 3.0 3.2 3.4 36.6 63.3 3.8 54.0 7.6 4.0 6.8 8.7 3.9 3.9 6.6 11.1 1.9 7.8 6.7 0.0 11.1 5.9 19.3 38.3 0.0 20.8 4.9 4.8 2.9 6.7 6.0 4.1 10.0 4.2 25.3 6.4 4.7 12.1 14.2 4.9 14.2 5.5 5.3 12.9 35.0 2.1 13.4 63.0 5.4 2.5 4.8 30.6 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 33.0;Early spermatids: 21.7;Late spermatids: 21.4;Spermatogonia: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 14.2;HMC-1: 9.5;PC-3: 8.2;SiHa: 16.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favorable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.3 0.0 0.8 0.0 0.8 0.1 14.2 1.2 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.8 3.6 9.5 0.2 0.2 0.0 0.0 0.1 0.4 2.5 0.0 0.0 1.0 0.6 0.3 0.1 0.1 2.8 8.2 0.0 0.0 0.8 0.7 0.1 1.1 0.9 16.7 3.1 0.0 0.0 3.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 8.9 4.3 0.0 1.5 1.1 33.0 0.8 0.0 2.7 4.5 3.5 7.9 1.3 3.3 1.7 21.7 1.0 0.2 0.0 2.7 1.4 2.5 0.9 4.6 0.0 1.1 1.6 4.1 3.7 0.0 21.4 2.6 2.1 1.7 2.8 1.0 2.0 2.6 0.0 1.1 0.1 11.0 6.5 1.4 7.5 37.1 1.9 2.1 0.0 0.6 0.7 KXD1 "BORCS4, C19orf50, FLJ25480, KXDL, MGC2749" ENSG00000105700 "KxDL motif containing 1" Q9BQD3 19 18557762-18569387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041507, HPA041599" Approved Approved "Nucleoli fibrillar center,Centrosome,Cytosol" NA NA "Nucleoli fibrillar center, Centrosome, Cytosol" "HPA041507: AB_10795698, HPA041599: AB_10795502" "unprognostic (8.48e-2)" "unprognostic (5.30e-2)" "unprognostic (3.16e-3)" "unprognostic (1.35e-1)" "unprognostic (8.60e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (8.46e-4)" "unprognostic (7.36e-2)" "unprognostic (1.81e-2)" "unprognostic (5.25e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (7.71e-10)" "unprognostic (7.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.45e-2)" "unprognostic (1.63e-1)" 52.9 42.2 47.2 48.7 44.9 49.1 42.8 28.4 60.9 37.2 44.5 56.7 34.3 43.7 48.9 43.2 45.9 45.6 44.1 43.2 43.3 41.8 39.6 73.3 42.2 56.1 46.7 34.2 52.3 58.9 33.6 48.2 53.7 43.7 46.6 43.2 40.0 60.4 45.4 58.3 46.8 39.9 49.3 56.2 48.3 44.5 75.4 38.9 42.1 47.0 45.5 53.2 57.2 54.0 26.9 37.1 41.3 46.4 29.7 37.6 30.6 33.3 33.8 27.7 31.5 28.8 33.3 45.4 37.0 29.8 27.7 32.2 27.6 40.0 23.1 43.6 32.9 23.1 25.5 42.6 45.3 25.0 27.9 60.1 25.3 26.4 24.9 33.3 39.4 27.8 35.3 32.3 41.6 49.8 30.3 39.2 31.4 39.2 36.5 28.8 38.8 35.4 29.0 34.9 41.9 51.7 34.2 21.8 33.6 28.2 30.6 25.8 33.2 24.2 21.7 31.0 30.3 18.4 27.2 31.8 25.0 22.0 79.8 48.0 43.5 32.4 34.5 43.2 46.4 36.1 15.0 41.0 35.0 29.8 46.4 27.7 26.9 27.6 29.5 37.1 26.4 22.2 24.2 41.3 29.7 43.4 22.1 37.6 30.6 47.2 44.9 28.4 60.9 43.3 41.8 46.7 34.2 43.7 38.9 17.9 34.3 40.9 62.3 30.7 19.6 4.2 28.1 18.7 25.0 15.7 11.8 92.1 68.0 73.5 155.9 50.4 48.5 23.3 98.7 103.8 57.5 68.0 42.7 30.5 108.5 15.9 41.3 44.8 50.9 25.8 31.1 50.7 55.6 151.5 43.0 22.9 81.0 40.7 27.6 42.9 16.0 38.8 55.6 29.3 19.8 36.3 93.3 49.0 44.2 59.1 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971806 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "granulocytes: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.7 15.2 15.0 15.3 27.9 8.3 17.0 42.6 24.4 13.4 17.8 14.1 9.7 13.9 12.6 11.2 24.4 9.7 14.2 10.6 14.0 14.0 21.4 27.8 10.2 17.2 14.8 14.9 10.6 10.3 25.2 22.4 12.7 22.7 13.8 21.0 9.1 21.2 12.5 13.5 21.8 19.8 12.6 15.3 14.3 13.9 9.8 18.5 23.4 12.0 9.4 18.2 16.9 15.7 12.3 15.3 9.6 15.3 18.9 19.7 10.0 9.6 22.6 14.6 11.7 15.1 13.1 10.5 15.8 13.1 13.6 12.4 15.6 6.4 19.6 9.3 16.2 15.1 19.0 19.4 14.1 13.1 13.0 8.8 30.9 18.4 27.3 11.9 27.8 43.2 14.0 11.1 10.6 13.8 12.9 13.2 16.6 18.7 10.8 16.1 41.2 14.7 21.1 6.3 28.9 9.7 16.5 25.3 20.5 11.9 27.2 10.4 15.9 12.0 18.5 12.3 16.7 15.4 25.4 15.7 13.5 9.3 12.4 18.8 8.5 26.5 18.1 11.8 39.9 14.3 5.4 9.4 9.6 18.7 14.6 17.5 12.3 18.7 15.2 15.3 10.1 19.5 17.5 2.3 18.9 15.3 11.5 19.7 10.0 15.0 27.9 42.6 24.4 14.0 14.0 14.8 14.9 22.7 18.5 32.8 27.7 10.4 12.9 23.2 35.2 17.1 20.4 45.5 39.8 7.0 9.8 21.3 13.3 21.4 1.6 15.0 19.3 0.0 21.0 22.3 16.2 9.1 262.5 12.3 16.9 25.4 7.5 8.6 12.3 2.1 7.5 7.8 3.3 14.4 16.3 20.9 17.2 14.0 12.7 17.9 20.8 6.5 9.2 15.6 9.0 21.7 14.8 15.4 13.9 20.1 LEPROT "FLJ90360, OB-RGRP, OBRGRP, VPS55" ENSG00000213625 "Leptin receptor overlapping transcript" O15243 1 65420587-65436007 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069444 Approved Centrosome NA NA Centrosome "HPA069444: AB_2686137" "unprognostic (3.64e-2)" "unprognostic (2.24e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "unprognostic (6.13e-3)" "unprognostic (1.52e-1)" "unprognostic (2.21e-1)" "unprognostic (4.88e-2)" "unprognostic (6.85e-2)" "unprognostic (6.43e-3)" "unprognostic (2.25e-2)" "unprognostic (4.56e-3)" "unprognostic (2.25e-3)" "unprognostic (8.22e-2)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" 37.3 30.0 13.9 12.6 14.0 17.1 37.8 9.2 13.3 25.4 20.5 18.0 16.1 12.5 42.6 18.4 25.5 20.7 20.8 22.1 11.4 11.0 50.7 31.1 26.3 24.5 16.5 10.1 28.7 30.8 22.5 21.7 44.3 18.9 25.4 16.9 30.4 21.4 20.5 13.6 16.2 23.5 26.2 20.0 24.3 18.1 17.4 11.7 6.5 34.2 14.0 14.7 28.5 19.5 2.2 8.1 15.3 18.0 4.1 4.9 8.4 10.7 4.5 4.7 2.0 41.7 28.2 15.0 16.6 23.3 13.5 13.7 3.8 6.8 2.5 9.6 16.6 16.0 6.7 2.5 6.9 17.3 11.5 2.6 12.3 5.8 6.9 11.5 2.4 6.6 38.6 17.6 10.8 8.5 17.9 15.4 1.7 7.3 6.1 24.2 2.7 0.9 2.8 7.5 3.7 4.9 0.5 10.4 3.8 60.6 8.0 4.8 6.4 10.1 9.0 9.6 18.9 6.9 4.6 18.0 13.7 10.1 10.5 6.2 7.5 6.6 1.1 11.0 6.3 8.7 15.3 12.7 10.7 4.1 12.7 4.9 2.2 3.9 3.7 8.1 1.5 3.9 3.8 11.8 4.1 18.0 6.7 3.0 8.4 13.9 14.0 9.2 13.3 11.4 11.0 16.5 10.1 18.9 11.7 154.9 49.4 25.7 74.0 51.2 17.8 51.3 89.2 85.6 66.0 169.3 21.6 193.8 69.6 117.2 5.0 175.0 47.0 46.7 125.5 93.2 138.0 69.9 60.2 71.7 95.6 36.5 53.6 190.3 110.3 5.1 184.1 107.1 69.2 63.1 58.2 82.8 129.1 63.0 140.0 131.1 26.2 187.5 142.2 17.1 17.5 58.5 307.6 40.3 43.3 74.9 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Cell line enhanced" "Detected in some" "AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.0 0.9 10.4 0.4 0.0 14.7 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 0.0 0.0 0.0 0.1 0.1 0.4 2.6 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 1.6 0.0 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-2 OS: 11.9" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMF2 "TMEM112B, TMEM153" ENSG00000100258 "Lipase maturation factor 2" Q9BU23 22 50502949-50507691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062626 Approved Approved Centrosome NA NA Centrosome "HPA062626: AB_2684812" "unprognostic (2.69e-1)" "prognostic favorable (3.47e-4)" "unprognostic (8.67e-2)" "unprognostic (2.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.13e-2)" "unprognostic (1.21e-2)" "unprognostic (2.70e-2)" "unprognostic (5.11e-2)" "unprognostic (2.90e-1)" "unprognostic (2.97e-2)" "unprognostic (3.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.08e-1)" "unprognostic (2.54e-2)" "unprognostic (8.75e-2)" 18.2 13.7 7.7 14.3 10.1 20.9 16.9 14.6 16.6 16.9 20.0 16.1 11.0 18.7 14.7 19.3 17.5 13.0 19.0 11.2 8.1 8.7 18.5 34.7 14.2 15.3 10.7 10.1 18.0 122.0 8.7 20.8 14.2 11.3 15.8 5.3 16.9 27.3 16.4 10.8 17.8 21.3 11.3 7.8 19.0 12.9 12.0 7.8 12.8 20.4 13.9 19.9 13.3 14.1 10.8 25.3 16.1 17.7 12.1 21.0 12.6 18.0 13.6 7.8 14.8 11.3 9.7 18.2 32.4 17.2 20.9 23.5 13.4 9.4 8.0 8.8 17.0 9.3 21.8 2.6 10.2 2.9 6.3 28.5 4.4 25.0 14.1 14.2 8.2 17.6 14.3 9.5 14.2 3.5 9.0 11.6 6.3 5.2 27.1 9.0 13.0 5.8 9.7 4.6 4.6 17.0 13.3 12.5 21.8 8.4 9.8 7.0 10.3 22.1 19.2 14.9 3.9 11.0 5.8 16.8 29.6 16.8 21.1 1.6 10.5 3.4 4.8 21.5 5.1 24.1 10.3 13.2 16.1 21.0 17.7 15.9 10.8 17.5 19.4 14.0 7.3 10.4 10.9 12.4 12.1 14.5 25.3 15.9 12.6 7.7 10.1 14.6 16.6 8.1 8.7 10.7 10.1 11.3 7.8 11.9 9.6 31.3 14.9 16.6 13.7 8.1 35.7 5.3 12.5 14.0 21.6 50.7 3.3 33.0 7.3 17.9 48.5 0.0 65.4 89.5 42.9 11.0 15.1 31.6 38.4 11.1 14.5 23.4 17.3 14.8 27.0 23.9 23.6 19.0 25.4 24.6 31.0 59.6 24.1 19.5 14.1 19.4 19.4 11.2 20.1 15.2 23.8 34.6 24.4 13.1 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Group enriched" "Detected in some" 15 "Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038640: AB_2676127" "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.6 2.4 3.1 5.5 1.2 0.2 0.0 0.3 0.2 0.1 0.0 3.5 0.1 0.2 0.1 0.3 0.9 0.1 1.0 0.8 2.0 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 0.1 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.7 0.1 0.5 0.4 0.2 0.2 0.2 6.7 0.1 6.9 0.2 0.4 3.9 0.8 0.3 1.5 0.3 0.2 0.9 24.0 0.2 0.8 1.3 1.7 0.3 1.6 2.6 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 0.0 0.0 0.5 1.1 0.0 0.0 0.4 0.0 26.8 2.3 0.0 0.0 0.2 1.7 0.0 38.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.7 LONRF1 "FLJ23749, RNF191" ENSG00000154359 "LON peptidase N-terminal domain and ring finger 1" Q17RB8 8 12721894-12756073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023584, HPA024814" Uncertain Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023584: AB_1853233, HPA024814: AB_1853235" "unprognostic (2.59e-1)" "unprognostic (2.17e-3)" "unprognostic (1.35e-2)" "unprognostic (3.56e-1)" "unprognostic (9.09e-2)" "unprognostic (3.96e-3)" "unprognostic (3.13e-1)" "unprognostic (5.78e-2)" "unprognostic (2.74e-3)" "unprognostic (1.18e-1)" "unprognostic (5.83e-2)" "unprognostic (3.39e-1)" "unprognostic (5.46e-3)" "unprognostic (8.97e-2)" "unprognostic (8.90e-2)" "unprognostic (3.08e-3)" "unprognostic (1.15e-1)" 16.5 7.6 7.6 4.9 9.9 4.9 10.4 9.9 8.4 14.0 8.1 6.3 8.8 2.2 11.1 13.0 12.9 11.2 9.4 6.5 8.9 5.3 6.3 9.3 8.1 8.7 6.9 6.9 20.4 10.3 12.6 4.9 9.6 5.5 12.8 4.2 13.9 7.9 10.9 18.4 29.7 5.3 10.0 6.1 9.2 6.9 16.1 4.5 6.2 8.6 7.3 7.3 10.6 19.0 1.1 0.9 2.4 2.1 0.1 1.6 0.2 0.6 1.6 8.6 2.6 9.1 4.4 5.7 2.1 3.6 2.3 3.3 0.5 2.2 13.2 0.5 3.7 7.5 1.0 6.8 2.6 2.6 2.0 3.8 4.3 0.3 3.5 8.5 1.1 1.7 4.1 4.7 1.5 5.2 2.2 3.6 5.4 0.6 32.4 1.5 2.4 5.6 3.8 8.8 2.7 0.5 3.1 5.9 2.4 2.1 5.7 18.0 2.1 1.2 2.9 16.8 6.4 0.6 5.8 1.6 1.3 2.2 5.1 1.6 2.4 11.0 6.9 6.9 4.0 3.9 0.0 0.5 2.4 0.5 1.8 1.6 1.0 1.0 0.6 0.4 1.1 0.0 0.0 1.9 0.1 2.1 0.9 0.0 0.2 7.6 9.9 9.9 8.4 8.9 5.3 6.9 6.9 5.5 4.5 8.9 18.9 3.9 28.3 54.0 22.8 8.7 7.6 13.4 15.9 10.4 15.7 2.8 6.6 5.4 50.1 13.5 3.2 0.0 3.5 6.8 12.7 23.1 5.8 11.9 4.9 7.9 2.4 6.7 7.3 44.0 27.0 10.1 42.2 1.8 5.4 9.2 4.5 5.8 18.7 5.7 12.9 19.4 29.5 7.7 17.7 64.4 6.1 5.0 4.7 22.2 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023302-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 4.9 7.1 7.0 9.3 12.0 4.5 20.3 10.8 4.6 7.0 5.7 9.5 11.1 4.4 5.0 8.0 10.5 5.8 3.1 7.7 3.9 5.9 12.9 5.6 6.5 8.3 4.7 3.7 15.5 4.5 4.8 4.9 6.5 6.6 3.6 4.9 13.6 5.0 4.3 10.2 9.4 5.2 3.3 7.6 10.4 3.1 9.9 7.1 9.8 6.8 6.5 5.0 5.1 2.3 3.3 5.0 3.2 2.8 4.6 3.1 9.8 11.2 3.4 7.0 1.4 1.9 13.4 6.9 2.9 4.2 3.5 10.0 6.8 7.4 6.2 1.4 4.3 11.6 3.3 4.1 0.9 4.5 21.3 4.7 20.5 13.5 1.2 5.5 11.8 1.9 1.7 2.5 0.6 1.7 6.1 7.2 3.3 3.3 1.1 16.7 12.3 18.4 3.5 8.0 15.1 10.1 6.7 4.1 2.7 9.2 10.6 10.4 3.1 16.5 5.8 1.8 13.5 6.4 3.5 7.3 9.3 11.6 11.7 6.4 1.6 1.1 3.9 4.8 7.6 5.0 3.2 3.6 3.9 2.4 4.0 1.5 4.5 4.6 2.2 2.3 2.4 3.1 0.2 2.8 1.0 3.3 3.8 3.1 7.1 9.3 20.3 10.8 7.7 3.9 8.3 4.7 6.5 9.9 6.0 2.1 1.9 4.2 3.9 4.5 2.4 10.2 14.7 7.9 3.5 0.0 8.9 5.0 6.8 1.1 3.1 9.1 0.0 4.2 22.5 4.0 3.5 4.6 11.1 7.4 4.8 4.6 8.6 5.9 1.1 6.6 2.5 8.5 2.8 9.8 5.0 5.0 8.6 6.0 6.5 4.0 0.0 3.8 1.4 11.0 2.0 2.5 5.3 10.3 2.0 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 37.9;Early spermatids: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Group enriched" "Detected in some" 6 "HaCaT: 10.5;HEL: 31.3" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.5 31.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 0.0 0.0 5.1 0.5 0.7 37.9 5.8 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 20.2 1.4 0.0 0.0 0.0 0.4 2.1 0.7 0.0 5.5 0.3 6.4 0.0 1.8 1.5 4.6 0.6 0.7 5.0 0.0 0.0 0.5 0.0 0.0 2.8 1.3 7.9 0.0 1.4 7.4 2.7 1.1 0.1 2.5 0.0 0.1 LRRCC1 "CLERC, KIAA1764, VFL1" ENSG00000133739 "Leucine rich repeat and coiled-coil centrosomal protein 1" Q9C099 8 85107147-85146076 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.1" "Group enriched" "Detected in many" 4 "Early spermatids: 124.2;Late spermatids: 120.8;Spermatocytes: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012893, HPA075880" Uncertain Supported Centrosome NA NA Centrosome "HPA012893: AB_1852434, HPA075880: " "unprognostic (1.01e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-3)" "unprognostic (2.37e-2)" "unprognostic (7.67e-2)" "unprognostic (7.76e-2)" "unprognostic (1.47e-2)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.31e-1)" "unprognostic (4.45e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-2)" "unprognostic (2.43e-2)" "unprognostic (2.67e-2)" "unprognostic (7.37e-2)" "unprognostic (1.52e-1)" 5.2 5.6 10.8 9.8 10.7 7.0 7.3 2.3 7.2 7.0 10.8 5.6 5.1 7.3 7.1 7.3 6.1 5.2 4.8 5.3 10.4 9.0 9.7 4.4 6.1 4.9 12.7 6.0 9.4 4.8 6.0 2.7 2.5 8.8 8.9 10.1 3.4 3.6 6.8 2.0 6.5 10.0 11.7 15.0 5.3 6.5 33.1 9.9 11.4 10.1 3.4 3.9 8.0 22.1 1.3 2.9 0.1 1.2 2.5 3.6 0.6 4.3 0.9 8.1 1.8 4.0 3.5 6.4 4.6 2.9 1.0 1.8 2.1 6.2 3.2 0.7 2.7 5.4 6.0 9.6 2.7 1.6 25.1 0.8 12.6 2.4 3.2 1.2 4.8 3.4 2.0 0.7 2.8 0.6 1.8 1.1 8.4 14.1 2.9 5.1 1.5 14.4 3.8 2.8 16.6 2.1 10.6 5.1 2.2 2.8 3.3 1.1 2.8 2.2 4.3 1.6 5.5 9.7 10.4 1.4 3.9 5.4 4.1 6.1 4.0 4.0 6.3 3.2 12.4 7.6 0.0 0.8 0.0 1.8 1.2 0.9 1.3 1.4 1.9 2.9 1.2 1.6 2.8 0.1 2.5 0.9 1.9 3.6 0.6 10.8 10.7 2.3 7.2 10.4 9.0 12.7 6.0 8.8 9.9 29.8 26.2 0.8 8.8 8.2 6.7 12.5 5.1 30.8 34.2 24.4 11.8 4.5 28.2 5.8 124.2 9.9 7.7 0.0 6.6 9.2 8.6 8.9 15.0 5.7 5.8 23.8 7.5 6.7 2.4 120.8 9.5 7.7 5.0 5.4 13.2 9.4 2.6 7.0 13.4 5.4 4.9 19.4 9.9 208.1 36.4 5.6 0.9 4.5 16.6 6.4 LTB "p33, TNFC, TNFSF3" ENSG00000227507 "Lymphotoxin beta" Q06643 6 31580525-31582522 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;lymphoid tissue: 81.5" "Cell type enriched" "Detected in many" 4 "B-cells: 1026.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;Daudi: 19.8;HDLM-2: 11.2;HMC-1: 5.8;NB-4: 12.8;REH: 12.2;U-698: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048884 Approved Approved Centrosome NA NA Centrosome "HPA048884: AB_2680543" "unprognostic (1.43e-2)" "unprognostic (3.89e-2)" "unprognostic (7.29e-2)" "prognostic favorable (2.36e-6)" "unprognostic (2.91e-3)" "prognostic favorable (1.74e-4)" "unprognostic (1.45e-1)" "unprognostic (9.49e-3)" "unprognostic (1.42e-3)" "unprognostic (4.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (8.91e-2)" "unprognostic (4.92e-2)" "unprognostic (6.56e-3)" "unprognostic (1.99e-1)" 1.0 0.2 0.2 35.9 0.2 3.4 0.5 0.1 0.1 0.2 1.5 0.0 0.0 1.3 0.2 0.3 2.7 0.4 0.7 1.9 0.2 0.1 4.2 1.3 4.2 27.8 0.2 0.0 0.5 0.8 0.0 0.2 0.3 0.1 0.7 0.6 0.5 6.1 0.3 0.1 0.6 18.0 0.3 0.3 69.7 2.0 0.2 0.0 81.5 1.1 0.8 41.6 1.6 0.5 44.1 15.6 17.8 3.6 5.2 39.3 10.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 19.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 12.8 0.0 0.0 0.0 12.2 0.0 2.7 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 2.5 0.4 17.8 3.7 2.0 26.8 42.5 39.3 17.3 0.6 44.1 33.5 14.2 14.5 5.2 3.6 15.6 22.2 10.7 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 13.6 1026.5 0.2 14.4 0.2 0.4 0.0 0.0 4.5 85.5 0.0 0.3 1.7 211.4 1.9 3.8 0.0 0.0 97.9 0.2 5.6 1.2 13.9 2.8 8.9 0.0 0.0 6.7 27.5 0.0 0.6 21.2 40.5 10.0 0.3 1.0 243.4 1.5 0.0 8.6 0.1 6.5 10.8 0.1 1.1 10.8 0.2 247.3 0.4 0.3 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982013-20999038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 21.2 16.9 17.3 15.6 17.4 10.3 17.9 20.7 24.7 18.5 18.3 25.3 20.6 18.9 24.9 14.0 16.5 18.3 21.2 15.8 15.4 10.9 17.2 13.1 16.2 12.8 19.6 16.5 21.7 16.2 24.9 26.0 18.8 19.0 16.9 12.9 18.9 17.5 18.0 17.2 15.0 15.7 21.9 14.0 19.3 14.5 10.8 19.2 10.8 19.6 12.6 12.5 18.5 16.4 1.6 2.2 0.2 3.4 1.8 3.0 1.5 6.3 5.2 7.8 9.4 17.9 12.4 6.3 13.0 9.1 7.4 10.2 3.0 2.6 6.7 4.8 14.5 6.9 8.6 5.8 10.6 3.0 12.5 13.6 7.2 6.8 4.5 9.6 3.9 9.6 11.4 5.4 9.4 6.8 11.8 14.4 6.3 30.0 11.7 8.4 3.8 6.9 3.7 2.4 7.7 5.7 8.2 11.3 2.6 5.9 8.6 7.7 11.4 7.1 12.3 7.6 4.9 5.7 7.2 12.8 17.4 8.9 7.8 7.0 5.1 4.4 2.0 7.8 3.8 8.4 0.0 2.5 0.2 3.0 3.1 1.6 1.6 1.5 2.8 2.2 1.0 2.1 1.5 0.1 1.8 3.4 1.2 0.5 1.5 17.3 17.4 20.7 24.7 15.4 10.9 19.6 16.5 19.0 19.2 11.9 10.4 9.7 1.4 1.9 8.1 11.2 2.5 6.7 5.7 8.7 5.9 3.6 1.7 6.6 0.8 9.5 7.8 0.0 4.3 3.2 5.4 2.0 5.7 6.2 6.9 3.2 8.7 12.3 11.6 1.3 8.1 4.9 6.8 4.6 9.1 6.6 5.7 5.9 9.2 6.1 9.3 0.0 7.2 2.6 1.7 3.1 3.0 6.9 5.8 0.9 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 44 "testis: 9.0" "Group enriched" "Detected in some" 25 "Spermatocytes: 4.7;Spermatogonia: 9.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/70: 37.0" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA055743: AB_2682902, HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 9.7 0.0 0.0 0.0 0.0 0.0 MAL ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 447.4" "Cell type enhanced" "Detected in many" 24 "Collecting duct cells: 354.2;Distal tubular cells: 200.6;Muller glia cells: 85.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1" "Lineage enriched" "Detected in many" 44 "T-cells: 57.9" "Cell line enhanced" "Detected in some" "HDLM-2: 45.9;MOLT-4: 64.2;RPMI-8226: 22.7;RPTEC TERT1: 232.7" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" NA NA "Golgi apparatus" Centrosome "HPA065691: AB_2685533" "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favorable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 2.3 2.0 14.3 3.5 21.8 3.7 2.0 1.8 20.6 35.8 3.7 43.2 0.4 2.0 1.8 3.4 447.4 3.4 2.2 3.3 18.2 8.3 53.1 1.7 4.3 5.9 27.4 13.2 2.0 1.9 1.6 0.2 2.2 11.8 2.5 2.9 2.8 42.5 3.9 2.0 3.7 2.4 2.1 27.6 3.2 9.3 1.7 27.2 35.0 5.8 56.1 90.1 2.6 64.8 0.6 0.2 0.4 0.1 1.3 57.9 13.7 4.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 0.0 0.0 0.0 22.7 232.7 5.8 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.6 42.0 7.5 0.0 0.5 57.9 26.4 0.4 1.3 0.0 0.2 40.1 13.7 14.3 21.8 1.8 20.6 18.2 8.3 27.4 13.2 11.8 27.2 0.0 0.0 0.0 0.1 1.0 1.1 8.1 0.0 0.0 0.0 354.2 3.9 0.1 200.6 0.1 5.3 0.1 0.0 0.0 0.0 0.0 1.9 0.2 1.1 0.0 0.1 4.8 0.0 4.3 0.0 16.2 0.9 0.5 16.9 0.0 0.0 85.5 0.1 0.0 0.0 2.8 2.5 6.5 1.5 0.0 0.4 0.9 0.2 17.0 0.0 0.7 MAP7D3 FLJ12649 ENSG00000129680 "MAP7 domain containing 3" Q8IWC1 X 136213220-136256482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 212.2;Late spermatids: 231.1;Spermatogonia: 128.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA035598, HPA058101" Approved Enhanced Centrosome NA NA Centrosome "HPA035598: AB_10671108, HPA058101: AB_2683604" "unprognostic (2.89e-1)" "unprognostic (1.23e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (8.83e-3)" "unprognostic (3.77e-3)" "unprognostic (4.16e-5)" "unprognostic (5.35e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (9.91e-2)" "prognostic unfavorable (7.91e-4)" "unprognostic (2.04e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.38e-5)" 26.1 4.8 2.9 9.3 3.8 4.5 21.2 0.9 2.2 14.3 9.0 1.7 6.8 2.2 11.4 12.3 10.6 13.7 6.7 17.7 2.7 1.9 9.9 6.5 6.9 6.4 4.1 1.1 23.6 2.8 8.3 14.1 32.6 5.5 9.4 3.5 4.6 3.8 8.6 27.9 5.3 6.2 15.3 6.5 11.8 6.5 16.0 3.1 9.5 9.6 10.2 4.9 13.9 14.6 9.8 6.2 5.9 9.2 8.4 9.3 3.9 15.7 5.6 4.3 7.3 9.7 10.2 5.9 15.2 8.4 12.5 17.2 5.6 7.9 8.2 24.7 13.3 13.3 7.6 12.4 8.1 17.2 7.4 12.4 4.9 9.0 0.0 10.6 11.9 5.1 20.6 4.7 12.8 16.0 7.1 9.7 13.6 4.1 12.9 9.2 9.9 14.1 4.5 6.0 3.9 0.1 14.0 11.6 4.0 0.4 2.4 3.0 6.4 8.8 3.3 5.5 7.7 0.0 5.5 29.0 13.4 7.7 17.0 19.3 8.8 10.5 9.4 9.1 20.1 6.3 5.9 4.8 1.4 7.5 5.5 9.3 9.8 7.1 8.2 5.8 8.5 7.6 6.0 1.0 8.4 9.2 6.2 5.0 3.9 2.9 3.8 0.9 2.2 2.7 1.9 4.1 1.1 5.5 3.1 14.9 7.0 15.9 5.2 6.4 0.7 34.1 17.8 6.7 11.4 17.4 0.0 9.6 1.7 8.2 212.2 18.4 1.6 0.0 12.2 78.9 27.3 1.4 34.6 25.0 13.2 19.1 5.2 60.8 18.1 231.1 58.7 17.4 6.8 25.2 2.3 12.0 11.4 14.0 44.9 26.1 2.6 38.8 44.3 41.7 128.3 4.3 11.2 17.5 3.0 2.6 MAPKAPK2 ENSG00000162889 "Mitogen-activated protein kinase-activated protein kinase 2" P49137 1 206684944-206734283 "Cancer-related genes, Enzymes, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 18.7" "Lineage enriched" "Detected in all" 6 "dendritic cells: 18.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263" "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 23.0 25.3 11.6 21.2 15.7 58.6 23.9 11.1 14.5 19.3 25.6 17.2 14.5 25.7 20.0 18.5 23.5 17.3 26.0 89.2 12.3 8.7 33.7 26.7 26.7 21.5 16.7 6.5 23.3 19.1 16.9 22.8 13.6 15.7 20.2 14.4 17.8 19.8 14.4 62.9 18.3 32.9 18.3 14.6 37.7 23.1 21.3 14.6 26.9 24.3 25.2 28.2 22.9 46.1 1.1 18.7 3.2 1.1 2.3 1.6 0.5 21.2 8.4 11.7 13.2 34.6 20.3 14.6 14.8 33.7 22.7 21.4 16.1 10.4 10.2 10.4 29.9 14.2 16.1 8.7 15.8 16.3 11.9 6.6 17.2 10.5 10.3 26.7 25.4 57.6 28.0 20.2 21.8 24.1 18.9 18.5 13.9 19.8 46.7 18.3 26.4 10.2 18.4 13.5 7.5 11.8 26.2 24.6 3.3 17.1 13.1 9.4 12.1 17.5 29.6 20.5 22.8 14.4 24.7 17.6 20.5 17.3 23.7 20.2 60.9 54.0 8.3 23.2 15.5 6.7 1.1 0.7 1.4 1.6 1.1 1.5 1.0 1.2 1.5 0.6 1.1 0.6 1.1 3.2 2.3 1.0 18.7 1.4 0.5 11.6 15.7 11.1 14.5 12.3 8.7 16.7 6.5 15.7 14.6 50.6 53.7 28.9 47.2 75.9 11.3 97.2 40.8 6.7 29.6 29.6 19.6 5.0 13.3 28.0 71.3 26.3 27.4 23.3 50.4 7.0 28.6 55.9 34.6 34.4 22.4 0.0 59.3 21.5 27.7 20.1 21.0 27.9 32.1 12.6 32.0 17.7 50.5 21.2 16.3 21.0 14.8 25.8 48.7 11.8 4.1 63.0 13.8 37.4 24.1 68.1 MDH1 ENSG00000014641 "Malate dehydrogenase 1" P40925 2 63588609-63607197 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 155.8" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027296, CAB047333, HPA054276" Uncertain Supported Centrosome,Cytosol NA NA 63000000 "Centrosome, Cytosol" "CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434" "unprognostic (1.01e-1)" "unprognostic (6.52e-3)" "unprognostic (1.61e-2)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.83e-1)" "unprognostic (8.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.79e-2)" "unprognostic (9.52e-2)" "unprognostic (2.05e-1)" "unprognostic (3.26e-1)" "unprognostic (8.80e-2)" "prognostic favorable (9.95e-4)" "unprognostic (6.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.97e-2)" "unprognostic (3.05e-1)" 32.0 28.6 28.0 10.5 58.1 9.2 18.4 38.0 69.5 12.4 21.4 12.5 9.0 19.3 13.4 22.6 16.7 14.7 11.5 155.8 33.6 37.5 47.6 33.2 11.2 14.7 33.4 40.1 10.9 8.9 26.0 18.3 11.4 65.9 16.1 24.9 13.8 15.4 19.9 91.1 11.1 17.1 21.5 18.6 9.4 22.4 8.6 12.2 14.1 15.6 47.1 20.2 15.6 10.2 61.7 57.1 50.7 61.5 46.7 74.5 67.8 44.2 36.3 49.1 32.1 69.7 51.7 50.8 34.9 51.6 53.1 53.9 42.9 39.4 55.8 20.7 45.7 66.4 39.0 55.2 64.6 76.3 33.7 42.6 52.3 33.9 68.2 38.3 60.2 41.5 51.2 44.2 49.8 29.4 43.3 40.5 56.8 28.9 40.6 69.9 26.6 52.7 60.8 28.7 66.4 45.2 42.1 57.8 54.7 88.0 42.0 45.5 27.1 29.2 47.2 66.8 39.1 34.4 62.9 23.6 40.8 40.0 33.9 43.8 50.7 44.4 68.3 50.4 54.5 33.7 50.7 45.8 45.8 52.7 61.5 55.0 61.7 61.3 57.6 57.1 56.4 60.5 57.5 7.0 46.7 55.7 43.3 74.5 67.8 28.0 58.1 38.0 69.5 33.6 37.5 33.4 40.1 65.9 12.2 56.6 41.7 76.8 91.9 72.5 153.0 1859.7 86.6 136.5 79.6 127.4 66.8 222.4 533.9 152.0 8.3 50.1 143.7 70.0 94.8 211.6 90.4 54.0 78.5 143.3 336.7 116.0 60.3 41.1 68.1 11.1 92.6 78.1 168.7 212.0 97.2 112.7 85.3 103.5 102.6 683.5 120.0 58.2 87.6 48.3 49.0 73.4 125.1 76.2 138.8 88.5 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 49.5;Spermatocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA040411, HPA041594" Uncertain Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 7.0 6.7 11.5 11.9 11.4 15.4 10.0 8.2 12.7 11.9 28.7 9.6 12.4 5.1 15.2 12.7 5.4 20.3 6.5 6.7 12.3 10.0 8.8 4.9 6.8 12.8 11.4 10.5 10.9 11.3 8.8 22.8 6.0 14.9 12.3 11.1 9.0 6.8 15.9 3.8 4.2 9.0 18.8 11.4 9.5 9.8 20.7 12.4 14.6 11.0 5.3 13.4 17.0 8.9 7.1 4.0 13.3 17.2 6.0 8.1 5.4 5.0 4.2 8.1 7.8 4.0 5.5 6.2 6.7 3.7 10.7 9.9 5.0 2.3 11.6 4.4 3.0 5.3 5.2 5.5 3.6 12.2 15.1 5.3 25.4 5.4 3.4 6.2 14.0 10.1 2.5 4.7 7.2 7.0 5.8 6.0 13.4 4.8 13.0 6.2 3.6 19.8 9.9 4.3 5.0 5.1 19.5 7.2 3.4 5.1 4.4 7.4 3.9 6.5 3.9 6.6 6.7 9.3 10.1 3.2 8.6 3.8 5.4 6.1 6.8 19.8 7.8 4.5 9.2 5.5 6.0 4.7 13.3 5.0 11.1 8.1 6.8 6.4 5.2 4.0 7.1 7.7 6.2 3.1 6.0 17.2 2.3 5.9 5.4 11.5 11.4 8.2 12.7 12.3 10.0 11.4 10.5 14.9 12.4 3.0 5.8 13.3 3.9 4.2 12.7 8.1 0.0 49.5 7.9 7.0 0.0 3.7 8.3 4.3 22.5 6.3 1.6 23.3 3.1 3.8 5.8 2.3 6.9 4.2 5.4 7.9 2.4 3.7 2.4 9.0 8.3 7.6 15.1 3.6 2.6 24.9 2.7 3.6 12.7 8.4 32.9 6.5 7.2 38.1 17.8 3.6 0.2 13.6 4.1 1.3 MED20 "DKFZp586D2223, PRO0213, SRB2, TRFP" ENSG00000124641 "Mediator complex subunit 20" Q9H944 6 41905354-41921139 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040717 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA040717: AB_10794146" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (2.58e-3)" "unprognostic (8.32e-2)" "unprognostic (9.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.16e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.58e-3)" "unprognostic (4.23e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.71e-2)" "unprognostic (4.63e-1)" "unprognostic (4.13e-3)" "unprognostic (2.31e-1)" 11.8 22.1 12.4 12.1 14.2 7.0 14.2 17.0 15.4 15.3 14.0 16.4 17.4 13.1 16.1 17.8 17.0 13.2 9.9 15.3 12.7 9.5 17.5 14.7 10.4 11.4 14.8 9.3 12.8 17.6 14.5 23.5 17.4 13.8 16.3 15.4 13.2 15.3 14.0 23.0 12.1 15.4 15.3 9.6 13.3 12.9 14.6 11.5 20.9 15.5 13.1 16.4 16.0 12.9 15.0 20.0 13.6 22.1 11.6 10.8 11.5 13.5 11.5 12.4 14.8 11.7 13.0 15.3 8.6 8.3 12.3 9.9 14.6 9.3 18.4 17.1 10.1 7.0 10.3 21.1 11.6 15.6 10.6 6.7 16.5 8.9 12.8 11.2 14.0 10.4 10.1 18.2 11.7 17.6 9.8 15.2 17.8 22.3 8.9 14.7 12.1 15.6 10.0 16.1 43.1 9.3 21.7 14.9 6.6 17.6 8.7 11.5 9.1 12.3 5.8 11.6 15.4 11.7 14.7 14.8 8.7 19.0 5.3 10.6 9.2 12.3 38.9 4.8 15.6 12.3 13.0 19.6 13.6 8.7 22.1 10.8 14.2 5.8 9.8 20.0 15.0 7.9 9.3 7.3 11.6 14.8 17.8 10.2 11.5 12.4 14.2 17.0 15.4 12.7 9.5 14.8 9.3 13.8 11.5 8.9 3.8 7.7 3.5 3.3 2.1 4.0 0.0 4.0 5.7 7.0 0.0 19.8 6.6 5.5 0.4 2.8 5.1 0.0 2.9 15.6 5.3 4.1 6.9 7.3 7.2 1.6 9.2 8.6 6.0 0.0 3.1 3.0 1.7 1.8 6.4 4.0 4.1 3.5 6.3 8.0 3.7 0.0 3.4 4.1 13.4 5.0 20.8 2.5 6.6 4.7 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824802 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favorable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 23.7 32.9 23.8 25.4 25.0 12.5 24.3 35.5 29.2 22.5 19.5 17.7 20.0 15.9 25.2 27.2 28.0 21.2 16.8 21.9 24.6 21.2 28.1 20.0 16.8 26.7 21.5 30.9 29.2 20.0 38.5 33.0 25.2 24.0 26.3 20.7 15.5 21.9 21.8 33.3 24.4 19.3 21.5 26.7 23.9 21.0 21.7 27.3 33.9 28.2 19.2 34.1 24.1 28.2 21.2 20.3 34.3 21.5 29.6 26.0 15.1 15.5 16.2 28.2 18.5 24.0 15.2 17.4 25.1 17.5 20.4 23.9 25.2 10.2 16.7 24.0 15.5 20.8 28.3 25.1 20.5 24.2 28.2 15.0 40.5 29.2 18.8 18.9 24.0 21.7 14.1 22.5 19.5 17.7 19.7 19.9 19.3 36.6 14.4 24.4 11.6 19.5 18.2 19.9 29.1 14.2 28.7 28.3 10.7 21.2 23.3 17.9 17.6 22.1 19.0 10.2 23.5 28.5 15.5 18.8 20.8 14.8 22.8 20.2 17.7 42.6 36.6 17.5 23.0 15.2 21.4 15.8 34.3 23.4 21.5 22.9 21.2 23.4 22.0 20.3 18.6 24.1 23.5 14.4 29.6 17.1 16.7 26.0 15.1 23.8 25.0 35.5 29.2 24.6 21.2 21.5 30.9 24.0 27.3 32.8 24.6 22.3 53.2 27.0 43.5 27.8 22.9 76.3 37.5 48.8 5.9 80.4 48.0 35.7 4.6 33.8 18.8 0.0 25.6 46.4 25.7 30.0 46.1 16.3 30.6 30.2 10.9 19.0 22.6 4.7 25.9 22.6 25.3 32.5 19.6 45.9 21.9 28.1 33.6 32.8 30.7 19.4 23.5 42.6 76.1 24.2 123.1 30.6 18.8 39.7 MKKS BBS6 ENSG00000125863 "McKusick-Kaufman syndrome" Q9NPJ1 20 10401009-10434222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Chaperone "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041071, HPA044233" Enhanced Supported Centrosome NA NA Centrosome "HPA041071: AB_10960408, HPA044233: AB_10962986" "unprognostic (9.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (1.84e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.84e-5)" "unprognostic (5.54e-2)" "unprognostic (1.19e-1)" "unprognostic (2.58e-1)" "unprognostic (1.01e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.79e-9)" "unprognostic (3.69e-1)" "unprognostic (6.18e-2)" "unprognostic (1.63e-2)" "unprognostic (3.01e-1)" 13.1 15.9 24.3 11.0 26.8 3.1 15.7 31.0 31.6 18.3 19.6 9.9 18.7 21.8 13.9 18.1 15.0 16.1 16.0 25.3 23.7 22.4 33.2 30.6 12.1 11.9 22.4 21.5 17.5 15.2 27.6 16.1 11.7 21.8 16.3 23.0 11.5 18.7 23.8 29.5 11.3 22.0 17.0 16.8 12.1 13.5 20.6 11.6 8.3 20.1 24.0 12.9 13.2 12.9 15.1 22.6 22.6 22.0 13.5 20.9 20.0 11.6 14.6 12.2 18.1 13.8 11.4 4.5 8.2 8.3 9.4 8.0 4.8 6.4 8.9 3.5 7.0 17.8 14.7 14.6 15.2 11.4 1.6 6.4 19.9 4.1 15.6 10.6 12.9 4.6 10.9 25.7 9.4 20.4 15.2 8.0 8.7 11.2 6.8 11.6 5.2 12.0 11.4 9.1 33.3 9.8 8.0 12.6 9.1 14.9 5.6 17.7 11.8 7.0 34.0 18.0 9.0 9.6 9.3 3.9 8.4 8.1 10.3 13.9 5.4 20.0 4.5 7.5 14.0 9.0 22.6 22.0 18.8 15.9 19.9 18.6 15.1 18.0 14.2 22.6 10.7 20.9 19.5 10.9 13.5 19.5 17.7 13.5 20.0 24.3 26.8 31.0 31.6 23.7 22.4 22.4 21.5 21.8 11.6 3.0 13.2 37.9 45.7 30.1 37.3 179.1 140.1 38.8 26.1 8.7 11.8 92.0 58.0 21.2 67.6 48.6 96.4 0.0 17.0 66.2 42.7 69.9 22.0 148.6 108.3 65.2 68.3 54.0 73.5 27.1 57.8 35.6 47.2 14.4 72.1 46.7 18.4 82.3 60.1 38.4 30.2 51.8 40.0 225.0 69.9 37.4 81.0 27.4 93.4 63.8 MOGAT3 "DC7, DGAT2L2, MGAT3" ENSG00000106384 "Monoacylglycerol O-acyltransferase 3" Q86VF5 7 101195007-101201021 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 61.6;liver: 16.0" "Cell type enhanced" "Detected in some" 22 "Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.0;liver cancer: 11.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CACO-2: 4.8;Hep G2: 16.2" HPA011940 Approved Approved Centrosome NA NA Centrosome "HPA011940: AB_1854057" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (7.14e-2)" "unprognostic (6.11e-2)" "unprognostic (3.20e-1)" "unprognostic (9.54e-3)" "unprognostic (9.36e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-3)" "unprognostic (1.87e-1)" "unprognostic (1.23e-1)" "unprognostic (9.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.59e-2)" 0.2 0.1 0.2 2.6 0.2 0.4 0.2 0.2 0.2 0.2 17.3 0.2 0.2 19.7 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.1 0.9 16.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.1 61.6 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.2 5.3 0.9 1.9 1.2 0.3 0.6 0.2 0.2 0.5 0.0 0.2 0.4 0.6 0.0 0.0 0.0 4.8 1.1 0.4 0.6 0.1 0.6 0.4 0.2 0.1 0.1 0.1 0.2 0.6 0.6 16.2 0.2 0.5 0.6 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.7 0.1 0.3 0.3 0.5 0.2 0.5 0.6 0.3 0.1 0.4 0.7 0.6 0.3 0.3 0.3 0.6 0.1 0.8 0.3 0.3 0.8 0.9 0.2 1.0 0.5 0.4 0.2 0.1 1.7 0.6 1.4 2.2 0.9 1.1 1.0 0.7 0.7 1.0 0.8 0.7 0.5 1.7 0.9 1.2 5.3 1.9 0.6 1.2 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 76.6 0.0 0.0 0.0 0.2 0.2 0.0 5.5 0.0 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.1 56.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.5 0.4 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 16050.3;Hepatocytes: 4100.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 885.9" "Low region specificity" "Detected in all" HPA075648 Approved Centrosome,Mitochondria NA NA Mitochondria Centrosome "HPA075648: AB_2686760" "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favorable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 97.1 90.4 163.1 166.1 571.6 120.3 71.9 208.6 52.3 32.7 59.8 150.2 89.8 241.1 85.5 140.9 53.6 185.3 25.3 223.3 65.2 94.9 104.4 173.3 885.9 279.0 83.9 178.2 155.8 210.6 228.8 62.4 218.5 246.4 65.5 125.0 95.5 172.9 119.9 173.6 67.7 228.6 41.1 103.4 109.2 39.3 70.3 107.2 174.1 205.2 49.5 67.0 102.3 162.1 69.9 366.4 115.3 224.3 209.4 86.0 107.1 125.8 79.8 156.5 73.2 128.4 61.7 242.4 40.1 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 208.4 153.9 1221.6 193.7 203.1 0.0 16050.3 1630.6 940.9 684.7 307.1 0.0 0.0 76.3 127.4 46.0 141.8 949.6 2499.6 297.1 0.0 116.0 126.2 448.0 4100.6 0.0 0.0 246.6 1665.3 1966.8 217.5 386.3 249.3 243.0 242.5 657.8 0.0 237.0 573.3 217.1 415.7 0.0 342.8 211.1 226.8 167.2 211.8 0.0 631.2 458.3 137.0 MTMR1 ENSG00000063601 "Myotubularin related protein 1" Q13613 X 150692971-150765103 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002977, HPA018502" Approved Approved Centrosome NA NA Centrosome "HPA002977: AB_2666735, HPA018502: AB_1854185" "unprognostic (2.37e-2)" "unprognostic (1.64e-3)" "unprognostic (2.07e-1)" "unprognostic (1.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (4.35e-2)" "unprognostic (3.16e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-2)" "unprognostic (1.67e-2)" "unprognostic (1.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.19e-1)" "unprognostic (8.40e-2)" 6.9 6.8 20.4 14.0 17.9 9.9 11.8 14.5 15.6 8.3 8.6 8.7 7.2 8.3 9.4 9.2 19.7 9.3 9.0 12.0 17.8 13.4 8.1 10.2 9.7 18.7 12.1 11.5 7.4 11.7 16.3 10.2 37.9 8.8 10.8 9.1 7.9 12.1 13.0 22.2 19.8 10.9 8.3 8.2 18.0 9.7 11.0 9.3 32.6 9.6 10.7 23.1 10.4 7.7 3.3 7.8 7.4 1.5 6.2 4.8 1.8 13.2 8.5 9.2 7.5 2.1 2.5 12.4 11.8 15.2 12.0 17.1 8.2 10.5 29.0 17.5 9.5 11.6 12.1 18.5 17.1 18.8 11.7 11.2 1.8 13.2 3.5 6.4 8.5 6.3 6.8 11.9 13.2 0.2 11.5 7.2 9.7 5.6 7.5 8.6 11.4 12.4 2.2 4.2 14.8 12.9 6.6 14.6 12.8 9.4 15.2 13.7 8.5 4.5 10.1 3.7 7.6 12.9 4.9 9.1 7.9 6.3 1.0 17.5 9.6 9.8 44.2 1.6 5.5 6.1 0.0 0.9 7.4 3.5 1.5 2.6 2.7 3.9 3.2 2.2 3.3 3.5 4.7 2.4 6.2 1.3 7.8 4.8 1.8 20.4 17.9 14.5 15.6 17.8 13.4 12.1 11.5 8.8 9.3 14.9 6.2 3.4 9.6 10.0 0.0 7.9 2.5 1.4 5.7 5.2 0.0 8.8 0.0 5.1 0.0 3.6 2.8 0.0 5.7 6.0 4.3 6.1 1.1 8.1 4.0 0.0 9.2 3.1 8.2 0.4 5.2 5.2 3.3 1.0 7.6 0.0 8.1 6.5 4.9 2.9 0.0 6.5 2.7 1.2 2.3 14.6 8.7 6.9 5.2 10.8 MTMR11 CRA ENSG00000014914 "Myotubularin related protein 11" A4FU01 1 149928651-149936869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 108.3;Mucus-secreting cells: 58.0;Paneth cells: 72.4;Undifferentiated cells: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 37 "dendritic cells: 4.2;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.7;OE19: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030351, HPA072906" Enhanced Approved Centrosome NA NA Centrosome "HPA030351: AB_10602185, HPA072906: " "unprognostic (1.14e-1)" "unprognostic (3.01e-3)" "unprognostic (1.42e-1)" "unprognostic (1.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.37e-2)" "unprognostic (5.81e-2)" "unprognostic (7.94e-2)" "unprognostic (2.98e-1)" "unprognostic (2.88e-2)" "unprognostic (1.22e-1)" "unprognostic (5.83e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (1.80e-2)" "unprognostic (9.12e-2)" 3.2 12.0 4.9 15.0 8.4 0.0 5.4 1.5 3.9 9.5 36.8 2.7 5.8 15.9 10.0 6.2 4.4 7.2 17.0 3.1 2.6 2.8 9.7 1.8 3.4 1.5 2.0 2.8 14.5 2.2 5.8 6.3 9.6 5.2 5.5 20.8 4.5 2.1 6.5 1.1 7.4 49.9 11.4 5.0 1.8 4.0 4.9 2.5 0.0 1.6 4.0 1.5 5.8 6.8 0.0 4.2 0.0 3.2 0.0 0.0 0.5 2.3 5.7 2.5 2.1 7.4 8.4 4.7 2.4 8.2 3.2 4.0 0.1 10.3 0.0 5.6 8.4 4.0 3.3 0.3 4.1 1.8 0.1 0.0 0.0 1.7 0.7 1.9 0.0 0.0 5.2 1.3 3.2 5.3 13.7 3.8 0.0 0.1 0.1 6.3 7.7 0.0 0.0 0.5 16.5 2.0 0.0 0.9 0.1 4.8 0.7 0.1 0.2 1.4 2.3 0.8 1.2 2.5 0.0 2.6 3.5 4.3 2.9 1.9 0.2 0.9 0.0 3.3 0.0 0.3 0.0 1.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 4.9 8.4 1.5 3.9 2.6 2.8 2.0 2.8 5.2 2.5 0.0 1.1 0.0 2.5 3.7 0.0 1.6 10.2 1.4 3.4 14.0 0.0 11.9 1.7 12.5 0.5 2.1 108.3 0.0 15.3 9.0 8.1 2.6 0.0 1.1 4.9 0.0 15.1 4.9 13.3 0.0 5.2 6.4 1.7 3.6 58.0 0.0 28.8 72.4 11.3 15.3 0.0 6.5 6.2 0.3 0.2 5.6 23.8 1.3 48.1 3.7 MTMR9 "C8orf9, DKFZp434K171, LIP-STYX, MTMR8" ENSG00000104643 "Myotubularin related protein 9" Q96QG7 8 11284416-11328146 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070944 Approved "Actin filaments,Centrosome" NA NA Centrosome "Actin filaments" "HPA070944: AB_2686325" "unprognostic (1.97e-2)" "unprognostic (1.95e-1)" "unprognostic (2.30e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-1)" "unprognostic (2.64e-2)" "unprognostic (8.09e-3)" "unprognostic (3.25e-1)" "unprognostic (2.05e-1)" "unprognostic (1.46e-1)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.08e-1)" "unprognostic (1.43e-2)" 8.2 7.0 11.5 7.5 14.0 8.0 9.2 18.2 26.2 6.6 9.9 10.3 2.7 4.4 8.3 5.7 6.4 5.6 5.9 12.9 11.6 14.4 8.2 5.7 6.6 6.9 11.7 12.2 6.9 7.2 9.4 8.4 7.8 13.1 9.3 6.3 6.4 4.8 7.6 9.1 6.9 5.2 11.1 10.8 6.6 5.3 16.8 7.4 8.2 7.1 3.7 7.4 6.4 5.6 4.5 4.1 3.6 3.9 2.3 3.7 1.2 2.6 7.3 6.6 5.2 8.2 7.0 5.2 8.3 5.5 6.7 6.2 6.6 2.0 6.8 2.2 9.9 6.3 3.8 7.3 7.3 7.7 1.4 4.5 9.0 5.9 3.3 8.9 2.3 5.3 6.9 5.9 9.5 12.1 5.5 10.4 4.1 6.1 5.5 10.8 2.0 4.0 2.4 11.9 7.8 4.4 2.9 10.8 2.1 7.3 6.7 2.5 10.1 5.6 2.5 5.9 11.0 3.0 4.8 12.9 7.9 5.9 4.4 4.4 1.5 3.0 3.9 6.6 5.1 7.7 1.5 3.2 3.6 3.2 3.9 2.8 3.5 2.7 2.7 2.8 4.5 3.2 3.7 3.1 2.3 3.2 4.1 2.0 1.2 11.5 14.0 18.2 23.2 11.6 14.4 11.7 12.2 13.1 7.4 11.9 12.6 15.9 10.8 12.0 0.0 22.1 30.6 13.4 13.6 14.0 0.0 9.8 3.3 10.1 9.5 16.1 8.4 0.0 6.1 11.2 15.4 20.3 13.9 12.9 12.6 0.0 15.5 26.4 20.8 5.2 21.6 22.5 15.1 13.6 9.7 0.0 10.9 6.8 18.4 9.1 0.0 38.8 13.9 65.6 27.4 11.3 3.8 21.8 8.2 7.3 MYO18B BK125H2.1 ENSG00000133454 "Myosin XVIIIB" 22 25742144-26031041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 141.2" "Group enriched" "Detected in some" 45 "Cardiomyocytes: 88.1;Early spermatids: 50.3;Late spermatids: 28.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;REH: 11.2;RH-30: 23.8;U-2 OS: 10.5;U-266/70: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000953 Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA000953: AB_1079440" "unprognostic (3.28e-2)" "unprognostic (1.79e-1)" "unprognostic (1.86e-2)" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-2)" "unprognostic (5.93e-4)" "unprognostic (2.46e-1)" "unprognostic (1.22e-1)" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (2.96e-3)" "unprognostic (3.93e-7)" "unprognostic (1.14e-1)" "unprognostic (3.12e-1)" "unprognostic (5.06e-2)" "unprognostic (1.65e-1)" 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.0 0.0 141.2 0.1 0.0 1.5 0.0 0.0 0.3 2.4 0.0 0.3 1.1 16.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 2.9 0.0 0.3 1.2 0.0 0.0 0.0 11.2 23.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 7.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 28.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 MZT2A "FAM128A, MOZART2A" ENSG00000173272 "Mitotic spindle organizing protein 2A" Q6P582 2 131464900-131492743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 70.8" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "prognostic favorable (3.04e-4)" "unprognostic (3.82e-2)" "unprognostic (7.14e-2)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-2)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (3.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (3.04e-11)" "unprognostic (1.51e-2)" "unprognostic (5.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.66e-1)" 17.7 17.1 34.7 22.1 22.6 31.3 17.1 9.6 25.1 17.5 20.3 7.6 23.0 30.0 11.9 22.3 23.5 14.0 17.5 57.5 28.0 20.7 14.4 15.9 7.5 15.6 18.9 16.4 20.8 55.4 5.6 7.2 5.3 8.8 16.4 3.4 9.3 48.5 19.7 40.7 12.6 22.8 17.3 12.0 15.5 24.0 11.1 5.5 28.3 17.8 23.8 17.0 16.2 12.8 11.9 5.4 31.9 1.0 2.6 9.3 2.2 36.0 19.5 0.4 7.5 0.5 1.3 7.8 12.2 2.9 4.7 4.6 47.7 12.5 23.4 15.9 0.5 0.5 16.3 1.2 8.2 0.1 9.2 59.4 9.6 21.8 56.4 2.9 16.8 3.6 3.7 4.5 3.0 1.4 1.0 3.8 20.6 18.9 24.6 1.1 32.6 23.2 70.8 12.6 4.6 44.6 19.8 6.7 52.3 2.9 16.7 28.3 3.5 12.4 8.5 22.3 0.3 13.3 30.4 10.7 12.4 30.2 5.2 11.9 23.1 17.1 18.8 17.4 10.9 7.3 6.9 1.0 31.9 3.8 0.6 4.2 11.9 8.5 4.9 3.4 6.2 9.3 4.5 0.4 2.6 0.3 5.4 8.4 2.2 34.7 22.6 9.6 23.1 28.0 20.7 18.9 16.4 8.8 5.5 14.9 14.4 124.6 117.1 131.5 40.9 255.9 112.1 8.1 19.4 68.0 19.6 68.5 144.2 181.3 20.5 65.2 170.0 23.3 144.3 204.7 90.3 143.8 24.1 118.5 108.3 25.4 104.6 85.3 77.6 66.4 141.5 90.6 97.8 130.8 207.2 54.1 253.1 157.8 193.0 188.7 35.9 90.5 69.3 35.8 155.3 125.0 35.5 160.8 232.9 112.8 MZT2B "FAM128B, FLJ14346, MOZART2B" ENSG00000152082 "Mitotic spindle organizing protein 2B" Q6NZ67 2 130181737-130190729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 93.9" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "unprognostic (8.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.40e-2)" "unprognostic (1.31e-2)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (9.37e-8)" "unprognostic (1.67e-1)" "unprognostic (2.04e-1)" "unprognostic (3.04e-1)" "unprognostic (2.09e-1)" 28.9 39.1 50.8 23.9 33.5 63.4 23.8 19.5 35.1 24.3 31.3 14.4 27.7 34.2 24.7 24.0 30.6 19.4 26.7 56.6 33.7 29.3 22.5 31.1 14.4 27.8 32.8 33.3 31.0 104.2 10.9 17.1 16.2 19.7 28.4 11.6 18.6 63.6 24.9 87.5 20.9 32.1 31.8 21.7 26.8 33.8 26.1 15.4 35.3 36.0 27.1 22.2 24.4 34.9 15.3 21.7 31.7 9.3 12.1 13.3 4.9 41.2 17.4 4.4 21.2 1.7 6.4 20.5 19.8 7.3 7.6 5.6 35.6 21.5 22.7 30.9 4.5 5.1 23.4 2.3 6.5 1.2 33.6 53.9 12.3 25.5 38.9 7.6 16.1 12.2 7.0 9.1 5.1 2.6 5.7 8.4 30.0 16.1 34.0 5.5 47.8 36.1 93.9 14.1 8.7 32.0 42.2 11.1 71.2 4.5 13.7 30.7 37.6 11.9 21.6 32.1 2.0 25.5 47.8 15.0 22.1 35.8 17.6 18.7 41.4 25.9 28.0 33.3 23.9 15.9 0.1 9.3 31.7 7.7 9.1 6.2 15.3 11.3 10.7 11.2 14.8 13.3 10.7 4.6 12.1 8.4 21.7 8.7 4.9 50.8 33.5 19.5 35.1 33.7 29.3 32.8 33.3 19.7 15.4 38.7 21.9 238.2 264.1 264.0 158.4 293.3 170.7 40.2 50.0 230.3 41.2 229.1 396.3 323.5 266.4 198.6 241.8 140.2 511.3 411.3 250.4 326.9 50.7 320.9 295.2 123.9 166.1 171.9 146.8 852.0 231.3 260.0 254.8 212.0 316.3 142.6 514.2 241.6 135.1 586.2 76.3 161.7 241.9 132.8 161.7 329.7 138.1 211.9 294.6 315.0 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113443-178126087 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.5" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 120.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4" "Group enriched" "Detected in many" 18 "B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favorable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 6.6 1.3 1.9 2.6 2.1 3.5 13.9 6.5 4.3 2.5 1.8 0.7 0.5 0.8 1.1 0.6 16.2 1.5 1.3 3.2 1.8 2.6 2.5 0.2 8.4 4.0 2.1 1.2 1.4 1.1 10.1 2.5 31.5 3.1 2.0 0.6 1.5 9.5 1.3 5.7 7.8 1.9 1.3 1.2 5.9 3.1 1.4 1.3 0.4 2.0 4.7 11.2 4.9 3.8 4.0 4.4 0.0 0.0 0.2 2.6 0.5 0.0 0.0 1.2 0.9 0.1 0.0 8.0 0.0 0.0 0.0 0.0 1.7 0.6 0.7 1.1 0.0 0.1 2.5 0.2 0.0 0.0 1.2 0.4 2.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 6.4 0.7 1.3 0.5 0.0 10.9 0.1 0.1 6.0 1.8 0.0 6.0 10.9 2.7 0.6 1.2 0.9 0.4 0.3 38.8 2.5 1.6 1.4 0.0 1.2 0.0 0.9 0.0 0.0 1.7 1.2 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 4.0 0.2 0.2 0.0 4.0 0.9 2.6 0.0 0.2 0.0 4.4 0.0 0.5 1.9 2.1 6.5 4.3 1.8 2.6 2.1 1.2 3.1 1.3 3.0 1.1 5.9 11.5 8.4 27.3 1.5 2.5 0.0 0.0 1.8 11.8 1.7 11.6 3.4 0.1 4.0 2.6 0.0 0.7 120.1 0.9 9.9 4.6 0.0 2.0 1.6 4.1 0.0 0.0 0.4 0.6 1.1 11.8 1.8 1.8 1.9 4.7 5.3 1.8 0.3 8.9 0.0 0.9 0.1 6.9 5.9 19.3 1.0 1.9 10.6 N6AMT1 "C21orf127, HEMK2, MTQ2, N6AMT, PRED28" ENSG00000156239 "N-6 adenine-specific DNA methyltransferase 1" Q9Y5N5 21 28872191-28885371 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034133, CAB034135, HPA059242" Approved Approved Nucleoplasm,Centrosome Yes No Centrosome Nucleoplasm "CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957" "unprognostic (2.20e-2)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (7.46e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.64e-1)" "unprognostic (1.04e-1)" "unprognostic (1.94e-2)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (5.24e-2)" "unprognostic (6.99e-2)" "unprognostic (5.43e-2)" "unprognostic (5.51e-3)" 5.4 10.9 10.1 6.0 18.6 2.0 10.5 7.4 14.8 9.9 7.0 17.0 6.0 6.7 13.8 13.7 5.6 9.3 6.2 10.8 10.8 9.2 9.0 6.3 5.5 6.7 21.3 8.4 18.3 6.6 14.6 15.6 13.1 14.1 10.1 7.4 8.4 6.5 9.0 11.3 8.0 6.2 7.8 14.5 7.9 6.7 7.6 19.3 3.9 12.1 4.0 6.9 8.7 9.2 2.2 2.0 1.6 2.1 4.1 4.8 1.8 3.4 3.1 7.8 10.8 6.5 7.2 6.0 7.4 3.1 4.4 2.6 3.8 6.2 3.8 3.8 4.0 7.8 4.1 6.6 3.7 5.4 4.8 5.1 8.0 4.7 4.8 5.8 4.8 3.1 3.7 8.0 4.4 3.1 8.2 3.2 4.7 9.9 6.8 9.0 3.4 2.3 3.9 9.8 7.2 4.3 3.4 7.4 2.9 8.0 5.0 5.9 8.3 6.7 2.4 2.7 7.3 3.3 4.2 7.5 3.7 6.6 6.7 4.5 4.1 4.6 2.1 5.8 12.6 6.8 1.1 1.5 1.6 1.8 2.1 2.0 2.2 3.4 2.3 2.0 2.2 4.8 3.4 0.5 4.1 1.6 1.7 1.4 1.8 10.1 18.6 7.4 14.8 10.8 9.2 21.3 8.4 14.1 19.3 3.0 4.8 1.4 5.3 1.6 11.1 14.0 7.6 21.4 6.8 12.2 7.9 15.0 6.6 9.7 2.5 4.9 0.9 23.3 5.5 9.8 6.1 3.4 1.1 2.8 6.2 9.5 0.0 4.9 1.2 3.4 8.9 2.6 1.7 2.8 2.6 10.3 6.4 4.8 9.6 7.3 10.0 0.0 8.2 2.6 8.1 3.1 12.5 2.5 3.3 4.8 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 25.1 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 21.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.4 15.0 0.0 11.1 0.0 0.0 0.0 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatogonia: 205.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome NA NA 53000 Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favorable (9.44e-5)" "unprognostic (1.97e-1)" 23.6 27.4 25.3 20.2 31.8 27.2 27.3 36.7 41.7 26.0 25.8 24.4 23.7 26.2 27.9 31.0 27.5 23.9 20.2 23.6 25.4 29.0 24.3 25.9 18.3 27.0 27.7 31.9 31.0 26.6 38.8 42.2 26.4 34.9 24.9 30.0 22.1 24.3 23.5 33.2 26.9 27.6 25.4 25.3 18.4 22.2 36.9 25.9 28.9 27.9 28.0 24.9 24.7 22.4 9.4 6.4 6.7 3.2 8.6 19.4 9.4 23.0 17.8 31.8 31.2 12.7 18.1 26.4 17.6 17.9 26.1 31.8 21.6 18.0 25.6 20.2 13.2 16.9 23.4 23.9 21.2 37.1 9.4 27.2 18.1 12.3 33.5 14.6 33.7 22.8 14.7 15.7 20.8 18.3 13.9 18.2 31.2 42.9 9.0 20.1 8.1 35.2 38.6 44.0 18.1 32.2 37.8 37.8 34.1 20.1 20.3 34.2 25.1 52.7 11.3 20.3 20.4 12.1 22.8 14.2 18.3 18.3 19.0 20.3 17.1 26.4 92.1 16.5 22.4 22.1 1.3 3.1 6.7 15.4 3.0 19.4 9.4 16.4 16.6 4.2 7.9 17.8 17.7 1.4 8.6 3.2 6.4 14.0 9.4 25.3 31.8 36.7 41.7 25.4 29.0 27.7 31.9 34.9 25.9 29.8 25.1 24.4 55.4 29.3 47.7 26.2 15.3 37.5 40.9 29.6 11.8 87.4 33.2 58.5 2.8 22.8 26.7 23.3 52.6 55.3 37.2 37.1 33.6 18.8 25.1 47.7 22.0 20.9 11.6 10.1 45.1 15.5 47.2 33.3 27.8 58.9 51.8 82.6 50.9 40.7 33.6 19.4 49.5 120.6 205.2 28.1 43.8 31.6 33.7 41.4 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80, kinetochore complex component" O14777 18 2571511-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066330 Supported Nucleoplasm,Centrosome NA Yes Nucleoplasm Centrosome "HPA066330: AB_2685661" "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavorable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 2.9 1.3 0.8 15.3 0.8 14.6 0.9 0.7 0.9 2.9 3.8 0.8 0.6 2.7 4.2 3.8 8.3 1.3 1.8 2.7 0.6 0.4 1.6 1.4 2.9 10.1 0.6 0.8 1.2 0.8 0.0 0.6 6.0 1.1 4.3 5.1 0.8 1.9 7.6 0.6 4.0 4.8 2.2 0.6 7.9 3.0 15.9 0.6 51.3 0.9 8.1 9.9 2.2 6.7 7.9 1.6 9.3 0.7 2.2 11.5 1.4 21.9 5.0 24.8 11.0 1.3 3.0 12.8 25.8 13.9 33.8 28.9 13.6 12.5 24.0 11.7 10.0 14.3 13.6 27.7 11.1 35.8 9.0 7.0 18.9 14.2 10.4 0.5 36.2 15.9 1.5 1.0 19.4 13.8 3.5 15.3 14.9 15.4 30.6 29.5 9.9 17.6 15.8 12.8 14.2 7.3 19.5 25.4 19.2 8.8 10.6 20.1 9.0 23.6 6.2 9.4 10.3 10.4 14.5 9.3 22.1 49.2 17.4 34.0 13.4 21.1 32.2 9.7 16.8 18.6 3.7 0.7 2.8 2.2 0.6 2.0 7.9 3.7 4.3 0.3 5.7 2.4 2.4 9.3 2.2 0.5 1.6 11.5 1.4 0.8 0.8 0.7 0.9 0.6 0.4 0.6 0.8 1.1 0.6 0.0 1.1 3.7 0.8 2.1 0.0 17.3 0.0 1.4 3.4 0.0 0.0 1.7 0.0 0.9 9.7 0.3 0.2 23.3 0.3 20.1 1.9 0.1 0.0 0.0 9.3 0.0 0.0 6.2 2.5 3.6 6.9 2.2 0.0 0.0 0.9 0.0 0.2 0.0 21.9 0.1 0.0 19.4 3.1 84.6 25.0 0.5 1.7 6.9 2.3 0.9 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "Neural precursor cell expressed, developmentally down-regulated 1" Q8NHV4 12 96907223-96953777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 165.2;Late spermatids: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Plasma membrane" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.94e-4)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 10.7 6.2 5.7 10.0 6.6 9.8 9.8 2.5 7.1 10.8 9.3 7.1 1.7 4.9 13.5 8.3 11.6 10.0 5.5 8.3 6.0 4.4 12.6 5.4 9.4 10.3 7.0 3.7 13.3 7.7 14.9 13.5 7.9 6.5 11.9 7.2 6.3 8.5 6.3 25.5 7.8 10.3 15.4 8.4 14.5 7.2 17.8 8.3 30.6 11.9 24.3 10.7 15.1 9.6 9.4 5.9 19.9 11.1 15.6 14.0 7.3 13.7 9.1 15.8 9.6 7.8 7.1 11.2 47.8 17.0 22.1 19.1 6.0 5.1 8.5 4.6 38.2 10.3 12.4 10.6 11.0 29.8 16.3 9.1 10.6 6.0 5.3 6.5 14.4 9.6 5.2 9.1 13.4 10.4 14.6 10.8 14.7 6.1 6.3 15.8 5.6 26.2 6.6 8.7 7.2 29.2 13.9 16.0 8.4 9.0 9.0 4.9 8.7 13.4 7.6 8.3 12.9 10.2 5.1 7.7 13.9 10.7 9.9 11.2 6.2 7.5 11.4 4.3 7.3 16.8 10.0 6.9 19.9 12.1 11.1 13.7 9.4 13.4 12.9 5.9 8.1 14.0 10.9 5.4 15.6 7.8 4.6 14.0 7.3 5.7 6.6 2.5 7.1 6.0 4.4 7.0 3.7 6.5 8.3 8.9 8.6 11.3 24.7 17.2 8.1 8.9 7.6 25.4 15.9 15.7 0.0 7.5 8.3 8.1 165.2 9.1 5.3 0.0 7.0 11.4 8.4 20.9 16.1 4.9 7.5 17.5 5.8 12.3 4.3 65.3 11.5 9.3 6.8 3.6 7.0 12.9 6.8 7.0 9.6 10.5 8.4 19.4 8.2 26.7 24.6 12.3 3.3 18.1 6.6 16.3 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0;testis: 41.0" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Not detected" "Not detected" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: AB_2685393" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (9.47e-6)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 1.1 0.7 0.6 6.7 0.5 7.4 1.3 0.3 0.9 0.9 2.5 0.3 0.3 3.4 0.3 1.2 4.2 0.7 1.4 0.9 1.0 0.3 0.6 0.6 1.0 3.9 0.3 0.3 0.6 0.3 0.0 0.3 1.2 0.4 0.9 3.6 0.4 1.0 0.3 0.3 1.8 3.0 0.6 0.6 1.6 1.1 41.0 0.4 14.0 0.3 1.5 4.8 0.6 1.6 1.8 0.9 2.7 0.5 3.9 4.3 0.9 30.7 22.2 17.0 12.2 1.0 1.7 18.8 11.9 11.2 21.0 18.1 11.8 30.3 16.4 5.7 9.2 13.3 16.5 14.8 8.9 26.5 25.0 12.3 7.8 19.4 15.9 0.1 15.4 10.7 0.5 1.1 16.1 17.4 5.1 13.5 16.7 21.4 28.8 21.0 8.6 16.8 10.4 16.1 19.9 11.4 16.6 26.1 24.9 7.3 8.8 15.4 17.1 17.2 19.2 14.9 15.2 29.6 9.2 7.0 10.5 20.8 20.6 31.9 11.9 22.0 21.7 9.1 11.9 17.4 2.7 0.5 0.4 0.5 0.3 0.2 1.5 0.6 0.3 0.1 1.8 1.1 0.7 2.4 3.9 0.4 0.9 4.3 0.9 0.6 0.5 0.3 0.9 1.0 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.8 0.5 2.6 0.7 0.4 0.0 2.7 3.4 0.0 0.0 0.9 0.0 0.1 44.4 0.1 1.1 93.5 0.2 11.4 0.2 0.3 0.0 0.0 4.7 3.2 0.0 2.5 2.8 28.5 2.3 1.1 0.0 0.0 1.2 0.8 0.0 0.8 0.7 0.0 1.9 6.5 0.0 191.1 25.4 1.5 1.1 0.7 2.3 0.9 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Group enriched" "Detected in all" 13 "Early spermatids: 932.5;Late spermatids: 859.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA063734: AB_2685107" "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.1 10.2 1.5 3.6 1.5 0.9 4.8 5.5 2.2 3.0 3.4 7.2 4.4 9.0 6.2 1.2 2.8 4.5 3.8 2.7 0.9 27.5 4.9 6.0 1.9 4.1 5.3 6.9 12.8 1.2 3.0 3.3 4.2 0.8 1.6 6.7 7.0 8.3 1.1 5.3 8.5 6.8 5.1 6.9 4.2 12.0 6.3 8.2 1.4 3.2 8.9 5.3 3.5 5.1 3.9 0.9 3.0 5.9 3.9 5.1 6.5 8.7 8.4 17.3 15.3 19.2 3.3 7.2 6.2 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 8.9 22.4 22.8 35.7 28.0 10.9 6.5 10.2 4.0 11.4 12.2 3.9 24.4 6.6 26.6 932.5 20.4 53.1 23.3 27.0 21.6 13.5 31.8 66.8 18.7 21.9 23.8 21.2 8.0 14.6 859.8 12.7 18.6 16.9 37.9 17.0 13.0 38.2 17.5 14.2 19.2 11.5 19.4 18.9 20.1 14.9 21.1 49.4 29.9 18.2 31.5 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome" NA NA Centrosome "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA005939: AB_2667474, HPA070691: AB_2686296" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 13.0 6.1 15.1 24.9 10.3 34.8 9.7 12.6 14.0 8.0 9.2 7.6 4.5 5.0 11.8 6.1 11.8 8.2 7.6 16.4 11.7 4.9 6.7 5.2 10.7 30.2 7.6 10.0 11.0 5.4 9.1 12.3 20.2 7.1 6.5 7.7 6.2 8.2 5.1 16.9 10.9 8.3 12.0 7.1 18.2 9.3 4.6 9.0 16.4 7.8 5.1 25.8 11.7 10.3 6.8 6.3 18.4 2.3 1.5 6.0 1.3 12.3 8.7 18.3 15.5 7.0 11.4 7.6 10.6 9.1 8.9 7.5 5.6 6.6 29.1 7.3 14.3 8.5 13.0 14.7 6.7 18.9 14.0 4.5 10.7 5.4 5.3 4.1 18.6 30.9 7.8 5.4 15.7 6.4 5.3 14.2 15.1 2.6 11.9 13.5 13.5 14.1 7.5 2.5 3.9 9.7 16.0 33.8 2.1 8.0 14.0 8.5 9.6 13.3 4.0 11.4 4.2 7.6 16.6 20.7 22.8 31.7 8.7 11.7 9.6 4.8 20.1 5.9 15.2 12.3 12.6 2.3 18.4 3.3 1.7 3.5 6.8 2.2 6.0 1.5 5.5 4.4 3.8 8.3 1.5 1.5 6.3 1.9 1.3 15.1 10.3 12.6 14.0 11.7 4.9 7.6 10.0 7.1 9.0 6.0 7.7 41.0 7.0 16.4 7.5 37.9 12.7 26.8 36.4 10.4 58.9 9.2 3.3 6.9 22.3 24.1 4.1 0.0 3.5 8.9 27.9 13.0 30.1 3.9 20.1 6.4 12.1 27.0 40.6 7.8 7.8 47.2 21.9 12.6 3.9 87.7 4.7 5.8 8.9 5.1 18.0 32.3 20.8 0.0 0.4 18.3 8.1 37.4 4.6 14.5 NIT2 ENSG00000114021 "Nitrilase family member 2" Q9NQR4 3 100334701-100361635 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 41.1" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036999, HPA041289" Approved Supported Centrosome,Cytosol NA NA 960000 Cytosol Centrosome "HPA036999: AB_10672105, HPA041289: " "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.06e-3)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.28e-2)" "unprognostic (2.10e-1)" "unprognostic (4.56e-1)" "unprognostic (1.12e-1)" "unprognostic (6.60e-3)" "unprognostic (2.21e-1)" "unprognostic (6.68e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (8.26e-2)" "unprognostic (1.47e-3)" 9.9 7.4 6.7 5.4 9.9 5.9 12.4 3.7 10.5 6.4 7.2 6.1 10.6 5.5 6.6 13.3 9.2 7.9 7.1 7.4 5.8 6.3 29.8 41.1 5.6 8.9 5.9 8.0 7.2 8.5 4.7 7.6 4.9 7.7 7.2 6.8 11.3 8.2 10.2 14.7 7.7 5.3 7.0 5.4 5.7 6.8 3.3 3.3 4.4 10.8 14.5 10.5 8.2 5.6 4.2 5.9 1.5 2.4 3.0 4.3 1.3 9.9 9.9 1.2 5.2 8.9 12.1 6.2 4.1 6.1 9.7 9.3 8.4 11.2 10.0 6.2 5.9 4.2 7.5 4.5 11.0 11.6 3.1 2.3 7.2 3.2 4.3 10.9 4.7 4.9 7.6 16.8 5.2 8.5 5.1 6.2 5.7 3.3 8.1 11.8 9.5 3.1 4.3 4.4 12.5 15.1 3.5 4.2 9.8 16.0 6.3 6.9 3.2 5.6 9.6 6.1 3.3 7.1 4.5 4.5 6.1 2.5 2.9 3.5 5.0 5.5 8.5 9.6 8.0 7.7 0.4 2.4 1.1 3.3 2.1 4.3 4.2 3.1 2.5 5.9 3.7 3.6 3.5 1.5 3.0 1.6 1.8 3.1 1.3 6.7 9.9 3.7 10.5 5.8 6.3 5.9 8.0 7.7 3.3 11.9 12.1 26.5 41.3 29.0 11.3 49.4 30.6 38.8 26.1 55.8 15.7 80.0 159.2 63.8 2.3 15.5 14.9 0.0 46.2 64.1 34.7 40.0 20.7 147.3 56.1 12.7 23.1 16.0 18.8 2.4 40.9 33.3 47.2 136.1 20.8 11.7 55.0 25.7 35.3 436.2 23.6 38.8 46.4 1.5 14.5 36.4 49.5 26.2 34.7 40.6 NLRC5 "CLR16.1, FLJ21709, NOD27" ENSG00000140853 "NLR family CARD domain containing 5" Q86WI3 16 56989485-57083531 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 22.9;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 41.5;NB-4: 22.8;U-2197: 15.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA060405, HPA074724" Supported Centrosome,Cytosol NA NA Cytosol Centrosome "HPA060405: AB_2684277, HPA074724: " "unprognostic (9.66e-2)" "prognostic favorable (9.69e-4)" "unprognostic (1.64e-2)" "unprognostic (1.23e-2)" "unprognostic (3.12e-1)" "unprognostic (9.27e-3)" "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "unprognostic (2.24e-2)" "prognostic favorable (2.30e-4)" "unprognostic (2.69e-1)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (2.99e-2)" "unprognostic (3.91e-2)" "unprognostic (5.06e-2)" "unprognostic (2.75e-3)" 10.0 5.7 3.4 26.4 7.0 24.9 6.0 1.6 6.2 5.4 7.0 4.2 2.9 4.9 10.8 4.4 6.4 4.9 8.9 3.7 4.3 2.4 5.5 5.5 12.8 21.3 7.0 2.0 3.9 3.6 2.1 20.2 2.3 6.0 5.2 5.6 4.7 8.9 3.0 3.5 10.9 16.1 5.8 7.8 24.6 7.2 1.3 6.3 9.4 5.9 6.6 29.7 7.3 7.0 5.4 1.7 13.2 4.0 2.7 7.0 2.7 4.9 0.9 0.1 0.3 0.3 1.7 0.0 2.7 4.3 8.8 8.6 0.0 8.6 10.1 2.1 4.5 3.5 3.3 1.1 0.3 1.0 0.4 0.3 41.5 8.8 1.0 3.1 1.4 2.5 3.3 0.1 7.1 0.8 2.8 3.4 1.4 0.0 2.0 1.8 0.1 2.2 22.8 0.0 0.1 0.9 10.8 3.1 4.2 1.0 0.4 0.3 0.3 5.6 0.5 1.2 0.0 0.6 5.5 4.3 4.2 1.5 15.4 2.2 4.1 2.1 10.3 7.5 3.1 0.8 6.4 4.0 13.2 7.0 2.2 4.2 5.4 4.0 6.6 1.7 3.1 2.6 2.7 9.8 2.7 2.5 1.3 4.6 2.7 3.4 7.0 1.6 6.2 4.3 2.4 7.0 2.0 6.0 6.3 0.0 15.7 22.9 0.8 6.1 0.4 3.1 0.0 2.7 5.7 5.2 0.0 0.0 0.0 5.5 0.4 10.5 19.1 0.0 7.2 0.1 2.8 1.7 9.2 3.9 4.4 0.0 8.1 9.8 17.0 0.0 0.9 7.3 0.0 6.4 10.5 0.3 6.9 10.5 0.4 0.6 1.3 0.0 5.7 0.0 0.0 8.7 0.1 30.5 9.0 3.8 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.9;Karpas-707: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA049795: AB_2680886" "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favorable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favorable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 15.5 7.7 11.1 15.9 10.7 6.9 14.3 21.5 14.6 13.2 15.2 5.8 20.1 12.2 8.1 15.6 24.6 9.4 10.9 9.4 10.2 9.7 22.1 40.3 15.4 19.9 10.8 9.7 15.2 30.6 45.8 18.1 19.7 10.2 15.9 10.3 10.9 29.5 17.7 15.0 15.6 26.6 8.3 8.7 18.8 13.6 6.7 8.9 14.4 31.6 11.2 22.0 12.6 14.8 6.7 8.8 7.3 6.7 8.2 24.2 10.1 5.1 1.1 1.5 3.5 12.2 16.5 8.3 7.5 11.8 1.9 3.1 0.0 13.6 3.0 4.5 7.2 3.6 9.0 1.7 5.0 6.0 29.9 1.8 2.1 2.4 2.6 10.9 2.0 0.4 11.4 12.9 3.1 6.4 11.4 13.0 5.2 0.2 36.8 13.2 3.8 1.9 1.8 1.9 19.4 4.7 0.6 13.5 19.3 15.3 9.2 1.0 0.2 3.2 3.3 4.2 10.3 8.5 2.2 8.9 6.5 1.2 5.9 2.0 16.3 13.0 1.8 10.6 2.2 6.6 7.3 2.7 4.5 13.9 2.5 16.7 6.7 24.2 16.0 3.1 3.9 22.1 16.7 5.2 8.2 6.7 8.8 15.4 10.1 11.1 10.7 21.5 14.6 10.2 9.7 10.8 9.7 10.2 8.9 35.7 17.1 17.1 33.3 18.7 8.5 15.1 15.3 20.1 22.7 22.7 7.9 52.7 44.7 25.5 14.0 20.7 33.3 0.0 31.3 65.3 17.5 21.3 1.1 34.4 51.6 11.1 4.1 39.3 19.7 24.5 21.9 10.5 25.3 102.8 28.0 9.6 23.2 24.6 11.7 75.6 7.6 12.9 15.2 6.6 3.8 23.6 38.1 29.9 22.4 26.0 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617297-98629868 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7" "Group enriched" "Detected in many" 6 "Peritubular cells: 306.6;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 128.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" NA NA 2490000 320000 "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 4.3 24.0 7.1 2.3 8.4 1.0 1.4 0.2 45.6 8.2 3.8 3.2 0.1 1.1 1.8 3.9 2.2 1.5 1.6 3.2 9.2 11.0 0.9 0.9 0.8 0.7 9.4 2.2 1.5 19.5 0.8 71.6 0.8 7.0 2.1 1.4 1.3 1.5 2.2 2.9 4.0 1.3 2.9 2.9 6.1 1.9 20.7 5.0 0.0 1.6 0.1 0.9 1.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 7.1 8.4 0.2 24.6 9.2 11.0 9.4 2.2 7.0 5.0 0.0 1.1 0.0 0.4 3.4 17.7 2.8 5.1 0.0 2.3 0.0 3.9 0.0 0.0 5.8 9.7 2.9 2.4 0.0 11.0 0.2 6.2 3.2 0.0 0.2 0.4 0.0 15.3 6.2 0.0 19.9 13.0 0.0 11.8 0.0 0.0 0.8 4.7 0.0 306.6 0.0 2.4 148.8 3.8 14.0 40.1 2.6 0.1 0.0 0.4 0.5 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.3 0.8 0.1 0.1 47.8 0.1 0.4 0.3 0.5 11.0 1.2 2.1 0.4 0.0 1.6 1.1 0.6 0.5 0.7 0.5 2.0 1.7 1.8 10.7 0.0 1.0 3.1 0.0 0.6 0.5 0.7 0.1 0.1 0.5 14.1 0.3 0.2 0.2 0.0 1.3 17.0 0.5 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 9.8 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.3 1.9 0.3 1.0 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 0.0 7.7 0.0 15.1 33.2 2.8 1.4 10.2 4.0 4.5 5.2 27.5 30.8 1.7 7.9 43.0 2.7 13.2 0.0 3.1 112.0 3.0 14.2 1.1 5.5 7.1 1.6 4.6 1.3 1.8 22.4 1.1 4.6 8.5 5.4 6.7 8.0 2.3 7.0 1.8 1.9 10.5 0.0 2.1 68.9 111.8 34.8 25.6 0.0 13.0 11.9 NUDT17 FLJ34433 ENSG00000186364 "Nudix hydrolase 17" P0C025 1 145845629-145848953 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 9.0;Spermatogonia: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 8 "dendritic cells: 18.4;granulocytes: 11.5" "Cell line enhanced" "Detected in many" "T-47d: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030145 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA030145: AB_10603883" "unprognostic (8.93e-3)" "unprognostic (2.28e-1)" "unprognostic (2.63e-3)" "unprognostic (8.72e-3)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.07e-3)" "unprognostic (6.55e-2)" "unprognostic (6.03e-2)" "unprognostic (1.24e-2)" "unprognostic (5.40e-2)" "prognostic unfavorable (1.81e-7)" "unprognostic (5.59e-2)" "unprognostic (1.63e-1)" "unprognostic (6.16e-2)" "unprognostic (1.96e-1)" 4.6 3.3 8.3 3.9 13.5 6.7 4.9 8.9 10.9 3.8 3.4 5.1 1.5 1.2 4.6 3.1 3.5 7.0 4.4 8.4 6.6 7.7 3.8 2.6 3.4 9.0 5.9 8.1 6.8 6.2 6.2 4.7 2.2 5.4 4.2 2.9 8.0 6.3 5.8 6.7 4.3 3.3 11.1 5.5 6.0 3.3 7.1 2.2 3.5 5.7 3.4 7.7 4.1 3.2 0.9 18.4 11.5 1.8 0.2 1.1 0.7 4.2 3.1 2.9 1.6 1.6 2.4 2.9 2.0 3.4 2.1 3.0 1.9 3.1 6.2 2.2 3.5 0.5 0.8 2.1 1.2 1.4 0.7 3.6 2.4 2.5 2.8 4.7 1.9 8.0 2.5 2.0 1.4 2.4 2.7 4.2 10.1 5.2 5.8 3.8 6.7 2.1 3.6 2.4 2.6 0.3 5.4 1.1 1.9 3.3 1.0 1.4 3.2 1.3 2.6 3.5 3.1 14.5 8.6 2.5 2.5 1.7 1.2 0.8 5.1 2.4 1.5 2.4 2.6 1.9 5.8 0.6 11.5 0.6 1.8 0.4 0.9 0.5 0.3 0.6 0.6 1.1 0.8 0.1 0.2 1.1 18.4 0.5 0.7 8.3 13.5 8.9 10.9 6.6 7.7 5.9 8.1 5.4 2.2 3.0 5.6 0.0 0.9 1.5 1.9 0.4 0.0 2.7 4.5 0.0 0.0 0.4 1.7 1.2 2.9 1.0 0.7 0.0 0.6 0.6 1.9 0.9 2.3 0.6 2.6 0.0 1.2 2.5 0.8 1.3 1.4 1.2 1.7 0.0 0.2 9.0 1.2 0.6 0.4 0.6 3.9 0.0 1.4 6.9 11.7 1.1 0.5 1.3 1.2 0.7 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165325-12196144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA 660000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavorable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 19.6 22.0 17.4 18.6 21.2 13.5 20.2 15.4 21.4 16.7 20.4 16.1 15.2 17.3 10.0 16.5 25.8 16.3 12.1 10.0 16.2 14.3 26.0 57.1 16.8 22.7 21.7 12.8 12.5 16.9 19.1 35.7 19.9 18.5 13.4 24.2 13.2 16.7 19.7 5.1 20.6 15.9 11.6 17.9 22.4 14.1 8.0 21.5 28.2 19.1 16.5 29.5 16.2 18.6 22.4 45.9 50.1 19.5 16.2 37.0 20.4 35.6 26.3 31.5 29.3 30.5 30.2 27.9 26.4 16.9 31.1 33.4 37.7 34.1 35.7 23.0 21.4 19.5 35.9 43.9 40.9 28.7 29.2 42.9 29.7 32.3 55.4 31.8 19.7 20.9 31.7 24.5 33.9 17.3 24.1 39.7 57.2 39.7 24.4 28.3 32.7 36.8 23.1 27.4 57.3 16.4 33.7 11.4 41.4 29.1 12.3 15.2 22.8 32.0 24.7 36.7 38.5 42.3 20.3 24.8 13.3 25.5 37.0 32.3 20.6 36.2 48.0 27.9 25.7 9.8 8.1 19.1 33.5 22.8 19.5 26.2 22.4 24.6 26.8 27.0 18.3 17.0 23.0 50.1 16.2 14.8 45.9 37.0 20.4 17.4 21.2 15.4 21.4 16.2 14.3 21.7 12.8 18.5 21.5 23.8 37.8 33.5 51.1 38.1 19.2 2.8 25.5 60.2 39.8 22.7 15.7 73.5 63.0 74.1 27.1 31.4 34.2 23.3 72.2 127.8 35.8 30.5 31.1 116.5 105.0 20.6 36.8 40.5 41.3 6.6 36.5 39.3 28.7 110.0 34.5 32.9 64.5 28.1 27.3 95.7 22.5 32.3 25.6 20.2 27.5 52.9 48.6 51.7 51.0 40.6 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686734-68745809 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 18.3 12.6 10.2 16.5 13.2 18.7 17.4 20.7 15.2 19.0 12.2 12.1 12.2 9.2 18.6 18.0 14.0 16.6 8.5 12.1 12.2 6.6 12.1 11.1 12.5 21.4 13.2 10.2 19.8 12.5 14.2 16.2 23.5 12.2 12.6 15.3 11.3 13.0 11.8 13.9 14.8 15.8 13.7 12.5 19.7 12.0 20.5 15.9 40.6 12.5 13.1 22.5 17.8 13.1 13.6 7.0 9.5 14.2 20.6 17.0 8.0 17.1 22.1 26.4 19.1 7.8 10.0 28.6 18.8 10.9 28.3 23.7 22.2 14.6 31.5 18.4 9.0 12.6 19.8 29.6 13.9 37.9 29.5 22.0 35.9 15.9 18.7 4.9 31.6 12.2 5.3 6.6 22.6 14.8 9.9 16.9 18.3 42.8 22.7 17.7 20.8 26.0 27.6 29.0 6.6 21.7 26.6 31.8 18.9 12.2 18.3 15.6 16.0 20.8 15.7 11.3 21.5 23.5 15.3 10.3 15.5 15.8 18.0 22.9 9.9 19.8 38.2 11.9 23.1 18.2 6.3 6.5 9.5 13.1 8.5 17.0 13.5 13.0 14.0 7.0 13.6 16.2 14.5 1.7 20.6 14.2 5.5 13.4 8.0 10.2 13.2 20.7 15.2 12.2 6.6 13.2 10.2 12.2 15.9 11.9 15.3 27.4 14.6 15.3 20.5 11.3 12.7 20.1 14.8 8.7 17.7 24.8 10.0 15.4 26.7 16.1 8.4 0.0 15.4 25.3 16.3 13.0 15.1 6.7 15.5 12.7 8.2 17.8 11.1 7.1 35.9 19.8 18.6 27.9 11.3 22.6 17.1 7.0 20.5 5.8 31.5 12.9 14.6 52.6 42.8 15.4 11.8 25.9 13.0 10.0 OAS2 ENSG00000111335 "2'-5'-oligoadenylate synthetase 2" P29728 12 112978395-113011723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 14.9;Endothelial cells: 14.3;Hofbauer cells: 15.1;Kupffer cells: 16.2;Macrophages: 15.1;T-cells: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;SK-MEL-30: 28.2;U-266/70: 26.3;U-266/84: 22.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA003320, CAB024984" Approved Approved Centrosome NA NA Centrosome "CAB024984: , HPA003320: " "unprognostic (2.39e-1)" "unprognostic (9.51e-2)" "unprognostic (2.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.34e-1)" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (7.64e-3)" "prognostic unfavorable (4.63e-4)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.94e-2)" 37.9 3.8 4.0 13.9 5.1 9.0 7.2 1.8 4.9 8.5 4.3 7.5 1.2 4.6 9.0 6.9 13.2 3.9 9.6 6.9 3.8 4.4 8.8 9.9 15.6 24.1 5.0 3.7 3.9 1.9 1.2 2.9 22.2 7.3 6.6 4.7 6.9 32.9 1.8 2.2 2.9 8.8 6.4 7.1 36.6 9.7 2.2 3.0 32.4 9.8 8.2 27.4 13.7 5.4 12.0 12.7 2.0 26.8 15.1 17.4 13.2 0.7 0.1 0.0 0.0 0.4 2.6 0.0 0.1 8.2 72.2 58.9 0.1 1.2 18.2 1.8 1.5 16.2 0.8 0.1 0.2 2.5 4.5 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 1.3 4.1 0.0 0.0 1.1 0.9 0.0 9.5 0.0 0.3 0.5 1.0 0.0 0.1 2.6 3.9 0.0 2.7 0.0 6.5 0.0 0.0 0.7 0.2 28.2 0.0 0.6 1.1 1.8 0.1 0.0 0.3 0.0 26.3 22.6 2.8 0.6 0.9 0.7 2.0 15.9 1.2 13.4 26.8 16.8 12.0 15.4 15.2 12.7 8.9 15.2 11.2 1.8 15.1 26.0 5.3 17.4 13.2 4.0 5.1 1.8 4.9 3.8 4.4 5.0 3.7 7.3 3.0 3.0 8.9 14.9 1.5 1.8 0.0 1.4 0.0 8.1 3.4 1.8 0.0 0.1 0.0 1.0 0.6 14.3 0.3 0.0 1.0 2.1 2.1 2.4 1.1 1.8 15.1 0.0 0.0 11.1 16.2 0.7 0.6 15.1 5.0 3.6 3.1 0.5 2.3 0.2 3.2 0.0 0.1 0.0 1.0 0.0 0.1 1.0 0.1 13.8 0.1 7.7 OBSL1 KIAA0657 ENSG00000124006 "Obscurin like 1" O75147 2 219550729-219571859 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 82.2" "Group enriched" "Detected in many" 4 "Early spermatids: 829.2;Late spermatids: 1255.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.8;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 10 "dendritic cells: 2.7;granulocytes: 6.8" "Cell line enhanced" "Detected in many" "BEWO: 45.0;SK-BR-3: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036404, HPA036405" Approved Approved Centrosome NA NA Centrosome "HPA036404: AB_10670437, HPA036405: AB_2675104" "unprognostic (2.36e-1)" "unprognostic (6.79e-2)" "unprognostic (3.86e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.27e-3)" "unprognostic (2.89e-2)" "unprognostic (9.89e-2)" "unprognostic (4.22e-3)" "unprognostic (1.25e-1)" "unprognostic (4.21e-3)" "unprognostic (7.00e-2)" "unprognostic (3.95e-2)" "unprognostic (3.62e-2)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (2.16e-1)" 10.7 26.9 13.4 7.0 11.5 1.2 11.7 18.0 16.2 17.6 8.7 10.3 10.5 3.8 18.2 23.3 7.3 19.9 14.5 30.7 12.8 8.2 19.6 14.5 9.3 3.4 5.5 10.9 82.2 35.6 23.5 16.6 19.3 11.5 15.1 2.3 19.1 25.5 19.1 21.0 14.8 4.8 10.5 8.8 8.2 10.3 15.5 11.5 0.8 34.1 12.4 2.6 10.1 12.1 0.1 2.7 6.8 0.4 0.1 0.2 0.0 9.5 6.4 11.9 24.7 8.2 6.1 45.0 7.2 10.6 9.2 8.5 5.6 14.9 0.0 15.3 9.8 8.9 9.8 9.2 5.4 1.9 0.0 16.1 20.7 6.2 28.3 6.2 0.5 0.1 16.5 4.5 2.1 3.5 16.4 1.0 0.0 8.5 0.2 6.5 23.6 0.0 5.9 28.2 2.7 6.6 10.6 10.4 0.0 16.6 9.0 5.2 17.8 8.2 43.7 16.4 31.4 4.0 17.9 2.4 9.8 10.6 3.0 2.8 0.0 0.0 0.0 5.7 0.0 9.7 6.8 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.8 0.1 0.4 2.7 0.0 0.0 13.4 11.5 18.0 16.2 12.8 8.2 5.5 10.9 11.5 11.5 8.9 14.8 0.0 19.2 7.4 33.3 45.9 25.5 8.1 10.3 50.6 2.0 55.5 44.7 13.5 829.2 12.0 2.0 0.0 10.7 57.4 14.5 10.9 4.6 13.9 6.6 39.7 19.7 10.4 1.0 1255.6 71.4 3.2 13.5 1.0 3.1 79.6 9.7 2.5 69.6 15.4 9.5 12.9 17.5 239.3 51.1 5.8 72.3 0.0 2.3 7.8 ODF2 "CT134, ODF84" ENSG00000136811 "Outer dense fiber of sperm tails 2" Q5BJF6 9 128455186-128501292 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 101.1" "Group enriched" "Detected in all" 22 "Early spermatids: 1694.9;Late spermatids: 5811.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001874, HPA048841" Enhanced Supported Centrosome NA NA Centrosome "HPA001874: AB_1079522, HPA048841: AB_2680536" "unprognostic (4.54e-3)" "unprognostic (9.91e-2)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (6.11e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-1)" "unprognostic (1.79e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.93e-2)" "unprognostic (9.23e-3)" "unprognostic (1.47e-1)" "unprognostic (1.62e-1)" "unprognostic (7.65e-2)" 6.2 4.8 5.6 9.9 6.7 10.2 7.0 14.3 7.7 7.1 5.7 6.7 5.4 4.0 9.7 6.4 5.2 8.8 5.7 5.7 6.3 5.1 4.7 6.7 5.8 8.9 6.2 4.1 6.4 5.1 7.6 18.2 6.0 7.5 6.6 6.0 5.4 5.3 8.3 3.7 7.2 5.3 8.0 5.2 7.3 5.7 101.1 7.1 18.4 5.5 3.7 9.6 6.4 6.4 8.3 8.8 16.0 16.3 11.0 14.6 9.1 14.7 17.9 29.9 34.0 11.9 14.3 24.1 24.9 11.7 20.7 10.9 17.6 10.9 26.5 9.4 20.2 16.1 38.8 21.8 14.8 21.1 17.5 10.1 23.5 27.2 14.7 6.9 25.4 29.8 11.8 9.4 22.0 15.6 12.9 18.0 20.3 27.7 14.9 19.5 45.2 26.9 31.1 11.6 30.3 12.9 24.7 28.8 20.5 10.8 11.5 18.0 15.4 23.3 22.3 8.1 14.1 20.8 18.5 17.1 25.9 16.0 29.7 24.1 28.0 40.3 19.1 11.8 23.2 22.4 16.0 8.9 9.8 12.4 13.4 14.6 8.3 10.9 12.9 8.8 8.2 7.9 10.0 3.1 11.0 16.3 8.4 8.0 9.1 5.6 6.7 14.3 7.7 6.3 5.1 6.2 4.1 7.5 7.1 6.0 5.0 9.0 13.5 14.8 8.2 8.9 10.2 46.8 9.1 7.0 9.8 10.4 10.0 9.2 1694.9 15.1 3.2 46.7 7.8 14.2 11.0 11.6 18.5 9.6 10.8 7.9 3.5 8.0 10.2 5811.6 39.4 10.0 10.1 9.0 8.2 6.5 7.1 2.9 31.8 5.9 8.2 12.9 13.9 171.1 48.6 11.5 27.8 12.5 6.6 11.8 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.9" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 PAFAH1B1 "LIS1, MDCR, MDS, NudF, PAFAH" ENSG00000007168 "Platelet activating factor acetylhydrolase 1b regulatory subunit 1" P43034 17 2593210-2685615 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport" "Developmental protein" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 520.4;Late spermatids: 1375.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004489, HPA020036" Approved Supported Centrosome NA NA 1100000 Centrosome "CAB004489: AB_627889, HPA020036: AB_1854925" "unprognostic (1.54e-3)" "unprognostic (6.84e-2)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (2.13e-1)" "unprognostic (3.19e-3)" "unprognostic (3.17e-2)" "unprognostic (6.36e-2)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" "unprognostic (3.89e-3)" "unprognostic (5.80e-2)" "prognostic favorable (3.16e-4)" "unprognostic (3.31e-1)" "unprognostic (3.51e-1)" "unprognostic (7.45e-2)" "unprognostic (5.58e-2)" 20.1 20.4 35.6 17.0 40.8 10.0 20.8 57.1 63.7 22.3 21.5 24.2 13.8 19.2 23.8 21.1 21.9 20.1 19.6 28.8 33.7 38.3 24.7 17.2 23.0 18.2 34.3 47.0 22.4 16.4 37.5 26.2 20.2 46.5 20.9 20.9 14.8 17.6 24.1 41.6 27.2 21.9 27.2 29.9 17.9 19.3 37.2 28.0 25.9 26.9 17.3 22.8 18.6 25.5 7.5 3.5 9.3 5.3 8.7 13.3 3.9 22.5 21.5 33.3 12.3 26.2 31.0 17.3 31.4 27.5 27.4 28.4 26.2 10.5 25.5 26.2 38.7 22.2 23.5 29.0 23.5 34.4 21.3 18.5 20.7 21.9 10.0 27.1 14.3 36.4 27.0 29.9 27.6 33.0 29.0 23.9 22.3 15.3 28.8 33.8 9.2 22.6 10.8 14.9 19.0 10.5 16.2 25.7 13.2 24.1 12.6 15.0 24.5 27.2 13.5 24.8 27.0 14.5 11.2 33.8 30.0 14.5 23.5 27.0 12.2 18.9 20.0 24.3 13.3 29.0 7.8 3.4 6.5 7.7 4.3 9.7 7.5 10.1 8.3 3.5 5.2 9.5 8.1 9.3 8.7 5.3 2.7 13.3 3.9 35.6 40.8 57.1 46.2 33.7 38.3 34.3 47.0 46.5 28.0 113.2 74.0 44.8 96.6 105.3 96.3 124.7 22.9 92.3 116.0 33.2 47.1 48.3 29.9 70.9 520.4 63.3 66.2 23.3 49.2 62.5 67.0 74.5 90.2 26.3 53.3 96.9 32.7 44.8 43.3 1375.7 59.2 66.4 54.0 88.4 38.4 60.1 76.0 63.1 53.4 41.6 60.4 45.3 76.8 129.3 79.2 115.8 108.4 59.8 34.4 107.5 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379234-133391694 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.7" "Group enriched" "Detected in many" 11 "Early spermatids: 115.5;Late spermatids: 346.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.4;K-562: 5.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 6.7 4.1 4.3 5.8 6.7 1.5 4.7 6.8 8.7 3.7 6.0 10.8 5.6 5.6 3.7 1.8 7.4 3.4 2.4 2.5 5.7 2.7 8.9 9.2 2.8 5.2 10.0 3.4 3.6 3.2 1.9 2.5 2.1 4.2 4.8 1.5 2.8 9.9 5.1 3.5 4.4 8.5 2.8 4.7 8.2 7.5 36.7 7.6 0.7 2.4 2.1 5.4 4.6 4.2 4.3 1.1 1.0 1.0 1.7 0.3 0.4 6.4 0.0 0.2 1.2 0.0 0.7 1.6 2.9 1.2 1.4 0.2 1.1 0.1 0.0 0.9 0.6 0.8 3.5 0.4 0.8 0.6 4.2 0.5 0.6 0.0 0.2 1.7 0.0 1.0 0.1 0.3 0.9 0.4 0.0 0.1 0.0 5.0 0.3 0.0 0.1 0.0 0.1 1.2 0.0 3.0 4.6 0.0 0.0 0.2 0.0 0.3 2.2 0.9 0.1 0.0 0.0 1.4 0.0 2.8 0.3 1.4 1.2 0.0 18.5 3.4 1.7 0.0 0.0 0.1 1.0 0.3 0.0 0.2 1.0 0.0 1.6 0.3 0.2 1.1 4.3 0.0 0.0 0.0 1.7 0.9 0.8 0.0 0.4 4.3 6.7 6.8 6.5 5.7 2.7 10.0 3.4 4.2 7.6 0.0 5.8 20.9 6.2 3.3 1.5 1.5 5.1 1.4 0.0 1.8 0.0 0.7 5.0 4.5 115.5 2.3 6.8 0.0 3.0 1.7 2.3 4.8 5.7 11.3 4.1 4.8 0.0 3.7 10.4 346.0 8.9 3.9 0.0 17.2 3.4 7.7 2.9 2.9 7.4 13.2 2.7 19.4 2.5 9.9 3.0 3.1 0.2 4.6 3.2 8.6 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Cell line enhanced" "Detected in many" "AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome NA NA 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.5 12.6 0.0 3.4 2.6 0.0 1.9 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.4 0.0 1.0 0.3 0.6 0.0 5.0 0.1 0.1 0.0 3.3 0.3 0.1 6.3 0.3 1.5 2.5 0.3 1.0 1.1 0.3 0.1 20.8 0.7 5.7 0.0 0.1 0.2 1.2 8.7 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.3 0.0 0.0 24.1 0.7 0.6 2.9 1.0 3.7 0.0 31.7 5.4 0.0 2.5 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 17.9 45.8 7.2 2.3 1.6 324.5 94.6 0.0 0.0 7.9 5.2 19.6 0.1 8.3 1.7 3.0 2.9 0.0 0.0 0.0 0.2 8.7 2.6 1.1 3.4 0.2 187.5 60.1 19.0 2.2 2.2 27.3 1.0 10.1 0.0 0.2 87.9 0.2 0.3 13.8 0.6 25.3 6.5 25.0 4.7 5.8 0.3 0.0 1.7 0.4 0.7 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364311-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.1;lymphoid tissue: 78.3" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 32.4;Extravillous trophoblasts: 120.0;Hofbauer cells: 92.8;Syncytiotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "T-reg: 24.2" "Lineage enriched" "Detected in many" 5 "T-cells: 24.2" "Low cell line specificity" "Detected in many" HPA047929 Supported Centrosome NA Yes Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.8 0.7 24.5 0.8 42.1 2.6 0.4 0.8 1.8 7.7 0.6 1.0 4.6 1.6 2.8 18.8 0.6 4.0 2.2 0.8 1.0 2.5 3.0 4.0 21.8 1.4 0.4 0.9 1.4 0.1 0.6 5.1 0.7 1.6 10.1 0.5 3.1 0.4 0.9 2.8 8.1 1.6 1.9 10.9 4.9 3.0 0.5 78.3 1.2 18.0 20.7 4.3 5.7 2.2 3.2 2.0 0.4 5.2 24.2 2.7 30.8 35.7 30.4 19.4 3.2 11.5 22.2 23.9 21.2 46.0 66.7 40.1 29.4 59.3 8.5 12.1 12.5 23.2 75.7 18.4 52.0 37.6 27.2 58.1 37.6 34.5 0.3 38.2 21.5 3.9 1.9 36.3 7.4 9.9 34.9 36.3 35.7 21.8 52.8 35.6 46.3 85.8 11.3 38.9 15.5 60.5 57.6 38.9 21.8 31.9 3.0 15.7 18.9 15.0 11.0 15.8 21.2 53.2 4.9 22.8 47.9 27.6 63.6 11.9 41.1 37.1 9.5 84.4 15.3 2.0 0.2 1.2 1.6 0.1 0.2 2.2 4.8 4.5 3.2 0.5 0.4 0.8 1.6 5.2 0.4 0.2 24.2 2.7 0.7 0.8 0.4 0.8 0.8 1.0 1.4 0.4 0.7 0.5 8.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 9.1 1.8 0.0 32.4 1.7 5.8 0.0 0.0 0.0 0.0 2.7 120.0 0.0 0.0 3.5 0.0 92.8 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 3.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 PCM1 PTC4 ENSG00000078674 "Pericentriolar material 1" Q15154 8 17922840-18029944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 451.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023370, HPA023374, CAB058695" Enhanced Enhanced "Nuclear membrane,Centrosome,Cytosol" NA NA Centrosome "Nuclear membrane, Cytosol" "CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073" "unprognostic (1.52e-2)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (3.35e-2)" "unprognostic (9.52e-2)" "unprognostic (1.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.74e-3)" "unprognostic (1.09e-1)" "unprognostic (2.26e-1)" "unprognostic (2.84e-1)" "unprognostic (2.83e-1)" "unprognostic (1.76e-2)" "unprognostic (2.16e-1)" "unprognostic (4.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.45e-1)" 19.6 19.0 26.2 26.7 40.4 25.1 25.1 29.2 29.0 25.0 21.1 21.6 22.8 12.4 23.3 27.3 16.4 26.4 17.8 23.0 22.9 18.4 18.8 22.0 19.1 21.1 24.5 24.9 29.1 27.0 42.0 35.8 19.8 26.4 20.2 16.3 16.2 19.4 25.3 63.1 17.6 18.3 26.7 27.2 20.8 17.9 80.0 28.0 40.2 28.2 19.1 20.4 27.0 22.6 11.5 14.9 19.9 7.5 11.2 13.0 4.3 20.6 22.1 34.0 45.0 19.2 20.0 17.6 17.5 21.5 18.7 21.1 14.9 12.4 27.1 12.1 17.4 16.1 15.0 21.7 16.1 31.9 8.9 8.4 46.6 15.6 30.3 21.4 20.4 12.0 17.4 17.2 21.7 24.1 16.4 21.4 28.4 31.4 21.1 22.8 10.3 43.6 33.7 28.0 17.3 6.4 26.3 30.4 9.7 15.5 28.8 26.0 19.6 18.7 10.3 26.8 15.2 16.2 29.7 19.1 17.1 14.0 20.8 14.7 9.0 19.9 24.3 14.4 22.5 17.4 19.9 6.0 14.4 11.5 3.8 12.0 11.1 10.4 13.0 5.9 11.5 11.6 11.6 6.4 11.2 7.5 14.9 10.3 4.3 26.2 40.4 29.2 29.0 22.9 18.4 24.5 24.9 26.4 28.0 119.1 118.7 34.0 55.5 30.0 182.6 220.7 38.2 392.1 177.5 82.0 329.9 42.5 24.9 61.5 377.1 62.9 27.3 70.0 51.3 30.8 46.8 39.6 133.4 45.3 37.2 122.3 68.3 61.4 51.5 176.2 85.4 63.1 52.3 59.5 45.1 137.5 50.9 39.3 91.9 20.6 207.3 122.9 58.7 451.7 165.6 33.4 50.6 87.1 43.7 42.1 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324122-46445769 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 82.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 10.7" "Group enriched" "Detected in many" 6 "dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Enhanced Enhanced Centrosome NA NA Centrosome "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151" "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 4.7 4.7 16.6 6.9 20.4 12.6 3.6 8.3 16.5 3.2 4.0 4.4 3.8 3.7 3.7 4.1 5.1 3.4 5.0 8.2 12.0 4.2 3.2 4.4 4.3 6.4 7.0 9.7 4.9 3.3 5.9 8.0 3.4 5.6 4.0 4.1 2.0 4.1 4.1 82.3 10.4 4.0 4.2 4.3 5.5 4.6 14.5 9.7 9.1 4.4 2.2 4.8 4.7 5.1 0.4 5.3 4.9 1.2 0.5 10.7 2.3 9.3 7.4 11.4 7.0 5.7 5.8 7.2 7.2 5.0 7.2 6.5 8.9 6.1 9.3 4.7 8.2 9.9 6.7 9.2 6.3 5.0 27.3 12.9 24.8 13.8 6.8 2.0 12.5 10.3 3.1 4.8 9.7 4.8 3.5 5.5 10.1 12.5 14.2 9.9 15.5 12.3 12.9 11.3 8.5 5.1 15.3 4.7 8.2 5.6 10.1 14.0 6.2 15.7 9.8 4.7 2.9 9.3 9.8 7.5 13.0 6.6 7.4 11.5 12.2 10.2 10.1 8.1 12.3 7.0 4.9 0.8 1.3 2.0 0.6 5.9 0.4 0.9 5.9 2.3 0.2 0.7 10.7 0.5 0.5 1.2 5.3 0.9 2.3 16.6 20.4 8.3 16.5 12.0 4.2 7.0 9.7 5.6 9.7 26.8 33.0 4.5 5.0 7.3 11.2 30.0 12.7 17.4 22.7 0.0 5.9 4.4 0.0 5.7 17.8 6.0 6.4 0.0 6.6 6.7 5.4 3.8 15.1 8.2 18.3 22.3 15.0 7.4 7.5 19.3 11.8 11.4 0.0 15.4 6.6 3.9 5.0 6.5 11.3 3.7 10.2 25.8 7.1 43.2 42.2 6.1 5.4 10.0 8.1 4.9 PDE4C DPDE1 ENSG00000105650 "Phosphodiesterase 4C" Q08493 19 18208652-18248200 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 28.6" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 141.8;Paneth cells: 179.9;Undifferentiated cells: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.0;Hep G2: 4.0;U-87 MG: 9.0" "HPA048975, HPA054218" Approved Approved "Midbody ring,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (5.22e-4)" "unprognostic (1.44e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (4.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-3)" "unprognostic (2.21e-1)" "unprognostic (7.25e-10)" "unprognostic (2.73e-2)" "unprognostic (2.65e-1)" "unprognostic (9.21e-2)" "unprognostic (2.45e-2)" 2.0 1.3 1.8 1.5 2.8 1.0 2.0 0.8 6.1 4.1 4.4 1.5 3.1 1.5 6.4 6.8 1.3 4.2 5.6 4.2 1.6 1.9 4.1 2.0 4.1 0.5 1.7 5.1 2.0 0.8 0.3 3.5 7.0 2.8 5.8 1.3 2.5 1.3 5.4 13.4 0.6 4.1 3.4 0.7 2.3 5.2 2.6 1.1 0.4 1.2 28.6 0.7 1.8 3.3 1.3 0.6 3.5 0.7 1.0 0.7 0.2 0.1 0.3 0.2 0.3 0.1 0.3 6.0 0.1 0.0 0.2 0.3 1.2 0.2 0.2 0.6 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.4 4.0 0.2 0.2 0.6 0.7 0.1 2.6 0.0 0.5 0.0 0.3 0.9 2.1 0.1 0.4 0.2 0.3 0.2 0.4 0.2 0.2 0.3 0.4 0.1 0.2 0.2 0.8 0.3 0.5 0.0 1.6 0.5 0.3 0.0 0.4 0.2 0.7 0.1 1.3 0.6 0.2 9.0 0.2 0.3 3.4 0.7 1.0 0.6 0.4 0.5 0.5 0.5 0.4 0.2 1.3 0.5 0.7 3.5 1.0 0.4 0.6 0.3 0.2 1.8 2.8 0.8 6.1 1.6 1.9 1.7 5.1 2.8 1.1 3.0 8.8 0.0 2.2 4.8 3.0 28.1 5.1 0.0 1.2 0.0 5.9 1.9 0.0 0.0 29.1 3.6 141.8 0.0 0.0 3.5 4.2 1.8 4.6 0.0 0.4 0.0 6.9 1.3 2.2 26.0 0.6 1.1 1.7 0.0 34.4 2.7 0.0 179.9 3.9 0.0 3.3 45.3 13.4 1.9 1.9 3.3 0.9 0.0 66.4 18.4 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.4 0.0 0.0 1.8 0.0 5.4 9.1 2.2 1.3 0.1 0.2 0.0 0.2 4.0 0.2 0.1 0.0 13.8 0.6 0.0 0.0 6.7 0.2 0.3 10.4 0.0 0.0 5.4 0.0 3.1 0.7 0.5 24.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 39.2 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 0.0 5.6 0.0 0.0 0.8 1.3 5.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.1 26.3 0.0 23.3 0.3 0.1 5.1 0.1 1.1 0.0 0.4 0.0 1.7 34.4 1.3 1.9 41.1 0.4 5.0 0.0 1.0 0.3 0.9 0.0 33.6 0.0 0.2 25.8 14.6 0.7 1.1 1.0 0.2 0.0 0.0 0.1 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102073-34108684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 2.5 3.6 3.9 4.1 8.5 6.7 3.4 5.3 11.1 2.6 2.8 4.8 4.7 3.2 2.6 3.9 3.8 4.6 2.4 4.0 5.4 3.6 3.4 5.3 2.4 5.2 6.0 6.1 3.0 4.6 4.9 6.7 2.5 12.7 3.0 3.4 3.2 3.3 2.6 18.6 4.4 5.1 2.2 4.0 6.0 4.5 7.9 5.8 4.5 3.3 2.0 4.2 3.2 2.7 2.8 1.7 6.4 1.4 1.6 2.6 0.6 2.0 3.6 2.5 4.1 7.4 4.9 1.5 3.1 3.0 2.0 2.5 2.5 2.7 4.1 2.6 2.4 4.0 5.6 1.4 3.6 2.5 4.3 3.8 6.7 6.9 1.8 3.1 2.3 6.1 3.8 4.1 2.6 4.7 3.4 2.2 7.6 4.6 5.0 4.1 1.4 3.7 5.4 1.0 4.1 2.7 5.6 3.4 2.1 2.6 4.2 3.7 3.4 1.6 3.5 1.1 3.1 3.5 3.6 2.5 6.1 3.5 3.2 2.0 5.9 3.8 2.3 5.4 5.2 3.6 6.4 1.4 1.5 1.3 1.2 1.1 1.5 1.7 1.3 0.8 2.8 2.6 2.4 3.2 1.6 0.9 1.7 1.3 0.6 3.9 8.5 5.3 11.1 5.4 3.6 6.0 6.1 12.7 5.8 0.0 2.7 4.9 1.9 0.7 5.3 3.7 2.5 5.3 3.4 0.0 5.9 1.5 8.3 1.1 8.8 1.4 3.2 0.0 0.6 0.6 0.6 1.8 1.1 1.7 1.1 9.5 0.0 4.3 3.5 10.2 1.1 2.1 0.0 1.8 1.8 3.8 1.7 0.9 0.4 0.7 6.1 12.9 0.9 6.0 0.7 0.3 2.7 4.5 1.7 1.4 PIAS4 "FLJ12419, Piasg, PIASY, ZMIZ6" ENSG00000105229 "Protein inhibitor of activated STAT 4" Q8N2W9 19 4007646-4039386 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 73.5;Late spermatids: 189.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010598, HPA076008" Enhanced Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA010598: AB_1079616, HPA076008: " "unprognostic (1.23e-1)" "unprognostic (8.94e-3)" "unprognostic (3.50e-2)" "prognostic favorable (1.18e-5)" "unprognostic (2.45e-1)" "unprognostic (4.77e-3)" "unprognostic (4.01e-3)" "unprognostic (9.79e-2)" "unprognostic (6.89e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.04e-4)" "unprognostic (1.33e-2)" "unprognostic (5.98e-2)" "unprognostic (4.52e-3)" "unprognostic (5.76e-2)" "unprognostic (1.25e-1)" "unprognostic (4.67e-3)" 11.0 9.2 12.4 11.1 16.8 8.6 7.6 22.5 15.7 8.8 11.9 16.7 8.1 13.0 9.5 9.2 9.1 8.4 9.7 6.9 9.7 7.1 7.3 12.4 7.8 10.2 18.2 9.3 11.2 16.0 7.1 9.3 12.9 12.6 9.9 5.4 6.5 14.7 8.7 15.2 12.2 11.2 8.0 12.3 12.0 13.9 38.1 15.9 11.0 6.6 6.3 8.3 8.8 9.8 17.9 11.8 20.2 19.1 16.3 17.3 11.3 10.6 7.7 7.2 6.8 3.5 3.2 11.5 6.5 3.6 6.9 6.3 12.0 5.0 8.1 5.9 3.5 7.5 11.2 7.4 5.2 3.0 13.0 11.6 5.8 5.5 9.2 7.3 8.4 10.3 3.7 5.7 6.2 3.8 3.8 8.1 8.5 10.8 11.2 3.3 10.9 15.3 9.9 15.9 5.2 7.1 13.7 7.3 10.6 4.5 6.0 13.2 14.7 9.3 9.1 7.1 5.6 8.4 7.8 5.9 6.9 9.9 14.3 10.1 21.1 15.7 10.3 5.7 10.4 8.4 10.5 14.9 20.2 17.3 16.0 12.2 17.9 12.6 15.9 11.8 15.9 11.1 12.5 16.6 16.3 19.1 11.8 13.4 11.3 12.4 16.8 22.5 15.7 9.7 7.1 18.2 9.3 12.6 15.9 3.0 12.9 7.5 7.0 16.4 17.6 3.0 5.1 13.4 7.9 8.7 11.8 19.8 6.6 16.0 73.5 9.8 12.3 0.0 15.5 13.7 7.1 11.8 6.9 9.3 12.6 25.4 21.2 10.4 9.8 189.7 13.0 8.3 6.8 11.8 14.3 10.4 13.0 5.8 17.3 10.2 21.3 6.5 7.2 35.8 35.3 13.6 30.4 7.5 10.8 7.4 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PLAG1 ZNF912 ENSG00000181690 "PLAG1 zinc finger" Q6DJT9 8 56160904-56211324 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 24.0;Horizontal cells: 30.2;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 13.1;ASC TERT1: 17.5;HSkMC: 12.3;hTERT-HME1: 12.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA072290 Supported "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA072290: AB_2686508" "unprognostic (1.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-3)" "unprognostic (1.63e-4)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (5.63e-3)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (7.99e-2)" "unprognostic (3.42e-2)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (2.83e-2)" "unprognostic (3.94e-1)" "unprognostic (1.21e-2)" "unprognostic (6.14e-2)" 1.9 3.6 2.4 3.5 2.9 2.1 2.5 11.0 2.7 7.6 3.8 4.1 9.0 3.4 3.4 9.8 2.0 7.5 2.1 6.8 1.9 1.8 3.7 1.2 4.6 6.7 4.8 2.1 11.6 2.2 2.1 17.8 8.0 4.6 5.1 1.6 7.9 7.5 9.2 1.4 3.4 5.5 2.5 6.3 6.2 3.0 5.2 4.5 11.7 3.5 1.5 5.2 4.8 7.0 3.5 0.2 1.1 0.5 0.7 4.6 1.0 1.5 0.0 9.6 0.1 13.1 17.5 3.0 4.3 5.5 2.0 0.9 0.6 5.0 0.2 4.2 2.3 0.5 0.3 2.7 5.7 2.1 0.1 5.9 6.1 0.5 1.4 2.8 2.0 1.9 12.3 3.2 1.1 12.8 5.6 3.8 4.3 2.6 0.1 4.2 0.0 0.5 3.6 2.8 0.4 1.4 4.7 0.7 3.7 2.6 0.5 0.1 0.0 0.1 0.0 0.3 6.8 0.1 1.9 5.7 3.0 3.8 4.8 1.0 1.5 1.1 2.3 3.4 0.7 0.8 1.1 0.1 1.1 0.3 0.1 0.2 3.5 1.0 0.6 0.1 2.0 4.6 4.3 1.0 0.7 0.5 0.2 0.2 1.0 2.4 2.9 11.0 2.7 1.9 1.8 4.8 2.1 4.6 4.5 6.0 2.7 6.2 2.3 0.9 24.0 9.4 2.5 1.4 2.3 5.2 23.6 6.8 0.0 0.6 4.6 3.3 2.1 0.0 1.2 3.6 3.7 2.8 1.1 0.5 4.5 30.2 5.2 19.6 1.3 4.5 14.1 1.9 15.1 0.0 3.0 18.4 1.2 0.9 9.6 0.5 28.0 0.0 0.7 4.3 6.8 0.6 5.9 1.0 1.6 5.3 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2" "Cell line enhanced" "Detected in many" "A-431: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" Yes No "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favorable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 12.8 2.9 17.2 7.8 36.9 11.4 19.8 7.3 29.4 15.2 15.9 67.3 9.3 10.2 31.6 9.9 26.4 19.8 17.5 12.5 24.2 12.8 19.5 16.5 8.4 4.0 40.7 21.6 16.8 22.7 17.9 3.7 22.3 19.5 12.3 12.1 13.6 19.6 31.6 5.9 19.6 10.0 20.7 24.5 16.0 11.5 5.1 40.9 1.2 14.5 6.4 5.3 16.6 17.1 0.0 0.7 16.7 1.9 6.4 12.2 2.9 29.0 13.5 11.3 17.1 1.2 0.0 19.7 3.3 3.9 5.2 4.2 14.2 12.9 0.0 5.9 3.1 1.8 28.1 7.6 25.9 1.8 0.0 6.6 12.9 16.7 3.4 1.5 0.4 6.2 1.5 15.0 1.1 9.4 8.7 3.4 0.1 0.0 0.1 1.7 13.7 0.0 11.8 3.8 7.7 14.5 0.1 5.6 2.0 14.3 21.3 3.9 6.9 6.7 10.1 9.7 10.9 11.0 2.9 6.5 2.3 23.4 0.1 4.5 0.0 0.0 0.0 0.2 1.3 4.0 4.5 1.9 11.7 12.2 1.1 8.6 0.0 3.7 5.2 0.7 0.0 0.4 2.7 16.7 6.4 0.7 0.0 1.1 2.9 17.2 36.9 7.3 29.4 24.2 12.8 40.7 21.6 19.5 40.9 3.0 3.8 0.8 15.7 17.2 3.6 6.9 17.8 2.7 3.4 45.4 0.0 6.9 10.0 25.0 0.7 3.0 14.7 0.0 17.7 8.6 8.4 13.8 1.1 9.6 4.4 0.0 33.4 1.8 6.0 0.9 6.9 3.3 5.0 0.0 22.8 11.7 28.1 20.1 24.1 7.0 0.8 25.8 16.5 0.0 1.1 18.7 2.2 5.7 15.0 33.4 PLEKHG6 "FLJ10665, MYOGEF" ENSG00000008323 "Pleckstrin homology and RhoGEF domain containing G6" Q3KR16 12 6310436-6328506 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.4;placenta: 39.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 64.9;Extravillous trophoblasts: 43.1;Paneth cells: 35.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 2.5;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.9;granulocytes: 2.5" "Cell line enhanced" "Detected in some" "BEWO: 56.1;CACO-2: 17.8;CAPAN-2: 9.8;OE19: 16.9;RT4: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041459, HPA058230" Uncertain Supported "Cell Junctions,Centrosome" NA NA "Cell Junctions" Centrosome "HPA041459: AB_10794518, HPA058230: AB_2683645" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" "unprognostic (1.44e-1)" "unprognostic (8.03e-3)" "unprognostic (5.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.20e-2)" "unprognostic (1.22e-1)" "unprognostic (3.13e-1)" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (4.18e-2)" "unprognostic (5.73e-2)" 7.5 0.2 0.3 8.9 0.7 1.0 15.8 0.3 0.4 4.4 30.3 0.4 1.1 19.4 0.6 1.6 19.9 0.5 6.7 1.2 0.3 0.0 1.1 2.5 1.8 0.3 0.3 0.3 0.6 4.5 1.9 3.3 39.6 0.5 2.6 9.6 0.7 8.8 2.3 0.3 6.7 43.4 0.5 0.3 0.4 5.7 0.5 0.3 0.5 3.4 11.3 8.6 6.8 8.6 0.3 3.9 2.5 0.2 0.1 0.4 0.1 0.2 2.1 0.2 0.0 1.1 0.1 56.1 0.1 0.0 0.1 0.1 17.8 9.8 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 3.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.2 4.6 16.9 0.3 0.0 0.0 0.1 0.0 18.9 0.1 0.0 0.4 8.4 0.1 4.2 2.7 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.4 2.5 0.1 0.1 3.9 0.1 0.1 0.3 0.7 0.3 0.4 0.3 0.0 0.3 0.3 0.5 0.3 0.0 0.0 0.0 5.7 4.4 0.0 0.3 5.1 0.0 0.0 1.8 0.0 13.8 0.0 8.3 1.1 0.3 64.9 0.0 1.6 43.1 1.1 6.7 0.0 2.1 2.4 0.0 8.1 0.0 0.0 1.5 2.3 0.0 0.0 0.0 18.6 0.9 2.5 35.4 0.7 0.7 0.0 0.0 3.1 0.2 0.5 6.0 20.0 0.0 20.6 16.8 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533301-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0;thyroid gland: 30.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 37.3;Mucus-secreting cells: 17.4;Rod photoreceptor cells: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;BEWO: 9.7;RT4: 9.8;SK-MEL-30: 12.1;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome NA NA Centrosome "HPA047707: AB_2680126, HPA051964: AB_2681675" "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favorable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" 1.3 4.5 9.7 1.6 33.7 0.5 2.9 8.6 26.8 3.5 6.8 61.0 2.5 11.6 1.9 8.9 1.6 3.8 2.5 1.1 16.2 8.7 2.7 0.8 1.2 0.6 35.8 16.6 0.6 7.7 10.3 3.3 2.0 26.9 10.7 7.0 5.1 20.3 2.9 1.1 4.1 9.0 1.3 38.1 1.3 6.6 2.3 34.4 0.0 30.2 0.0 0.7 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 2.0 10.0 0.2 0.0 9.7 0.0 0.0 0.1 0.1 3.1 1.6 0.0 1.6 0.0 0.9 2.2 3.5 0.8 0.1 0.3 3.5 0.0 1.6 2.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.2 3.7 0.0 0.0 7.2 0.0 0.2 3.0 5.7 0.6 0.1 0.3 1.4 1.1 9.8 2.7 2.5 0.8 1.9 12.1 4.9 9.6 2.0 0.0 0.8 3.7 1.0 0.6 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 33.7 8.6 18.1 16.2 8.7 35.8 16.6 26.9 34.4 3.0 8.3 0.0 0.7 0.1 6.9 3.1 2.5 1.4 0.0 8.7 37.3 2.2 3.3 1.8 0.4 0.0 11.9 0.0 3.5 0.3 0.4 3.5 0.0 0.0 0.7 3.2 7.0 0.0 0.8 0.0 0.3 0.8 3.3 0.0 17.4 5.5 2.5 8.6 0.4 1.3 37.9 0.0 0.4 0.4 1.4 1.9 8.9 0.0 16.1 1.0 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751454-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 152.6;Club cells: 46.6;Exocrine glandular cells: 28.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.7;OE19: 31.9;RT4: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037583 Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favorable (1.03e-4)" 0.2 0.1 0.2 1.6 0.2 0.0 11.7 0.2 0.2 26.8 18.5 0.2 10.2 17.0 1.0 2.2 0.8 3.4 6.4 0.2 0.2 0.1 0.6 0.2 4.8 0.2 0.2 0.2 1.3 26.6 0.0 1.9 0.3 0.3 3.5 1.8 0.4 53.1 4.9 0.2 0.7 38.8 0.2 0.2 0.2 2.9 1.1 0.2 0.2 0.2 1.3 2.0 0.8 0.2 0.8 0.5 1.3 0.3 0.7 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 31.9 0.0 0.0 2.7 0.0 0.9 10.5 0.0 0.1 0.0 0.9 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.2 2.1 0.1 0.0 0.0 0.0 1.3 0.8 0.1 0.2 0.3 0.1 0.1 0.8 0.2 0.2 0.0 0.5 0.2 0.3 1.3 0.7 0.3 0.5 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 3.0 2.7 0.0 0.3 0.1 0.0 0.4 0.0 152.6 46.6 0.0 0.0 0.0 0.0 2.8 7.1 0.0 13.8 0.0 28.3 0.0 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.0 1.1 0.0 1.4 0.8 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.3 PLK4 "Sak, STK18" ENSG00000142731 "Polo like kinase 4" O00444 4 127880861-127899195 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017327, HPA035026, HPA043198" Approved Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504" "unprognostic (2.44e-1)" "unprognostic (4.24e-2)" "prognostic favorable (7.46e-5)" "unprognostic (2.18e-1)" "unprognostic (3.79e-1)" "unprognostic (9.20e-2)" "unprognostic (1.06e-5)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.44e-3)" "unprognostic (5.66e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.27e-1)" "unprognostic (2.22e-11)" "unprognostic (2.29e-2)" "unprognostic (3.58e-1)" "unprognostic (4.75e-2)" "unprognostic (7.93e-2)" 1.4 1.3 1.5 4.7 2.4 16.5 2.2 0.5 2.2 2.0 3.2 0.3 0.6 2.3 1.3 1.3 5.4 1.1 1.2 2.0 1.2 1.3 1.5 0.9 1.5 5.9 1.2 1.4 1.5 0.9 0.3 0.6 5.0 2.6 1.4 3.7 0.8 1.7 0.7 0.4 2.7 3.2 1.9 1.8 2.7 1.6 21.7 1.0 21.7 1.0 2.1 6.0 1.5 2.2 0.7 0.7 1.5 0.8 1.4 4.0 0.8 11.8 5.6 21.1 10.8 0.7 2.1 9.6 11.6 8.2 15.5 16.0 7.8 12.2 16.0 4.3 6.4 12.6 7.8 14.8 9.3 23.9 12.4 6.1 14.5 9.0 7.3 0.2 20.4 17.1 0.6 0.9 14.1 6.5 2.8 11.9 12.3 16.8 21.4 13.0 8.2 31.4 9.1 9.8 12.1 6.4 16.4 14.7 5.5 5.1 7.6 11.6 9.6 7.3 6.7 3.5 9.3 5.4 8.8 5.1 12.2 11.8 8.3 14.4 11.0 12.1 22.8 6.2 15.5 13.5 0.0 0.4 1.5 1.6 0.8 1.1 0.3 1.8 1.7 0.7 0.7 0.6 2.3 0.0 1.4 0.3 0.4 4.0 0.8 1.5 2.4 0.5 2.2 1.2 1.3 1.2 1.4 2.6 1.0 0.0 1.1 0.8 0.6 1.4 2.1 0.5 0.0 2.7 0.0 1.8 0.0 3.6 0.0 0.6 48.9 0.4 0.0 23.3 0.3 10.4 0.7 0.4 1.1 0.2 3.1 0.0 2.4 0.6 1.0 60.1 2.6 1.6 0.0 1.8 1.9 1.1 0.1 0.0 0.4 0.3 0.7 0.0 0.3 27.0 12.1 0.6 3.2 1.8 2.1 0.9 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Cell line enriched" "Detected in some" 28 "EFO-21: 112.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 6.0 0.0 0.0 0.7 20.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.7 32.1 0.0 0.0 2.3 0.1 5.6 1.4 0.0 0.0 1.4 0.0 0.0 41.7 2.7 0.6 0.0 3.8 21.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.4 0.4 14.6 0.1 0.0 0.0 1.7 POFUT1 "FUT12, KIAA0180, O-Fuc-T, O-FUT" ENSG00000101346 "Protein O-fucosyltransferase 1" Q9H488 20 32207880-32238667 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "monocytes: 16.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054519, HPA059935" Approved Approved Centrosome "Intracellular and membrane" NA NA 140000 Centrosome "HPA054519: AB_2682515, HPA059935: AB_2684171" "unprognostic (6.61e-2)" "unprognostic (4.10e-3)" "unprognostic (8.83e-2)" "unprognostic (5.51e-3)" "unprognostic (6.90e-2)" "unprognostic (1.62e-1)" "unprognostic (4.65e-1)" "unprognostic (8.51e-2)" "unprognostic (1.84e-1)" "unprognostic (5.57e-2)" "unprognostic (3.01e-1)" "unprognostic (2.19e-1)" "unprognostic (6.76e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.03e-2)" "unprognostic (5.86e-3)" 15.9 13.5 8.2 15.5 8.9 7.4 19.4 6.6 11.3 15.5 20.2 13.1 10.4 16.4 18.1 19.6 13.9 17.4 23.6 20.1 7.5 6.3 18.8 44.6 14.8 22.2 8.8 6.6 18.3 24.6 19.2 11.3 22.4 7.8 16.0 16.0 16.9 13.3 16.0 13.5 13.3 27.5 20.8 7.7 12.4 12.5 16.5 7.0 12.7 20.1 13.9 13.0 15.7 12.6 2.8 3.9 3.3 16.4 1.7 3.3 3.2 15.1 12.2 10.6 11.6 18.3 17.9 19.9 15.8 18.7 26.6 17.5 36.5 20.6 10.3 23.8 17.5 29.6 16.9 10.1 19.5 23.2 5.3 6.4 15.3 11.2 16.5 14.2 13.1 9.8 15.7 15.4 20.1 13.2 11.4 14.8 9.9 11.5 5.9 18.5 7.4 9.0 10.1 5.4 14.7 19.8 7.5 28.2 9.5 8.1 10.1 7.0 8.9 36.1 10.1 13.4 8.5 14.9 15.8 12.8 38.7 14.4 24.1 26.7 7.2 9.2 9.5 23.4 45.7 24.4 3.3 4.4 2.1 2.9 12.8 3.3 2.8 2.6 2.7 3.9 2.4 3.3 2.4 0.9 1.7 16.4 2.9 2.7 3.2 8.2 8.9 6.6 11.3 7.5 6.3 8.8 6.6 7.8 7.0 8.9 7.4 2.2 3.6 2.6 3.3 11.7 10.2 6.7 6.8 7.0 2.0 12.9 1.7 8.7 0.7 6.0 18.8 0.0 8.9 23.4 9.6 5.3 4.7 32.6 9.2 7.9 11.5 14.1 3.3 0.9 9.8 4.3 5.0 4.6 15.0 5.2 7.5 7.0 13.4 4.5 4.1 12.9 5.1 2.3 7.2 1.5 6.4 4.3 17.5 3.5 POLR3H "KIAA1665, RPC8" ENSG00000100413 "RNA polymerase III subunit H" Q9Y535 22 41525804-41544606 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046787 Approved Supported Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA046787: AB_2679806" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (9.57e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.05e-2)" "unprognostic (1.33e-2)" "unprognostic (5.43e-2)" "prognostic favorable (5.41e-4)" "unprognostic (6.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (1.49e-1)" "unprognostic (4.00e-2)" "unprognostic (1.70e-1)" 16.8 14.0 30.0 9.1 28.8 5.5 13.5 21.0 27.4 12.1 7.5 15.8 12.6 6.1 10.5 11.7 17.0 19.0 10.3 14.8 24.0 20.5 10.0 18.9 14.7 10.9 22.2 17.6 22.4 13.7 13.1 11.5 7.9 17.2 11.0 6.8 12.1 12.2 14.2 7.7 14.6 6.2 14.4 14.2 7.2 7.9 14.2 16.5 7.0 15.4 8.2 9.3 8.1 9.1 11.6 11.2 0.6 13.8 3.9 10.2 7.5 16.3 11.0 10.2 14.9 11.2 10.2 6.8 13.7 12.8 23.4 18.9 22.2 5.4 13.9 10.8 23.0 13.2 7.5 18.6 22.4 14.7 12.7 23.0 8.3 17.5 10.6 11.6 34.4 14.2 12.7 14.6 30.8 8.3 8.9 11.4 13.9 17.4 8.9 13.0 15.5 8.8 9.4 7.2 21.7 14.3 13.5 8.0 14.5 10.9 9.6 9.8 5.9 17.9 18.2 8.7 6.6 7.2 9.8 10.2 14.0 15.2 24.3 18.1 6.8 12.6 21.0 24.4 12.3 13.3 0.0 10.0 0.1 7.3 13.8 10.2 11.6 7.1 8.6 11.2 10.1 10.0 8.1 0.6 3.9 12.7 10.8 4.4 7.5 30.0 28.8 21.0 26.9 24.0 20.5 22.2 17.6 17.2 16.5 0.0 23.5 18.2 9.8 15.8 16.9 5.1 12.7 9.4 21.6 15.7 15.7 29.8 39.7 26.3 30.8 8.2 2.9 23.3 25.7 23.4 15.5 13.0 11.5 29.7 27.4 20.6 13.7 9.2 6.9 113.5 15.5 10.0 23.6 22.6 4.1 18.5 23.5 7.0 19.1 28.8 20.6 0.0 10.5 44.7 55.2 22.3 15.0 10.2 8.5 11.3 PPP4R3B "FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2" ENSG00000275052 "Protein phosphatase 4 regulatory subunit 3B" Q5MIZ7 2 55547292-55618880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001233, CAB017185" Approved Supported "Nucleoplasm,Nuclear speckles,Centrosome" NA NA "Nucleoplasm, Nuclear speckles" Centrosome "CAB017185: , HPA001233: AB_1080033" "unprognostic (9.60e-2)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-2)" "unprognostic (6.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (3.27e-2)" "unprognostic (8.27e-3)" "unprognostic (7.62e-2)" "unprognostic (1.07e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (6.03e-4)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" 11.9 10.4 12.1 10.6 13.1 8.1 10.9 17.5 13.1 11.2 11.4 8.6 7.4 11.5 8.8 7.8 12.0 12.5 9.1 5.3 12.8 12.7 18.1 8.3 13.0 13.3 7.9 10.8 13.6 10.7 11.7 11.1 11.4 9.5 10.6 7.8 9.6 9.1 6.0 11.0 14.4 10.3 11.1 10.8 11.0 8.0 12.3 18.7 12.6 6.2 14.3 11.3 10.0 17.6 16.9 23.9 19.6 20.0 25.3 21.6 19.8 15.5 17.2 14.5 18.4 19.4 23.6 16.1 17.6 13.9 12.0 18.3 19.3 27.1 32.7 15.9 22.1 17.3 19.5 13.2 20.9 38.9 8.1 27.0 14.6 24.4 29.8 30.7 22.4 15.0 32.0 17.0 29.3 17.9 21.8 15.0 25.5 27.4 18.3 23.3 19.7 20.2 16.9 26.1 12.3 18.5 26.0 20.4 19.1 20.9 21.3 13.0 17.5 24.2 26.0 12.0 15.3 24.9 17.1 21.3 27.4 10.4 22.1 28.4 21.3 10.4 20.0 29.3 22.7 21.2 15.6 23.9 20.4 19.6 23.0 17.6 21.5 21.2 16.9 16.9 25.3 22.0 18.1 20.0 19.3 9.2 21.5 21.6 41.7 35.8 11.1 36.9 0.0 44.1 0.0 17.8 115.1 53.4 15.7 31.4 25.9 33.2 27.6 4.8 23.3 28.5 0.0 35.4 23.5 13.4 47.5 27.9 46.9 23.3 50.9 17.5 23.9 37.1 5.9 25.9 31.9 0.0 36.9 39.3 48.7 31.4 28.1 33.9 42.6 36.0 6.5 0.0 36.3 23.1 0.0 39.9 35.5 36.7 53.1 PRR32 CXorf64 ENSG00000183631 "Proline rich 32" B1ATL7 X 126819764-126821786 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "heart muscle: 8.9;tongue: 26.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "glioma: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "THP-1: 1.3" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8" "Low region specificity" "Detected in many" HPA048386 Uncertain Approved "Nuclear speckles,Plasma membrane,Centrosome" NA NA "Plasma membrane" "Nuclear speckles, Centrosome" "HPA048386: AB_2680380" "unprognostic (7.10e-3)" "unprognostic (7.97e-2)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 1.1 3.4 0.0 8.9 0.2 0.1 0.0 0.3 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 1.7 0.0 3.1 0.1 0.0 0.3 0.5 0.3 0.0 0.0 0.1 0.0 0.0 26.7 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMB5 "MB1, X" ENSG00000100804 "Proteasome subunit beta 5" P28074 14 23016543-23035230 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049518, HPA061796" Approved Supported Nucleoplasm,Centrosome NA NA 8200000 "Nucleoplasm, Centrosome" "HPA049518: AB_2680802, HPA061796: AB_2684612" "unprognostic (3.03e-1)" "unprognostic (1.99e-2)" "unprognostic (8.35e-2)" "unprognostic (6.13e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.85e-4)" "prognostic unfavorable (2.90e-5)" "unprognostic (2.55e-2)" "unprognostic (9.95e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.19e-1)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.73e-4)" 28.1 38.8 33.6 19.3 35.5 9.6 29.0 19.4 42.9 24.7 28.3 26.8 25.4 21.0 24.2 49.2 31.6 31.6 22.0 37.7 32.9 33.3 35.3 45.4 20.6 18.3 37.5 35.4 22.2 36.6 35.4 26.6 32.5 33.9 27.2 32.2 21.1 28.4 28.7 101.2 22.3 17.2 34.9 32.5 16.7 25.1 27.6 27.3 15.7 29.0 47.3 22.7 20.6 25.2 32.3 53.4 24.6 39.9 19.4 46.8 39.5 22.5 48.1 34.4 32.6 46.4 40.1 34.0 32.2 38.4 56.9 48.4 40.5 36.0 28.0 30.1 43.8 39.5 30.8 54.9 40.2 55.0 17.2 37.9 17.8 35.1 142.5 36.6 21.6 21.4 44.7 37.7 42.2 35.2 37.8 58.8 24.7 26.7 16.0 46.5 66.5 12.3 29.6 38.2 43.6 78.0 16.6 26.0 18.7 44.2 32.7 43.9 34.2 22.7 46.1 31.0 47.0 22.2 28.1 31.6 27.9 28.4 25.8 31.6 13.8 27.3 21.0 21.8 17.4 34.5 24.6 39.9 17.3 29.3 39.0 34.2 32.3 35.1 28.1 42.6 30.1 46.8 35.6 15.5 19.4 27.9 53.4 28.7 39.5 33.6 35.5 19.4 42.9 32.9 33.3 37.5 35.4 33.9 27.3 71.5 50.9 58.0 134.8 124.6 57.4 134.8 129.9 149.9 80.8 90.7 27.5 350.9 233.8 261.5 57.3 106.7 63.2 0.0 201.1 383.6 136.2 130.9 30.1 134.4 190.5 66.7 148.5 90.9 54.9 77.1 109.9 70.7 109.6 199.2 94.1 137.0 244.2 80.7 114.9 331.7 53.8 97.0 134.4 207.4 76.8 137.3 359.7 49.8 123.0 163.4 PXN ENSG00000089159 Paxillin P49023 12 120210439-120265771 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 124.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 49.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003841, HPA051309" Supported Enhanced "Focal adhesion sites,Centrosome,Cytosol" NA NA "Focal adhesion sites" "Centrosome, Cytosol" "CAB003841: AB_562188, HPA051309: AB_2681436" "unprognostic (4.00e-2)" "unprognostic (1.94e-2)" "unprognostic (3.51e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (1.09e-4)" "prognostic unfavorable (3.72e-5)" "prognostic unfavorable (7.12e-5)" "prognostic unfavorable (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (9.19e-3)" "unprognostic (2.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-2)" "unprognostic (3.35e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.75e-2)" 35.4 26.2 17.9 26.7 16.5 31.6 45.9 15.5 18.6 25.0 29.0 12.4 31.7 25.6 27.6 30.9 16.0 29.8 31.8 26.2 18.0 7.6 27.6 13.1 35.8 42.9 15.7 8.1 14.8 16.3 17.6 13.9 34.0 15.8 24.9 23.5 24.7 22.1 40.1 98.5 19.7 34.7 44.4 20.3 34.0 20.6 19.8 14.4 9.9 26.7 22.8 11.6 30.1 45.7 0.5 7.6 49.5 12.3 14.4 26.3 14.5 33.2 16.5 5.9 5.9 11.9 31.0 40.1 28.2 24.6 23.0 12.1 19.2 21.0 2.3 18.5 28.6 22.3 23.8 4.1 51.4 18.4 1.8 3.7 0.4 12.2 6.9 17.2 0.5 0.7 15.1 33.6 24.0 27.4 26.0 40.8 6.2 5.9 3.8 44.9 22.1 2.0 0.7 8.4 14.5 57.5 4.9 9.8 2.0 23.6 32.0 9.7 2.9 25.3 7.8 15.2 14.5 19.2 2.7 53.7 16.0 17.5 19.9 33.5 4.0 2.2 0.8 46.0 5.0 31.2 9.8 12.3 13.4 26.3 4.4 14.2 0.5 12.1 17.2 7.6 0.4 9.6 12.8 49.5 14.4 0.2 1.2 9.1 14.5 17.9 16.5 15.5 18.6 18.0 7.6 15.7 8.1 15.8 14.4 53.6 30.4 3.0 29.8 37.5 7.1 11.5 25.5 28.1 35.2 40.1 31.4 31.3 16.6 30.3 1.2 56.8 59.3 0.0 34.6 124.5 18.0 29.6 17.4 15.3 29.4 11.1 52.5 57.1 49.0 1.6 22.5 13.7 25.3 10.0 49.9 6.9 56.8 50.3 17.7 11.6 30.4 6.5 10.5 3.8 8.0 16.9 20.9 28.7 28.4 33.9 QRSL1 "DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA" ENSG00000130348 "Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1" Q9H0R6 6 106629578-106668417 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "memory B-cell: 32.6;naive B-cell: 26.1" "Lineage enriched" "Detected in all" 7 "B-cells: 32.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029585, HPA029587" Approved Approved Vesicles,Centrosome NA NA Vesicles Centrosome "HPA029585: AB_10599823, HPA029587: AB_10602311" "unprognostic (1.86e-3)" "unprognostic (5.58e-2)" "unprognostic (6.19e-3)" "unprognostic (3.45e-1)" "unprognostic (2.11e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (8.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.03e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.06e-1)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.46e-1)" 9.8 10.8 12.4 17.0 14.7 8.5 15.6 10.1 15.6 7.6 11.7 10.1 11.9 11.3 9.5 10.8 10.3 8.5 8.3 13.9 10.4 9.1 15.5 12.5 7.7 21.0 15.8 8.3 10.2 10.8 10.9 11.9 8.7 9.9 8.3 13.7 7.5 10.6 12.5 35.7 8.8 14.8 8.8 11.9 16.7 11.0 10.6 13.7 13.8 13.7 14.6 21.3 8.9 8.6 32.6 4.0 1.6 4.5 2.6 3.1 2.2 6.2 6.5 9.0 13.0 5.8 7.3 12.7 7.1 7.4 9.6 9.6 7.5 5.2 20.9 6.6 7.9 9.9 11.1 13.3 8.6 12.1 9.9 10.2 10.1 6.9 7.8 9.1 22.9 9.1 7.2 13.5 10.2 15.1 7.3 6.8 13.2 18.4 6.8 7.9 7.0 7.3 11.2 9.3 10.9 7.6 20.1 11.5 5.3 10.4 7.2 7.8 8.0 5.7 13.4 10.5 8.2 8.7 17.8 6.6 6.8 5.6 7.2 11.0 4.0 5.6 12.2 9.3 15.6 10.0 1.6 2.4 0.4 2.6 3.6 2.5 32.6 2.9 2.2 4.0 26.1 2.7 2.6 0.7 2.6 4.5 3.2 3.1 2.2 12.4 14.7 10.1 15.6 10.4 9.1 15.8 8.3 9.9 13.7 17.9 8.4 62.4 6.4 3.5 14.2 24.6 10.2 26.8 7.9 10.4 15.7 18.2 14.9 13.3 10.4 10.4 10.5 0.0 15.9 19.4 7.2 6.4 17.4 13.0 11.3 3.2 16.7 8.0 13.2 4.5 7.8 9.0 8.5 14.4 10.5 9.4 12.8 7.0 8.5 14.6 18.7 0.0 6.6 20.7 12.0 4.6 10.3 11.4 19.0 8.4 RAB22A ENSG00000124209 "RAB22A, member RAS oncogene family" Q9UL26 20 58309696-58367507 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058894, HPA066920" Approved Uncertain Centrosome NA NA Centrosome "HPA058894: , HPA066920: AB_2685749" "unprognostic (4.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.68e-1)" "unprognostic (8.34e-3)" "unprognostic (6.20e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.12e-1)" "unprognostic (2.00e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (7.01e-3)" 12.4 19.3 19.1 9.5 21.5 7.7 12.4 11.9 23.0 12.8 13.2 15.9 5.9 13.0 11.5 15.3 19.3 9.3 10.7 8.6 17.6 17.0 14.2 13.6 11.1 9.9 16.5 10.3 11.3 10.4 27.7 15.1 11.3 18.1 10.4 13.1 6.8 11.3 11.2 7.8 13.8 17.3 11.1 17.1 10.9 12.7 9.9 13.4 11.8 16.0 11.6 12.9 10.7 12.6 4.3 3.6 5.2 5.1 5.8 6.3 2.1 11.1 4.6 5.9 3.8 12.2 11.5 3.5 8.5 9.8 11.7 7.1 7.7 7.7 6.2 10.6 11.8 13.1 9.0 3.0 13.3 13.3 4.1 2.9 4.3 6.6 6.1 9.5 5.4 7.7 7.8 16.3 8.3 8.6 8.3 7.3 4.9 3.8 8.9 12.2 16.0 6.3 5.1 1.4 9.9 11.5 3.3 5.7 5.3 7.3 7.2 4.5 6.1 11.9 22.6 9.8 3.2 8.3 7.4 11.5 19.4 8.0 12.0 10.1 7.7 10.6 4.1 19.9 5.2 6.6 3.1 2.9 2.1 6.3 3.3 5.8 4.3 4.7 5.4 3.6 3.8 4.4 5.3 5.2 5.8 5.1 2.9 3.8 2.1 19.1 21.5 11.9 23.0 17.6 17.0 16.5 10.3 18.1 13.4 20.8 14.4 20.7 58.6 49.7 13.9 16.5 30.6 24.1 18.2 19.2 7.9 14.1 43.1 34.7 4.4 20.2 23.8 23.3 31.5 20.3 31.8 63.8 11.5 22.1 24.4 11.1 18.5 22.7 19.6 6.5 29.1 27.3 23.6 17.2 22.0 25.7 53.3 21.2 19.4 31.6 10.7 12.9 38.1 21.9 33.3 60.2 29.6 31.5 18.8 120.4 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7" "Group enriched" "Detected in many" 7 "Bipolar cells: 34.1;Intestinal endocrine cells: 95.4;Mucus-secreting cells: 41.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 13.9;HeLa: 15.2;MCF7: 9.1;SCLC-21H: 19.3;SK-BR-3: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" No No "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favorable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.6 1.0 13.6 0.4 19.9 0.5 0.9 30.5 13.5 2.0 4.1 0.5 1.5 5.7 0.4 2.3 1.2 0.9 1.1 1.2 18.0 6.2 0.7 21.9 0.6 0.6 5.6 9.1 0.6 24.6 3.1 9.2 0.3 2.5 2.2 5.4 0.7 17.7 1.6 1.1 1.2 6.0 0.4 1.9 0.6 5.3 0.6 3.2 0.0 1.2 0.0 1.1 0.9 0.0 0.8 0.2 0.0 0.1 0.0 1.1 0.7 1.1 13.9 0.0 3.5 0.2 0.1 0.1 0.6 1.1 0.5 0.9 0.4 2.8 0.2 1.0 0.9 0.4 2.2 0.7 0.2 0.0 1.5 1.4 0.5 15.2 1.2 0.6 0.0 0.4 0.5 0.1 0.1 0.2 3.3 0.3 2.2 0.3 0.0 1.6 9.1 0.0 0.6 0.8 4.5 1.3 1.1 1.1 2.3 5.4 0.9 19.3 3.8 0.3 17.5 0.7 0.2 5.7 0.2 0.6 0.0 2.5 0.2 0.2 2.0 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 13.6 19.9 30.5 13.5 18.0 6.2 5.6 9.1 2.5 3.2 0.0 0.6 1.4 1.9 1.1 34.1 1.2 2.5 0.0 2.3 0.0 3.9 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.8 0.0 0.0 1.6 0.0 7.3 0.2 1.6 95.4 0.6 0.3 0.0 0.0 0.0 3.3 0.0 41.2 8.1 0.8 1.9 0.0 0.4 8.4 0.0 0.1 0.0 2.3 0.1 0.1 0.0 2.7 1.4 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 94.1;Distal tubular cells: 33.2;Horizontal cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 13.8;SCLC-21H: 25.3;SH-SY5Y: 12.1;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favorable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.4 3.2 3.8 1.0 1.4 2.1 1.2 1.4 1.9 0.9 0.6 3.4 2.3 1.7 1.3 2.7 11.0 1.3 0.7 0.7 3.5 1.3 4.0 3.8 1.0 2.3 4.2 3.2 1.3 0.8 0.4 2.8 0.4 4.2 0.7 1.2 1.3 3.2 5.1 0.6 1.9 2.8 13.8 3.6 0.2 2.8 1.5 0.5 25.3 12.1 1.0 4.4 2.4 1.0 0.9 0.4 0.4 1.3 0.9 17.5 1.2 2.1 4.6 0.8 3.3 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 0.0 0.0 0.9 2.1 2.9 94.1 1.1 2.5 0.0 0.0 15.7 7.9 1.4 33.2 2.1 2.4 1.4 1.4 0.0 0.8 3.6 3.9 1.4 0.0 1.5 4.3 87.4 9.2 3.1 1.6 0.0 4.0 4.3 10.1 2.8 2.3 11.3 0.8 2.0 5.3 6.3 28.8 0.0 8.6 0.3 2.8 4.3 1.5 2.2 3.7 1.4 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 12.2" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.2 1.7 6.0 5.9 9.5 1.7 3.3 6.3 20.9 4.3 3.4 4.2 0.4 2.4 4.7 9.0 2.7 29.3 2.8 3.3 7.0 6.0 3.5 3.4 12.9 1.8 4.0 7.5 7.4 2.6 1.2 6.3 1.6 6.4 3.8 2.0 3.8 5.2 12.2 2.2 2.1 2.2 3.6 4.8 2.7 2.1 4.8 4.3 2.0 5.5 2.0 3.1 2.1 2.7 8.8 9.8 2.5 7.6 12.2 10.4 5.5 2.6 4.3 6.0 4.8 5.0 7.3 4.6 2.4 2.0 3.5 2.5 3.8 1.6 3.7 10.4 0.8 2.5 2.7 3.0 0.3 2.3 5.1 5.8 1.8 0.1 0.5 4.1 0.8 1.3 2.6 5.2 0.7 1.5 5.1 2.5 5.5 1.7 0.9 2.1 2.1 12.2 0.9 3.3 2.2 1.5 2.3 2.3 1.6 2.4 0.6 2.5 8.5 2.3 2.6 2.2 1.9 0.5 3.5 0.6 0.5 0.8 0.9 1.7 3.6 3.8 0.8 7.1 2.7 1.2 0.0 4.8 2.5 7.1 7.6 7.7 8.8 10.4 7.2 7.5 8.0 8.6 6.8 0.5 12.2 7.2 9.8 5.0 5.5 6.0 9.5 6.3 20.9 7.0 6.0 4.0 7.5 6.4 4.3 8.9 7.2 7.5 4.3 3.9 7.0 4.0 0.0 119.1 12.5 7.0 9.8 2.8 11.6 6.7 9.4 3.0 5.2 0.0 2.7 2.2 7.3 3.0 11.5 3.9 3.1 15.9 6.9 6.7 2.8 9.8 7.5 4.6 6.8 6.4 3.7 6.5 4.0 3.5 6.7 5.0 17.6 0.0 6.6 20.4 8.3 4.3 2.1 5.7 4.3 3.4 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783663 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 59.0" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 167.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 8.2 8.2 12.4 11.1 22.1 8.1 12.9 19.7 21.2 13.0 8.4 12.7 12.6 7.9 13.9 59.0 8.1 41.9 9.4 5.8 13.1 15.3 10.6 7.0 14.4 13.3 9.9 16.5 17.8 9.6 10.9 16.7 7.4 14.3 10.0 11.0 9.5 9.5 11.6 5.1 13.8 8.6 10.2 9.5 11.5 9.1 12.2 14.5 12.6 17.9 3.5 12.3 9.4 9.2 13.6 13.2 9.2 19.4 10.8 16.8 10.3 13.3 12.1 20.8 16.2 23.3 18.6 15.2 10.0 11.1 8.1 11.1 3.4 11.8 8.6 8.9 14.3 13.2 17.5 9.4 11.7 8.8 7.4 13.4 7.4 20.9 8.8 9.7 20.9 8.0 15.8 16.0 10.6 13.4 24.1 9.0 15.5 5.6 10.9 16.1 16.8 10.4 9.2 7.9 8.2 9.1 17.6 12.0 9.0 15.7 13.3 8.9 16.2 12.2 10.8 7.5 15.0 10.7 6.5 13.8 7.8 15.6 6.6 6.7 9.2 4.2 4.2 14.7 5.2 10.9 1.0 10.9 9.2 16.8 17.4 12.2 11.2 13.0 13.7 11.6 13.6 15.2 14.7 4.3 10.8 19.4 13.2 13.0 10.3 12.4 22.1 19.7 21.2 13.1 15.3 9.9 16.5 14.3 14.5 11.9 11.2 10.4 10.3 4.7 14.6 3.6 12.7 167.3 29.6 21.0 29.5 10.4 11.6 17.3 17.0 7.3 7.8 0.0 9.5 9.3 8.5 7.5 3.5 6.4 10.7 15.9 5.2 5.5 10.1 16.3 13.0 8.5 16.9 15.4 7.2 12.9 9.0 3.5 10.3 12.2 37.4 6.5 10.3 27.4 27.0 5.0 5.6 15.8 10.1 6.3 RABL6 "bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1" ENSG00000196642 "RAB, member RAS oncogene family like 6" Q3YEC7 9 136807943-136841187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044037 Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA044037: AB_10966437" "unprognostic (3.10e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "prognostic favorable (4.00e-4)" "unprognostic (9.23e-2)" "unprognostic (2.44e-2)" "unprognostic (1.90e-3)" "unprognostic (7.55e-3)" "unprognostic (1.65e-1)" "unprognostic (4.92e-2)" "prognostic favorable (1.46e-4)" "unprognostic (5.23e-2)" "unprognostic (1.03e-3)" "prognostic favorable (9.14e-4)" "unprognostic (4.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.15e-1)" 20.8 17.7 31.0 21.6 42.8 32.9 17.9 43.6 41.4 12.5 25.1 18.0 14.8 29.4 13.7 14.6 17.9 12.8 22.2 29.4 28.2 22.2 17.1 7.3 17.2 18.5 22.7 21.6 13.9 39.6 17.4 23.3 16.0 16.7 24.3 16.6 13.1 24.8 16.9 98.6 21.5 29.4 15.6 20.6 20.0 24.5 16.5 17.2 20.9 13.9 22.6 13.9 13.8 19.9 4.7 4.1 2.9 5.7 6.1 5.2 1.4 19.2 25.6 18.4 21.5 7.5 8.5 48.4 17.5 11.3 17.0 12.5 28.5 20.5 27.3 11.0 13.6 17.9 42.3 20.4 15.5 5.8 28.4 26.3 16.7 32.0 33.3 13.6 30.9 21.5 9.4 16.0 10.5 11.7 10.4 17.7 23.6 36.3 13.4 11.6 38.5 33.0 21.4 34.4 23.7 22.1 43.3 22.0 26.6 11.2 17.2 60.6 25.1 30.9 36.3 21.6 10.2 31.2 31.2 21.3 22.1 19.2 23.2 28.3 11.5 13.1 22.2 18.5 15.1 20.6 1.2 4.8 2.9 3.7 5.7 3.8 4.5 3.9 3.6 3.3 4.7 3.2 4.1 2.3 6.1 2.0 4.1 5.2 1.4 31.0 42.8 43.6 41.4 28.2 22.2 22.7 21.6 16.7 17.2 26.8 48.3 8.9 15.4 16.0 37.2 29.1 0.0 8.1 7.9 24.4 19.6 20.7 26.6 28.0 10.1 16.9 100.2 0.0 49.7 27.9 22.0 31.8 15.0 0.0 27.4 36.5 49.8 0.0 0.0 10.9 18.1 26.0 38.8 26.2 55.1 18.1 55.1 51.0 25.1 38.5 38.3 0.0 17.3 15.4 26.4 16.9 23.7 12.9 57.2 21.6 RAPGEF6 "PDZ-GEF2, PDZGEF2, RA-GEF-2" ENSG00000158987 "Rap guanine nucleotide exchange factor 6" Q8TEU7 5 131423921-131635236 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037982, HPA037983" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" "unprognostic (1.86e-1)" "unprognostic (5.16e-2)" "unprognostic (5.64e-2)" "unprognostic (2.69e-1)" "unprognostic (3.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (3.72e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (3.57e-1)" "unprognostic (4.10e-2)" "unprognostic (6.31e-2)" "unprognostic (2.81e-4)" 7.2 7.3 8.4 15.2 11.2 15.7 9.9 34.1 12.7 7.2 6.7 13.7 6.1 5.0 6.9 5.9 6.5 6.1 7.7 6.6 9.4 10.5 6.2 8.4 9.5 24.6 13.1 9.0 8.6 6.2 12.5 9.5 8.0 17.1 7.2 7.8 5.4 6.9 7.9 6.9 8.1 7.3 6.9 10.9 11.3 6.5 19.7 14.5 21.2 7.1 5.5 22.0 7.7 7.2 5.4 1.6 8.7 2.0 5.3 14.2 5.4 7.0 5.1 7.2 6.7 3.8 4.3 6.9 7.8 6.2 6.7 10.1 9.3 5.0 16.5 5.2 5.2 10.3 5.7 10.0 8.2 13.6 8.0 5.5 10.4 7.4 5.0 3.1 7.2 11.0 3.1 3.9 9.7 9.5 4.7 5.9 9.3 5.9 10.0 5.9 3.6 7.4 5.8 3.1 3.9 3.8 11.1 10.4 8.7 4.8 5.5 24.9 5.7 8.1 3.7 9.7 8.2 5.2 6.3 5.7 8.9 6.3 7.1 8.9 5.8 6.9 17.9 5.1 9.5 7.5 1.4 1.7 6.3 6.3 2.0 10.7 4.5 8.5 6.8 1.4 5.4 14.2 10.1 8.7 5.3 1.5 1.6 9.6 5.4 8.4 11.2 34.1 12.7 9.4 10.5 13.1 9.0 17.1 14.5 11.9 16.2 5.3 4.7 14.1 10.0 3.6 0.0 8.1 7.9 7.0 19.6 4.9 1.7 3.6 30.7 3.8 3.6 0.0 2.4 2.9 7.4 5.7 2.3 4.4 6.6 1.6 13.3 8.0 11.4 13.2 4.0 11.2 13.5 7.2 7.8 4.2 3.8 5.8 4.9 1.9 8.8 0.0 5.1 11.6 10.6 15.3 5.8 14.4 6.8 4.7 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437757-47449178 "Disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 10.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RH-30: 72.9" "Low region specificity" "Detected in single" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 1.7 0.8 0.2 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 2.7 0.7 0.1 0.1 1.4 0.4 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.4 0.0 0.3 0.8 0.0 45.3 0.2 0.2 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.4 14.8 0.4 0.0 0.0 0.2 0.1 2.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.7 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.3 10.0 0.0 0.0 0.0 1.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 RFPL4A "RFPL4, RNF210" ENSG00000223638 "Ret finger protein like 4A" A6NLU0 19 55759014-55763175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.9" "Cell type enhanced" "Detected in some" "classical monocyte: 12.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 12.7" "Cell line enriched" "Detected in some" 17 "U-2 OS: 44.7" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (3.74e-1)" "unprognostic (2.96e-2)" "unprognostic (9.20e-2)" 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.2 0.0 0.1 0.2 0.0 0.0 0.0 0.4 7.1 0.0 0.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.6 0.4 3.8 0.0 0.1 0.0 0.0 0.0 3.8 1.7 12.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.7 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 12.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 1.7 0.0 0.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 RFPL4AL1 RNF210B ENSG00000229292 "Ret finger protein like 4A like 1" F8VTS6 19 55769141-55773179 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 5.4;myeloid DC: 2.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.5;monocytes: 5.4" "Cell line enriched" "Detected in some" 24 "U-2 OS: 24.8" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (8.87e-2)" 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.0 0.0 0.3 3.0 0.0 0.4 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 2.3 0.2 1.5 0.3 0.0 0.3 0.0 0.0 2.5 0.4 5.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 RGL4 Rgr ENSG00000159496 "Ral guanine nucleotide dissociation stimulator like 4" Q8IZJ4 22 23688136-23699176 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3;bone marrow: 55.8" "Cell type enriched" "Detected in some" 7 "T-cells: 53.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "neutrophil: 81.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 81.3" "Group enriched" "Detected in many" 5 "MOLT-4: 15.1;U-937: 35.7" HPA035979 Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA035979: AB_10673227" "unprognostic (1.48e-4)" "unprognostic (2.75e-4)" "unprognostic (4.44e-2)" "unprognostic (1.11e-4)" "unprognostic (3.10e-1)" "unprognostic (2.93e-4)" "unprognostic (4.92e-2)" "unprognostic (2.06e-2)" "unprognostic (2.78e-1)" "unprognostic (3.11e-1)" "unprognostic (4.25e-2)" "unprognostic (3.80e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-3)" 1.6 1.0 0.5 9.8 0.6 55.8 0.6 1.0 0.8 0.4 1.0 0.2 0.0 1.3 1.0 1.0 1.1 1.2 1.8 10.8 0.5 0.5 0.8 1.5 6.7 19.9 0.6 0.0 1.4 1.0 0.0 0.7 0.8 0.5 0.5 0.2 0.4 2.2 0.0 0.8 1.9 4.1 0.0 0.6 21.6 0.9 18.4 0.3 11.1 1.0 0.3 8.9 1.1 3.6 0.9 0.8 81.3 12.0 4.8 17.8 5.8 0.9 0.3 3.5 1.5 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.6 1.1 0.3 0.0 0.6 1.7 0.0 0.0 0.0 1.1 2.2 0.5 1.2 0.2 0.0 1.9 2.3 0.0 0.0 0.0 0.0 1.8 0.0 1.2 1.2 1.8 0.0 0.5 15.1 2.1 0.2 0.3 0.4 5.4 1.2 0.8 0.0 1.0 1.1 1.7 1.0 2.2 0.3 2.0 0.7 1.2 1.5 2.0 1.2 1.3 0.6 3.2 0.5 0.8 1.1 35.7 0.9 11.8 0.4 58.6 9.5 2.9 9.8 0.9 12.4 10.9 0.8 0.7 17.8 15.9 81.3 4.8 12.0 0.1 17.0 5.8 0.5 0.6 1.0 0.5 0.5 0.5 0.6 0.0 0.5 0.3 0.0 7.9 5.0 0.0 0.8 0.5 0.4 0.0 0.0 2.3 0.0 2.0 0.0 0.0 1.9 4.4 0.0 0.0 0.0 1.5 0.1 0.2 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.8 0.4 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.3 0.0 53.2 0.0 0.0 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064685-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;brain: 9.5" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Erythroid cells: 23.3;monocytes: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1" "Cell line enhanced" "Detected in many" "HDLM-2: 16.7;U-266/84: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA053111: AB_2682047, HPA061001: AB_2684409" "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 1.6 0.6 3.6 2.7 2.0 4.0 2.3 4.0 9.5 0.8 1.1 0.4 1.3 1.1 3.3 2.5 0.9 5.5 1.0 1.4 2.2 2.7 0.9 0.7 2.6 6.8 2.0 5.1 1.0 0.6 0.2 0.7 1.4 1.9 0.5 1.8 0.4 1.0 1.3 0.6 5.6 1.8 1.0 1.2 5.2 1.2 3.0 0.9 2.5 0.8 0.0 3.9 1.0 4.1 3.1 0.9 10.6 1.6 1.3 10.1 1.2 0.9 2.0 1.2 2.9 0.7 0.1 1.2 0.9 2.7 5.1 5.8 1.8 1.6 2.8 0.9 0.2 2.9 0.8 0.8 1.1 2.3 16.7 0.1 2.7 1.4 0.9 0.6 1.1 5.8 0.3 0.4 2.6 0.8 0.3 2.0 5.0 3.5 8.1 1.9 0.8 1.2 6.8 1.8 3.5 2.9 2.6 1.8 4.4 0.4 0.1 0.6 1.7 0.7 0.7 4.5 1.8 0.3 1.8 1.0 1.6 2.6 3.1 0.9 9.8 33.3 1.7 1.3 4.1 0.6 10.6 0.3 0.7 7.3 1.6 10.1 1.9 3.1 3.9 0.7 3.1 1.0 3.8 0.6 1.3 1.4 0.9 6.1 1.2 3.6 2.0 4.0 9.5 2.2 2.7 2.0 5.1 1.9 0.9 0.0 0.0 4.3 0.2 1.1 1.5 0.8 2.5 9.4 2.3 0.0 0.0 0.1 0.0 0.4 0.4 1.4 0.0 23.3 0.2 0.4 0.8 0.3 0.0 0.0 1.5 3.2 0.0 1.3 0.0 0.4 0.0 1.8 0.0 7.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 5.0 1.8 0.1 5.1 0.2 0.0 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell type enriched" "Detected in some" 43 "Muller glia cells: 2424.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2424.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 RMDN1 "CGI-90, FAM82B, FLJ20665, RMD1" ENSG00000176623 "Regulator of microtubule dynamics 1" Q96DB5 8 86468257-86514357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026495 Approved Supported "Actin filaments,Centrosome" NA NA Centrosome "Actin filaments" "HPA026495: AB_1848414" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.02e-1)" "unprognostic (2.09e-1)" "unprognostic (1.60e-1)" "prognostic favorable (8.51e-4)" "unprognostic (2.08e-1)" "unprognostic (7.15e-2)" "unprognostic (4.71e-3)" "unprognostic (3.47e-1)" 20.4 20.1 19.0 19.5 18.4 12.2 16.9 10.8 13.3 13.8 22.5 13.9 7.7 16.3 11.6 13.3 21.1 12.4 14.2 44.3 17.6 16.7 35.0 32.5 21.0 23.6 22.2 10.7 11.6 13.0 14.5 15.6 12.7 19.1 12.6 17.2 13.6 12.2 18.9 45.2 18.5 29.0 17.7 23.1 19.2 16.9 14.4 15.3 25.6 29.3 27.1 18.0 14.3 11.2 17.8 22.1 38.6 27.9 15.5 18.0 12.6 21.2 9.2 10.8 6.1 21.3 35.1 13.2 15.6 14.1 12.4 12.2 10.9 13.7 25.4 13.3 13.0 11.6 20.7 13.8 15.6 14.9 21.6 10.9 13.3 10.9 27.3 11.5 6.0 0.3 19.0 14.8 16.6 25.7 22.3 27.9 15.1 14.0 14.0 19.7 19.2 21.2 2.8 5.5 37.3 23.2 12.1 15.2 26.1 14.7 13.4 5.1 11.4 12.9 51.6 22.0 12.0 29.0 11.3 15.1 13.9 22.6 17.6 9.4 18.2 15.0 19.7 18.1 9.7 18.8 5.6 17.1 38.6 12.3 21.6 14.3 17.8 12.8 14.4 19.5 12.3 10.6 13.7 6.8 15.5 27.9 22.1 18.0 12.6 19.0 18.4 10.8 12.5 17.6 16.7 22.2 10.7 19.1 15.3 38.7 30.0 8.2 11.9 11.9 13.3 104.4 28.1 37.5 44.3 19.2 15.7 37.2 41.4 36.4 68.7 24.1 20.2 0.0 46.2 44.7 20.4 7.5 1.1 52.1 48.2 19.1 9.8 20.3 43.0 59.6 12.0 27.5 15.1 44.1 20.5 25.6 40.0 14.0 8.5 46.4 20.2 0.0 18.6 44.1 30.4 13.6 23.8 19.2 26.4 9.7 RNF39 "HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.3;skin 1: 26.4" "Group enriched" "Detected in many" 4 "Basal glandular cells: 43.3;Glandular cells: 56.0;Urothelial cells: 159.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "OE19: 8.8;U-266/84: 6.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 8.0;hippocampal formation: 4.2" "Group enriched" "Detected in some" 5 "cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: AB_2679938" "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.3 0.2 0.1 0.3 0.3 0.4 5.1 0.3 0.9 7.3 0.7 0.0 1.1 0.9 0.8 0.3 28.3 0.8 1.1 0.2 0.2 0.1 0.3 0.3 3.6 0.3 0.2 0.0 0.6 2.3 0.4 0.4 9.7 0.3 8.1 0.4 0.6 10.2 0.6 0.4 26.4 0.4 1.0 0.2 0.2 4.3 0.8 0.0 0.3 0.4 10.1 11.7 7.8 12.4 0.0 0.0 1.3 0.0 0.2 0.0 0.0 2.4 0.0 0.6 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 1.4 0.0 1.2 0.0 0.4 2.2 1.0 0.2 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 1.4 0.0 1.8 0.6 0.5 0.0 0.8 0.0 1.1 0.0 8.8 0.0 0.3 0.3 0.0 1.6 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.5 0.0 0.2 1.6 6.7 0.6 0.5 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.2 0.1 0.2 0.0 0.3 0.0 3.0 2.4 0.0 43.3 15.9 0.5 0.3 5.1 1.4 3.4 0.0 0.0 0.0 0.0 5.5 0.4 0.0 0.4 0.0 2.9 0.0 0.4 56.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 1.0 1.7 0.0 14.8 0.0 1.1 0.0 0.5 0.0 0.9 0.0 0.2 20.8 0.6 0.0 0.5 159.5 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364636-89412270 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 118.0;Distal tubular cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.3" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;monocytes: 3.9" "Cell line enhanced" "Detected in many" "Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA068664: AB_2686016" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 8.1 8.4 9.2 2.6 12.8 8.9 8.8 22.4 16.3 8.7 3.3 7.9 3.1 2.2 2.1 6.6 12.8 11.9 3.7 29.9 8.6 7.4 21.8 5.0 6.4 2.8 8.5 7.9 2.2 6.4 16.0 11.5 3.4 10.7 5.9 2.4 12.8 38.7 4.2 60.0 5.5 2.1 7.5 12.6 4.4 2.3 6.1 9.2 4.1 23.3 13.9 5.2 9.2 9.3 0.1 0.7 6.3 3.9 0.1 0.6 0.3 0.0 0.7 1.9 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 10.0 0.0 10.7 0.0 0.0 0.0 5.3 2.4 0.0 0.0 0.8 7.1 8.5 0.2 0.6 0.0 0.0 0.0 0.0 7.4 0.2 28.2 0.0 0.7 3.4 3.5 1.6 0.0 0.7 7.1 10.3 0.1 2.6 0.2 14.8 0.8 0.2 1.0 12.0 0.6 0.3 5.6 0.0 0.8 1.2 5.1 1.3 35.7 16.5 0.0 2.7 5.4 0.8 3.9 1.2 2.6 0.0 1.1 0.1 0.1 0.4 0.0 0.7 0.0 0.3 0.6 6.3 0.1 3.9 0.6 0.0 0.3 9.2 12.8 22.4 9.1 8.6 7.4 8.5 7.9 10.7 9.2 8.9 11.8 7.5 12.1 14.3 18.0 118.0 15.3 13.4 5.7 14.0 29.5 0.4 99.5 14.2 15.2 3.6 0.0 0.0 14.9 1.2 6.0 29.7 4.6 8.6 46.1 44.5 1.2 3.1 19.9 10.4 2.8 8.5 37.1 5.4 0.3 18.0 12.3 0.0 3.9 15.6 14.2 0.0 6.6 8.4 25.7 19.7 0.6 1.5 0.0 25.7 RSPH1 "CILD24, FLJ32753, RSP44, RSPH10A, TSGA2" ENSG00000160188 "Radial spoke head 1 homolog" Q8WYR4 21 42472486-42496354 "Disease related genes, Predicted intracellular proteins" Meiosis "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.4;fallopian tube: 85.5" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 938.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 6.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 6.7" "Group enriched" "Detected in some" 4 "MCF7: 7.6;OE19: 27.9;RPTEC TERT1: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016816, HPA017382" Enhanced Supported Centrosome NA NA Centrosome "HPA016816: AB_1858393, HPA017382: AB_1858392" "unprognostic (1.76e-3)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.12e-3)" "unprognostic (5.48e-2)" "unprognostic (2.43e-1)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-1)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (1.10e-2)" "unprognostic (8.41e-2)" "unprognostic (2.58e-2)" "unprognostic (5.22e-3)" "unprognostic (1.99e-1)" 0.6 2.5 11.5 0.9 16.4 0.7 1.7 1.2 4.7 4.5 2.6 15.9 3.1 4.5 3.6 22.5 1.0 85.5 3.8 0.6 11.6 15.0 3.8 0.8 17.4 0.7 4.8 4.5 12.9 2.2 4.8 21.4 0.6 38.4 2.2 2.5 1.0 0.9 2.4 0.9 2.4 4.1 1.1 4.6 0.6 3.4 21.9 7.7 0.2 4.8 0.0 0.7 1.5 0.2 0.6 6.7 0.5 0.3 0.0 0.3 0.3 1.1 0.9 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.4 0.1 0.4 0.0 0.3 1.4 0.0 0.4 0.0 0.1 0.0 3.8 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 7.6 0.1 0.2 0.2 27.9 0.4 0.0 0.2 0.0 11.4 0.9 1.8 0.7 1.8 2.7 0.2 0.0 3.1 0.3 0.1 0.0 0.1 0.1 0.0 0.3 1.7 0.1 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.2 0.1 0.4 0.3 0.3 0.3 0.6 0.3 0.2 0.2 0.0 0.1 6.7 0.2 0.3 11.5 16.4 1.2 4.7 11.6 15.0 4.8 4.5 38.4 7.7 0.0 3.8 0.5 4.2 4.5 10.6 0.6 22.9 938.2 117.2 17.4 35.3 0.0 33.2 9.3 60.0 0.8 10.6 0.0 3.4 0.0 0.4 12.6 0.0 0.0 0.1 3.2 8.6 0.0 0.0 85.8 1.7 0.3 0.0 1.8 9.8 10.5 2.3 10.5 2.5 14.3 26.5 0.0 0.3 90.5 12.3 4.0 0.7 0.0 8.5 5.8 RTTN DKFZP434G145 ENSG00000176225 Rotatin Q86VV8 18 70003031-70205945 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 15.9;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041343, HPA041967, HPA075089" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: " "unprognostic (1.76e-1)" "unprognostic (2.13e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-2)" "unprognostic (3.44e-2)" "unprognostic (6.16e-3)" "unprognostic (4.63e-3)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (4.66e-2)" "unprognostic (1.90e-1)" "unprognostic (8.25e-2)" "unprognostic (6.94e-3)" "unprognostic (1.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" 5.5 6.2 6.2 8.1 13.0 12.9 8.0 12.3 8.0 8.0 5.2 26.5 4.0 5.6 12.1 6.1 4.7 6.0 5.9 8.3 7.2 6.4 8.9 9.0 6.3 8.5 14.2 5.9 11.0 8.4 13.0 7.0 6.8 12.8 5.5 6.2 13.9 5.2 6.4 5.9 6.0 6.1 7.5 12.4 7.9 5.4 14.3 12.5 20.4 5.2 5.5 13.0 5.0 6.8 2.5 1.3 0.6 0.9 1.5 3.1 0.5 3.5 5.4 8.4 2.0 1.2 1.4 3.1 6.4 2.9 5.8 5.7 2.4 2.1 2.9 0.9 3.7 5.6 3.9 5.4 9.3 9.3 11.1 2.8 3.3 5.4 2.2 0.8 5.0 3.4 1.2 10.2 6.4 19.9 2.4 3.3 4.9 3.2 6.8 5.1 1.2 5.6 1.8 1.4 0.7 4.2 4.7 7.3 2.8 0.8 2.4 3.0 3.8 3.5 1.6 2.2 5.1 2.3 3.6 3.3 7.5 2.0 2.4 4.7 3.1 2.9 6.5 4.5 3.4 4.8 0.6 0.9 0.6 1.1 0.2 1.9 2.5 2.1 1.3 0.4 1.7 3.1 1.9 0.4 1.5 0.3 1.3 1.3 0.5 6.2 13.0 12.3 8.0 7.2 6.4 14.2 5.9 12.8 12.5 0.0 11.3 1.9 1.4 1.3 7.0 4.5 0.0 0.0 6.8 0.0 0.0 3.2 0.0 1.0 4.8 2.3 2.0 0.0 1.4 1.6 2.3 1.0 4.7 3.4 2.0 15.9 0.0 1.8 1.0 2.6 2.0 2.6 0.0 0.0 1.6 2.9 1.5 3.1 1.8 2.7 9.6 12.9 2.3 9.2 6.5 1.5 2.5 2.2 1.7 1.8 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993448-49015995 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Group enriched" "Detected in all" 4 "Ciliated cells: 184.7;Early spermatids: 493.7;Late spermatids: 663.3;Spermatocytes: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 6.9 5.3 6.7 7.5 7.1 13.4 4.8 8.2 10.4 4.8 9.9 7.6 6.3 11.2 8.3 5.5 16.1 5.5 7.2 9.1 6.9 6.0 7.6 10.3 5.5 8.2 7.7 8.1 6.5 8.7 1.6 6.4 5.5 6.7 6.0 3.2 6.5 10.0 6.6 27.8 7.7 10.0 3.7 7.1 6.9 10.7 59.0 5.8 14.6 8.8 9.4 8.1 6.4 12.9 12.6 16.4 5.6 14.3 11.0 12.5 15.2 28.9 29.8 3.5 20.0 1.5 2.7 9.4 15.7 6.8 18.0 11.8 15.4 12.6 27.2 12.1 3.1 5.1 15.4 2.2 10.3 2.1 16.5 12.2 17.7 9.0 7.8 5.0 34.8 12.4 3.1 2.1 4.0 2.1 3.3 6.6 23.0 30.7 11.6 1.6 5.9 30.7 4.1 10.8 6.0 4.4 25.5 16.1 17.5 3.2 11.2 14.3 20.6 15.8 13.2 5.6 1.1 11.6 13.4 9.7 11.4 16.8 7.5 38.7 23.5 26.8 28.1 8.4 17.1 16.3 5.6 14.3 4.2 11.1 11.1 11.2 10.9 11.1 9.1 16.4 12.6 12.2 8.0 1.0 11.0 10.8 12.5 12.5 15.2 6.7 7.1 8.2 10.4 6.9 6.0 7.7 8.1 6.7 5.8 11.9 20.2 23.7 40.9 24.6 15.0 38.6 28.1 184.7 36.4 31.4 31.4 91.2 39.7 59.0 493.7 24.1 23.6 23.3 61.9 63.4 32.5 34.0 12.7 31.1 44.6 17.5 16.8 27.6 18.3 663.3 33.4 26.7 25.3 43.3 33.6 23.6 48.7 31.6 40.3 61.6 24.1 19.4 37.1 292.2 46.3 24.1 96.9 25.3 49.4 33.5 SDCCAG8 "BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7" ENSG00000054282 "Serologically defined colon cancer antigen 8" Q86SQ7 1 243256034-243500092 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025737, HPA044477, HPA072495" Approved Enhanced Centrosome NA NA Centrosome "HPA025737: AB_2671761, HPA044477: AB_2678955, HPA072495: AB_2686527" "unprognostic (4.12e-1)" "unprognostic (3.94e-2)" "unprognostic (7.58e-2)" "unprognostic (2.86e-2)" "unprognostic (2.61e-1)" "unprognostic (3.78e-2)" "unprognostic (9.34e-2)" "unprognostic (3.95e-2)" "unprognostic (4.37e-2)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-2)" "unprognostic (1.38e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (3.68e-3)" "unprognostic (4.69e-2)" 13.5 12.6 17.2 10.0 17.7 7.9 13.0 12.3 17.6 11.4 10.5 22.5 10.4 7.5 13.3 17.7 11.6 17.9 17.6 12.8 16.8 13.5 15.2 7.9 14.8 10.4 17.4 12.0 19.9 17.3 18.0 32.4 11.4 14.2 15.5 8.3 10.7 16.8 13.1 15.1 10.2 9.3 11.3 18.9 15.0 11.0 8.0 20.9 17.4 32.7 7.2 10.4 11.8 10.7 9.8 9.9 9.3 10.7 12.5 8.6 5.2 5.5 4.7 0.7 3.5 5.2 3.0 5.7 3.5 3.0 0.6 1.3 4.5 9.9 2.1 5.8 3.0 0.5 1.9 0.6 4.2 1.4 3.6 5.6 1.8 3.5 2.0 3.3 1.8 4.6 6.1 4.0 3.1 6.6 5.8 4.3 3.8 2.6 3.3 2.5 1.5 0.7 4.3 0.6 6.2 7.9 2.9 0.8 1.8 6.2 3.6 4.8 4.8 4.1 2.1 7.9 0.8 3.7 2.8 4.2 6.0 1.4 1.8 1.9 4.5 2.2 1.0 2.8 3.8 26.3 9.3 10.7 9.0 6.0 10.5 3.8 7.5 6.4 7.8 9.9 9.8 8.6 6.5 6.9 12.5 5.7 7.9 5.0 5.2 17.2 17.7 12.3 17.6 16.8 13.5 17.4 12.0 14.2 20.9 38.7 84.7 13.8 32.4 33.1 69.9 24.6 38.2 72.3 44.3 38.4 82.5 40.2 64.6 55.3 13.0 36.0 15.4 0.0 26.3 74.3 34.9 29.8 47.5 24.3 104.6 62.0 30.7 43.6 40.6 25.5 48.9 49.4 33.7 31.5 16.5 60.3 40.6 23.4 41.8 25.3 72.7 38.8 19.5 47.6 11.3 43.0 22.0 14.9 22.0 20.9 SEC14L4 "dJ130H16.5, TAP3" ENSG00000133488 "SEC14 like lipid binding 4" Q9UDX3 22 30488913-30505711 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 35.8;testis: 13.4" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.6;Cholangiocytes: 15.3;Hepatocytes: 13.9;Muller glia cells: 8.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 3.1;neutrophil: 2.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 4 "BEWO: 29.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.0" HPA069748 Approved Centrosome NA NA 44000 Centrosome "HPA069748: AB_2686187" "unprognostic (6.98e-4)" "unprognostic (2.72e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.07e-2)" "unprognostic (9.88e-2)" "unprognostic (4.93e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (1.88e-2)" "unprognostic (8.87e-2)" "unprognostic (4.06e-8)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "unprognostic (5.98e-2)" 0.1 1.1 0.1 0.1 0.1 6.7 0.1 0.2 0.4 0.4 0.2 0.1 0.1 0.0 0.1 1.0 0.3 0.2 0.4 0.1 0.1 0.1 0.3 35.8 8.5 0.1 0.1 0.1 0.2 0.2 6.7 0.2 0.3 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.5 0.4 13.4 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.7 0.5 3.1 0.4 0.4 0.4 0.1 1.7 5.6 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 3.1 0.4 0.4 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.4 2.6 0.4 0.3 0.5 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 20.8 8.6 0.0 0.5 0.1 0.1 0.6 15.3 1.4 2.3 1.8 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.2 0.2 0.4 1.1 13.9 0.1 1.6 0.0 0.6 0.3 0.0 0.6 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SENP5 MGC27076 ENSG00000119231 "SUMO1/sentrin specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006575 Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA "Nucleoplasm, Nucleoli" "Centrosome, Cytosol" "HPA006575: " "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 13.8 13.5 20.0 15.3 20.0 25.7 16.1 28.3 23.8 15.0 15.1 16.1 14.5 11.3 14.6 16.2 16.3 12.9 14.4 15.9 18.9 21.7 13.6 19.5 15.2 15.9 19.4 18.4 17.5 15.7 19.8 21.5 17.8 23.5 15.1 14.0 12.0 13.2 15.9 17.8 16.4 13.0 16.8 18.2 17.1 14.0 36.6 16.4 19.3 14.1 9.2 21.1 14.9 20.1 8.9 7.8 15.8 8.7 7.6 8.9 4.2 13.3 6.1 9.8 8.8 8.3 9.9 7.8 8.5 9.1 9.3 15.0 10.6 5.3 12.5 23.8 9.3 15.9 9.2 10.1 4.5 15.1 6.7 6.6 16.9 9.1 7.4 9.6 14.0 8.0 8.5 12.3 9.5 10.1 6.7 9.0 11.2 11.2 19.4 10.8 11.5 13.1 8.2 7.6 7.3 12.0 8.5 7.9 8.5 4.5 7.6 6.1 8.1 9.5 10.8 10.5 10.3 18.1 10.7 10.1 9.1 9.3 12.4 17.4 20.8 36.3 27.0 12.2 11.3 10.3 15.8 7.6 7.1 8.9 8.1 8.1 8.9 8.6 8.8 5.0 8.5 8.0 8.6 14.9 7.6 8.7 7.8 6.9 4.2 20.0 20.0 28.3 23.8 18.9 21.7 19.4 18.4 23.5 16.4 20.8 13.0 17.1 20.7 54.0 26.0 12.5 10.2 9.4 14.8 8.7 15.7 15.8 10.0 14.8 27.7 20.4 12.4 0.0 12.2 12.8 21.0 19.3 25.5 16.6 12.0 27.0 20.7 13.5 16.1 36.8 15.0 18.8 13.5 14.4 13.2 15.4 20.6 17.5 15.6 14.7 27.7 25.8 24.0 36.7 40.5 54.3 19.1 26.7 10.1 28.1 SENP7 ENSG00000138468 "SUMO1/sentrin specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 17.0 9.0 11.0 19.1 14.5 19.5 16.5 35.5 19.5 21.7 13.1 11.8 8.2 6.4 24.3 15.2 11.9 18.6 12.8 10.0 13.2 9.1 10.5 7.7 11.5 19.0 12.9 10.8 27.9 15.9 22.4 24.4 17.0 18.7 15.1 10.0 9.2 10.2 11.1 11.1 18.6 13.8 16.0 17.3 14.1 13.6 7.9 16.8 32.1 16.0 9.4 15.4 17.2 14.0 6.8 3.2 24.5 4.1 6.2 7.6 3.8 7.0 4.8 23.6 13.0 4.5 6.9 4.3 4.1 3.0 6.8 8.5 3.1 6.6 5.4 6.4 3.9 6.3 7.1 7.3 3.7 13.8 10.1 2.2 9.8 3.7 4.2 3.7 5.7 9.7 5.3 6.8 3.4 7.8 6.2 9.8 10.7 8.1 14.0 6.4 4.6 10.4 6.6 4.8 3.7 5.1 11.6 6.3 4.9 8.2 4.1 9.1 7.0 3.8 3.9 5.1 12.7 6.3 7.6 8.0 9.5 5.9 3.2 4.0 9.9 5.9 12.8 3.3 7.6 7.7 24.5 4.1 3.8 4.2 3.6 5.2 4.2 5.6 4.2 3.2 6.8 7.6 5.1 12.6 6.2 3.8 2.8 4.5 3.8 11.0 14.5 35.5 19.5 13.2 9.1 12.9 10.8 18.7 16.8 14.9 26.4 9.5 7.3 8.0 47.4 19.3 5.1 38.8 25.0 15.7 19.6 5.0 5.0 6.0 2.1 22.9 5.6 0.0 4.5 2.2 13.9 6.7 34.8 9.6 6.7 49.3 12.6 42.4 22.1 2.5 17.0 11.6 10.1 1.8 6.3 20.1 6.1 2.9 18.4 6.7 33.6 45.3 9.9 20.4 17.1 8.7 2.1 22.4 4.9 3.9 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 145.8;Urothelial cells: 161.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: AB_2675727" "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 4.9 8.9 3.0 1.9 4.2 4.4 9.1 4.1 2.7 1.8 1.9 18.0 25.9 0.8 4.2 5.2 4.2 14.5 4.1 10.8 2.6 0.7 2.2 0.6 1.1 9.6 1.5 0.6 1.9 5.1 6.0 4.7 12.3 5.1 3.3 24.6 1.6 4.3 4.8 8.6 10.0 2.4 4.2 7.0 3.1 12.0 2.7 1.3 5.3 24.7 0.2 2.9 3.6 8.5 15.9 16.2 3.7 3.1 3.6 5.3 1.5 5.3 5.0 5.6 1.5 13.0 9.9 1.7 21.5 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 56.6 23.8 3.7 42.8 5.7 3.7 7.5 22.9 2.7 23.9 15.7 0.0 14.2 8.3 21.5 1.4 17.5 72.2 0.0 16.8 20.9 20.6 145.8 8.1 74.0 19.5 3.2 57.7 43.0 25.4 4.2 17.0 27.0 5.0 36.1 63.6 60.6 25.3 57.5 37.4 4.6 4.8 32.3 3.8 1.2 7.9 8.5 108.0 16.7 74.3 161.9 SERPINB6 "CAP, DFNB91, PI6, PTI" ENSG00000124570 "Serpin family B member 6" P35237 6 2948159-2972165 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 821.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009668, HPA012736" Enhanced Approved Centrosome NA NA 5100000 Centrosome "HPA009668: AB_1079919, HPA012736: AB_1856729" "unprognostic (3.44e-1)" "unprognostic (1.03e-1)" "unprognostic (8.72e-2)" "unprognostic (1.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.56e-2)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (7.63e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.51e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.59e-1)" "unprognostic (5.08e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 31.6 38.8 21.1 23.5 34.8 17.3 29.6 13.4 20.8 31.8 44.6 35.2 38.1 54.9 30.3 30.3 36.0 35.9 42.4 58.7 21.1 21.3 32.4 20.1 36.2 45.3 33.7 20.4 45.3 85.3 26.5 23.7 38.5 28.5 37.8 30.9 32.6 23.4 32.6 51.0 12.0 85.5 36.6 32.4 41.4 29.9 55.5 28.9 5.9 32.6 34.2 23.7 31.7 24.5 8.4 30.8 34.2 31.3 23.6 18.6 24.0 30.4 20.0 6.6 27.3 17.9 40.0 20.4 28.5 34.6 22.6 26.4 7.0 22.1 0.2 32.9 32.2 25.8 46.3 18.3 29.0 21.2 40.0 8.3 17.9 23.9 11.8 31.4 0.3 10.9 23.0 20.3 21.5 5.6 39.6 53.5 0.2 23.2 0.5 40.2 21.6 0.2 0.3 3.9 34.7 38.5 2.0 12.3 25.6 28.5 7.4 0.4 16.9 23.4 3.5 31.6 25.6 15.4 14.6 38.2 23.1 8.5 51.3 19.2 0.6 0.1 0.6 17.8 18.0 23.7 13.9 31.3 34.2 16.8 30.4 8.3 8.4 9.5 11.1 30.8 6.9 11.3 18.6 2.8 23.6 24.6 3.1 1.3 24.0 21.1 34.8 13.4 20.8 21.1 21.3 33.7 20.4 28.5 28.9 47.6 66.6 38.9 56.1 18.2 24.1 116.6 30.6 123.1 58.0 71.5 19.6 135.2 84.6 164.5 478.1 107.4 297.6 0.0 298.9 268.0 77.3 94.3 101.6 31.0 159.4 28.6 70.0 185.4 162.5 821.7 77.1 104.2 60.8 173.1 110.7 143.7 252.9 244.7 79.9 156.8 48.0 77.6 110.5 190.3 30.0 23.1 135.0 42.4 162.8 77.4 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle, Centrosome" Cytosol "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.3 6.0 10.8 9.1 0.0 2.3 8.5 15.3 6.5 19.4 13.2 9.8 12.2 15.5 4.6 8.4 8.3 10.7 14.4 6.2 21.2 13.3 7.4 20.6 3.9 5.6 0.0 16.0 8.0 0.4 0.4 15.5 5.2 1.8 9.4 13.2 10.7 6.6 12.8 8.8 24.3 14.4 12.5 17.2 11.2 16.0 23.2 7.2 4.3 4.4 13.8 5.1 5.1 8.0 3.2 7.5 7.1 12.3 3.8 7.7 11.1 7.1 18.4 4.0 8.5 15.6 1.9 12.5 22.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 0.0 0.0 2.2 0.5 1.8 0.0 0.6 0.0 2.7 2.3 0.0 0.0 1.3 0.0 0.9 5.1 0.8 0.2 0.0 1.2 19.6 0.8 0.4 0.0 0.2 4.6 0.0 0.0 2.5 1.9 6.0 1.4 2.2 0.0 1.0 0.3 0.2 0.6 0.9 1.1 0.3 0.0 0.0 0.9 18.7 13.5 2.5 1.8 1.0 2.7 0.1 SLAIN2 "FLJ21611, KIAA1458" ENSG00000109171 "SLAIN motif family member 2" Q9P270 4 48341322-48426212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035824, HPA063599" Approved Enhanced Centrosome,Cytosol NA NA 13000 Centrosome Cytosol "HPA035824: AB_10602399, HPA063599: AB_2685056" "unprognostic (6.20e-2)" "unprognostic (1.80e-1)" "prognostic favorable (5.77e-4)" "prognostic favorable (7.98e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (1.33e-3)" "unprognostic (2.58e-1)" "unprognostic (1.59e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.50e-4)" "unprognostic (1.75e-1)" "unprognostic (5.72e-2)" "unprognostic (1.85e-1)" "unprognostic (8.00e-2)" 14.8 9.3 6.8 11.7 8.6 7.0 12.6 9.2 10.7 18.4 20.7 6.1 11.7 6.9 18.1 12.2 24.0 14.3 12.3 21.3 7.3 5.6 12.8 16.1 14.0 10.6 7.6 7.2 16.4 10.4 17.2 9.4 29.7 8.0 19.0 13.1 14.1 15.2 17.3 49.2 20.1 15.5 30.6 6.2 11.4 13.2 23.6 5.8 23.8 12.1 22.2 16.9 24.9 23.7 7.7 8.5 10.9 8.6 10.7 13.5 4.2 12.5 4.9 9.0 8.8 13.9 17.2 6.3 19.4 24.8 17.4 18.1 4.9 10.6 7.6 12.0 22.2 31.3 8.3 36.7 18.2 30.7 6.2 3.7 13.3 7.3 5.6 15.0 12.1 13.6 14.6 27.0 20.1 23.5 13.1 10.2 6.8 8.4 8.5 17.4 6.4 13.9 10.0 3.8 9.9 7.1 7.9 17.5 4.8 15.2 13.9 6.0 7.6 7.9 5.9 8.3 8.6 7.4 8.7 12.9 19.1 18.1 12.0 19.7 11.6 12.0 6.5 15.0 13.8 13.7 10.9 8.0 9.6 8.8 5.8 9.9 6.1 11.0 13.5 8.5 7.7 9.1 9.8 7.5 10.7 8.6 2.9 7.1 4.2 6.8 8.6 9.2 10.7 7.3 5.6 7.6 7.2 8.0 5.8 50.6 34.2 23.6 40.6 74.9 14.4 68.6 15.3 75.0 27.3 26.2 13.7 24.2 18.3 26.4 122.5 23.3 27.7 0.0 30.2 23.9 23.6 48.5 21.8 28.9 19.9 33.4 24.2 22.1 17.5 234.7 25.3 24.3 18.6 29.7 30.2 19.7 25.2 28.8 34.6 20.7 38.1 32.3 32.3 69.6 47.8 79.9 63.2 29.8 19.0 50.2 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell type enriched" "Detected in some" 22 "granulocytes: 603.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Cell line enriched" "Detected in some" 20 "HMC-1: 91.2" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.2 91.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 8.9 27.6 0.0 0.0 1.6 0.6 0.2 0.0 1.4 4.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.4 603.6 0.0 0.7 0.0 8.5 11.6 1.8 0.0 0.6 0.6 1.7 0.0 0.0 0.3 0.1 0.0 4.6 0.0 0.7 0.0 0.2 0.2 0.1 2.4 0.0 0.0 0.0 0.0 SLC1A4 "ASCT1, SATT" ENSG00000115902 "Solute carrier family 1 member 4" P43007 2 64988477-65023865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Melanocytes: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 72.7;U-266/70: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034963, HPA034964" Approved Enhanced Centrosome NA NA Centrosome "HPA034963: AB_2797223, HPA034964: AB_2674386" "unprognostic (7.61e-2)" "prognostic favorable (3.59e-4)" "unprognostic (2.49e-1)" "unprognostic (3.19e-3)" "unprognostic (1.26e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.23e-5)" "unprognostic (1.26e-2)" "unprognostic (2.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.28e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.37e-3)" "unprognostic (4.14e-2)" "unprognostic (3.53e-2)" "unprognostic (1.98e-2)" 6.0 20.3 31.4 7.6 34.4 10.3 12.7 8.8 43.1 13.5 8.3 8.1 6.1 5.6 11.7 7.8 6.5 4.7 3.8 5.1 20.6 23.5 1.9 11.1 4.5 8.7 17.1 21.2 12.2 28.4 6.1 10.3 6.0 15.4 9.1 7.8 12.1 5.7 6.9 29.6 15.9 5.1 11.3 5.8 6.3 7.0 7.8 8.5 15.7 5.3 11.5 15.8 5.4 7.8 1.1 8.4 2.0 10.1 5.5 3.9 1.4 3.7 2.9 1.7 8.8 3.8 2.5 2.4 7.1 3.5 3.0 5.1 0.8 0.5 12.2 1.6 11.1 3.7 10.8 3.4 0.9 3.1 4.9 1.3 6.3 3.5 7.5 8.1 10.6 5.9 1.1 18.8 4.0 6.2 1.0 1.8 12.3 4.9 30.9 2.1 3.3 9.0 7.0 1.2 4.9 3.5 3.3 0.4 30.3 1.2 1.9 7.5 3.6 4.4 4.0 72.7 0.8 4.8 11.7 0.4 4.1 4.9 7.9 4.3 34.0 16.8 29.6 6.0 21.4 21.7 0.0 2.3 2.0 1.0 5.3 1.4 1.1 1.1 1.8 4.4 0.3 0.0 1.0 0.0 5.5 10.1 8.4 3.9 1.4 31.4 34.4 8.8 25.9 20.6 23.5 17.1 21.2 15.4 8.5 0.0 2.4 14.5 2.0 17.7 5.4 4.4 2.5 4.0 1.2 1.8 31.4 0.9 0.0 1.4 23.4 4.5 0.7 0.0 8.1 1.1 5.6 2.5 6.9 10.9 17.4 6.4 8.1 9.2 4.5 34.0 10.3 9.5 81.0 5.4 6.2 14.7 8.6 0.0 28.0 1.2 16.5 0.0 9.0 1.1 0.6 5.4 2.1 2.5 4.4 0.9 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favorable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 25.6 17.5 16.0 14.0 16.7 11.4 24.9 29.7 16.0 27.9 22.6 17.9 21.3 15.1 28.2 18.8 21.7 20.5 17.5 19.6 15.3 11.5 21.0 22.0 20.1 16.0 17.2 13.3 30.5 25.0 30.0 28.9 30.6 14.2 27.8 17.4 18.4 23.1 22.8 39.7 18.2 23.4 27.6 13.9 21.7 19.3 17.6 18.4 38.8 35.0 13.9 18.1 29.0 24.1 3.6 3.6 3.4 1.8 2.9 4.7 1.3 8.5 11.4 30.9 8.9 12.8 19.8 17.4 15.1 16.6 20.3 25.5 7.0 2.0 14.3 4.5 13.0 10.4 14.2 17.3 6.8 21.6 12.4 9.8 9.9 11.4 8.0 12.7 17.2 7.8 8.9 11.5 10.0 14.7 19.6 14.7 7.3 11.1 13.2 12.0 4.5 10.2 5.0 16.1 4.6 7.1 13.3 15.7 14.0 9.7 3.7 19.1 11.3 14.1 2.6 9.4 13.7 7.0 10.0 11.0 17.2 8.0 4.3 10.0 19.9 13.8 12.4 11.2 6.7 11.3 0.8 1.8 1.8 3.2 1.1 3.7 2.2 3.3 2.6 3.6 3.6 4.0 4.7 3.4 2.9 1.3 2.9 4.3 1.3 16.0 16.7 29.7 16.0 15.3 11.5 17.2 13.3 14.2 18.4 20.8 23.2 11.8 18.4 22.8 13.2 33.5 40.8 16.0 19.4 21.0 19.6 15.5 10.0 16.2 7.3 23.2 15.6 0.0 10.8 16.8 23.8 31.7 4.6 40.0 13.2 14.3 38.1 23.9 26.1 11.4 30.8 16.7 27.0 5.4 33.8 18.9 18.1 24.3 28.7 18.5 20.8 25.8 29.2 13.9 16.2 23.8 10.5 13.8 26.2 22.5 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Group enriched" "Detected in some" 11 "GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.9 0.0 0.0 0.3 1.3 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.1 0.2 21.5 13.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 0.0 0.0 0.0 0.0 0.0 46.7 0.8 0.0 0.0 0.0 0.0 58.9 1.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 30.2 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 8.9 0.5 0.0 1.1 0.0 59.2 0.0 0.0 25.0 2.4 0.0 3.7 0.0 0.0 0.0 SNCG "BCSG1, persyn, SR" ENSG00000173267 "Synuclein gamma" O76070 10 86958618-86963260 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6" "Cell type enhanced" "Detected in many" 12 "Smooth muscle cells: 114.4;Urothelial cells: 347.2" "Group enriched" "Detected in all" 8 "ovarian cancer: 84.1;urothelial cancer: 301.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 95.9;RT4: 79.0" "Region enhanced" "Detected in many" "pons and medulla: 292.8" "Low region specificity" "Detected in many" "CAB001452, HPA014404, CAB040581" Enhanced Supported Supported Centrosome NA NA Centrosome "CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715" "unprognostic (2.06e-1)" "unprognostic (2.58e-1)" "unprognostic (6.87e-3)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (4.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-3)" "unprognostic (3.75e-1)" "prognostic unfavorable (2.29e-8)" "prognostic unfavorable (7.15e-4)" "unprognostic (2.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.77e-3)" 74.1 78.3 82.3 5.3 20.8 1.0 28.9 12.3 44.5 9.5 5.8 4.6 6.4 4.8 6.1 12.0 11.0 26.5 6.2 9.0 40.0 92.9 4.1 1.9 4.6 4.9 72.9 35.1 15.0 3.5 1.6 1.7 4.9 100.1 11.9 2.7 10.8 10.9 44.4 6.6 8.5 5.4 5.8 35.2 20.2 2.6 2.9 5.3 0.2 3.4 3.3 9.6 76.6 18.3 0.0 0.7 0.0 2.4 0.0 1.8 0.6 0.2 1.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 95.9 0.0 2.0 0.1 0.0 8.0 0.0 0.3 0.0 0.0 0.0 0.6 18.6 0.3 0.1 0.0 0.1 0.4 7.5 0.0 0.0 0.0 6.8 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.0 0.0 0.7 1.0 0.1 0.0 20.8 0.0 17.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.6 82.3 20.8 12.3 44.5 40.0 92.9 72.9 35.1 100.1 5.3 0.0 0.0 0.0 64.9 25.5 30.2 1.4 0.0 1.4 5.7 52.4 5.9 12.2 106.1 3.7 0.4 107.8 0.0 0.0 1.0 0.4 12.1 11.4 0.0 0.2 4.3 82.6 0.0 108.1 1.6 0.6 54.7 2.9 21.9 1.0 0.0 45.4 2.9 0.0 9.2 0.9 69.6 90.5 114.4 0.5 0.5 17.2 5.1 0.0 0.0 347.2 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 126.5" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 479.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.6;eosinophil: 2.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.6" "Cell line enhanced" "Detected in many" "CACO-2: 15.2;HMC-1: 26.6;SK-MEL-30: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, CAB032850, HPA043084" Enhanced Supported "Plasma membrane,Focal adhesion sites,Centrosome" NA NA "Focal adhesion sites" "Plasma membrane, Centrosome" "CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favorable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 95.0 6.4 23.0 16.4 21.6 1.8 23.5 16.8 22.5 14.9 70.2 18.7 22.1 8.1 41.8 12.5 45.0 25.1 28.9 83.7 20.9 8.3 5.9 14.7 8.7 1.4 13.4 14.1 9.8 7.3 17.5 3.5 9.9 19.2 42.0 20.0 6.4 7.2 65.7 46.4 6.3 15.5 126.5 20.6 2.9 40.0 5.5 19.3 0.0 4.0 12.7 1.2 63.9 31.4 0.1 0.0 7.6 1.2 0.6 1.0 0.2 0.7 0.7 6.4 1.6 2.4 0.1 0.9 0.2 0.1 0.2 0.0 15.2 5.7 0.0 1.2 0.1 2.4 0.3 1.2 0.3 0.1 1.8 2.3 3.7 0.2 9.1 0.8 0.0 26.6 0.4 0.2 0.3 0.1 0.1 2.6 0.9 6.0 1.2 0.6 0.4 0.0 0.3 3.0 2.8 1.4 0.5 2.2 0.2 7.2 10.0 2.8 2.0 0.9 0.3 22.8 4.6 1.2 0.2 0.2 0.0 2.3 0.1 1.2 0.8 0.2 0.1 2.8 0.2 6.4 7.6 0.2 2.2 0.7 1.2 1.0 0.1 0.3 0.4 0.0 0.1 0.3 0.1 0.2 0.6 0.2 0.0 0.5 0.2 23.0 21.6 16.8 20.7 20.9 8.3 13.4 14.1 19.2 19.3 20.8 18.1 0.5 5.1 10.3 5.9 479.0 12.7 0.0 2.3 1.8 2.0 17.9 3.3 4.4 61.7 19.0 1.0 0.0 2.6 1.9 15.3 5.3 15.1 42.9 2.7 6.4 5.8 38.6 4.9 26.4 6.9 1.1 13.5 1.0 14.0 18.2 2.8 3.5 72.2 4.3 5.4 0.0 64.3 2.8 4.7 10.9 24.7 0.0 5.2 3.3 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SPICE1 "CCDC52, SPICE" ENSG00000163611 "Spindle and centriole associated protein 1" Q8N0Z3 3 113442718-113515187 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064843 Approved Supported Centrosome NA NA Centrosome "HPA064843: AB_2685367" "unprognostic (2.66e-1)" "unprognostic (1.27e-2)" "unprognostic (1.12e-1)" "unprognostic (4.95e-3)" "unprognostic (2.69e-1)" "unprognostic (1.01e-1)" "unprognostic (4.99e-3)" "unprognostic (1.17e-1)" "unprognostic (6.30e-2)" "unprognostic (2.24e-1)" "unprognostic (1.17e-3)" "unprognostic (1.89e-2)" "unprognostic (4.75e-3)" "unprognostic (6.53e-2)" "unprognostic (4.47e-1)" "unprognostic (3.64e-3)" "unprognostic (2.95e-2)" 8.1 6.3 9.3 13.4 8.6 6.1 11.7 17.8 8.4 14.0 9.6 8.1 20.6 6.4 16.3 9.8 10.2 13.5 11.1 8.3 8.9 4.9 7.8 7.7 11.5 6.6 7.1 7.6 15.3 11.2 12.5 40.4 7.7 8.6 11.6 10.9 7.8 15.0 19.6 5.1 10.2 8.9 11.3 9.9 6.8 10.5 10.5 8.9 17.1 12.9 4.7 10.7 13.2 14.4 8.5 12.0 4.5 5.4 3.2 9.3 2.5 15.8 10.4 13.0 11.1 8.0 9.8 9.2 8.3 5.7 10.1 12.7 8.7 9.4 10.0 10.6 6.8 10.1 15.4 6.7 7.7 14.1 6.2 3.6 9.3 10.6 6.1 4.0 16.9 7.0 6.8 7.7 10.5 4.7 10.3 7.4 17.5 5.6 8.5 4.3 16.5 14.4 8.0 12.7 13.6 12.5 11.1 9.7 7.9 4.4 11.2 7.1 12.0 8.9 9.1 5.4 13.2 10.3 8.0 7.2 7.3 9.7 4.9 7.0 8.5 5.5 14.2 11.1 10.1 8.2 4.5 5.4 1.9 4.5 3.7 6.9 7.3 6.7 5.2 3.7 8.5 9.3 6.9 2.8 3.2 3.4 12.0 3.2 2.5 9.3 8.6 17.8 8.4 8.9 4.9 7.1 7.6 8.6 8.9 0.0 3.4 9.0 6.6 6.1 6.8 2.0 2.5 12.0 3.4 5.2 7.9 3.8 0.0 3.8 4.7 3.5 4.9 0.0 3.8 4.0 5.1 5.5 1.1 3.9 3.8 3.2 3.5 2.5 2.2 2.1 9.2 4.8 0.0 0.0 8.1 10.1 4.4 3.5 3.2 2.8 27.6 6.5 4.8 17.6 11.8 6.8 2.9 4.3 6.8 7.1 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2354806 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 82.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: AB_2676429" "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favorable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 5.4 4.6 5.0 11.7 5.4 11.7 4.0 6.9 6.9 3.4 9.0 7.9 9.6 19.3 4.7 10.0 3.2 5.2 9.8 3.3 5.6 4.2 3.9 3.5 10.3 7.1 4.7 3.4 13.8 6.3 11.0 6.8 7.1 4.7 3.9 6.0 10.5 8.7 7.5 8.7 16.2 5.0 7.0 8.1 13.8 20.1 6.4 9.3 3.0 3.7 5.7 2.3 2.0 14.4 17.4 9.3 7.7 6.2 8.2 5.9 8.3 13.4 5.8 10.2 4.8 4.9 14.8 11.0 3.2 4.0 4.3 9.4 9.6 8.0 10.4 5.1 3.8 11.3 1.9 3.8 1.2 9.3 8.4 5.3 21.0 12.5 9.0 9.3 7.0 7.1 4.3 3.8 2.7 6.3 5.6 16.8 8.6 20.5 2.4 9.3 10.1 11.9 10.8 7.5 5.5 16.9 3.0 22.1 4.4 21.1 10.3 9.8 11.0 6.7 8.4 3.9 11.2 15.7 12.5 7.4 5.3 18.6 8.6 27.1 9.7 8.4 9.2 10.9 12.8 9.3 7.7 7.0 6.6 7.5 4.8 9.0 6.0 6.5 9.4 14.4 7.8 8.2 3.4 6.2 5.1 17.4 5.9 5.9 3.0 15.0 22.0 6.2 0.0 23.4 5.1 28.1 20.1 9.1 24.4 45.2 44.0 1.7 13.7 36.9 9.0 59.3 0.0 10.0 18.3 4.6 7.2 6.9 10.6 10.4 30.2 39.1 14.7 9.5 82.4 13.8 5.3 0.0 5.4 51.1 13.7 10.1 30.8 14.9 6.2 39.6 0.0 8.1 41.9 12.4 0.0 35.8 4.5 38.9 4.3 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523518-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Group enriched" "Detected in many" 5 "Early spermatids: 151.6;Late spermatids: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome NA NA Centrosome "HPA042324: AB_10794273, HPA075418: AB_2686749" "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favorable (8.34e-5)" "prognostic unfavorable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.16e-4)" "prognostic favorable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 7.7 9.3 5.7 5.5 9.0 8.6 8.2 12.1 7.9 8.1 6.9 10.0 7.2 5.5 10.0 7.8 6.1 7.9 6.0 8.6 5.6 5.9 6.3 7.6 5.7 5.3 6.1 5.1 9.4 11.6 5.2 12.8 6.4 6.3 7.3 8.0 9.4 7.0 9.0 10.2 8.9 6.2 7.9 6.4 5.2 5.8 49.0 7.0 4.6 11.8 4.6 5.6 6.8 7.7 4.2 3.5 0.3 2.1 6.9 5.2 1.9 4.8 1.5 8.7 6.1 11.9 11.8 2.1 6.3 4.8 2.7 4.0 2.8 4.8 2.1 2.6 2.5 8.1 3.4 10.2 8.1 4.1 3.1 6.0 5.9 7.6 1.8 6.8 5.0 6.4 2.2 2.0 3.1 6.4 6.4 8.7 7.4 3.4 6.9 11.0 1.9 2.6 2.0 3.9 2.3 5.3 4.2 4.6 0.8 5.5 6.0 6.4 3.9 3.4 4.7 4.4 1.6 3.6 3.0 8.3 6.2 6.1 8.0 6.0 1.8 1.3 2.1 5.6 8.0 13.5 0.1 1.8 0.2 2.4 2.1 3.9 4.2 3.6 1.8 1.7 1.8 5.2 2.8 0.3 6.9 1.6 3.5 2.4 1.9 5.7 9.0 12.1 7.9 5.6 5.9 6.1 5.1 6.3 7.0 20.8 8.1 4.5 14.2 15.0 16.4 6.1 20.4 12.0 13.6 8.7 5.9 11.0 8.3 7.6 151.6 11.9 5.1 0.0 7.4 5.7 9.2 11.9 8.1 6.8 7.5 23.8 5.2 4.9 7.8 193.4 16.7 7.5 20.3 4.6 9.5 19.1 6.4 3.5 15.2 5.7 22.0 19.4 7.6 33.6 11.3 15.9 5.1 8.7 9.7 9.3 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023265-132075943 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 41.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 5.4 1.4 1.1 13.5 5.1 25.9 3.3 3.8 1.1 18.0 6.4 0.3 34.8 3.7 42.3 29.6 11.7 6.0 5.2 1.9 1.2 2.3 3.5 3.2 6.7 12.8 1.2 0.3 4.7 4.0 10.2 5.8 50.7 1.2 11.5 4.8 2.2 6.3 22.4 1.2 5.1 6.1 19.1 1.5 8.5 4.7 5.2 0.8 44.7 2.3 6.8 10.2 18.0 6.6 8.4 6.2 26.4 11.6 22.0 13.3 10.2 9.1 3.2 0.4 0.0 1.5 1.4 21.0 0.3 1.1 0.1 0.1 8.4 8.3 12.5 5.7 2.0 6.5 10.4 23.4 14.7 0.0 10.8 19.1 18.0 7.9 7.9 1.4 37.6 1.5 2.0 8.8 0.0 9.9 4.4 4.1 17.2 8.0 11.8 3.5 8.1 38.7 35.0 18.8 6.2 1.2 28.0 11.6 16.1 9.5 14.8 7.8 8.6 5.5 5.0 0.2 17.0 6.4 9.9 0.1 3.8 4.0 11.4 13.5 9.1 14.2 13.9 3.4 41.0 1.9 26.4 5.1 16.6 13.3 6.7 13.0 8.4 9.1 11.3 6.2 7.3 11.8 12.2 10.0 22.0 11.6 2.3 4.0 10.2 1.1 5.1 3.8 1.1 1.2 2.3 1.2 0.3 1.2 0.8 20.8 14.1 8.6 27.8 0.0 0.0 1.1 5.1 12.0 14.8 10.4 0.0 44.8 3.3 4.4 0.4 0.4 0.9 0.0 6.3 28.5 4.9 17.5 10.5 3.0 10.7 0.0 1.2 0.6 10.1 0.0 3.1 7.2 0.0 9.0 6.4 0.0 8.6 3.5 2.1 1.2 0.0 6.5 2.9 1.1 2.3 0.0 49.4 17.5 6.3 15.3 STK32A "MGC22688, YANK1" ENSG00000169302 "Serine/threonine kinase 32A" Q8WU08 5 147234963-147387852 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 19.7;brain: 21.1;retina: 31.9" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 5.0;Melanocytes: 15.1;Muller glia cells: 4.6" "Cancer enhanced" "Detected in many" "melanoma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "RT4: 9.8;SK-MEL-30: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040236 Approved Centrosome NA NA Centrosome "HPA040236: AB_10795416" "unprognostic (1.90e-1)" "unprognostic (4.71e-4)" "unprognostic (5.32e-2)" "unprognostic (3.49e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (2.96e-3)" "unprognostic (4.85e-2)" "unprognostic (2.36e-2)" "unprognostic (3.87e-1)" "unprognostic (8.38e-2)" "unprognostic (2.50e-3)" "unprognostic (5.53e-5)" "unprognostic (2.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.67e-3)" 2.1 19.7 4.8 1.3 7.1 0.4 2.3 21.1 7.7 1.2 1.8 6.2 0.6 1.2 1.6 5.6 1.0 1.3 4.3 1.6 4.9 12.6 6.3 0.6 2.1 0.5 12.1 2.2 5.1 4.2 0.4 8.5 0.7 20.7 2.1 1.1 31.9 1.2 1.8 0.6 2.9 1.1 1.4 12.4 0.8 1.4 2.1 6.9 0.0 15.7 0.5 0.5 4.1 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 3.8 9.8 0.9 0.4 0.0 0.1 34.7 0.1 0.0 0.0 0.1 0.0 0.6 0.4 0.4 1.1 0.2 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.8 7.1 21.1 2.3 4.9 12.6 12.1 2.2 20.7 6.9 0.0 1.6 0.0 0.2 1.3 1.2 0.4 0.0 0.0 1.2 1.8 0.0 0.0 1.7 1.2 5.0 0.0 0.0 0.0 2.4 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.9 0.0 15.1 0.0 0.0 4.6 4.1 0.0 3.9 3.0 0.9 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.6 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.6 2.8 5.2 5.7 9.1 7.3 10.6 11.7 6.7 7.2 6.0 6.4 2.6 2.1 3.9 7.0 9.6 5.3 9.3 6.8 8.6 6.7 8.9 14.1 9.2 3.5 4.9 5.8 12.5 4.1 5.1 12.4 6.3 5.9 11.2 7.5 10.5 12.1 9.2 5.7 5.4 4.8 3.7 6.2 6.5 5.9 11.3 7.4 7.6 4.1 5.9 4.6 14.4 9.2 5.6 7.4 7.9 7.5 12.3 11.1 5.5 8.9 6.4 6.3 7.3 4.4 8.4 11.0 8.8 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 6.0 4.8 2.9 2.0 4.2 21.5 7.3 5.1 4.0 2.3 1.8 43.2 13.3 5.0 1.6 14.8 7.9 4.9 0.0 1.2 7.9 3.7 2.2 3.5 3.6 8.6 9.5 2.9 8.6 19.0 8.6 2.6 7.5 1.7 1.0 2.7 19.5 2.1 3.5 4.2 5.0 40.7 6.5 3.4 16.4 10.9 2.9 31.8 6.9 4.0 4.1 TBC1D31 "Gm85, MGC21654, WDR67" ENSG00000156787 "TBC1 domain family member 31" Q96DN5 8 123041968-123152153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 29.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 10.5;T-cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023710 Approved Approved Centrosome NA NA Centrosome "HPA023710: AB_1858819" "unprognostic (1.39e-1)" "unprognostic (5.44e-3)" "unprognostic (7.21e-2)" "unprognostic (3.18e-5)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.53e-2)" "unprognostic (6.59e-2)" "unprognostic (8.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.18e-4)" "unprognostic (1.78e-3)" "unprognostic (1.57e-1)" "unprognostic (1.76e-2)" "unprognostic (2.33e-1)" 3.8 4.4 6.7 9.7 10.9 7.3 3.6 13.5 7.7 3.2 5.2 4.5 5.2 6.9 3.8 2.4 4.6 7.5 3.6 5.3 7.2 5.7 4.4 3.8 3.9 11.0 5.5 5.6 2.9 5.4 5.5 8.4 2.7 7.5 3.4 6.3 5.6 3.6 4.1 3.7 4.7 5.9 4.8 4.7 7.4 3.9 9.2 4.7 29.0 5.1 5.2 10.3 5.2 4.1 2.4 2.6 3.0 3.3 9.5 16.8 4.0 10.8 4.6 8.2 6.4 2.8 3.1 4.0 5.9 3.5 7.8 7.1 4.3 4.8 5.0 4.6 2.5 4.9 7.0 7.8 3.9 10.9 10.3 7.7 11.9 4.9 3.7 4.4 5.4 8.4 2.5 2.3 6.4 6.6 2.1 5.5 14.6 9.9 12.1 5.5 8.7 16.9 3.6 6.3 13.7 7.9 8.3 7.3 5.3 5.2 2.9 7.6 5.9 13.1 39.2 4.0 5.6 6.2 4.5 2.9 6.1 12.6 5.0 8.6 9.5 13.7 6.0 5.0 9.8 9.1 2.7 3.1 3.0 8.3 3.3 16.8 2.4 3.8 6.3 2.6 2.3 4.7 5.3 1.6 9.5 1.4 1.6 3.0 4.0 6.7 10.9 13.5 7.7 7.2 5.7 5.5 5.6 7.5 4.7 0.0 4.3 2.2 0.9 0.5 3.1 10.5 0.0 2.7 1.2 1.8 5.9 1.1 0.0 1.4 3.5 1.0 0.9 0.0 1.0 2.1 1.8 0.5 7.0 1.7 3.3 0.0 2.9 0.6 7.5 1.7 1.4 2.1 1.7 3.6 1.9 1.0 0.9 0.0 1.4 1.8 5.7 0.0 2.3 8.4 2.4 1.1 0.1 12.8 2.7 0.3 TBX15 TBX14 ENSG00000092607 "T-box 15" Q96SF7 1 118883046-118989556 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.3;skeletal muscle: 84.9;tongue: 37.5" "Group enriched" "Detected in some" 4 "Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052245, HPA053713" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA052245: AB_2681771, HPA053713: " "unprognostic (1.94e-1)" "unprognostic (2.75e-3)" "unprognostic (1.92e-2)" "unprognostic (3.94e-2)" "unprognostic (5.72e-3)" "unprognostic (7.79e-2)" "unprognostic (5.82e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-3)" "unprognostic (1.39e-1)" "unprognostic (3.81e-3)" "unprognostic (5.03e-2)" "prognostic unfavorable (5.57e-8)" "unprognostic (2.63e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-3)" "unprognostic (2.31e-1)" 18.1 0.1 0.2 0.1 0.5 0.1 12.5 0.4 0.8 0.1 0.1 0.2 0.0 0.0 0.1 2.1 1.2 0.1 0.3 1.2 0.5 0.0 0.1 23.3 0.2 1.3 0.2 0.2 0.1 0.1 0.2 0.5 0.1 2.1 0.7 0.0 0.2 2.8 0.1 84.9 3.6 0.1 0.2 0.6 0.0 0.1 0.4 0.4 0.0 1.9 37.5 2.4 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 28.2 12.0 0.0 2.4 3.3 6.4 10.8 0.0 0.0 0.0 1.4 14.4 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 20.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.1 1.2 0.0 0.1 0.0 15.3 0.2 1.6 0.7 0.3 0.0 0.8 0.0 0.3 0.3 0.0 0.3 0.0 3.5 2.1 14.3 0.1 0.2 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.8 0.5 0.0 0.2 0.2 2.1 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 11.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.1 1.8 0.0 0.0 0.0 0.0 TCEA2 TFIIS ENSG00000171703 "Transcription elongation factor A2" Q15560 20 64049836-64072347 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043836 Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA043836: AB_2678694" "unprognostic (6.51e-2)" "unprognostic (2.02e-1)" "unprognostic (3.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.80e-1)" "unprognostic (4.91e-3)" "unprognostic (2.38e-1)" "unprognostic (2.91e-1)" "unprognostic (1.65e-3)" "unprognostic (9.03e-3)" "unprognostic (2.49e-2)" "unprognostic (9.67e-2)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.70e-1)" "unprognostic (2.28e-1)" "unprognostic (3.79e-1)" 14.8 19.5 31.4 7.9 32.8 6.6 9.3 34.7 40.4 18.3 11.7 17.7 11.0 5.6 18.8 10.9 8.4 24.5 13.5 19.1 27.7 30.0 14.8 27.5 10.9 9.2 27.2 32.8 30.3 16.1 18.6 17.9 14.7 26.5 16.9 3.2 14.5 17.9 22.3 30.7 10.4 7.8 11.7 18.3 16.2 10.5 32.0 18.9 8.7 15.0 6.1 5.2 10.9 15.4 9.7 3.0 4.4 2.6 3.6 5.5 1.6 7.6 8.3 13.2 22.4 11.8 7.4 5.4 8.0 8.9 14.1 6.8 4.9 13.6 8.7 18.0 9.2 8.1 20.5 5.2 6.8 2.8 5.4 10.5 3.3 14.5 12.8 17.6 3.6 4.6 11.5 6.1 3.6 4.7 18.9 9.6 10.9 5.7 16.4 4.3 16.6 14.8 17.7 8.5 9.3 20.0 14.5 10.0 22.5 7.1 5.1 13.1 22.1 8.1 5.5 20.0 4.4 15.2 9.1 13.7 25.5 13.5 14.3 4.9 19.1 12.5 4.6 22.7 4.2 5.0 2.4 1.7 4.4 3.6 1.6 1.6 9.7 3.2 2.6 2.1 5.0 5.5 3.4 0.8 3.6 2.6 3.0 5.4 1.6 31.4 32.8 34.7 37.6 27.7 30.0 27.2 32.8 26.5 18.9 0.0 1.9 12.3 28.6 20.0 50.6 26.9 22.9 6.7 7.9 68.0 25.5 21.6 91.2 30.0 85.6 40.8 1.7 0.0 13.9 11.1 39.4 27.1 2.3 35.5 14.9 62.0 18.3 33.7 14.8 118.7 48.1 23.3 59.1 21.6 2.8 84.3 20.7 2.5 46.3 82.3 30.1 25.8 42.9 95.9 31.9 17.7 17.4 13.8 1.7 17.4 TCHP "MGC10854, TpMs" ENSG00000139437 "Trichoplein keratin filament binding" Q9BT92 12 109900264-109983841 "Predicted intracellular proteins" "Apoptosis, Cilium biogenesis/degradation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038638, HPA061543" Supported Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA038638: AB_10670785, HPA061543: AB_2684556" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (2.58e-1)" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.59e-2)" "unprognostic (9.75e-2)" "unprognostic (1.15e-3)" "unprognostic (4.63e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.52e-4)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" 8.6 10.4 16.0 11.3 29.3 8.3 9.3 22.9 25.0 10.2 11.2 19.0 7.5 9.9 13.0 10.9 18.3 8.7 8.3 10.3 15.9 11.0 8.5 7.0 10.0 14.5 23.8 13.9 11.3 12.7 12.1 12.1 10.4 18.6 10.7 9.6 11.0 13.4 11.6 10.8 36.1 10.2 15.0 15.9 15.0 10.2 12.5 24.2 10.9 12.0 7.7 15.1 11.4 15.4 3.2 3.3 4.5 5.2 9.2 7.4 4.4 16.2 14.6 7.9 9.4 7.0 7.6 10.6 15.5 8.2 13.6 7.6 9.1 5.7 22.9 4.5 9.0 7.4 13.7 8.6 9.7 12.3 12.2 8.4 16.6 9.0 8.9 8.5 22.4 12.7 6.2 12.0 14.2 10.8 8.6 12.1 14.5 17.8 4.6 11.2 11.2 20.4 22.8 9.5 4.0 14.8 18.8 15.5 19.3 6.1 14.7 11.7 12.4 11.3 12.2 10.9 5.9 11.0 16.3 13.3 13.9 9.7 8.9 19.7 13.4 16.9 16.4 14.8 18.6 14.5 0.0 4.2 3.4 6.2 2.7 4.3 3.2 5.4 7.4 3.3 2.3 5.4 4.2 4.5 9.2 5.2 2.4 7.2 4.4 16.0 29.3 22.9 25.0 15.9 11.0 23.8 13.9 18.6 24.2 17.9 18.4 6.7 7.8 8.8 25.8 12.2 15.3 36.1 11.4 7.0 17.7 9.1 8.3 17.1 25.7 12.1 10.7 23.3 13.3 7.9 7.2 6.6 12.7 6.6 10.1 23.8 14.3 6.2 12.9 33.9 10.3 9.7 6.8 12.6 9.2 14.6 13.8 10.5 26.2 4.3 23.5 12.9 10.0 18.4 34.3 21.7 5.8 14.9 9.8 34.8 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 46.5" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.7 3.5 8.8 4.2 10.9 1.6 4.6 18.0 9.9 2.6 3.3 6.3 7.5 2.5 2.0 6.2 2.1 2.4 2.3 3.6 8.8 8.9 3.1 3.7 4.4 5.4 8.1 7.8 1.4 3.5 46.5 5.5 3.7 15.9 6.2 4.3 2.9 6.4 6.7 4.5 2.5 2.5 3.1 7.6 5.9 3.1 19.3 4.9 8.0 7.3 1.0 5.2 3.7 2.0 3.8 5.3 5.3 7.0 7.3 13.1 4.2 6.3 5.5 4.9 11.4 0.3 0.5 4.8 1.1 0.6 3.4 2.3 3.6 9.2 7.4 10.1 0.4 8.1 3.9 7.2 7.5 5.3 19.2 5.1 7.4 1.6 2.5 2.2 1.4 1.2 0.6 3.0 7.3 3.1 1.0 3.6 14.7 5.7 6.7 1.0 17.2 11.7 2.2 3.8 9.5 9.6 1.4 3.1 15.4 6.0 3.1 7.2 11.8 7.9 6.4 7.4 9.4 13.9 5.6 1.4 1.6 2.9 5.0 6.1 13.8 16.9 8.3 7.4 6.0 2.2 5.3 0.9 1.9 8.8 4.3 13.1 3.8 8.2 8.8 2.0 3.6 6.0 7.5 0.7 7.3 7.0 5.3 9.4 4.2 8.8 10.9 18.0 9.9 8.8 8.9 8.1 7.8 15.9 4.9 3.0 8.8 0.9 1.9 0.2 3.4 2.6 0.0 1.4 2.3 7.0 3.9 2.2 1.7 2.5 17.5 1.0 0.1 0.0 2.2 2.5 0.4 1.7 4.6 0.6 4.4 6.4 0.0 1.3 1.3 48.0 0.3 1.3 1.7 3.6 0.9 1.5 1.8 0.0 2.1 1.3 3.0 12.9 1.2 46.8 21.1 0.1 2.1 1.3 1.0 0.9 TGIF2 ENSG00000118707 "TGFB induced factor homeobox 2" Q9GZN2 20 36573488-36593950 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053786, HPA064522" Enhanced Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053786: AB_2682261, HPA064522: " "unprognostic (1.42e-2)" "unprognostic (8.27e-2)" "unprognostic (2.80e-1)" "unprognostic (2.10e-3)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (7.19e-2)" "unprognostic (4.88e-2)" "unprognostic (2.70e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (1.51e-1)" "unprognostic (3.75e-2)" "unprognostic (8.53e-2)" "unprognostic (1.22e-1)" "unprognostic (8.79e-3)" "unprognostic (1.14e-2)" 14.0 6.1 2.8 20.0 3.1 4.1 7.8 1.3 3.5 13.7 8.8 4.0 3.5 3.2 23.7 7.9 6.8 18.0 10.2 7.6 2.7 2.5 9.2 13.2 13.7 16.6 4.4 1.6 17.9 33.3 10.5 3.4 9.1 3.9 9.3 3.7 12.1 14.9 5.7 4.1 5.6 8.1 13.7 3.2 20.3 7.0 16.9 2.8 26.7 12.9 6.9 22.1 10.0 7.2 8.2 7.7 14.7 5.4 4.2 7.6 3.8 7.0 1.7 20.3 23.0 3.0 2.7 7.4 4.0 4.7 9.7 7.3 10.4 9.0 19.0 10.7 3.9 4.4 7.3 16.5 10.5 9.5 8.9 5.9 23.8 4.1 13.7 4.6 10.0 5.8 4.3 7.0 2.0 7.6 8.8 9.6 9.2 11.4 11.7 4.7 10.0 17.0 19.2 17.0 10.3 5.1 14.7 24.3 10.3 6.4 4.7 6.1 18.1 1.3 10.8 10.1 17.0 12.9 22.5 6.9 1.5 6.4 0.1 7.6 13.4 5.0 17.9 0.1 12.1 7.6 14.7 5.4 1.7 4.8 4.9 5.2 8.2 4.4 4.9 7.4 6.5 7.6 6.3 2.2 4.2 3.4 7.7 4.2 3.8 2.8 3.1 1.3 3.5 2.7 2.5 4.4 1.6 3.9 2.8 8.9 9.1 6.5 26.2 39.6 0.1 11.2 12.7 5.3 9.1 7.0 2.0 5.2 6.6 16.4 2.0 14.3 0.0 0.0 6.7 1.0 16.9 15.0 16.1 5.9 8.7 0.0 6.3 11.6 7.0 1.9 5.8 8.8 13.5 7.2 2.6 7.2 13.3 6.2 7.1 6.1 1.9 6.5 15.6 2.3 25.6 22.2 7.6 12.8 3.3 13.9 THAP6 MGC30052 ENSG00000174796 "THAP domain containing 6" Q8TBB0 4 75513946-75550473 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 108.2;Spermatocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035767 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA035767: AB_10696510" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.52e-1)" "unprognostic (6.89e-2)" "unprognostic (8.96e-2)" "unprognostic (3.37e-3)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (9.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.47e-2)" "unprognostic (8.54e-2)" "unprognostic (2.38e-2)" 15.7 14.9 11.5 18.7 17.6 14.4 18.6 21.2 17.0 18.4 17.0 24.4 16.5 14.9 20.2 23.8 15.5 15.6 13.5 17.2 12.0 11.9 17.8 21.9 13.1 17.9 21.9 14.0 19.3 14.9 19.9 30.9 24.3 17.8 18.3 14.5 17.3 17.0 13.3 20.3 20.8 21.1 18.8 19.2 17.8 13.1 26.5 21.3 18.0 20.4 16.9 15.2 16.5 14.3 10.7 7.1 18.5 8.7 6.8 13.6 6.5 6.9 5.0 11.1 7.7 12.7 12.5 6.3 16.6 8.6 8.7 9.1 6.3 17.4 10.1 8.6 5.4 9.8 7.4 9.9 7.9 10.7 11.5 6.9 7.3 8.2 8.0 17.5 9.8 8.3 10.5 13.8 9.9 15.4 14.0 4.7 12.1 12.6 20.9 9.2 8.1 8.9 6.7 6.3 9.7 5.1 8.7 12.2 7.0 8.1 5.9 8.5 8.8 7.8 10.7 9.2 9.7 11.6 8.2 5.7 14.9 9.9 17.2 8.5 18.7 9.2 9.6 10.4 7.9 12.5 14.6 8.7 12.2 9.8 7.5 13.0 8.9 11.9 9.2 7.1 10.7 13.6 10.4 18.5 6.8 8.0 5.9 13.0 6.5 11.5 17.6 21.2 16.5 12.0 11.9 21.9 14.0 17.8 21.3 11.9 8.3 14.8 14.8 7.3 20.4 15.1 10.2 22.7 9.1 21.0 29.5 8.4 13.3 7.2 108.2 7.9 9.3 0.0 5.6 7.9 10.4 10.1 10.4 8.5 6.5 15.9 12.1 8.6 13.9 18.2 13.0 10.9 6.8 6.4 10.3 14.3 6.5 7.8 10.6 10.2 17.2 0.0 9.9 56.5 15.1 5.9 6.4 10.1 7.4 6.4 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Cell type enriched" "Detected in some" 18 "B-cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Group enriched" "Detected in some" 55 "Daudi: 38.2;REH: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 0.0 1.4 39.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.0 1.2 0.6 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Group enriched" "Detected in some" 6 "AF22: 6.1;ASC diff: 8.7;Daudi: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 6.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 0.0 0.0 0.0 0.0 0.3 14.3 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 1.7 0.0 0.0 0.4 0.1 0.0 14.2 0.0 2.1 0.0 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM170B ENSG00000205269 "Transmembrane protein 170B" Q5T4T1 6 11538278-11583524 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.1" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 23.8;Kupffer cells: 40.6;Macrophages: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9" "Cell line enhanced" "Detected in many" "THP-1: 18.2;U-937: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055134 Uncertain Approved Centrosome NA NA Centrosome "HPA055134: AB_2682709" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.71e-4)" "unprognostic (6.67e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (4.62e-3)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (2.45e-5)" "unprognostic (3.49e-1)" "unprognostic (1.26e-1)" "unprognostic (4.27e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-4)" "unprognostic (3.97e-2)" 10.1 4.8 11.7 6.4 9.6 31.1 6.1 13.5 18.6 3.1 3.3 4.9 2.0 1.6 4.1 5.2 2.5 2.8 3.0 4.5 10.1 8.8 5.9 12.8 8.8 3.5 8.3 8.7 3.9 3.3 5.8 4.2 4.0 8.4 3.4 2.2 4.2 2.5 3.7 8.3 1.8 2.0 4.7 8.2 5.7 2.4 5.2 6.0 4.2 4.4 1.2 2.2 2.7 3.1 0.2 3.2 2.4 2.9 0.1 0.3 0.5 0.7 1.2 7.5 6.7 1.4 0.1 1.5 0.6 1.7 1.0 1.2 0.4 0.4 5.9 3.4 0.4 1.9 0.0 8.4 0.5 2.7 1.6 4.3 3.3 0.8 1.0 0.5 5.3 3.5 0.5 0.1 1.1 0.0 1.7 0.7 5.6 0.2 0.1 1.5 1.1 6.3 9.2 2.1 0.7 1.0 3.2 7.2 0.9 0.8 1.5 5.1 4.4 0.4 2.4 2.7 11.2 2.4 18.2 0.1 1.4 1.6 2.8 1.7 5.2 10.4 5.3 1.2 13.6 1.8 2.4 2.9 1.5 0.2 1.6 0.1 0.0 0.1 0.1 1.8 0.2 0.3 0.2 1.1 0.1 0.6 3.2 0.0 0.5 11.7 9.6 13.5 13.5 10.1 8.8 8.3 8.7 8.4 6.0 3.0 1.3 0.5 0.7 1.5 12.0 5.2 2.5 0.0 2.3 0.0 3.9 1.8 5.0 0.6 0.4 1.4 0.0 0.0 1.2 0.3 2.3 1.0 1.1 5.8 6.6 23.8 1.7 1.8 40.6 0.2 0.9 21.8 0.0 1.0 0.5 11.8 0.9 0.0 1.4 4.5 8.4 6.5 1.2 5.4 4.6 0.6 1.6 1.7 0.6 0.4 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.8;pituitary gland: 21.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.4 14.1 3.4 1.0 8.4 1.1 5.2 63.8 16.3 1.5 5.8 1.9 0.0 1.8 0.3 6.8 4.8 0.6 0.5 0.3 3.2 9.7 0.7 0.4 0.9 0.6 4.6 6.0 0.4 6.7 1.2 21.1 1.1 6.6 0.4 4.3 0.9 1.3 0.2 0.8 4.4 2.2 1.1 1.8 3.2 3.1 9.9 1.2 0.0 3.2 0.6 0.6 0.3 2.9 0.1 0.7 2.0 1.7 1.7 1.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 11.8 2.3 0.0 2.0 1.6 2.5 0.9 0.0 0.8 0.9 0.2 1.2 0.0 0.0 2.0 0.1 0.0 5.0 0.0 0.1 0.0 0.0 5.6 0.0 15.9 0.0 5.9 1.6 0.1 0.5 0.0 0.0 0.0 0.8 8.1 0.2 0.0 21.7 3.2 0.2 19.2 0.0 0.4 1.9 1.0 0.0 0.0 4.1 0.0 0.0 1.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.5 1.0 0.7 0.1 0.5 0.4 2.0 1.7 1.7 0.0 0.0 0.4 3.4 8.4 63.8 13.0 3.2 9.7 4.6 6.0 6.6 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 7.2 0.0 2.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 2.0 3.2 18.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.1 0.1 0.3 6.6 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 30.6;Hepatocytes: 28.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.5 0.7 1.3 1.8 6.3 2.2 4.8 1.2 1.1 1.3 1.7 0.9 1.0 0.6 0.9 11.2 8.8 2.5 5.9 1.2 4.0 3.7 0.8 1.7 2.1 1.3 1.8 0.5 9.2 6.0 3.5 0.8 2.4 6.4 10.0 0.9 1.9 2.4 6.0 2.8 12.6 1.1 5.1 2.1 3.9 1.8 0.8 4.9 1.3 2.2 8.4 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 6.0 2.4 0.8 0.4 3.0 7.6 0.5 30.6 0.0 1.2 0.0 2.0 0.4 0.0 0.9 2.0 1.7 5.2 0.0 0.2 0.3 1.1 1.1 0.0 28.9 0.9 9.5 10.3 0.0 6.2 3.6 0.9 1.7 3.3 1.8 1.9 1.1 0.8 0.0 0.4 0.8 3.6 0.0 0.5 1.6 1.1 1.9 0.2 4.6 1.9 1.7 TNFAIP3 "A20, OTUD7C" ENSG00000118503 "TNF alpha induced protein 3" P21580 6 137867188-137883312 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Inflammatory response, Ubl conjugation pathway" "DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 112.4" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002116 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA002116: AB_1858162" "unprognostic (5.50e-3)" "unprognostic (9.98e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-2)" "unprognostic (4.01e-2)" "unprognostic (9.47e-2)" "unprognostic (5.01e-3)" "unprognostic (4.40e-2)" "unprognostic (2.92e-2)" "unprognostic (2.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (6.06e-2)" "unprognostic (3.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" 27.4 6.0 1.5 58.6 1.8 112.4 17.2 0.4 1.5 7.7 15.7 3.2 2.6 5.1 9.7 7.3 12.7 12.1 17.0 11.7 2.1 1.3 6.8 8.1 45.1 38.8 2.1 2.6 37.5 7.2 2.1 3.7 14.5 4.6 13.8 6.3 7.2 8.2 3.5 10.7 20.5 17.2 8.2 3.8 25.9 8.0 9.3 2.1 38.6 5.7 9.2 31.4 23.3 9.5 7.1 18.6 10.0 9.7 7.5 20.5 9.0 8.9 1.4 0.5 0.8 3.0 5.1 2.1 5.1 19.9 1.4 1.8 9.9 2.9 2.0 13.1 5.8 31.8 6.8 0.3 14.7 2.6 14.5 0.5 2.0 5.1 5.8 3.3 2.7 3.6 4.6 2.1 16.8 16.0 1.7 0.8 5.3 4.0 48.1 2.4 0.5 14.7 11.5 0.3 0.6 0.4 41.8 10.4 1.4 4.3 4.3 0.2 0.0 1.0 1.5 4.3 2.1 1.0 3.3 4.0 14.4 1.7 12.9 2.9 15.5 35.9 4.1 5.2 3.4 1.7 5.6 9.7 5.5 14.8 7.1 20.5 6.2 15.1 13.3 10.3 7.1 10.0 7.4 10.0 7.5 3.7 18.6 14.7 9.0 1.5 1.8 0.4 1.5 2.1 1.3 2.1 2.6 4.6 2.1 35.7 83.1 25.1 141.6 688.4 1.0 4.2 30.6 41.5 26.1 0.0 27.5 5.5 1.7 50.3 2.3 27.0 39.0 0.0 23.4 88.6 55.5 117.9 248.4 10.2 45.4 0.0 11.3 45.4 74.2 2.4 6.4 241.1 123.2 82.0 12.5 1.7 27.9 8.2 5.6 2.2 13.3 6.5 87.3 0.9 2.3 651.8 19.3 101.2 8.5 60.3 TRAF5 RNF84 ENSG00000082512 "TNF receptor associated factor 5" O00463 1 211326615-211374946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 48.9;Early spermatids: 42.9;Late spermatids: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008052, CAB010277" Enhanced Supported Centrosome,Cytosol NA NA Cytosol Centrosome "CAB010277: AB_2287961, HPA008052: AB_1858230" "unprognostic (6.44e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.39e-2)" "unprognostic (6.44e-3)" "unprognostic (7.94e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.94e-10)" "unprognostic (3.72e-1)" "unprognostic (1.34e-1)" "unprognostic (1.71e-2)" "prognostic favorable (7.29e-5)" 7.5 3.1 3.9 33.6 6.5 3.1 6.1 1.2 4.6 11.1 11.6 3.3 9.9 4.2 24.3 17.4 6.1 17.1 10.4 4.5 3.4 2.3 5.3 1.9 5.4 22.7 1.9 3.1 8.6 19.4 1.7 3.1 4.4 5.3 8.7 8.1 9.6 13.3 17.8 1.6 2.9 15.5 21.4 1.9 16.5 8.6 5.6 1.7 15.9 3.1 4.1 27.4 12.0 6.5 14.7 0.9 5.3 0.3 13.1 11.9 4.8 3.8 2.9 5.2 4.6 4.6 3.3 1.8 5.5 6.6 8.0 7.2 1.4 7.7 11.8 3.2 8.7 4.1 0.7 9.7 0.9 4.0 22.7 3.5 0.6 4.2 0.0 6.6 1.8 8.7 3.9 1.7 4.3 1.3 12.1 5.6 10.4 4.7 5.6 2.2 3.0 5.1 2.1 6.2 6.1 2.4 7.8 7.2 10.9 6.1 2.7 9.2 9.6 4.1 0.2 11.8 20.0 2.9 0.2 3.4 5.2 4.1 1.7 6.1 1.6 2.3 12.6 1.4 0.0 1.9 5.3 0.2 0.3 6.3 0.2 11.9 14.7 7.9 8.4 0.9 13.0 7.2 7.0 0.4 13.1 0.3 0.7 10.8 4.8 3.9 6.5 1.2 4.6 3.4 2.3 1.9 3.1 5.3 1.7 11.9 11.1 48.9 3.5 3.3 1.0 2.0 0.0 13.4 10.3 10.4 0.0 7.1 0.0 0.7 42.9 7.4 1.6 0.0 8.4 1.7 8.6 2.6 14.0 0.0 8.4 0.0 14.3 6.2 3.7 38.6 13.3 7.5 8.5 23.4 10.9 0.8 7.3 8.6 25.8 0.5 0.4 12.9 10.3 3.0 1.1 3.4 1.1 26.3 10.2 1.6 TRIM2 "CMT2R, KIAA0517, RNF86" ENSG00000109654 "Tripartite motif containing 2" Q9C040 4 153152342-153339320 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 5.4" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "AF22: 28.6;NTERA-2: 23.5;RPTEC TERT1: 26.7;SK-MEL-30: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035853, HPA035854" Enhanced Approved Centrosome NA NA Centrosome "HPA035853: AB_10669533, HPA035854: AB_10669659" "unprognostic (8.94e-2)" "unprognostic (7.89e-2)" "unprognostic (6.21e-3)" "unprognostic (7.51e-3)" "unprognostic (2.07e-2)" "unprognostic (2.32e-1)" "unprognostic (1.16e-2)" "unprognostic (2.30e-3)" "unprognostic (5.30e-2)" "unprognostic (6.77e-2)" "unprognostic (1.93e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.58e-14)" "unprognostic (5.89e-2)" "unprognostic (1.17e-2)" "unprognostic (4.19e-2)" "unprognostic (4.13e-2)" 4.2 9.9 28.4 4.4 35.7 0.6 12.2 28.9 56.9 19.6 17.8 67.0 5.9 13.5 9.7 15.1 8.5 12.9 10.3 6.2 38.9 25.3 22.1 6.4 5.9 2.3 39.4 34.6 10.9 8.2 1.0 10.9 2.5 45.3 11.5 19.2 4.6 30.1 11.8 1.8 3.8 14.4 6.6 44.2 8.8 23.5 1.9 44.7 0.0 38.9 0.6 4.3 7.6 5.5 1.9 0.8 0.3 0.6 0.3 5.4 0.7 4.8 0.2 28.6 12.5 10.8 12.4 0.5 6.4 8.7 1.8 2.7 2.8 0.3 0.2 4.1 11.1 5.5 4.3 13.3 2.4 1.9 0.1 5.0 0.2 2.9 0.6 12.6 0.2 0.1 8.0 1.4 3.6 2.3 7.0 1.7 0.3 0.2 0.1 2.2 0.4 1.4 0.0 23.5 14.3 5.7 0.8 5.2 0.0 26.7 6.3 9.2 18.1 3.0 11.6 25.6 4.3 1.2 0.2 2.4 8.0 2.3 6.2 3.0 0.1 0.0 0.1 11.9 0.1 9.8 0.3 0.6 0.1 0.1 0.0 0.0 1.6 5.4 0.1 0.8 1.9 1.6 1.0 0.2 0.3 0.0 0.1 2.6 0.7 28.4 35.7 28.9 41.1 38.9 25.3 39.4 34.6 45.3 44.7 6.0 22.3 3.2 14.9 6.3 65.3 26.2 12.7 81.7 61.4 55.8 27.5 1.4 86.2 8.4 2.7 14.0 51.1 0.0 23.1 0.4 18.1 22.3 1.1 10.9 1.1 104.9 59.8 18.4 1.5 2.1 27.3 2.6 60.8 4.6 59.2 78.7 19.0 31.6 30.8 12.2 20.8 25.8 9.9 0.4 0.9 3.4 0.6 1.0 74.3 26.7 TRIM34 RNF21 ENSG00000258659 "Tripartite motif containing 34" Q9BYJ4 11 5619764-5644398 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in single" 24 "Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.5;SK-BR-3: 17.6" HPA077996 Approved Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" "unprognostic (8.66e-3)" "unprognostic (9.94e-2)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.71e-1)" "unprognostic (5.88e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.74e-1)" "unprognostic (9.16e-3)" "unprognostic (8.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.40e-1)" "unprognostic (6.76e-2)" 15.9 14.6 2.7 12.2 2.9 1.4 7.3 0.9 3.4 9.3 7.9 6.0 8.5 6.6 15.7 10.6 8.7 7.8 5.6 4.1 3.6 2.2 7.1 4.4 7.9 11.7 2.6 3.9 11.4 5.5 4.5 5.5 8.7 4.7 9.5 6.8 7.8 10.2 6.3 2.0 6.2 14.2 5.8 6.2 16.6 6.1 4.6 4.3 12.5 7.0 5.0 14.3 10.0 7.8 12.8 15.9 15.2 15.9 5.9 9.5 7.8 2.3 1.3 0.5 0.2 5.3 8.3 16.5 3.5 10.2 9.1 8.9 1.0 8.1 8.1 1.6 4.7 6.8 3.7 0.3 7.5 4.6 10.6 0.3 4.3 0.4 0.4 2.4 4.7 3.0 8.7 6.5 4.6 1.5 7.1 11.6 7.2 0.2 0.6 4.3 1.0 4.2 2.7 0.0 3.2 0.7 6.3 0.3 0.5 5.4 6.2 0.0 0.0 0.1 17.6 2.6 1.6 3.1 2.3 9.3 2.4 0.5 0.9 1.3 0.9 1.1 3.1 6.8 0.6 1.2 8.7 14.3 3.6 5.6 15.9 6.1 12.6 5.4 6.9 15.9 12.8 6.8 5.7 15.2 5.9 13.5 8.1 9.5 7.8 2.7 2.9 0.9 3.4 3.6 2.2 2.6 3.9 4.7 4.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TRIM38 "RNF15, RORET" ENSG00000112343 "Tripartite motif containing 38" O00635 6 25962802-25991226 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "B-cells: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031685 Approved Approved "Plasma membrane,Cell Junctions,Centrosome" NA NA Centrosome "Plasma membrane, Cell Junctions" "HPA031685: AB_10603218" "unprognostic (6.62e-2)" "unprognostic (1.65e-3)" "unprognostic (3.34e-1)" "unprognostic (2.72e-2)" "unprognostic (1.25e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (3.27e-2)" "unprognostic (2.78e-2)" "prognostic favorable (8.95e-5)" "unprognostic (2.81e-2)" "unprognostic (6.28e-2)" "unprognostic (2.73e-1)" "unprognostic (3.36e-1)" "unprognostic (4.49e-2)" "prognostic favorable (8.20e-5)" "prognostic favorable (4.94e-9)" 13.3 8.4 2.5 15.7 2.3 12.0 7.9 1.1 3.4 17.2 12.1 3.1 20.5 6.7 26.2 22.3 15.7 8.9 9.2 5.8 2.8 2.3 26.1 8.8 14.0 14.4 3.7 1.8 11.5 4.3 1.0 4.3 10.3 3.5 15.5 7.8 9.2 9.8 16.5 9.0 5.3 14.6 13.1 4.5 17.6 6.6 5.3 2.9 16.6 13.7 9.5 20.1 18.0 15.4 16.5 10.1 12.1 12.9 6.7 7.9 6.3 3.5 2.0 0.3 4.3 10.4 13.9 3.6 4.5 9.0 8.8 14.6 1.6 3.8 7.9 7.4 5.5 8.5 5.6 2.7 4.4 5.2 8.0 1.8 3.6 3.3 1.4 13.8 4.2 7.4 13.9 3.3 5.4 1.9 7.3 7.6 3.9 2.3 4.4 10.4 1.7 4.0 4.8 1.4 0.0 2.7 6.2 4.3 8.2 10.4 7.1 0.1 0.1 3.4 7.1 12.0 0.5 1.0 5.5 7.7 1.6 2.7 2.7 3.0 5.1 3.7 8.9 4.3 5.2 9.7 10.1 10.6 4.7 7.6 12.9 7.4 14.3 6.5 6.8 10.1 16.5 6.2 6.7 12.1 6.7 11.4 9.5 7.9 6.3 2.5 2.3 1.1 3.4 2.8 2.3 3.7 1.8 3.5 2.9 23.8 43.9 100.5 47.4 13.3 0.6 3.5 22.9 17.4 29.6 43.6 0.0 19.8 14.9 19.1 0.9 42.0 39.9 0.0 13.0 17.5 17.0 35.9 34.6 14.8 28.8 0.0 17.4 27.0 84.3 2.2 18.4 61.3 10.1 49.5 29.9 0.3 17.8 40.3 17.7 62.8 0.7 6.5 18.9 0.2 0.2 8.2 17.7 36.2 23.3 78.5 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "kidney: 30.3;salivary gland: 9.5;testis: 8.0" "Cell type enriched" "Detected in single" 9 "Ciliated cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "A549: 10.1" HPA077996 Uncertain Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" 0.9 0.7 0.4 0.6 0.4 0.1 0.9 0.4 0.4 1.4 0.4 0.0 0.7 0.8 1.5 1.6 1.9 0.7 0.2 1.4 0.4 0.3 30.3 0.4 0.7 0.1 0.3 0.0 1.7 2.7 1.1 0.4 1.4 0.3 1.5 0.2 2.2 9.5 1.9 0.4 0.4 0.6 1.9 0.4 1.1 0.4 8.0 0.0 0.0 1.7 0.0 1.5 1.1 0.5 0.5 1.5 1.3 0.8 0.9 0.2 0.2 0.0 10.1 0.0 0.0 0.2 0.8 1.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 1.1 0.0 0.0 0.7 0.6 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.2 0.2 0.1 0.4 0.0 0.1 1.5 0.5 0.1 0.1 1.3 0.9 0.4 0.3 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.6 0.0 0.5 0.1 0.3 0.6 5.4 0.2 0.0 0.0 0.0 4.3 1.0 0.2 1.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.3 0.5 0.1 13.3 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 5.6 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.8 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 0.0 4.5 1.4 4.0 16.7 0.8 2.4 2.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 1.6 10.8 0.0 0.0 0.7 4.3 2.9 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 2.8 2.2 6.8 0.0 0.7 2.0 0.8 0.8 3.2 0.8 0.9 0.0 0.9 0.0 1.1 21.5 0.5 2.1 0.6 2.2 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484432-12539623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.8 10.6 9.7 8.8 19.1 6.7 10.9 16.5 14.0 10.4 9.8 12.7 8.4 5.8 14.0 9.9 7.9 12.8 10.3 14.3 10.5 12.3 9.8 7.3 7.3 10.9 11.5 7.6 18.0 11.9 14.3 15.3 4.9 10.2 10.5 10.9 13.5 7.2 13.1 16.7 15.3 6.1 12.3 12.3 6.1 8.5 11.3 9.1 9.9 12.5 9.6 8.1 8.6 8.3 8.5 7.1 2.6 4.2 5.0 13.7 5.6 7.8 13.7 7.4 9.6 12.5 13.3 17.0 7.4 6.6 8.0 5.8 7.7 8.4 9.4 5.2 6.0 9.5 7.3 12.3 12.7 9.1 7.4 15.2 10.3 18.3 7.9 9.6 16.2 4.0 11.5 14.8 14.5 17.8 5.9 6.4 13.8 15.3 5.2 9.2 14.8 12.4 7.4 10.4 22.2 16.5 9.4 5.1 18.9 11.9 8.1 4.8 8.4 6.9 6.2 5.8 5.3 11.2 11.3 5.7 5.1 5.0 6.9 11.5 4.9 12.5 11.8 6.8 16.4 6.3 2.4 4.2 0.3 6.4 4.2 10.9 8.5 9.8 7.4 5.9 8.3 13.7 11.7 2.6 5.0 3.6 7.1 3.5 5.6 9.7 19.1 16.5 14.0 10.5 12.3 11.5 7.6 10.2 9.1 3.0 3.5 10.9 9.7 2.6 27.2 6.2 15.3 9.4 2.3 10.4 41.2 7.4 1.7 4.9 1.3 5.6 2.6 0.0 3.7 3.2 3.8 5.0 4.7 5.5 4.1 9.5 4.1 3.1 4.0 2.1 8.3 3.2 3.3 1.0 4.7 8.7 3.5 3.5 9.6 5.0 33.9 6.5 5.1 10.3 19.3 4.3 1.6 5.7 8.2 8.0 TTC30A "FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612992-177618966 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.7 4.1 3.8 1.5 7.1 0.4 5.6 2.2 7.1 4.2 3.4 5.9 7.8 2.2 5.0 10.9 2.4 8.4 4.8 4.4 3.7 4.2 6.9 4.6 3.7 1.4 3.6 6.6 5.5 4.4 11.6 8.1 1.9 4.8 3.9 3.3 5.0 8.1 4.0 3.5 1.9 2.5 3.6 3.0 1.7 3.6 24.5 2.1 2.6 9.6 4.6 1.7 3.1 1.7 0.5 1.6 1.9 1.6 0.2 2.7 1.0 5.7 3.3 3.3 0.0 6.7 5.6 2.4 2.8 8.1 5.0 5.3 1.0 4.2 1.3 5.4 4.8 6.8 4.8 2.2 6.1 5.5 0.4 1.8 1.1 1.6 1.4 2.7 1.4 1.3 3.4 4.0 2.8 1.1 4.8 2.3 2.9 0.8 0.5 3.5 2.9 4.4 2.6 1.8 2.0 1.2 2.9 8.8 0.6 6.3 1.5 10.8 7.2 2.5 4.9 3.0 8.1 2.8 1.4 2.1 3.1 1.9 3.4 2.3 2.2 2.1 0.4 7.7 0.1 3.0 0.0 1.3 1.9 0.4 1.6 0.1 0.4 0.1 0.4 1.6 0.5 2.7 1.2 0.7 0.2 1.3 0.6 1.0 1.0 3.8 7.1 2.2 7.1 3.7 4.2 3.6 6.6 4.8 2.1 8.9 1.9 0.0 1.1 0.7 2.2 3.1 2.5 29.4 4.5 7.0 2.0 0.8 1.7 4.1 31.2 1.4 1.7 0.0 3.5 0.7 1.5 1.0 0.0 2.9 0.7 15.9 6.9 4.3 0.3 6.8 2.0 0.2 1.7 0.0 2.5 10.6 2.4 0.0 2.1 3.8 11.3 0.0 0.9 33.6 4.6 0.4 0.2 0.0 2.3 0.3 TTC30B "fleer, FLJ30990, IFT70B" ENSG00000196659 "Tetratricopeptide repeat domain 30B" Q8N4P2 2 177548998-177553014 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 42.8;Spermatocytes: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (2.15e-2)" "unprognostic (9.10e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.89e-2)" "unprognostic (3.26e-1)" "unprognostic (5.45e-2)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (5.27e-2)" "unprognostic (9.77e-2)" "unprognostic (9.61e-2)" "unprognostic (9.25e-3)" "unprognostic (1.65e-1)" 2.4 4.6 4.4 1.9 4.9 0.7 10.5 3.2 5.1 4.8 4.0 7.7 3.8 3.1 4.9 8.9 3.7 13.2 4.5 2.3 3.9 3.8 10.8 4.3 5.5 2.5 3.1 1.5 6.0 5.2 8.0 7.0 3.3 3.4 3.5 3.7 4.5 4.4 4.2 1.2 3.0 3.7 3.1 5.2 3.1 4.7 11.5 2.9 7.7 10.4 1.6 2.8 3.3 2.2 3.2 3.9 6.5 3.4 1.9 2.2 1.6 2.8 4.3 5.7 1.1 5.1 6.0 3.9 1.8 5.3 4.7 5.0 2.4 7.1 1.1 4.7 3.3 5.4 7.0 6.8 7.2 4.5 1.6 3.4 2.0 2.7 2.1 4.3 2.5 3.5 4.9 6.8 4.6 3.5 5.7 3.7 5.4 2.6 1.0 2.8 4.8 5.0 3.9 2.6 3.9 1.1 3.9 4.9 1.2 7.0 3.1 13.9 7.8 2.1 4.9 3.3 8.1 5.0 4.8 3.2 2.6 1.4 3.3 1.5 2.6 2.9 0.3 5.9 1.0 4.3 6.5 3.4 2.8 1.7 3.3 1.1 1.4 1.2 1.8 3.9 3.2 2.2 2.2 2.0 1.9 2.2 2.8 1.0 1.6 4.4 4.9 3.2 5.1 3.9 3.8 3.1 1.5 3.4 2.9 3.0 2.9 0.5 0.4 0.6 2.1 0.8 5.1 42.8 9.1 0.0 2.0 2.1 5.0 3.6 6.2 1.6 2.3 0.0 2.5 1.1 2.1 0.5 1.1 2.4 1.1 4.8 1.2 2.5 1.8 4.0 1.4 1.0 1.7 0.0 2.5 6.6 2.4 0.0 2.1 3.7 11.0 0.0 1.3 23.3 3.4 0.6 0.5 0.5 2.3 0.1 TTC39A "C1orf34, DEME-6, KIAA0452" ENSG00000085831 "Tetratricopeptide repeat domain 39A" Q5SRH9 1 51287258-51345116 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 357.0;Late spermatids: 452.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 23.4" "Lineage enriched" "Detected in single" 46 "dendritic cells: 23.4" "Cell line enhanced" "Detected in some" "HDLM-2: 21.9;MCF7: 17.2;SK-BR-3: 53.6;T-47d: 38.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028098, HPA043440" Uncertain Enhanced Centrosome NA NA Centrosome "HPA028098: AB_10601705, HPA043440: AB_2678483" "unprognostic (5.05e-2)" "unprognostic (1.95e-1)" "unprognostic (3.35e-2)" "unprognostic (7.60e-2)" "unprognostic (8.53e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (8.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.89e-2)" "unprognostic (1.73e-3)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 1.2 4.9 3.2 6.0 5.5 0.6 23.4 0.7 4.3 8.5 18.0 0.2 8.1 3.3 1.4 10.4 10.4 4.5 17.9 8.3 3.3 7.4 40.4 3.1 12.4 0.5 4.2 2.4 0.9 22.3 6.1 12.1 0.9 10.1 12.3 20.2 3.1 10.1 10.7 2.2 5.6 4.5 0.8 4.9 0.3 18.7 28.2 2.0 0.2 5.5 8.5 6.2 5.0 5.0 0.1 23.4 0.5 0.0 0.0 0.0 0.2 2.2 1.3 0.2 0.1 0.1 0.2 9.5 0.1 0.0 0.0 0.0 5.8 0.9 0.0 4.2 0.1 0.1 0.0 1.2 0.0 0.0 21.9 4.4 0.1 0.5 1.1 0.4 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 17.2 0.2 0.0 1.6 11.9 0.2 0.0 0.0 1.4 9.4 2.9 7.9 0.7 0.1 53.6 0.5 0.7 38.8 0.2 0.2 0.1 1.0 0.1 0.1 2.2 2.9 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 23.4 0.0 0.2 3.2 5.5 0.7 4.3 3.3 7.4 4.2 2.4 10.1 2.0 3.0 25.1 1.5 3.8 1.3 1.3 11.3 7.6 10.7 4.5 8.7 0.0 0.4 10.0 31.3 357.0 1.4 9.5 23.3 46.7 4.0 0.6 16.7 3.5 0.6 1.6 0.0 39.7 0.6 0.3 452.0 2.3 0.8 0.0 4.6 53.2 1.7 28.2 8.6 2.5 21.6 6.2 6.5 1.4 6.0 5.9 5.6 2.9 1.3 17.1 11.4 TTC6 "C14orf25, NCRNA00291" ENSG00000139865 "Tetratricopeptide repeat domain 6" Q86TZ1 14 37595847-38041442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 9.7;prostate: 20.5" "Cell type enhanced" "Detected in some" 14 "Club cells: 18.2;Early spermatids: 30.4;Late spermatids: 14.0" "Group enriched" "Detected in some" 7 "breast cancer: 2.2;prostate cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 7.3;MCF7: 10.7;RT4: 7.5;T-47d: 20.7" HPA069293 Approved Centrosome NA NA Centrosome "HPA069293: AB_2686110" "unprognostic (7.92e-2)" "unprognostic (6.95e-2)" "unprognostic (9.22e-2)" "unprognostic (1.98e-1)" "unprognostic (7.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.68e-1)" "unprognostic (3.60e-4)" "unprognostic (6.75e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-4)" "unprognostic (5.60e-2)" "unprognostic (8.91e-8)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-1)" "unprognostic (6.07e-3)" 0.0 0.0 0.3 1.3 0.6 0.0 9.7 0.3 0.6 0.2 2.2 0.2 0.0 0.6 0.0 1.3 0.6 0.4 1.0 0.0 0.8 0.9 0.0 7.9 5.6 0.0 0.7 0.4 0.4 0.0 0.0 1.1 0.3 0.1 20.5 0.5 0.0 3.0 1.1 0.0 0.8 1.2 2.5 0.6 0.0 3.8 6.0 0.0 0.0 0.0 0.6 2.3 2.2 4.6 0.6 0.2 0.4 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.4 0.0 0.0 2.2 1.2 0.2 0.0 0.0 3.1 0.0 0.9 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 10.7 0.0 0.0 0.0 1.5 4.0 0.0 0.0 0.0 1.0 7.5 2.2 0.0 0.0 4.1 0.0 0.0 20.7 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.3 0.6 0.8 0.9 0.7 0.4 0.1 0.0 0.0 6.7 0.0 2.6 0.0 0.0 0.6 2.5 8.1 18.2 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 2.5 0.0 0.0 7.5 0.0 0.0 14.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.8 2.7 TTI2 "C8orf41, FLJ23263" ENSG00000129696 "TELO2 interacting protein 2" Q6NXR4 8 33473386-33513601 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023523, HPA029823" Approved Enhanced Centrosome NA NA Centrosome "HPA023523: AB_1845776, HPA029823: AB_10602337" "unprognostic (6.30e-2)" "unprognostic (3.09e-2)" "unprognostic (9.34e-3)" "unprognostic (5.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" "unprognostic (4.25e-3)" "unprognostic (2.64e-1)" "unprognostic (3.10e-1)" "unprognostic (2.97e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.07e-2)" "unprognostic (2.05e-1)" "unprognostic (1.94e-1)" "unprognostic (9.35e-2)" 10.7 13.1 8.0 9.7 12.2 12.0 10.7 11.1 13.5 11.0 9.3 11.2 6.4 8.7 11.8 10.9 11.4 10.5 7.3 12.7 9.4 7.5 10.7 14.0 9.3 14.9 10.1 10.5 10.9 9.9 11.7 16.5 9.2 9.6 9.8 9.5 11.4 12.1 8.7 14.8 11.0 10.5 9.8 10.7 14.3 9.7 25.7 9.0 22.9 13.2 7.6 17.1 10.3 10.2 22.1 36.7 19.3 14.6 17.2 19.3 24.0 5.2 9.8 12.8 12.7 9.4 6.7 5.4 7.9 9.0 13.3 13.2 7.5 4.4 14.9 12.0 5.8 11.8 9.3 20.5 9.2 11.8 6.7 6.2 8.9 5.8 7.9 10.5 8.1 9.0 5.5 11.8 9.9 9.0 8.0 11.5 19.0 13.5 11.9 9.2 10.5 24.5 8.6 17.1 14.4 6.5 16.7 10.4 7.1 7.3 5.6 15.7 8.3 7.7 7.2 9.6 12.1 7.3 6.7 7.5 8.2 7.3 8.5 7.5 6.5 6.3 22.2 8.1 8.3 8.8 10.4 14.1 19.3 15.7 14.0 16.1 19.2 16.0 15.6 11.9 22.1 19.3 18.1 13.0 17.2 14.6 36.7 15.2 24.0 8.0 12.2 11.1 13.5 9.4 7.5 10.1 10.5 9.6 9.0 6.0 4.5 7.8 6.7 4.7 5.4 0.5 0.0 9.4 6.8 7.0 19.6 8.4 3.3 8.0 8.9 5.8 3.8 0.0 8.0 7.9 5.8 4.4 3.5 4.3 8.3 6.4 2.9 3.1 4.3 1.7 6.4 6.0 5.0 13.6 4.8 6.0 5.9 2.9 7.1 6.8 10.9 6.5 3.8 27.2 10.4 7.0 7.3 6.1 5.3 4.2 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278630-133312337 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Ciliated cells: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.3 26.7 16.7 17.3 25.6 29.4 21.4 28.6 33.4 20.3 19.3 22.5 25.2 19.2 23.2 18.9 19.8 35.1 21.7 18.6 21.9 17.2 24.4 22.2 22.8 27.7 16.3 26.5 28.3 30.9 31.9 23.0 17.0 22.3 20.8 16.0 19.0 26.8 22.3 30.4 24.1 19.7 17.6 16.7 25.6 20.1 33.5 15.4 25.6 23.0 18.3 19.5 19.3 18.2 6.1 14.3 17.3 11.9 12.1 10.4 8.7 18.3 25.5 9.4 9.6 10.1 11.0 12.1 14.4 23.4 17.8 18.0 26.6 12.9 13.9 8.1 16.4 6.5 12.4 12.6 11.8 7.9 13.0 24.1 8.9 12.6 14.6 12.7 19.0 16.4 11.4 10.3 16.5 20.6 18.1 11.7 9.2 10.8 11.3 14.4 25.1 10.4 21.0 8.2 12.0 20.3 8.3 11.0 6.0 11.6 9.6 6.5 12.8 10.3 11.6 11.5 6.0 8.4 9.7 14.1 8.7 7.8 11.4 12.8 11.3 7.7 16.2 34.9 8.6 5.5 5.0 11.9 11.9 7.6 11.2 8.5 6.0 7.6 8.0 14.3 6.1 8.7 9.0 17.3 12.1 11.8 6.5 10.4 8.7 16.7 25.6 28.6 33.4 21.9 17.2 16.3 26.5 22.3 15.4 44.7 36.3 20.8 22.9 12.4 41.4 30.5 22.9 143.2 43.3 38.4 29.5 33.5 19.9 30.5 19.9 21.8 31.4 23.3 32.0 27.4 24.7 25.0 38.2 26.3 41.0 36.5 28.2 28.3 39.5 22.0 31.4 45.0 13.5 75.7 32.6 38.3 28.6 31.7 33.2 44.0 69.1 32.3 15.9 63.2 56.2 12.0 35.6 26.1 32.4 26.7 TUBGCP4 "76P, FLJ14797" ENSG00000137822 "Tubulin gamma complex associated protein 4" Q9UGJ1 15 43369221-43409771 "Disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043212 Approved Supported Centrosome NA NA Centrosome "HPA043212: AB_10796690" "unprognostic (1.34e-2)" "unprognostic (3.57e-2)" "unprognostic (4.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (3.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.09e-2)" "unprognostic (2.91e-2)" "unprognostic (5.65e-1)" "unprognostic (1.73e-1)" "unprognostic (7.49e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-1)" 8.2 9.6 10.9 10.4 16.2 9.6 11.6 23.6 19.4 11.6 9.9 9.4 4.3 10.7 11.6 8.4 10.9 10.9 6.8 10.8 9.8 13.1 9.4 12.8 7.9 9.6 11.4 9.2 12.6 15.2 19.4 14.1 8.5 13.3 10.6 12.2 11.8 11.5 9.1 14.6 10.5 9.8 11.4 8.6 8.4 9.1 10.9 11.6 12.6 10.7 8.8 12.1 10.0 9.1 3.9 5.8 14.5 3.3 5.4 4.2 2.5 11.2 3.5 8.6 8.8 8.5 9.2 6.6 6.5 4.7 9.1 9.1 11.3 7.0 7.1 9.9 5.5 12.7 18.8 18.0 11.5 10.6 11.7 17.2 18.3 20.1 9.8 7.1 12.5 11.5 5.0 11.6 9.3 13.0 7.2 7.3 11.8 17.3 6.1 6.6 3.9 10.0 9.7 4.0 19.0 14.2 13.6 11.3 10.4 5.9 10.8 23.0 7.9 7.9 15.4 2.7 5.7 9.0 9.8 6.0 8.6 8.9 11.8 14.2 6.6 7.5 12.4 8.0 18.2 9.6 0.1 2.7 14.5 4.2 3.3 3.1 3.9 3.2 3.0 5.8 3.6 2.4 3.5 0.3 5.4 1.6 3.1 3.5 2.5 10.9 16.2 23.6 19.4 9.8 13.1 11.4 9.2 13.3 11.6 17.9 12.6 18.2 11.4 9.7 28.3 1.2 12.7 13.4 14.8 15.7 21.6 14.0 6.6 10.2 24.5 6.8 7.2 0.0 8.5 12.0 9.9 11.5 11.5 9.6 6.0 52.4 13.8 11.1 5.7 32.2 14.1 6.5 3.3 5.4 8.2 14.2 10.0 10.5 11.7 4.4 54.3 6.5 9.8 20.9 14.2 7.9 9.6 12.1 15.6 13.9 TUBGCP5 "GCP5, KIAA1899" ENSG00000275835 "Tubulin gamma complex associated protein 5" Q96RT8 15 22983192-23039673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 36.2;Spermatogonia: 33.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039366, HPA040366" Supported Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA039366: AB_10673243, HPA040366: AB_2676942" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.30e-1)" "unprognostic (4.27e-3)" "unprognostic (2.94e-1)" "unprognostic (2.79e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.27e-1)" "unprognostic (1.42e-2)" "unprognostic (1.18e-2)" "unprognostic (6.40e-2)" "unprognostic (1.13e-2)" "unprognostic (9.53e-3)" 5.1 5.7 5.7 5.1 8.4 5.5 7.3 4.0 10.4 7.9 4.6 6.0 4.6 4.2 7.4 8.7 5.9 4.9 4.7 6.6 7.7 6.3 6.8 5.6 5.5 6.0 11.0 5.0 10.0 10.2 6.3 4.8 12.9 7.5 5.3 5.3 4.0 7.4 14.5 7.3 3.0 9.3 10.0 4.8 5.3 12.9 5.9 5.4 8.6 7.0 6.1 4.6 0.8 5.3 4.0 1.5 3.3 5.4 7.6 2.5 12.2 13.0 15.4 9.0 11.9 7.8 8.9 15.3 16.9 17.0 14.7 9.9 5.8 9.3 6.6 14.0 8.9 12.4 10.1 11.9 14.2 14.4 4.0 16.8 13.1 5.3 4.0 17.0 7.4 12.7 4.5 11.3 10.5 5.5 10.1 16.7 11.8 15.1 10.7 8.0 11.4 7.4 9.1 12.2 11.9 14.1 16.9 1.9 9.8 19.2 5.2 9.0 12.5 8.8 8.0 7.9 14.2 8.0 8.7 11.6 7.6 9.0 22.6 11.9 11.9 25.1 15.3 11.3 10.9 0.2 2.3 0.9 4.5 3.3 4.6 3.7 6.7 7.2 3.6 5.3 6.0 7.6 1.5 5.4 3.3 4.0 5.4 2.5 14.9 15.3 5.1 2.9 3.0 27.8 10.3 5.1 9.4 6.8 5.2 13.7 6.6 5.0 5.5 5.7 5.7 2.2 0.0 4.1 6.0 4.7 1.6 5.8 7.5 6.5 9.5 4.1 6.7 5.9 9.8 10.3 5.8 3.3 2.8 4.6 13.5 5.8 3.4 12.0 5.3 18.4 0.0 6.7 36.2 33.1 2.4 2.9 5.1 4.2 1.6 TWSG1 TSG ENSG00000128791 "Twisted gastrulation BMP signaling modulator 1" Q9GZX9 18 9334767-9402420 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 91.3;Peritubular cells: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014898 Uncertain Supported Centrosome,Cytosol "Secreted - unknown location" No No 6600000 "Centrosome, Cytosol" "HPA014898: AB_1858467" "unprognostic (2.55e-1)" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (8.95e-3)" "unprognostic (2.92e-3)" "unprognostic (1.83e-1)" "unprognostic (8.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" 13.0 8.9 8.3 6.9 8.5 2.9 17.3 5.0 6.2 21.9 17.4 9.3 56.2 4.7 33.0 21.5 19.0 14.4 16.4 9.2 8.4 7.1 19.8 4.8 12.6 6.6 11.0 6.1 20.4 4.4 12.7 11.4 10.7 9.1 26.5 10.2 10.6 9.4 34.8 6.1 7.6 8.6 36.0 12.3 9.4 12.0 13.0 8.1 4.3 20.5 8.7 6.8 26.0 17.9 3.3 7.8 7.5 4.1 4.1 7.5 3.1 15.0 5.5 15.8 7.8 31.3 28.3 7.3 28.9 36.0 15.9 22.8 5.8 19.9 2.1 14.7 38.1 10.3 5.3 15.5 11.4 29.3 5.9 4.3 3.9 4.7 2.8 27.8 2.8 8.1 28.7 9.4 13.3 6.4 21.8 24.6 2.1 5.9 4.0 40.6 4.6 3.0 3.4 5.1 8.9 4.5 5.4 16.2 1.3 18.0 20.2 2.1 5.5 22.7 6.3 6.0 6.9 7.1 6.6 20.3 29.2 14.6 27.3 17.9 5.8 5.1 4.1 17.9 3.9 10.2 7.5 4.1 5.8 6.7 2.2 4.4 3.3 3.2 6.8 7.8 2.8 3.8 7.5 2.0 4.1 0.7 7.8 1.4 3.1 8.3 8.5 5.0 6.2 8.4 7.1 11.0 6.1 9.1 8.1 23.8 20.2 4.8 20.9 35.1 4.7 6.5 10.2 6.7 18.2 71.5 0.0 5.0 1.7 8.5 91.3 12.0 2.6 0.0 6.8 11.9 72.5 30.5 5.8 7.4 13.6 3.2 5.8 14.1 6.2 20.4 34.8 9.2 21.9 19.0 7.2 15.6 8.5 10.5 89.5 10.7 4.7 71.1 66.9 21.6 4.9 23.5 3.9 7.5 14.3 15.0 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179686-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: AB_2686525" "prognostic favorable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favorable (5.53e-4)" "prognostic unfavorable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favorable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.5 29.4 20.2 19.4 27.5 14.0 17.9 23.2 26.4 20.3 23.7 17.0 23.4 16.6 30.4 24.7 24.2 25.0 24.6 16.4 18.5 13.9 20.9 44.8 19.0 19.9 25.6 13.4 26.5 23.6 31.5 35.9 19.3 21.8 24.6 18.5 20.8 23.9 23.3 16.5 31.0 18.9 28.3 19.9 23.5 21.2 38.4 22.9 17.0 22.8 18.8 26.0 19.3 23.5 8.0 14.3 8.4 12.2 14.2 13.9 9.0 19.5 16.8 17.5 19.7 22.8 30.0 14.2 28.1 22.4 27.2 26.1 18.7 21.3 22.4 11.5 27.2 8.9 22.2 23.9 18.4 24.8 25.6 18.5 35.5 24.4 24.4 24.2 25.7 28.2 30.0 24.8 28.7 13.6 20.1 21.4 27.3 14.4 23.2 22.2 10.9 18.8 16.6 25.5 14.0 15.5 22.2 26.6 19.7 18.6 25.1 18.4 18.9 29.1 18.5 29.8 22.5 17.1 15.7 22.2 28.8 24.9 37.9 35.8 34.7 26.8 20.4 29.8 35.1 26.5 8.4 9.0 4.5 13.9 9.7 11.9 7.3 9.6 10.3 6.9 8.0 8.4 9.1 1.3 14.2 12.2 14.3 7.0 9.0 20.2 27.5 23.2 26.4 18.5 13.9 25.6 13.4 21.8 22.9 20.8 21.3 7.7 9.2 7.8 13.9 7.7 10.2 28.1 19.4 14.0 37.3 8.8 1.7 15.8 11.5 15.8 11.9 0.0 14.2 12.0 17.1 10.3 12.7 28.6 15.9 25.4 25.2 16.0 12.4 13.3 22.2 11.7 5.0 20.8 15.4 13.8 18.6 2.9 19.4 11.8 24.5 12.9 21.1 21.8 24.5 10.7 5.7 10.2 12.1 6.7 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 90.7;Late spermatids: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 18.0;PC-3: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.5 6.9 0.5 4.1 0.8 0.6 2.5 1.2 0.9 1.4 1.3 4.3 6.1 8.6 4.0 0.3 0.3 18.0 0.7 2.7 0.3 5.4 6.2 0.5 1.9 2.1 1.7 0.7 0.0 1.3 5.2 1.2 2.2 0.8 1.0 3.1 0.0 2.6 0.6 4.2 3.2 3.5 2.2 2.3 27.7 5.7 1.6 3.8 0.6 1.6 5.0 2.6 4.2 9.4 3.6 0.2 6.1 0.7 1.7 1.6 1.1 3.0 5.4 9.8 5.9 4.2 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 8.9 4.0 13.7 13.8 12.7 6.8 4.3 25.5 1.4 5.7 10.4 0.0 30.0 14.9 6.8 90.7 6.7 14.8 0.0 8.3 6.8 6.3 10.9 13.8 14.3 10.7 0.0 13.7 6.7 9.5 154.7 8.6 8.0 11.8 2.8 10.6 6.2 5.1 10.5 7.4 12.4 4.5 6.5 4.7 41.1 11.1 16.2 14.0 11.8 20.3 5.2 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA 9600 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473" "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 19.1 25.3 29.7 22.2 31.0 53.7 26.8 30.9 31.4 20.3 19.7 31.3 15.9 16.1 22.8 25.4 25.4 19.5 18.4 38.2 23.8 22.7 24.7 17.6 19.3 28.7 37.5 21.2 20.4 15.1 17.9 28.0 27.8 40.8 22.6 22.6 21.8 28.0 20.4 25.0 27.6 21.9 24.0 30.2 27.8 17.3 13.5 31.9 28.4 18.2 17.2 31.0 22.9 20.4 18.9 22.3 35.6 27.8 20.2 22.2 26.0 26.8 11.4 28.1 17.1 26.3 34.9 21.7 24.1 27.3 26.3 26.5 14.1 19.0 20.5 7.0 25.9 26.5 15.5 21.6 27.6 30.0 37.3 13.7 27.7 21.5 14.2 20.3 27.1 23.3 27.4 18.5 24.8 20.8 32.4 33.8 16.9 11.4 17.6 34.6 9.6 17.8 18.3 24.9 34.1 9.8 13.9 20.8 18.8 41.9 34.4 12.1 16.9 25.4 18.5 20.6 31.6 12.6 26.7 25.6 20.0 17.6 25.9 33.4 20.2 32.3 24.4 20.5 30.2 25.4 34.7 25.4 35.6 14.3 27.8 16.1 18.9 18.9 17.6 22.3 16.0 17.9 18.0 24.4 20.2 27.7 11.4 22.2 26.0 29.7 31.0 30.9 31.4 23.8 22.7 37.5 21.2 40.8 31.9 32.8 28.9 17.1 23.8 30.0 21.0 57.2 20.4 37.5 23.9 33.2 37.3 64.4 16.6 30.4 10.9 27.1 14.3 0.0 20.5 47.2 31.1 21.5 40.5 16.2 30.1 31.8 17.9 20.3 43.2 7.9 37.4 39.1 28.7 53.3 15.3 27.7 25.3 8.6 35.7 26.4 44.9 25.8 29.3 32.3 33.0 37.4 47.5 33.8 16.6 28.2 UBE2Q1 "NICE-5, PRO3094, UBE2Q" ENSG00000160714 "Ubiquitin conjugating enzyme E2 Q1" Q7Z7E8 1 154548577-154559028 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063368 Approved Approved Nucleoplasm,Centrosome No No Nucleoplasm Centrosome "HPA063368: AB_2684996" "unprognostic (3.88e-1)" "unprognostic (2.13e-1)" "unprognostic (4.44e-3)" "unprognostic (3.64e-3)" "unprognostic (5.32e-3)" "unprognostic (6.10e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (2.92e-1)" "unprognostic (2.07e-1)" "unprognostic (9.92e-3)" "unprognostic (3.79e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.84e-7)" "unprognostic (2.20e-1)" "unprognostic (4.46e-1)" "prognostic favorable (1.86e-5)" "unprognostic (1.04e-2)" 17.3 18.7 26.5 16.2 29.4 24.2 19.4 26.4 29.0 20.0 21.2 18.7 8.2 16.2 18.3 25.4 20.9 21.8 18.2 17.6 24.5 25.8 25.7 27.4 23.0 26.3 22.8 21.0 21.7 27.2 21.4 29.3 24.5 27.2 21.4 25.7 18.5 19.0 19.8 19.1 21.6 21.4 21.9 19.1 26.0 20.5 30.0 22.0 25.1 21.0 14.0 29.9 19.3 18.5 3.2 5.1 8.1 3.1 4.7 6.2 1.6 17.2 14.9 21.1 16.1 21.7 22.4 18.3 17.1 26.0 22.0 17.8 16.7 18.4 21.2 24.6 23.8 18.4 15.0 24.8 19.8 19.0 21.3 15.7 16.8 13.3 16.1 27.4 27.3 27.1 21.5 26.3 17.8 20.7 24.0 28.2 19.7 14.1 26.3 28.1 26.7 16.6 20.1 28.8 41.3 25.4 19.2 14.7 22.3 24.2 18.3 21.5 30.1 17.3 32.6 27.9 37.7 19.9 41.7 19.6 14.3 15.9 16.9 18.2 32.2 23.8 28.1 16.0 19.4 21.5 8.1 2.8 5.6 4.8 3.1 4.3 3.0 4.5 5.9 2.5 3.2 5.0 5.7 4.4 4.7 2.6 5.1 6.2 1.6 26.5 29.4 26.4 29.0 24.5 25.8 22.8 21.0 27.2 22.0 29.8 21.6 22.7 16.5 14.3 38.7 26.9 25.5 34.8 20.5 15.7 3.9 15.3 10.0 13.0 2.7 27.8 23.7 0.0 18.0 14.1 15.8 22.6 10.4 34.2 23.2 57.2 32.3 32.5 41.4 4.3 16.4 19.3 13.5 15.4 30.4 45.6 21.9 11.5 18.0 15.1 19.3 12.9 13.2 30.7 24.4 16.7 16.4 20.8 20.4 22.9 UBL3 "DKFZP434K151, FLJ32018, HCG-1, PNSC1" ENSG00000122042 "Ubiquitin like 3" O95164 13 29764371-29850684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 305.5;Late spermatids: 259.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBF TERT88: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053772, HPA058781" Uncertain Approved Centrosome NA NA Centrosome "HPA053772: AB_2682258, HPA058781: AB_2683818" "unprognostic (2.83e-2)" "unprognostic (5.48e-2)" "unprognostic (3.20e-1)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (3.22e-1)" "unprognostic (3.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "prognostic favorable (4.23e-4)" "unprognostic (8.49e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.84e-1)" 11.9 11.7 27.9 9.1 35.2 10.3 16.7 22.6 32.3 22.9 16.5 28.8 12.2 15.0 24.0 14.8 24.0 15.4 17.5 10.8 32.6 30.5 19.9 22.4 20.2 9.3 36.7 23.6 17.8 30.5 20.6 17.4 13.6 31.2 12.8 15.5 17.1 14.9 13.5 14.7 13.0 17.3 17.5 45.9 12.9 38.4 11.6 30.0 10.8 22.7 8.3 9.9 12.4 15.4 2.7 7.7 8.0 8.4 5.0 23.7 6.3 4.0 2.5 8.0 4.8 11.4 11.0 8.5 33.5 19.7 14.4 11.6 6.0 9.2 3.5 7.6 33.2 6.6 4.0 3.6 5.0 41.4 5.5 4.5 3.7 3.5 4.8 3.6 5.4 5.0 6.4 16.3 7.5 4.9 12.5 5.1 4.2 1.8 2.5 6.0 27.2 4.0 4.6 4.8 9.5 3.7 4.6 10.4 4.0 9.4 4.8 9.4 4.7 4.7 16.4 33.7 17.9 8.8 9.3 4.4 18.7 4.6 10.2 4.4 6.0 2.3 2.7 6.6 4.7 12.3 5.4 8.2 6.8 8.2 8.0 3.8 2.2 10.4 7.9 7.7 2.7 6.0 7.4 8.0 5.0 8.4 3.6 23.7 6.3 27.9 35.2 22.6 29.7 32.6 30.5 36.7 23.6 31.2 30.0 178.6 37.4 26.8 90.8 68.5 165.7 26.8 53.5 69.6 71.7 34.9 72.6 12.5 77.9 33.9 305.5 46.6 52.9 0.0 32.7 68.1 38.8 65.5 13.9 50.8 33.9 90.6 58.3 30.7 50.9 259.4 32.2 45.6 92.8 38.7 52.9 150.0 46.0 25.9 31.1 38.3 62.8 19.4 45.3 48.6 18.5 69.9 24.7 39.5 31.8 92.4 UBR4 "KIAA0462, KIAA1307, RBAF600, ZUBR1" ENSG00000127481 "Ubiquitin protein ligase E3 component n-recognin 4" Q5T4S7 1 19074506-19210276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" "Calmodulin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013394, HPA021046" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA013394: , HPA021046: AB_1858578" "unprognostic (1.37e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" "unprognostic (2.02e-1)" "unprognostic (8.78e-2)" "unprognostic (9.77e-2)" "unprognostic (1.14e-3)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (9.14e-3)" "unprognostic (7.48e-2)" "unprognostic (2.53e-1)" "unprognostic (7.68e-3)" "unprognostic (4.30e-1)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.52e-1)" 24.4 25.4 22.4 29.0 25.4 58.3 23.7 28.5 32.5 22.4 28.5 26.3 31.5 18.2 34.0 32.5 22.7 20.3 27.3 20.5 23.3 15.9 25.5 29.7 31.2 20.3 21.0 20.9 35.5 21.0 40.9 31.4 28.4 25.0 30.7 20.5 30.6 24.7 27.1 55.9 69.0 25.5 39.3 20.2 26.5 30.2 41.1 21.6 37.7 26.1 17.3 25.9 43.4 29.0 4.6 9.1 18.3 18.5 2.7 3.4 4.6 22.2 22.5 20.4 15.0 38.1 19.7 17.6 17.3 18.4 18.9 17.3 35.9 19.2 13.4 16.3 22.9 16.6 15.3 15.9 17.3 17.7 11.1 14.1 30.7 21.7 23.3 26.9 18.8 20.4 17.6 22.2 38.5 37.2 18.5 20.7 23.9 21.0 12.5 17.9 15.9 8.9 22.9 16.5 45.7 12.7 12.4 15.9 11.2 17.1 13.1 14.4 14.3 20.5 11.8 14.8 19.5 8.2 14.8 32.0 22.2 13.9 26.2 19.4 14.9 9.0 15.6 15.2 29.1 18.8 18.3 18.5 2.9 3.4 3.8 2.9 4.6 3.0 1.9 9.1 2.9 2.7 2.5 9.8 2.7 1.3 4.3 2.1 4.6 22.4 25.4 28.5 32.5 23.3 15.9 21.0 20.9 25.0 21.6 32.8 42.3 16.3 79.1 240.8 54.0 15.6 40.8 30.8 26.1 29.6 143.3 19.2 11.6 31.4 14.7 21.1 36.4 23.3 35.5 14.1 29.1 39.1 18.5 77.9 54.8 74.7 16.8 28.8 47.4 19.9 28.4 42.8 47.2 36.1 30.4 30.7 51.2 14.0 33.6 88.2 48.0 19.4 26.8 37.4 17.9 220.9 28.4 21.0 19.5 215.5 UBXN2A UBXD4 ENSG00000173960 "UBX domain protein 2A" P68543 2 23927285-24004909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065482, HPA069096" Supported Approved Centrosome NA NA Centrosome "HPA065482: AB_2685495, HPA069096: AB_2686084" "unprognostic (5.29e-2)" "unprognostic (1.93e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.86e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (9.26e-2)" "unprognostic (2.76e-1)" "unprognostic (1.15e-2)" "unprognostic (1.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (8.85e-2)" "unprognostic (2.14e-1)" "unprognostic (4.60e-2)" "unprognostic (6.75e-2)" 12.7 10.6 10.8 8.3 10.7 9.6 13.8 16.7 10.6 9.4 14.0 12.2 9.5 12.1 13.4 9.1 11.7 9.2 8.2 17.7 10.0 11.6 9.1 12.0 10.0 7.8 12.7 8.9 9.3 7.8 17.3 13.6 14.0 13.3 9.9 9.1 11.1 9.9 11.4 24.3 10.3 13.3 14.9 11.3 6.8 8.2 7.3 11.9 9.8 9.4 7.5 9.1 12.0 15.0 6.5 7.3 6.9 4.0 8.6 7.1 2.8 10.8 7.2 10.1 6.8 11.7 10.3 5.1 11.2 7.6 11.0 7.6 5.4 4.9 9.4 3.5 7.1 7.7 4.7 9.7 8.0 9.8 18.9 9.2 11.1 5.1 8.0 8.7 7.0 5.0 12.5 6.4 9.6 7.3 7.8 6.4 7.3 12.4 9.5 9.4 8.2 9.1 4.5 8.0 7.0 5.3 12.5 25.1 4.1 4.6 8.6 5.0 12.1 10.7 5.4 13.9 7.6 3.1 4.0 10.6 7.9 8.3 7.2 7.1 13.7 14.6 13.5 6.1 6.5 7.9 6.9 4.0 4.4 6.2 2.2 6.8 6.5 6.5 5.9 3.1 5.8 7.1 6.5 4.0 8.6 2.7 7.3 4.7 2.8 10.8 10.7 16.7 10.6 10.0 11.6 12.7 8.9 13.3 11.9 23.8 19.2 18.0 25.0 22.7 15.9 39.2 5.1 13.4 12.5 15.7 41.2 29.3 14.9 23.7 1.1 20.2 23.1 0.0 23.5 27.6 23.0 29.0 16.3 13.4 13.3 39.7 4.1 22.1 13.3 1.6 24.5 15.0 33.7 28.9 13.1 23.5 28.6 28.1 25.1 14.7 28.8 32.3 20.6 16.2 12.0 27.4 31.2 22.4 17.2 32.8 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria NA NA 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.5 14.5 13.9 9.3 47.4 61.5 58.3 35.6 29.1 19.2 22.9 37.1 23.4 28.9 10.7 38.2 17.5 12.1 16.8 22.3 31.2 19.3 7.1 18.3 10.3 25.3 22.7 16.1 16.1 40.3 40.9 18.0 18.6 25.9 26.6 9.8 9.1 11.7 80.1 10.8 21.8 15.2 33.3 45.0 10.2 17.9 27.6 16.6 34.0 16.0 7.3 6.0 28.4 36.6 13.5 44.1 10.4 11.5 36.3 20.1 31.7 29.9 18.7 21.0 9.4 36.6 24.1 25.3 61.3 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 26.8 52.5 51.7 74.0 67.3 48.5 238.8 89.2 73.6 69.4 45.4 60.9 359.1 205.6 116.3 61.0 61.3 412.6 0.0 90.6 369.3 148.4 77.6 65.8 448.9 107.3 82.6 42.9 66.3 100.6 64.7 73.4 90.8 91.1 173.1 112.3 37.4 81.0 167.8 72.9 209.2 49.4 71.1 124.3 71.2 57.5 50.6 395.3 112.8 144.5 90.3 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026911-41039217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 52.2;kidney: 60.9;liver: 29.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 40.8;Collecting duct cells: 21.0;Exocrine glandular cells: 59.0;Hepatocytes: 25.2;Pancreatic endocrine cells: 25.3;Proximal tubular cells: 29.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 31.1;RPTEC TERT1: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015725 Enhanced Approved Centrosome NA NA Centrosome "HPA015725: AB_2669283" "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 0.4 0.2 0.4 0.6 0.4 0.3 0.5 0.4 0.4 0.4 9.9 0.5 0.4 23.7 0.8 0.8 0.5 0.7 10.2 0.4 0.4 0.1 60.9 29.9 0.9 0.4 0.4 0.4 0.5 17.7 0.1 0.6 0.8 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.6 52.2 0.4 0.4 1.2 15.9 0.6 0.4 0.4 0.7 0.4 0.4 0.4 0.4 0.3 1.0 0.7 0.3 0.0 2.4 0.2 0.3 0.1 0.4 0.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.9 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.2 0.0 0.7 0.9 0.4 0.0 2.6 0.1 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.0 2.0 0.3 0.3 0.0 0.1 0.6 1.5 0.2 31.1 0.1 0.6 0.0 0.3 9.5 0.0 0.4 0.4 0.0 0.0 0.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.0 3.1 1.5 0.4 0.0 1.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.2 0.7 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.3 1.0 2.4 0.2 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 3.0 1.4 0.9 0.6 0.7 0.2 0.6 40.8 0.0 0.0 21.0 3.9 0.4 3.3 14.5 1.7 0.2 5.9 0.0 59.0 0.7 0.4 0.5 0.0 25.2 0.3 1.6 1.2 1.3 0.6 0.0 0.3 1.0 1.7 1.0 2.7 0.3 25.3 1.5 0.7 29.6 0.3 0.0 0.3 0.4 0.7 0.1 0.7 0.5 4.1 0.3 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 4.0 5.0 4.7 12.1 4.7 3.4 2.1 3.4 2.1 2.0 3.7 2.2 9.3 3.9 5.4 3.4 3.3 5.3 4.2 4.0 2.8 2.2 6.6 2.5 6.1 3.6 12.1 7.4 6.7 7.7 3.9 4.4 3.2 5.0 7.1 3.1 5.0 4.4 7.4 6.7 6.7 3.6 7.1 4.1 2.9 3.9 3.7 7.5 7.4 2.4 3.6 5.1 2.9 6.1 3.6 3.9 9.0 6.8 3.3 7.2 1.8 3.0 5.8 3.2 11.1 3.8 5.1 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 20.8 10.8 4.8 9.6 0.0 20.4 0.0 10.2 22.7 11.4 24.4 13.7 6.7 21.6 7.4 4.6 10.8 9.7 0.0 10.3 3.1 5.4 14.9 4.7 36.5 6.7 12.7 5.8 20.3 16.4 9.1 12.0 10.4 0.0 3.6 13.2 11.3 10.2 16.5 13.1 18.7 17.2 6.5 0.0 9.5 3.9 0.0 12.1 13.4 13.3 17.8 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA036990: AB_2675419, HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favorable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.8 4.5 4.0 6.9 5.3 5.3 3.0 7.7 7.5 7.2 6.1 13.1 7.2 6.0 5.5 6.5 4.6 3.8 9.5 7.7 5.9 14.6 6.1 5.5 5.4 2.8 7.3 11.1 5.5 6.4 7.1 7.3 5.9 5.1 7.1 6.9 11.9 18.9 4.7 7.7 14.5 2.1 3.6 9.8 8.9 9.5 6.0 5.7 4.6 5.6 8.2 7.4 6.0 10.5 6.7 3.1 6.4 4.2 8.4 6.6 5.4 5.7 8.0 21.1 35.7 10.9 6.7 8.5 5.5 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 20.8 13.7 10.5 16.5 47.6 7.5 15.1 7.6 13.4 14.8 0.0 11.8 10.9 1.7 7.5 27.8 12.0 18.4 0.0 6.6 5.8 9.7 16.1 3.5 32.7 9.2 7.9 29.4 17.8 14.5 15.4 6.4 12.2 11.8 1.8 19.9 13.6 8.5 11.5 8.9 14.2 8.2 12.9 15.1 9.5 5.1 51.7 22.3 13.4 14.5 38.1 VCPIP1 "DUBA3, FLJ23132, KIAA1850, VCIP135" ENSG00000175073 "Valosin containing protein interacting protein 1" Q96JH7 8 66628487-66667217 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023932 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA023932: AB_2671373" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (4.01e-2)" "unprognostic (5.56e-2)" "unprognostic (5.23e-2)" "unprognostic (7.21e-2)" "unprognostic (2.80e-1)" "unprognostic (3.96e-1)" "unprognostic (5.23e-3)" "unprognostic (7.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-2)" "unprognostic (8.58e-3)" 9.5 8.7 15.7 12.6 14.5 30.9 8.9 14.4 15.1 7.5 8.4 7.0 3.8 7.0 7.8 8.7 8.1 6.9 7.0 6.7 10.2 9.2 8.3 12.3 10.5 13.6 10.3 13.7 7.8 9.0 14.0 5.9 8.0 12.3 7.0 7.8 6.0 9.0 7.1 14.8 7.3 10.0 6.3 9.6 14.7 8.0 10.8 11.7 11.6 8.0 2.8 13.3 7.9 7.0 2.6 3.4 11.3 8.8 2.8 4.3 1.7 9.0 8.2 4.2 5.6 13.0 9.2 4.1 7.3 7.4 5.6 6.5 4.8 8.5 12.2 2.1 9.7 6.9 8.0 6.8 6.1 8.0 9.0 4.9 13.5 8.1 6.0 7.8 4.5 14.6 9.9 9.0 6.1 11.1 6.9 6.0 6.7 9.1 11.8 8.2 4.4 9.7 7.8 8.0 7.6 5.7 6.3 6.6 6.1 8.1 7.1 2.5 4.8 5.6 8.6 6.3 5.6 8.8 7.5 12.0 7.4 5.5 6.5 4.8 10.5 5.1 13.1 7.3 6.5 5.5 9.2 3.2 6.7 4.3 5.2 3.6 2.0 2.7 3.1 3.4 2.6 2.2 2.9 11.3 2.8 8.8 1.3 3.3 1.7 15.7 14.5 14.4 15.1 10.2 9.2 10.3 13.7 12.3 11.7 17.9 14.6 9.0 8.1 15.0 11.1 16.5 12.7 12.0 11.4 7.0 21.6 8.8 3.3 9.7 4.3 9.9 14.0 23.3 11.7 4.8 12.3 11.3 18.5 20.2 12.4 11.1 5.8 15.4 47.5 4.5 7.5 18.0 10.1 10.8 15.0 11.8 10.8 15.3 14.9 9.9 10.8 6.5 10.8 26.8 14.7 18.1 8.2 26.6 13.3 14.2 VPS25 "DERP9, EAP20, MGC10540" ENSG00000131475 "Vacuolar protein sorting 25 homolog" Q9BRG1 17 42773436-42779599 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004978, HPA052217, HPA057284" Uncertain Approved Centrosome NA Yes Centrosome "CAB004978: AB_426095, HPA052217: AB_2681765, HPA057284: AB_2683397" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-4)" "unprognostic (7.37e-2)" "unprognostic (7.57e-2)" "unprognostic (9.83e-3)" "unprognostic (2.76e-3)" "unprognostic (5.84e-2)" "unprognostic (1.25e-1)" "unprognostic (2.90e-1)" "unprognostic (8.10e-3)" "unprognostic (3.88e-1)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" 18.5 22.8 14.0 16.9 17.4 17.9 26.2 11.0 28.2 21.0 28.8 20.9 23.9 25.3 21.5 32.8 45.9 28.7 22.6 18.0 15.5 12.2 48.7 48.0 17.4 22.0 12.7 15.3 21.7 41.3 28.5 15.7 36.7 17.3 21.3 33.3 27.4 32.6 18.7 24.7 26.0 37.9 20.5 11.3 21.2 25.1 26.6 11.5 32.1 29.2 31.9 37.4 18.7 22.8 19.8 33.2 42.4 35.4 31.0 20.2 22.3 17.4 36.3 27.7 16.7 35.3 24.2 25.7 22.2 31.4 45.7 32.0 31.1 20.6 17.5 37.2 32.3 24.2 18.3 38.1 48.4 29.7 15.9 47.9 13.2 24.0 46.0 36.5 24.7 17.7 32.8 31.3 40.5 43.5 27.2 28.6 21.1 45.0 17.7 27.4 25.1 35.5 27.3 21.3 39.9 25.6 13.3 33.5 28.3 54.8 20.0 23.6 18.2 12.5 16.2 33.6 44.6 37.3 26.3 15.4 29.1 18.7 16.3 23.6 17.5 9.9 25.4 25.5 16.9 21.3 28.8 32.2 42.4 17.1 35.4 17.4 19.8 18.7 20.2 33.2 17.0 19.1 18.1 18.7 31.0 31.2 22.4 17.1 22.3 14.0 17.4 11.0 28.2 15.5 12.2 12.7 15.3 17.3 11.5 23.8 27.6 21.6 37.4 12.4 22.7 23.4 50.9 58.9 38.7 59.3 13.7 121.4 112.7 124.9 2.0 24.1 66.4 46.7 133.4 153.4 26.3 34.8 28.8 40.4 88.0 22.3 39.4 25.2 36.7 4.2 25.6 28.4 40.5 55.1 64.5 42.1 108.5 61.4 28.7 82.0 23.0 32.3 21.5 37.9 47.3 19.9 101.7 28.4 58.3 47.7 VPS37A "FLJ32642, HCRP1, PQBP2, SPG53" ENSG00000155975 "VPS37A, ESCRT-I subunit" Q8NEZ2 8 17246571-17302427 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024705, HPA024781" Supported Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA024705: AB_10601776, HPA024781: AB_10602100" "unprognostic (8.28e-2)" "unprognostic (1.84e-1)" "unprognostic (9.39e-3)" "unprognostic (3.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.31e-2)" "unprognostic (5.88e-3)" "unprognostic (2.28e-2)" "unprognostic (1.43e-1)" "unprognostic (3.17e-1)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (2.18e-1)" 23.5 21.3 15.1 13.5 15.6 12.8 22.1 23.1 18.1 21.3 23.5 15.8 16.4 18.6 19.1 15.1 22.7 13.3 15.5 34.4 15.8 14.9 23.3 25.9 18.4 14.4 16.6 10.4 21.7 15.8 34.2 20.8 31.6 16.1 20.0 16.2 20.7 15.2 22.7 41.8 16.5 27.3 24.4 20.2 16.4 14.9 27.7 14.6 17.3 18.0 16.4 14.8 27.6 22.7 10.1 11.7 25.0 15.2 20.6 15.5 11.4 7.1 11.7 10.2 9.0 22.8 18.2 11.2 25.5 21.6 23.5 20.4 7.9 7.0 6.1 13.9 20.4 21.8 7.0 11.5 11.2 27.9 6.3 3.4 11.2 6.0 8.3 26.6 4.3 10.7 17.6 21.8 21.7 22.3 16.4 16.7 9.8 8.3 16.0 24.7 4.9 13.2 11.2 10.2 16.0 6.2 6.5 11.5 7.3 19.7 9.9 12.3 6.5 10.1 10.1 15.7 21.4 6.7 9.2 14.2 14.2 7.2 20.3 13.2 5.1 10.2 7.1 16.2 8.4 14.5 25.0 15.2 13.5 12.9 11.3 15.5 9.9 12.4 12.3 11.7 10.1 11.6 13.8 15.9 20.6 10.0 10.8 11.4 11.4 15.1 15.6 23.1 18.1 15.8 14.9 16.6 10.4 16.1 14.6 14.9 10.4 17.9 24.6 35.0 25.3 34.3 17.8 13.4 17.0 7.0 55.0 31.3 31.5 25.5 50.2 19.4 18.4 23.3 13.6 47.1 22.9 36.7 9.2 19.8 37.7 20.6 17.2 22.7 16.2 26.4 23.9 24.0 20.3 20.8 14.4 22.6 24.3 15.6 24.4 36.8 59.4 25.8 38.9 96.4 34.1 33.1 94.5 22.3 14.0 42.5 WAPL "FOE, KIAA0261, WAPAL" ENSG00000062650 "WAPL cohesin release factor" Q7Z5K2 10 86435256-86521815 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037874, HPA037875, HPA066141" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol" "HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: " "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.91e-2)" "unprognostic (6.63e-2)" "unprognostic (3.51e-1)" "unprognostic (3.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (5.78e-2)" "unprognostic (5.56e-2)" "unprognostic (7.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (4.56e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 15.3 15.4 16.0 15.5 16.9 19.8 15.6 23.6 15.0 13.4 14.0 12.1 6.8 12.5 16.0 8.7 20.4 12.6 11.2 13.3 15.3 8.2 14.5 23.1 17.5 19.3 14.8 11.5 14.8 13.6 18.1 18.2 19.0 13.4 13.9 13.1 9.4 14.9 10.6 34.4 20.4 16.0 16.0 16.4 18.2 13.5 28.1 16.4 39.2 15.9 9.4 22.4 15.1 15.9 5.2 6.2 14.3 8.7 3.9 7.7 3.1 20.2 9.5 16.7 22.0 13.3 14.2 14.7 17.8 22.0 15.2 16.6 20.6 17.9 30.8 12.1 15.9 13.4 19.1 18.9 15.3 23.4 20.0 12.4 18.6 15.2 22.6 15.2 37.6 21.5 11.1 17.9 19.4 32.7 17.3 16.9 18.0 19.5 18.6 17.3 17.3 23.4 14.1 14.8 12.7 9.6 16.7 13.5 12.2 13.1 18.0 6.5 12.6 15.7 10.6 19.3 17.3 23.2 20.1 16.2 14.6 17.4 12.8 23.3 18.3 25.4 32.6 13.4 26.9 10.3 14.3 4.7 9.4 4.7 5.3 7.0 5.2 6.3 6.5 6.2 4.8 7.2 5.7 7.3 3.9 8.7 4.7 7.7 3.1 16.0 16.9 23.6 15.0 15.3 8.2 14.8 11.5 13.4 16.4 77.4 51.5 21.9 40.4 0.0 47.2 0.0 12.7 25.4 38.7 15.7 19.6 36.2 18.3 52.5 61.6 29.2 15.6 70.0 46.0 25.0 22.4 50.1 23.3 41.2 35.6 52.4 17.5 28.8 48.6 27.3 29.7 49.5 0.0 56.9 31.7 45.3 46.8 37.1 30.4 26.7 127.3 64.7 0.0 125.1 82.8 0.0 63.6 38.9 32.2 54.7 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666800-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favorable (3.12e-4)" 6.4 7.8 10.2 6.2 9.1 8.8 6.5 17.2 14.5 7.1 5.2 9.1 2.3 4.9 5.8 6.1 5.9 11.3 5.2 9.2 8.5 8.9 8.1 5.9 6.0 8.3 12.4 11.6 9.2 11.6 9.4 6.7 4.9 9.1 6.9 2.6 7.7 14.6 6.9 4.6 11.3 6.3 3.8 7.0 7.4 7.1 9.2 10.6 11.7 9.2 2.6 5.8 6.0 5.7 8.8 19.4 5.4 11.1 17.6 11.3 8.6 4.9 8.3 4.7 6.5 9.3 3.5 3.8 4.7 4.4 5.7 6.0 9.6 4.3 7.5 6.9 4.2 3.2 5.6 5.5 7.3 1.0 7.6 12.2 5.9 5.5 6.0 7.4 8.2 7.0 6.4 5.9 4.6 3.8 3.8 5.7 16.3 5.2 0.8 2.6 18.8 11.9 6.7 3.8 5.8 14.4 8.5 6.1 7.0 5.4 5.9 9.9 6.6 5.1 7.0 4.1 2.7 3.9 8.1 3.1 6.4 2.0 5.1 4.9 19.1 12.8 3.3 10.0 6.3 4.1 4.5 11.1 4.6 9.2 9.6 10.7 8.1 8.9 8.6 11.1 8.8 8.7 11.3 5.4 17.6 4.7 19.4 9.8 8.6 10.2 9.1 17.2 14.5 8.5 8.9 12.4 11.6 9.1 10.6 0.0 15.6 12.6 11.4 13.7 20.5 4.2 12.7 10.7 7.9 17.4 11.8 11.1 14.9 13.6 13.8 10.5 9.3 0.0 15.2 11.6 11.0 13.4 13.9 7.2 11.5 19.1 9.2 9.2 11.6 43.7 14.7 14.8 15.1 18.0 6.7 15.0 11.1 5.9 17.0 22.6 20.4 19.4 13.2 25.0 16.9 14.1 7.6 16.2 8.1 12.2 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.3" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.2 13.1 9.6 10.5 6.1 6.5 43.3 7.4 8.2 4.4 5.1 16.7 4.6 10.4 8.6 9.9 12.1 2.5 9.1 7.7 3.3 12.2 12.2 7.7 11.2 14.2 8.0 4.7 16.2 9.6 6.1 4.6 3.5 6.6 10.4 7.1 9.8 3.4 8.5 3.7 7.9 3.8 23.5 3.4 7.8 6.4 9.4 4.9 7.4 10.2 11.4 11.2 6.3 17.1 11.8 11.2 4.7 10.2 14.2 9.5 5.0 5.2 8.1 4.2 0.0 17.2 3.8 6.8 5.3 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 11.9 9.4 11.5 14.3 13.5 56.5 22.9 48.4 14.7 7.9 24.4 13.7 13.2 10.0 21.0 0.2 17.9 19.8 0.0 20.2 15.4 16.9 18.3 14.9 33.1 15.5 9.5 14.9 13.5 11.8 0.8 18.4 17.7 8.5 19.0 19.5 19.9 20.8 17.3 21.5 15.8 22.4 6.5 14.4 0.0 3.2 9.8 31.8 12.5 21.9 11.5 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483237 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Yes No Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: AB_2669673, HPA049003: AB_2680596" "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 9.6 7.1 6.6 13.8 13.7 16.6 10.1 12.7 11.5 9.5 7.5 11.4 6.8 7.6 9.8 7.5 8.4 8.4 6.4 5.5 7.0 6.8 9.1 6.6 8.5 16.9 11.5 8.8 8.3 8.2 19.1 10.0 12.4 8.8 8.8 8.5 9.6 9.8 9.1 9.7 12.2 11.1 8.5 7.7 13.7 8.6 9.0 12.1 17.4 10.8 5.2 17.1 10.0 10.2 5.7 2.2 1.7 1.5 2.4 5.3 1.0 3.9 4.1 3.8 9.4 6.1 6.2 6.2 4.5 6.3 5.8 6.6 5.7 3.1 16.9 5.9 5.7 6.9 5.2 9.5 7.1 8.7 10.4 9.3 13.7 5.5 4.3 4.5 11.1 7.0 6.2 5.9 5.8 10.1 4.0 4.7 8.0 11.4 9.5 5.9 6.8 15.8 7.5 9.3 4.0 4.6 10.0 5.3 7.0 7.1 6.8 6.4 5.6 5.8 6.2 14.4 5.5 4.3 12.1 4.6 4.7 4.7 3.9 9.8 4.6 3.6 17.3 6.1 8.8 7.8 0.1 1.2 1.7 1.5 1.1 0.9 5.7 3.0 1.8 1.4 5.6 3.9 2.2 0.8 2.4 1.5 2.2 5.3 1.0 6.6 13.7 12.7 11.5 7.0 6.8 11.5 8.8 8.8 12.1 11.9 7.8 15.9 6.2 9.0 17.3 3.3 7.6 8.1 5.7 3.5 29.5 7.0 3.3 6.8 1.3 4.5 5.5 0.0 7.9 9.4 7.3 5.9 9.2 5.0 6.9 9.5 9.2 3.1 12.6 1.1 6.6 8.9 8.5 22.6 11.1 8.1 5.5 3.5 6.0 6.1 63.1 0.0 4.2 4.6 29.8 8.4 6.5 14.9 7.8 5.8 ZFAND1 FLJ14007 ENSG00000104231 "Zinc finger AN1-type containing 1" Q8TCF1 8 81701334-81732903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023383 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA023383: AB_1859008" "unprognostic (6.45e-2)" "unprognostic (1.48e-2)" "unprognostic (7.74e-2)" "unprognostic (8.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.04e-3)" "unprognostic (8.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.30e-2)" "unprognostic (3.77e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.35e-2)" "unprognostic (2.36e-2)" 18.9 17.7 12.5 10.8 23.2 14.8 25.8 24.3 25.9 22.8 19.4 8.6 16.0 16.1 21.6 17.9 19.9 20.8 14.4 14.8 12.7 15.8 19.6 26.6 16.2 13.8 14.8 16.2 35.8 35.1 16.0 31.1 12.6 27.4 23.7 18.7 10.3 23.3 18.1 16.9 13.5 20.2 23.7 16.5 17.5 20.3 10.3 13.2 19.0 42.6 16.1 17.0 26.7 21.3 18.5 20.0 6.4 13.9 17.2 25.1 16.8 19.2 6.1 8.6 7.5 11.8 23.8 8.6 11.5 15.5 10.1 13.2 6.8 15.2 18.9 13.6 8.7 11.3 13.0 9.9 16.5 15.3 15.9 9.9 10.8 10.4 8.0 21.7 13.2 7.2 19.4 39.8 7.0 69.1 17.5 12.6 18.1 16.3 27.1 10.5 12.6 16.3 9.6 2.5 40.4 19.4 11.2 7.3 8.4 12.7 17.8 8.8 5.7 8.3 5.3 18.9 10.3 17.5 9.8 8.0 7.5 11.0 10.7 15.9 10.8 6.6 11.6 8.9 1.2 5.7 6.4 13.9 3.9 11.3 10.2 19.4 18.5 18.5 15.0 20.0 13.4 25.1 18.7 1.4 17.2 11.8 11.6 21.1 16.8 12.5 23.2 24.3 25.9 12.7 15.8 14.8 16.2 27.4 13.2 23.8 31.8 35.2 67.7 85.2 26.9 16.8 43.3 10.7 26.1 24.4 3.9 30.8 87.9 21.1 2.7 39.1 10.5 46.7 43.0 38.4 35.5 55.7 34.6 19.1 26.1 22.3 22.5 24.5 42.4 2.3 36.8 31.1 47.2 22.6 34.4 13.7 30.0 28.1 28.0 54.2 12.7 32.3 63.4 18.2 18.1 68.5 27.3 52.2 30.5 52.1 ZFP90 "KIAA1954, NK10, ZNF756" ENSG00000184939 "ZFP90 zinc finger protein" Q8TF47 16 68530090-68576072 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029017 Uncertain Supported "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "HPA029017: AB_10669653" "unprognostic (3.27e-1)" "unprognostic (1.71e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (7.33e-2)" "unprognostic (1.35e-3)" "unprognostic (3.43e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.47e-2)" "unprognostic (2.37e-1)" "unprognostic (1.33e-1)" "unprognostic (9.60e-2)" 9.6 9.0 16.9 11.5 19.3 7.8 16.2 24.0 19.5 14.2 8.9 18.9 10.4 4.4 15.8 18.2 7.6 14.3 9.5 10.3 15.5 19.8 11.6 7.9 9.6 12.4 16.7 20.5 18.1 8.7 29.1 16.5 8.3 20.0 13.1 9.3 11.4 8.7 13.6 10.0 13.2 8.3 13.6 16.1 13.2 11.2 11.6 19.6 15.8 11.0 3.6 15.5 11.3 9.6 5.8 2.6 7.8 1.9 5.2 8.8 3.0 7.0 7.7 14.5 13.8 13.0 13.9 6.5 6.7 7.7 9.2 10.7 5.4 4.8 7.6 8.7 8.5 7.8 6.7 8.9 8.6 10.6 6.7 3.7 1.9 1.5 9.1 10.1 0.0 7.2 12.0 14.1 8.5 11.9 16.6 7.4 14.7 3.8 2.9 11.3 12.7 7.6 7.3 5.5 4.2 5.8 13.9 5.1 5.0 6.3 5.1 16.6 12.6 19.2 1.4 7.2 11.3 11.6 10.1 5.2 8.7 5.2 7.3 3.9 5.5 10.3 9.3 2.9 2.7 6.9 7.8 1.7 2.8 6.4 1.9 8.8 5.8 6.0 7.4 2.4 4.1 8.7 7.5 0.5 5.2 1.3 2.6 6.8 3.0 16.9 19.3 24.0 19.5 15.5 19.8 16.7 20.5 20.0 19.6 17.9 6.2 6.4 6.3 3.1 20.5 8.5 12.7 29.4 10.3 19.2 13.7 3.0 6.6 8.7 13.2 7.1 0.9 0.0 5.4 1.7 8.2 5.2 11.5 4.3 5.7 17.5 15.4 9.8 8.2 11.3 15.3 6.1 3.3 0.0 5.2 11.8 5.8 2.9 16.6 5.7 16.9 0.0 7.5 6.3 18.3 4.0 1.1 11.4 4.5 2.7 ZNF112 "ZFP112, ZNF228" ENSG00000062370 "Zinc finger protein 112" Q9UJU3 19 44326555-44367217 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 7.0;Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023856 Approved Approved Centrosome NA NA Centrosome "HPA023856: AB_1859018" "unprognostic (1.99e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "unprognostic (1.04e-1)" "unprognostic (4.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.34e-2)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (2.53e-2)" "unprognostic (1.65e-3)" "prognostic favorable (1.54e-5)" "unprognostic (1.65e-1)" "unprognostic (9.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.57e-3)" 5.7 6.5 9.0 1.7 11.4 0.3 8.0 20.5 10.8 6.3 5.7 6.7 3.2 4.8 7.2 7.4 5.0 7.6 4.4 6.1 9.1 5.5 5.5 3.0 4.6 1.5 12.9 5.8 8.6 5.2 9.1 16.4 4.6 8.1 7.8 5.5 5.2 5.2 7.8 3.8 5.2 4.8 5.4 12.7 3.5 5.8 13.1 13.1 1.0 7.8 4.2 2.8 5.2 6.0 1.6 1.8 0.0 1.7 0.4 0.2 0.3 4.1 2.6 7.3 4.3 4.4 3.9 1.7 3.9 6.6 3.7 5.6 1.7 3.0 0.0 2.9 3.3 3.4 3.7 4.3 2.7 6.0 0.0 5.3 4.8 4.2 1.7 3.6 0.0 0.0 4.1 4.8 2.9 6.0 6.4 4.4 0.0 1.7 11.6 4.3 1.0 0.0 0.0 4.0 1.0 1.5 0.0 7.9 2.1 3.5 4.5 3.5 5.7 5.2 1.0 2.7 6.5 2.1 0.0 5.9 5.9 4.4 16.9 3.2 0.0 0.0 0.1 3.5 0.0 4.6 0.0 0.4 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.8 1.6 0.0 0.2 0.0 0.4 1.7 0.5 0.0 0.3 9.0 11.4 20.5 10.8 9.1 5.5 12.9 5.8 8.1 13.1 0.0 0.3 0.0 1.0 0.3 7.0 3.9 0.0 2.7 1.2 0.0 0.0 1.0 1.7 1.2 2.6 0.3 1.1 0.0 1.1 0.6 1.0 0.6 0.0 0.0 0.4 7.9 1.2 2.5 0.0 0.8 0.6 0.0 0.0 0.0 1.7 4.3 0.6 0.0 1.4 1.1 2.2 0.0 0.3 2.6 1.7 0.4 0.2 0.0 1.2 0.3 ZNF12 "GIOT-3, KOX3, ZNF325" ENSG00000164631 "Zinc finger protein 12" P17014 7 6688433-6706923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063402 Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA063402: AB_2685005" "unprognostic (2.68e-1)" "unprognostic (6.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.84e-1)" "unprognostic (8.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-3)" "unprognostic (1.41e-1)" "unprognostic (6.67e-2)" "unprognostic (2.89e-3)" "unprognostic (5.52e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" "unprognostic (2.10e-2)" "unprognostic (4.36e-2)" "unprognostic (8.46e-3)" 16.7 12.1 12.1 15.6 11.7 8.8 17.0 25.4 13.5 18.9 17.7 9.2 16.0 12.2 17.4 17.9 15.1 15.1 11.9 12.6 10.1 9.7 15.6 13.8 12.2 15.1 10.3 12.8 19.6 13.2 25.2 20.0 20.3 10.3 23.9 13.2 8.6 14.7 16.1 9.5 13.8 18.6 12.5 16.1 18.6 12.9 7.5 13.9 21.1 21.9 7.9 16.0 21.9 29.3 2.1 1.9 9.4 0.9 1.9 3.5 0.4 12.0 5.7 11.4 14.3 11.7 12.0 11.0 7.6 13.8 9.8 10.3 7.8 7.0 9.2 5.3 9.4 22.1 14.5 9.4 7.4 15.0 3.5 7.1 9.2 8.6 7.7 11.0 14.6 10.0 13.1 16.6 7.0 11.4 14.6 7.1 7.4 14.6 8.5 12.9 9.5 5.6 13.5 13.8 3.8 8.8 7.4 16.4 5.6 8.0 12.0 10.5 18.6 8.8 16.1 9.2 15.0 10.2 16.7 7.0 11.1 14.0 8.8 10.0 8.1 5.2 9.4 9.0 9.9 14.6 9.4 0.9 1.1 2.5 0.7 3.5 2.0 2.1 2.8 0.9 2.1 2.7 3.4 0.9 1.9 0.8 1.9 1.7 0.4 12.1 11.7 25.4 13.5 10.1 9.7 10.3 12.8 10.3 13.9 8.9 9.9 13.7 14.1 23.9 26.7 16.2 12.7 9.4 10.3 3.5 15.7 9.8 1.7 7.7 0.4 15.5 6.8 23.3 5.7 7.5 14.2 10.8 11.5 9.0 8.4 35.0 7.5 16.0 11.5 0.8 20.8 7.2 5.0 5.4 11.1 19.5 7.5 7.0 21.2 5.7 19.8 25.8 14.4 12.3 6.0 19.6 7.2 6.4 11.5 14.9 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.7 5.0 6.0 12.5 2.8 3.3 9.3 2.7 2.4 4.0 5.0 8.7 3.4 8.8 7.7 2.1 2.2 7.7 12.2 7.1 5.7 4.2 19.8 27.5 12.3 7.7 3.5 13.6 13.8 4.5 6.3 4.0 10.5 3.6 2.9 9.7 9.8 15.0 2.9 6.5 10.1 31.3 14.8 3.1 8.7 6.5 8.2 6.1 3.9 33.0 10.7 5.4 5.3 5.2 3.1 12.5 4.3 4.4 4.2 12.8 7.2 4.4 6.9 16.0 8.7 10.4 3.5 8.0 4.4 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 6.0 8.0 14.1 29.6 20.0 6.5 9.7 7.6 10.7 17.0 8.7 11.8 10.7 6.6 9.0 1.1 7.1 3.3 23.3 4.7 9.4 7.3 18.2 14.0 9.6 4.6 6.4 13.1 9.2 8.9 0.4 5.8 9.2 8.5 1.8 9.2 2.5 9.4 3.5 7.8 4.2 7.0 6.5 6.6 5.4 11.3 27.7 8.8 13.8 12.3 32.8 ZNF274 "ZKSCAN19, ZSCAN51" ENSG00000171606 "Zinc finger protein 274" Q96GC6 19 58183029-58213562 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 39.1" "Low region specificity" "Detected in all" HPA028880 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA028880: AB_10601929" "unprognostic (2.38e-3)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (3.84e-1)" "prognostic favorable (6.16e-4)" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (6.57e-2)" "unprognostic (2.19e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.58e-3)" 9.9 7.6 5.9 8.8 7.0 8.8 15.4 16.6 6.7 7.5 9.9 11.7 14.0 6.3 10.0 12.2 11.7 9.8 14.7 12.0 5.9 4.8 7.3 14.0 12.0 12.8 12.5 5.5 16.8 8.9 20.3 10.9 7.6 9.5 10.4 5.8 14.5 8.6 11.0 11.2 11.4 10.6 10.6 8.7 10.7 8.3 19.3 7.9 6.1 15.3 8.6 10.9 11.2 12.8 16.3 6.7 23.0 8.0 14.0 18.1 8.8 9.0 6.4 10.7 4.4 6.8 10.1 10.4 7.5 4.1 8.2 7.4 3.7 6.7 3.1 4.9 4.6 8.8 2.6 5.0 10.5 11.4 6.4 39.1 14.6 6.3 6.0 11.1 10.4 24.2 8.0 13.5 10.1 19.5 8.5 6.5 5.0 10.9 14.1 6.1 5.9 5.6 9.3 10.2 5.3 6.3 12.7 2.7 13.4 6.2 3.8 7.0 3.1 10.0 4.4 8.4 8.5 10.6 19.7 6.2 4.5 6.7 5.1 8.4 6.4 6.8 10.3 2.0 11.5 9.3 13.7 4.7 23.0 9.3 5.1 14.3 13.8 12.2 13.2 6.7 16.3 18.1 13.0 17.3 14.0 8.0 3.1 15.3 8.8 5.9 7.0 16.6 6.7 5.9 4.8 12.5 5.5 9.5 7.9 14.9 18.7 18.2 36.1 9.3 30.1 14.3 12.7 10.7 10.3 17.4 41.2 9.0 1.7 10.9 14.5 11.3 11.9 0.0 4.9 9.9 6.6 25.3 28.8 6.8 6.8 19.1 6.3 4.3 10.2 8.1 11.2 13.4 6.8 10.0 8.8 20.1 9.3 17.5 11.3 9.0 60.4 19.4 11.8 17.9 12.8 10.7 14.0 25.3 7.6 21.2 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630181-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 16.5 15.7 10.5 9.2 13.3 22.8 16.5 23.0 18.8 21.1 14.3 14.2 12.6 8.1 21.2 9.0 12.0 18.2 9.9 11.4 10.3 7.0 11.0 14.0 11.4 9.8 11.3 14.9 27.2 16.9 14.4 28.0 12.2 16.9 18.1 12.4 8.5 18.8 11.7 22.0 9.8 11.2 24.8 16.3 11.1 14.6 8.4 14.5 46.3 13.6 8.4 10.0 23.6 19.6 6.1 5.9 10.0 4.1 3.0 4.3 1.8 8.6 4.9 9.1 13.9 9.2 12.9 6.7 13.4 9.5 5.6 6.4 3.4 9.0 14.6 5.6 9.4 5.3 6.4 4.5 3.5 6.7 7.4 2.7 1.5 8.1 5.3 9.2 13.1 4.4 8.4 4.9 3.8 5.4 13.7 12.2 15.2 7.6 17.0 8.5 6.1 8.7 1.5 0.0 10.2 4.0 2.8 15.0 10.4 6.5 10.1 7.3 13.4 11.2 6.9 4.3 0.5 7.6 12.2 10.7 8.2 12.4 7.5 10.7 8.9 13.4 0.0 9.2 19.5 8.8 10.0 4.1 5.4 3.6 3.7 3.6 6.1 3.4 3.1 5.9 5.5 3.5 4.3 0.6 3.0 3.2 5.9 3.0 1.8 10.5 13.3 23.0 18.8 10.3 7.0 11.3 14.9 16.9 14.5 8.9 17.6 17.1 16.1 9.8 79.9 32.7 15.3 9.4 13.6 3.5 78.5 18.6 6.6 10.3 12.9 31.2 14.9 0.0 12.2 17.5 22.1 18.3 17.3 26.7 30.7 65.2 31.0 31.9 32.7 32.5 30.8 15.5 15.1 10.0 22.7 21.1 10.9 3.5 19.8 11.5 78.5 6.5 18.4 45.7 26.2 12.2 11.1 18.8 19.7 11.6 ZNF296 ZNF342 ENSG00000170684 "Zinc finger protein 296" Q8WUU4 19 45071500-45076588 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.8;lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 36.9;Paneth cells: 28.6;Undifferentiated cells: 23.5" "Cancer enhanced" "Detected in all" "testis cancer: 19.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 16.6;SK-BR-3: 11.2;U-698: 19.4" "Low region specificity" "Detected in many" "HPA046940, HPA049576" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA046940: AB_2679871, HPA049576: AB_2680821" "unprognostic (1.32e-1)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.83e-3)" "unprognostic (1.67e-2)" "unprognostic (9.70e-2)" "unprognostic (9.55e-2)" "unprognostic (3.20e-3)" "unprognostic (1.12e-1)" "unprognostic (2.67e-5)" "unprognostic (7.14e-3)" "unprognostic (1.52e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-3)" 1.4 0.8 2.4 22.8 3.4 10.5 7.3 6.6 1.4 3.0 7.1 0.4 3.2 6.4 1.0 1.2 11.3 1.4 4.0 1.4 2.0 1.7 1.4 1.0 3.4 15.9 1.1 0.1 0.6 2.7 0.3 3.5 0.7 0.8 2.4 1.0 0.8 13.8 3.4 0.8 6.2 10.1 0.6 1.3 16.9 5.5 2.6 0.6 4.3 1.7 9.5 26.2 2.0 2.7 29.8 26.7 14.7 6.2 14.7 3.5 2.6 3.0 2.1 0.0 0.4 0.0 0.2 1.8 0.5 0.0 0.2 0.2 3.5 1.2 16.6 1.9 0.1 0.0 5.8 0.8 1.3 0.0 3.5 4.4 4.8 0.9 3.4 0.9 2.7 5.1 0.7 0.6 0.7 0.0 0.1 0.5 0.3 3.5 5.9 0.0 4.6 0.2 4.6 1.9 2.0 4.4 9.3 0.0 10.0 0.4 1.1 3.1 0.3 2.1 11.2 0.1 0.3 2.4 5.5 1.1 0.0 1.7 0.1 0.0 6.1 6.1 19.4 0.1 3.5 0.1 14.7 3.6 5.7 3.0 6.2 3.5 29.8 1.6 3.3 8.8 22.4 0.7 1.7 1.8 14.7 5.8 26.7 1.4 2.6 2.4 3.4 6.6 1.4 2.0 1.7 1.1 0.1 0.8 0.6 0.0 1.1 18.6 12.1 10.8 0.9 0.9 0.0 2.7 1.2 3.5 3.9 0.3 0.0 1.9 0.4 0.0 13.3 0.0 0.8 1.9 1.7 2.8 9.2 0.0 3.0 0.0 5.1 1.3 3.0 0.0 0.0 4.1 3.3 36.9 19.9 0.5 1.0 28.6 1.1 0.3 1.6 0.0 2.0 0.9 10.9 8.8 0.7 10.2 23.5 5.7 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA043161: AB_2678346, HPA046692: AB_2679755" "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favorable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favorable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 8.8 9.7 7.7 5.4 10.9 0.4 10.1 10.6 15.4 13.1 8.6 7.9 9.5 6.9 12.7 10.8 6.8 9.2 11.5 13.3 8.4 6.9 9.5 7.0 7.9 6.7 8.8 7.0 14.8 6.9 15.0 18.0 8.6 11.8 12.3 8.6 8.6 8.2 15.5 7.7 5.0 7.9 9.7 10.7 8.7 7.6 8.2 12.5 4.3 13.6 6.7 7.2 11.8 8.4 11.2 7.9 10.5 11.2 17.6 11.4 4.9 5.8 4.4 17.5 20.1 11.5 15.4 6.3 7.8 10.4 10.9 13.2 8.6 3.6 7.1 18.9 6.8 13.7 7.4 13.0 5.1 13.7 10.9 11.8 12.5 5.8 8.4 13.1 0.0 11.4 9.4 18.0 7.2 8.2 13.7 9.4 8.8 14.3 7.6 12.0 3.3 8.8 10.5 5.1 5.4 5.4 9.8 12.4 10.1 6.7 9.3 14.2 15.0 9.3 8.8 16.4 8.9 8.2 8.1 9.3 18.2 7.3 7.4 7.9 8.0 16.0 6.8 3.9 2.0 18.3 3.3 8.7 10.5 11.4 7.4 8.3 11.2 5.8 7.4 7.0 10.5 6.8 9.9 8.3 17.6 11.2 7.9 4.4 4.9 7.7 10.9 10.6 15.4 8.4 6.9 8.8 7.0 11.8 12.5 6.0 8.0 16.7 14.7 3.5 32.6 4.8 10.2 10.7 15.9 8.7 7.9 10.4 29.9 14.8 2.6 13.5 8.7 0.0 8.9 9.8 12.8 21.0 12.7 6.0 11.3 44.5 18.9 14.1 6.5 2.5 27.9 10.4 8.5 8.2 12.9 25.0 13.2 11.8 24.8 11.1 12.6 32.3 14.6 17.0 10.2 5.6 8.0 8.5 9.4 21.0 ZNF616 MGC45556 ENSG00000204611 "Zinc finger protein 616" Q08AN1 19 52113091-52139922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062639, HPA071539" Approved Approved Centrosome NA NA Centrosome "HPA062639: AB_2684815, HPA071539: AB_2686414" "unprognostic (5.98e-3)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (2.58e-2)" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (4.78e-3)" "unprognostic (1.97e-1)" "unprognostic (1.19e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (3.01e-2)" "unprognostic (1.32e-3)" 10.5 18.1 9.2 4.9 10.6 2.7 8.6 18.7 10.2 9.1 6.6 6.2 5.6 4.9 9.4 8.6 7.2 9.8 6.0 6.3 8.7 4.8 8.4 8.5 7.6 6.3 12.6 8.1 16.1 10.4 12.7 17.7 9.0 9.1 9.9 8.2 6.1 8.0 11.5 5.4 8.0 6.4 8.0 13.7 7.6 6.7 5.3 10.3 11.9 11.6 4.4 7.2 9.3 12.5 4.7 4.5 4.7 10.9 15.7 6.3 2.5 4.1 3.7 12.6 8.6 15.2 12.4 0.1 5.7 6.7 5.4 8.6 4.2 3.5 5.8 3.9 5.3 3.2 2.9 13.0 6.3 8.4 4.0 17.2 10.3 9.7 9.1 8.9 9.8 6.4 9.0 9.0 4.8 18.0 10.0 7.4 8.2 11.4 2.8 7.9 2.9 9.5 5.2 12.9 3.6 11.2 8.4 17.1 8.4 3.9 10.7 12.8 7.0 9.4 4.6 2.9 12.0 5.6 3.3 5.9 4.3 5.0 4.7 5.7 5.7 8.5 8.2 3.6 5.8 8.1 3.2 3.5 4.0 6.3 2.3 5.8 3.8 5.8 5.1 3.9 4.7 5.3 4.9 4.7 15.7 10.9 4.5 3.7 2.5 9.2 10.6 18.7 10.2 8.7 4.8 12.6 8.1 9.1 10.3 6.0 2.7 1.7 3.6 3.7 3.3 2.7 2.5 4.0 1.2 7.0 3.9 2.7 5.0 2.8 0.0 2.1 2.7 0.0 1.6 2.8 3.1 2.6 0.0 1.6 2.7 6.4 1.2 1.8 2.6 0.0 6.1 2.0 1.7 4.6 3.9 4.9 2.2 0.0 2.5 2.0 8.5 0.0 2.4 2.4 3.8 2.3 1.6 3.2 2.8 3.8 ZNF620 MGC50836 ENSG00000177842 "Zinc finger protein 620" Q6ZNG0 3 40505992-40518736 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;monocytes: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA031452, HPA059383" Uncertain Approved Centrosome NA NA Centrosome "HPA031452: AB_10603939, HPA059383: AB_2732636" "unprognostic (1.42e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-3)" "unprognostic (2.15e-2)" "unprognostic (7.73e-2)" "unprognostic (3.78e-2)" "unprognostic (1.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.21e-5)" "unprognostic (1.28e-1)" "unprognostic (4.78e-1)" "unprognostic (2.61e-2)" "unprognostic (9.19e-4)" 5.8 5.7 5.2 3.0 8.2 8.0 6.1 15.6 8.5 3.7 5.0 8.9 4.8 4.4 4.0 6.3 3.1 5.3 3.2 4.4 5.6 5.7 6.2 4.5 6.2 3.4 10.3 5.8 4.5 8.1 8.7 15.2 6.3 6.4 5.2 5.9 6.1 3.5 5.7 6.3 2.4 4.7 4.3 5.3 5.2 7.3 3.0 7.4 3.7 9.5 3.7 3.1 4.8 4.5 2.0 1.3 14.2 1.0 3.1 3.9 1.2 2.4 3.5 8.4 3.1 0.9 0.9 4.4 0.6 0.9 4.0 5.8 8.2 5.2 0.0 2.6 0.4 3.5 0.6 12.5 1.1 2.9 7.1 9.7 6.0 8.8 4.6 1.5 2.1 1.2 0.5 0.8 2.5 1.1 1.0 2.7 0.1 3.1 1.0 0.5 4.0 0.4 1.8 9.8 4.6 1.9 3.2 3.6 1.1 3.7 8.5 9.9 7.5 0.6 5.9 3.8 8.7 7.7 2.3 1.8 0.4 5.7 0.8 2.6 1.3 2.1 0.1 1.3 1.2 1.5 14.2 0.6 1.2 2.6 1.0 3.2 0.8 1.0 2.7 0.6 2.0 2.1 2.7 0.9 3.1 0.3 1.3 3.9 1.2 5.2 8.2 15.6 8.5 5.6 5.7 10.3 5.8 6.4 7.4 6.0 2.6 0.8 3.1 0.5 8.8 1.4 5.1 2.7 4.5 0.0 3.9 6.2 5.0 4.5 0.1 4.5 1.9 23.3 2.6 1.3 1.1 2.7 6.9 1.7 1.2 3.2 8.6 4.3 1.8 0.0 0.3 1.6 0.0 18.0 3.3 8.3 2.6 2.8 0.4 3.4 10.6 0.0 3.6 3.1 6.5 0.1 1.6 2.5 3.8 1.3 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.5" "Group enriched" "Detected in many" 11 "Early spermatids: 557.4;Late spermatids: 339.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 19.6;SuSa: 17.4" HPA023106 Approved Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.1 7.3 5.9 4.3 8.3 4.2 9.3 13.0 7.3 7.4 7.0 13.9 1.3 2.9 12.3 5.7 4.6 9.7 6.2 9.4 5.3 4.3 6.3 2.3 6.8 7.3 9.9 4.8 14.3 4.4 9.1 9.9 7.5 6.6 8.9 3.4 7.6 7.4 6.2 3.9 7.5 3.9 8.1 10.5 7.0 5.7 40.5 8.7 6.7 10.1 5.2 5.0 8.2 6.6 17.4 14.5 10.1 2.8 10.3 15.4 4.1 0.2 0.2 11.4 0.4 3.9 6.0 2.0 7.4 5.6 7.7 7.0 0.0 0.4 0.1 5.6 6.4 9.7 0.7 0.0 5.8 2.3 0.2 4.1 0.3 0.5 0.2 9.6 0.1 7.6 10.3 0.0 7.4 0.1 0.2 3.4 0.1 0.1 0.5 5.2 0.2 6.2 0.2 19.6 0.1 2.6 0.1 0.0 0.2 2.2 3.0 0.2 10.8 0.2 2.8 0.1 17.4 0.4 0.3 2.1 12.1 0.2 0.2 4.9 0.3 0.1 0.2 0.2 0.3 0.1 10.1 2.2 6.4 5.1 2.8 7.3 9.6 7.2 5.6 6.1 17.4 15.4 10.0 2.6 10.3 1.8 14.5 4.5 4.1 5.9 8.3 13.0 7.0 5.3 4.3 9.9 4.8 6.6 8.7 23.8 3.2 10.7 23.0 10.2 23.9 15.9 15.3 9.4 17.0 19.2 13.7 10.7 29.9 13.8 557.4 22.4 0.7 23.3 6.0 17.2 15.5 23.9 13.9 0.4 6.7 27.0 0.0 22.7 4.0 339.6 25.3 10.3 13.5 9.0 2.4 20.1 6.5 0.0 16.3 2.2 19.1 19.4 17.6 39.3 35.1 12.8 9.8 10.4 1.9 22.1 ZNF747 MGC2474 ENSG00000169955 "Zinc finger protein 747" Q9BV97 16 30530367-30535347 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003203, HPA069173" Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA003203: AB_1080753, HPA069173: AB_2686097" "unprognostic (3.82e-2)" "prognostic favorable (6.53e-4)" "unprognostic (3.73e-2)" "unprognostic (1.31e-2)" "unprognostic (4.01e-2)" "unprognostic (4.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.22e-3)" "unprognostic (2.45e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.46e-4)" "unprognostic (1.01e-2)" "unprognostic (2.60e-3)" "unprognostic (2.27e-1)" "unprognostic (4.66e-2)" "unprognostic (3.00e-1)" "unprognostic (1.01e-1)" 12.5 10.5 11.0 8.9 12.4 5.7 10.3 13.1 19.4 14.1 11.3 18.5 6.3 9.6 14.3 10.3 8.9 11.8 10.5 13.2 10.3 8.9 11.4 17.0 8.4 9.3 11.5 8.0 13.2 15.5 23.1 10.4 6.2 10.6 14.6 9.2 13.6 11.2 15.3 14.1 11.0 10.5 11.8 9.4 11.4 10.2 12.4 13.3 18.2 11.8 6.7 9.0 12.8 8.8 8.8 8.1 9.0 4.8 6.6 8.9 4.1 3.8 3.7 1.2 6.1 4.9 4.3 6.2 3.2 4.8 4.6 4.5 2.2 4.9 8.3 2.2 3.8 0.6 5.7 2.8 4.0 2.0 9.8 6.2 7.2 4.0 3.4 5.4 3.3 10.3 4.9 5.1 3.7 5.8 3.0 3.0 10.5 2.0 7.2 3.2 4.2 14.8 4.6 7.2 2.0 2.5 17.7 0.4 7.6 4.0 2.0 8.6 7.6 4.8 3.2 3.5 3.0 6.2 6.6 2.4 5.9 2.7 4.6 0.1 13.7 9.6 4.7 1.2 5.1 6.9 9.0 4.8 6.4 4.5 2.6 5.2 7.4 5.1 5.2 6.0 8.8 8.9 6.6 2.7 6.6 2.4 8.1 3.8 4.1 11.0 12.4 13.1 19.4 10.3 8.9 11.5 8.0 10.6 13.3 3.0 7.5 2.4 3.0 1.3 7.3 5.6 0.0 8.1 2.3 0.0 3.9 1.9 6.6 5.6 1.3 6.3 5.5 0.0 5.0 1.7 4.6 3.4 3.5 7.8 6.1 6.4 7.0 6.2 6.5 0.0 5.5 4.0 0.0 10.8 6.3 5.2 4.6 10.2 9.2 6.4 6.8 12.9 5.2 11.8 2.7 1.0 1.0 4.5 6.0 2.0 ZNF766 ENSG00000196214 "Zinc finger protein 766" Q5HY98 19 52269571-52296046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044882, HPA063496" Uncertain Supported Centrosome NA NA Centrosome "HPA044882: AB_10965173, HPA063496: AB_2685024" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (4.15e-1)" "unprognostic (1.20e-1)" "unprognostic (9.45e-2)" "unprognostic (9.28e-3)" "unprognostic (6.85e-3)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (6.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (2.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.75e-1)" "unprognostic (3.85e-3)" 11.9 9.9 9.0 10.5 13.7 16.5 14.9 12.3 13.7 13.1 10.8 8.9 13.1 7.3 12.3 9.8 12.4 11.9 7.7 9.6 8.5 7.3 10.2 7.0 10.2 13.7 13.0 7.3 18.4 10.9 12.6 23.5 11.9 12.8 14.4 10.1 9.9 11.6 12.1 11.3 13.8 10.1 13.7 14.9 14.2 9.7 26.4 13.7 17.5 17.1 7.2 12.9 18.1 11.0 18.8 8.7 22.5 12.1 18.1 27.6 11.5 7.0 11.5 8.3 9.8 8.6 12.4 6.3 7.0 6.7 4.5 8.9 3.0 5.7 11.7 6.5 7.1 6.8 7.1 7.9 6.7 8.0 9.0 10.8 12.1 6.7 3.3 5.1 13.4 8.2 9.7 9.9 5.1 12.2 8.8 6.9 15.5 7.9 6.7 7.8 4.7 17.6 5.8 9.7 10.2 12.8 12.2 14.8 10.2 5.8 20.5 10.5 8.8 10.5 8.3 5.9 13.7 9.7 8.0 8.3 4.2 6.0 3.7 7.2 11.4 32.7 17.6 4.0 6.9 8.1 22.5 8.6 16.6 16.1 12.1 22.2 18.8 17.5 18.2 8.7 16.2 27.6 21.6 9.2 18.1 12.0 6.1 17.9 11.5 9.0 13.7 12.3 13.7 8.5 7.3 13.0 7.3 12.8 13.7 20.8 8.3 9.3 14.2 4.8 13.8 17.3 12.7 9.4 10.3 14.0 3.9 11.1 13.3 14.9 61.1 9.8 3.5 0.0 9.1 8.8 7.4 17.8 9.3 5.4 5.7 14.3 8.7 9.8 7.1 39.4 10.6 6.8 3.3 16.2 9.7 10.3 10.0 10.7 9.9 7.7 10.4 0.0 8.0 12.6 36.6 6.8 10.0 11.7 7.9 12.2 ZNF780A ZNF780 ENSG00000197782 "Zinc finger protein 780A" O75290 19 40069152-40090938 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (1.92e-1)" "unprognostic (9.25e-2)" "unprognostic (7.38e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (1.46e-2)" "unprognostic (1.19e-2)" "unprognostic (2.17e-1)" "unprognostic (4.47e-3)" "unprognostic (1.13e-1)" "unprognostic (9.49e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.30e-4)" 6.9 9.2 11.1 8.6 8.5 4.1 7.7 12.8 10.8 8.7 6.6 5.8 13.9 5.7 8.2 10.8 10.4 7.8 7.8 6.7 7.1 6.1 7.9 11.8 7.0 11.3 10.5 8.9 8.6 11.0 15.8 14.1 7.0 6.8 7.9 6.0 6.8 10.0 11.4 4.5 8.0 9.1 6.0 10.4 12.0 8.2 7.9 9.7 7.8 11.2 5.3 11.3 8.8 7.9 3.9 4.6 8.4 7.7 3.3 5.9 2.5 4.9 9.4 6.2 5.7 5.6 5.2 4.4 5.8 4.7 4.7 7.2 6.1 3.4 4.4 3.8 2.8 4.7 4.2 3.9 3.3 5.3 7.5 5.3 6.9 7.8 5.8 5.0 7.2 5.8 5.3 3.7 4.8 4.0 6.4 4.9 5.0 7.8 7.5 4.0 2.9 2.9 2.4 4.9 4.8 2.9 2.3 10.9 2.6 3.9 10.2 3.8 7.3 8.6 3.3 3.8 5.7 4.1 8.7 3.6 5.8 7.7 5.3 4.6 7.4 6.5 4.4 3.7 5.0 3.9 2.7 5.4 8.4 3.9 4.9 5.1 3.7 4.2 3.5 4.6 3.9 5.9 5.1 4.7 3.3 7.7 3.6 4.5 2.5 11.1 8.5 12.8 10.8 7.1 6.1 10.5 8.9 6.8 9.7 8.9 12.2 4.4 3.5 3.4 5.7 3.7 7.6 8.1 9.1 8.7 2.0 5.0 8.3 11.9 17.3 7.7 7.4 0.0 42.0 6.3 5.5 3.0 16.1 33.6 13.1 4.8 3.4 11.6 25.0 1.1 4.0 17.9 11.8 8.2 7.2 3.5 24.5 8.6 4.9 13.3 6.6 6.5 6.2 5.8 2.5 2.3 4.9 11.5 6.6 2.7 ZNF780B ZNF779 ENSG00000128000 "Zinc finger protein 780B" Q9Y6R6 19 40028260-40056209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.1;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (3.28e-1)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (3.56e-3)" "unprognostic (5.54e-2)" "unprognostic (1.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.24e-2)" "unprognostic (4.59e-3)" "unprognostic (1.83e-3)" "unprognostic (1.33e-2)" "unprognostic (4.89e-3)" "unprognostic (4.71e-2)" "unprognostic (1.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-3)" 6.3 8.2 12.4 9.8 18.8 3.3 10.3 22.2 14.0 8.2 8.5 8.2 11.6 5.7 10.8 12.3 5.5 10.0 6.6 12.5 9.4 7.2 9.4 6.7 5.9 9.7 8.1 10.8 16.6 8.1 10.5 24.7 7.1 11.6 9.7 7.6 9.3 7.9 10.5 6.9 7.1 7.6 9.7 7.8 9.2 7.2 5.0 11.4 8.7 14.0 6.4 9.8 9.1 8.2 4.2 5.9 1.5 3.2 2.3 5.1 1.3 2.6 3.5 5.9 4.1 3.6 2.4 0.0 3.1 2.3 3.4 4.5 6.3 2.4 6.6 2.9 3.2 3.4 1.6 4.9 1.9 4.0 5.5 2.5 5.1 6.2 3.9 2.4 7.6 4.3 3.4 1.2 4.7 2.9 2.6 3.2 3.0 5.3 8.9 3.4 1.2 2.5 1.2 5.8 2.3 3.7 3.5 10.4 2.3 2.0 14.5 6.5 6.9 5.4 2.4 1.9 3.7 2.8 3.3 5.8 3.3 8.3 5.8 4.7 6.7 8.6 5.1 3.1 4.0 2.8 0.1 3.2 1.5 2.8 2.8 2.9 2.5 3.4 3.3 2.4 4.2 5.1 4.2 0.6 2.3 1.8 5.9 1.9 1.3 12.4 18.8 22.2 14.0 9.4 7.2 8.1 10.8 11.6 11.4 8.9 8.1 4.2 2.3 1.6 28.1 13.0 10.2 4.0 10.3 8.7 31.4 1.6 3.3 4.4 6.0 5.8 2.6 0.0 8.6 1.2 2.7 2.1 7.0 4.9 3.2 9.5 9.9 9.8 4.8 1.1 3.4 7.2 5.0 5.4 4.3 7.2 4.7 4.5 2.8 2.4 35.0 6.5 3.9 2.7 1.3 2.6 0.6 5.2 4.2 2.2 ZSCAN10 ZNF206 ENSG00000130182 "Zinc finger and SCAN domain containing 10" Q96SZ4 16 3088890-3099317 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 3.9" "Cell type enhanced" "Detected in single" 25 "Cytotrophoblasts: 1.5" "Cancer enriched" "Detected in single" 207 "testis cancer: 19.5" "Region enriched" "Detected in single" 7 "cerebellum: 2.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "NTERA-2: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076826 Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA076826: " "unprognostic (4.37e-2)" "unprognostic (5.13e-2)" "unprognostic (9.15e-2)" "unprognostic (6.65e-3)" "unprognostic (6.24e-2)" "unprognostic (7.60e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.72e-1)" "unprognostic (1.85e-11)" "unprognostic (5.98e-2)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" 0.2 0.2 0.3 0.2 0.2 1.3 0.2 2.7 1.4 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.5 0.2 1.3 0.9 0.3 0.2 0.2 0.1 0.2 0.2 0.2 1.1 2.8 0.3 0.2 0.2 0.6 1.2 3.9 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.8 0.7 2.4 0.8 0.6 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 36.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 2.4 0.8 0.8 0.4 0.6 1.1 0.8 0.2 1.0 0.4 0.8 0.5 0.6 1.3 0.6 0.7 0.7 0.1 0.2 0.3 0.2 2.7 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0